Acid	O
pH	O
activation	O
of	O
the	O
PmrA	O
/	O
PmrB	O
two	O
-	O
component	O
regulatory	O
system	O
of	O
Salmonella	B-Organism
enterica	I-Organism
<EOS>	B-X
Acid	B-X
pH	B-X
often	B-X
triggers	B-X
changes	B-X
in	B-X
gene	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
the	B-X
identity	B-X
of	B-X
the	B-X
gene	B-X
products	B-X
that	B-X
sense	B-X
fluctuations	B-X
in	B-X
extracytoplasmic	B-X
pH	B-X
.	B-X
The	B-X
Gram-negative	B-X
pathogen	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
experiences	B-X
a	B-X
number	B-X
of	B-X
acidic	B-X
environments	B-X
both	B-X
inside	B-X
and	B-X
outside	B-X
animal	B-X
hosts	B-X
.	B-X
Growth	B-X
in	B-X
mild	B-X
acid	B-X
(	B-X
pH	B-X
5.8	B-X
)	B-X
promotes	B-X
transcription	B-X
of	B-X
genes	B-X
activated	B-X
by	B-X
the	B-X
response	B-X
regulator	B-X
PmrA	B-X
,	B-X
but	B-X
the	B-X
signalling	B-X
pathway	B-X
(	B-X
s	B-X
)	B-X
that	B-X
mediates	B-X
this	B-X
response	B-X
has	B-X
thus	B-X
far	B-X
remained	B-X
unexplored	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
this	B-X
activation	B-X
requires	B-X
both	B-X
PmrA	B-X
's	B-X
cognate	B-X
sensor	B-X
kinase	B-X
PmrB	B-X
,	B-X
which	B-X
had	B-X
been	B-X
previously	B-X
shown	B-X
to	B-X
respond	B-X
to	B-X
Fe	B-X
(	B-X
3+	B-X
)	B-X
and	B-X
Al	B-X
(	B-X
3+	B-X
)	B-X
,	B-X
and	B-X
PmrA	B-X
's	B-X
post-translational	B-X
activator	B-X
PmrD	B-X
.	B-X
Substitution	B-X
of	B-X
a	B-X
conserved	B-X
histidine	B-X
or	B-X
of	B-X
either	B-X
one	B-X
of	B-X
four	B-X
conserved	B-X
glutamic	B-X
acid	B-X
residues	B-X
in	B-X
the	B-X
periplasmic	B-X
domain	B-X
of	B-X
PmrB	B-X
severely	B-X
decreased	B-X
or	B-X
abolished	B-X
the	B-X
mild	B-X
acid-promoted	B-X
transcription	B-X
of	B-X
PmrA-activated	B-X
genes	B-X
.	B-X
The	B-X
PmrA/PmrB	B-X
system	B-X
controls	B-X
lipopolysaccharide	B-X
modifications	B-X
mediating	B-X
resistance	B-X
to	B-X
the	B-X
antibiotic	B-X
polymyxin	B-X
B.	B-X
Wild-type	B-X
Salmonella	B-X
grown	B-X
at	B-X
pH	B-X
5.8	B-X
were	B-X
>	B-X
100	B-X
000-fold	B-X
more	B-X
resistant	B-X
to	B-X
polymyxin	B-X
B	B-X
than	B-X
organisms	B-X
grown	B-X
at	B-X
pH	B-X
7.7	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
protonation	B-X
of	B-X
the	B-X
PmrB	B-X
periplasmic	B-X
histidine	B-X
and/or	B-X
of	B-X
the	B-X
glutamic	B-X
acid	B-X
residues	B-X
activate	B-X
the	B-X
PmrA	B-X
protein	B-X
,	B-X
and	B-X
that	B-X
mild	B-X
acid	B-X
promotes	B-X
cellular	B-X
changes	B-X
resulting	B-X
in	B-X
polymyxin	B-X
B	B-X
resistance	B-X
.	B-X

Acid	O
pH	O
often	O
triggers	O
changes	O
in	O
gene	O
expression	O
.	O
<EOS>	B-X
In	B-X
breast	B-X
cancer	B-X
cells	B-X
,	B-X
knock-down	B-X
of	B-X
multiple	B-X
H1	B-X
variants	B-X
deregulates	B-X
many	B-X
genes	B-X
,	B-X
promotes	B-X
the	B-X
appearance	B-X
of	B-X
genome-wide	B-X
accessibility	B-X
sites	B-X
and	B-X
triggers	B-X
an	B-X
interferon	B-X
response	B-X
via	B-X
activation	B-X
of	B-X
heterochromatic	B-X
repeats	B-X
.	B-X
However	B-X
,	B-X
how	B-X
these	B-X
changes	B-X
in	B-X
the	B-X
expression	B-X
profile	B-X
relate	B-X
to	B-X
the	B-X
re-distribution	B-X
of	B-X
H1	B-X
variants	B-X
as	B-X
well	B-X
as	B-X
to	B-X
genome	B-X
conformational	B-X
changes	B-X
have	B-X
not	B-X
been	B-X
yet	B-X
studied	B-X
.	B-X
Despite	B-X
the	B-X
small	B-X
changes	B-X
in	B-X
H1	B-X
variants	B-X
distribution	B-X
,	B-X
knock-down	B-X
of	B-X
H1	B-X
translated	B-X
into	B-X
more	B-X
isolated	B-X
but	B-X
de-compacted	B-X
chromatin	B-X
structures	B-X
at	B-X
the	B-X
scale	B-X
of	B-X
topologically	B-X
associating	B-X
domains	B-X
(	B-X
TADs	B-X
)	B-X
.	B-X
Such	B-X
changes	B-X
in	B-X
TAD	B-X
structure	B-X
correlated	B-X
with	B-X
a	B-X
coordinated	B-X
gene	B-X
expression	B-X
response	B-X
of	B-X
their	B-X
resident	B-X
genes	B-X
.	B-X

However	O
,	O
little	O
is	O
known	O
about	O
the	O
identity	O
of	O
the	O
gene	O
products	O
that	O
sense	O
fluctuations	O
in	O
extracytoplasmic	O
pH	O
.	O
<EOS>	B-X
Acid	B-X
pH	B-X
often	B-X
triggers	B-X
changes	B-X
in	B-X
gene	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
the	B-X
identity	B-X
of	B-X
the	B-X
gene	B-X
products	B-X
that	B-X
sense	B-X
fluctuations	B-X
in	B-X
extracytoplasmic	B-X
pH	B-X
.	B-X
Growth	B-X
in	B-X
mild	B-X
acid	B-X
(	B-X
pH	B-X
5.8	B-X
)	B-X
promotes	B-X
transcription	B-X
of	B-X
genes	B-X
activated	B-X
by	B-X
the	B-X
response	B-X
regulator	B-X
PmrA	B-X
,	B-X
but	B-X
the	B-X
signalling	B-X
pathway	B-X
(	B-X
s	B-X
)	B-X
that	B-X
mediates	B-X
this	B-X
response	B-X
has	B-X
thus	B-X
far	B-X
remained	B-X
unexplored	B-X
.	B-X
Substitution	B-X
of	B-X
a	B-X
conserved	B-X
histidine	B-X
or	B-X
of	B-X
either	B-X
one	B-X
of	B-X
four	B-X
conserved	B-X
glutamic	B-X
acid	B-X
residues	B-X
in	B-X
the	B-X
periplasmic	B-X
domain	B-X
of	B-X
PmrB	B-X
severely	B-X
decreased	B-X
or	B-X
abolished	B-X
the	B-X
mild	B-X
acid-promoted	B-X
transcription	B-X
of	B-X
PmrA-activated	B-X
genes	B-X
.	B-X
The	B-X
PmrA/PmrB	B-X
system	B-X
controls	B-X
lipopolysaccharide	B-X
modifications	B-X
mediating	B-X
resistance	B-X
to	B-X
the	B-X
antibiotic	B-X
polymyxin	B-X
B.	B-X
Wild-type	B-X
Salmonella	B-X
grown	B-X
at	B-X
pH	B-X
5.8	B-X
were	B-X
>	B-X
100	B-X
000-fold	B-X
more	B-X
resistant	B-X
to	B-X
polymyxin	B-X
B	B-X
than	B-X
organisms	B-X
grown	B-X
at	B-X
pH	B-X
7.7	B-X
.	B-X

The	O
Gram	O
-	O
negative	O
pathogen	O
Salmonella	B-Organism
enterica	I-Organism
serovar	I-Organism
Typhimurium	I-Organism
experiences	O
a	O
number	O
of	O
acidic	O
environments	O
both	O
inside	O
and	O
outside	O
animal	O
hosts	O
.	O
<EOS>	B-X
The	B-X
Gram-negative	B-X
pathogen	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
experiences	B-X
a	B-X
number	B-X
of	B-X
acidic	B-X
environments	B-X
both	B-X
inside	B-X
and	B-X
outside	B-X
animal	B-X
hosts	B-X
.	B-X
The	B-X
PmrA/PmrB	B-X
system	B-X
controls	B-X
lipopolysaccharide	B-X
modifications	B-X
mediating	B-X
resistance	B-X
to	B-X
the	B-X
antibiotic	B-X
polymyxin	B-X
B.	B-X
Wild-type	B-X
Salmonella	B-X
grown	B-X
at	B-X
pH	B-X
5.8	B-X
were	B-X
>	B-X
100	B-X
000-fold	B-X
more	B-X
resistant	B-X
to	B-X
polymyxin	B-X
B	B-X
than	B-X
organisms	B-X
grown	B-X
at	B-X
pH	B-X
7.7	B-X
.	B-X

Growth	O
in	O
mild	O
acid	O
(	O
pH	O
5	O
.	O
8	O
)	O
promotes	O
transcription	O
of	O
genes	O
activated	O
by	O
the	O
response	O
regulator	O
PmrA	O
,	O
but	O
the	O
signalling	O
pathway	O
(	O
s	O
)	O
that	O
mediates	O
this	O
response	O
has	O
thus	O
far	O
remained	O
unexplored	O
.	O
<EOS>	B-X
Acid	B-X
pH	B-X
often	B-X
triggers	B-X
changes	B-X
in	B-X
gene	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
the	B-X
identity	B-X
of	B-X
the	B-X
gene	B-X
products	B-X
that	B-X
sense	B-X
fluctuations	B-X
in	B-X
extracytoplasmic	B-X
pH	B-X
.	B-X
The	B-X
Gram-negative	B-X
pathogen	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
experiences	B-X
a	B-X
number	B-X
of	B-X
acidic	B-X
environments	B-X
both	B-X
inside	B-X
and	B-X
outside	B-X
animal	B-X
hosts	B-X
.	B-X
Growth	B-X
in	B-X
mild	B-X
acid	B-X
(	B-X
pH	B-X
5.8	B-X
)	B-X
promotes	B-X
transcription	B-X
of	B-X
genes	B-X
activated	B-X
by	B-X
the	B-X
response	B-X
regulator	B-X
PmrA	B-X
,	B-X
but	B-X
the	B-X
signalling	B-X
pathway	B-X
(	B-X
s	B-X
)	B-X
that	B-X
mediates	B-X
this	B-X
response	B-X
has	B-X
thus	B-X
far	B-X
remained	B-X
unexplored	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
this	B-X
activation	B-X
requires	B-X
both	B-X
PmrA	B-X
's	B-X
cognate	B-X
sensor	B-X
kinase	B-X
PmrB	B-X
,	B-X
which	B-X
had	B-X
been	B-X
previously	B-X
shown	B-X
to	B-X
respond	B-X
to	B-X
Fe	B-X
(	B-X
3+	B-X
)	B-X
and	B-X
Al	B-X
(	B-X
3+	B-X
)	B-X
,	B-X
and	B-X
PmrA	B-X
's	B-X
post-translational	B-X
activator	B-X
PmrD	B-X
.	B-X
Substitution	B-X
of	B-X
a	B-X
conserved	B-X
histidine	B-X
or	B-X
of	B-X
either	B-X
one	B-X
of	B-X
four	B-X
conserved	B-X
glutamic	B-X
acid	B-X
residues	B-X
in	B-X
the	B-X
periplasmic	B-X
domain	B-X
of	B-X
PmrB	B-X
severely	B-X
decreased	B-X
or	B-X
abolished	B-X
the	B-X
mild	B-X
acid-promoted	B-X
transcription	B-X
of	B-X
PmrA-activated	B-X
genes	B-X
.	B-X
The	B-X
PmrA/PmrB	B-X
system	B-X
controls	B-X
lipopolysaccharide	B-X
modifications	B-X
mediating	B-X
resistance	B-X
to	B-X
the	B-X
antibiotic	B-X
polymyxin	B-X
B.	B-X
Wild-type	B-X
Salmonella	B-X
grown	B-X
at	B-X
pH	B-X
5.8	B-X
were	B-X
>	B-X
100	B-X
000-fold	B-X
more	B-X
resistant	B-X
to	B-X
polymyxin	B-X
B	B-X
than	B-X
organisms	B-X
grown	B-X
at	B-X
pH	B-X
7.7	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
protonation	B-X
of	B-X
the	B-X
PmrB	B-X
periplasmic	B-X
histidine	B-X
and/or	B-X
of	B-X
the	B-X
glutamic	B-X
acid	B-X
residues	B-X
activate	B-X
the	B-X
PmrA	B-X
protein	B-X
,	B-X
and	B-X
that	B-X
mild	B-X
acid	B-X
promotes	B-X
cellular	B-X
changes	B-X
resulting	B-X
in	B-X
polymyxin	B-X
B	B-X
resistance	B-X
.	B-X

Here	O
we	O
report	O
that	O
this	O
activation	O
requires	O
both	O
PmrA	O
'	O
s	O
cognate	O
sensor	O
kinase	O
PmrB	O
,	O
which	O
had	O
been	O
previously	O
shown	O
to	O
respond	O
to	O
Fe3	O
+	O
and	O
Al3	O
+	O
,	O
and	O
PmrA	O
'	O
s	O
post	O
-	O
translational	O
activator	O
PmrD	O
.	O
<EOS>	B-X
Growth	B-X
in	B-X
mild	B-X
acid	B-X
(	B-X
pH	B-X
5.8	B-X
)	B-X
promotes	B-X
transcription	B-X
of	B-X
genes	B-X
activated	B-X
by	B-X
the	B-X
response	B-X
regulator	B-X
PmrA	B-X
,	B-X
but	B-X
the	B-X
signalling	B-X
pathway	B-X
(	B-X
s	B-X
)	B-X
that	B-X
mediates	B-X
this	B-X
response	B-X
has	B-X
thus	B-X
far	B-X
remained	B-X
unexplored	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
this	B-X
activation	B-X
requires	B-X
both	B-X
PmrA	B-X
's	B-X
cognate	B-X
sensor	B-X
kinase	B-X
PmrB	B-X
,	B-X
which	B-X
had	B-X
been	B-X
previously	B-X
shown	B-X
to	B-X
respond	B-X
to	B-X
Fe	B-X
(	B-X
3+	B-X
)	B-X
and	B-X
Al	B-X
(	B-X
3+	B-X
)	B-X
,	B-X
and	B-X
PmrA	B-X
's	B-X
post-translational	B-X
activator	B-X
PmrD	B-X
.	B-X
Substitution	B-X
of	B-X
a	B-X
conserved	B-X
histidine	B-X
or	B-X
of	B-X
either	B-X
one	B-X
of	B-X
four	B-X
conserved	B-X
glutamic	B-X
acid	B-X
residues	B-X
in	B-X
the	B-X
periplasmic	B-X
domain	B-X
of	B-X
PmrB	B-X
severely	B-X
decreased	B-X
or	B-X
abolished	B-X
the	B-X
mild	B-X
acid-promoted	B-X
transcription	B-X
of	B-X
PmrA-activated	B-X
genes	B-X
.	B-X
The	B-X
PmrA/PmrB	B-X
system	B-X
controls	B-X
lipopolysaccharide	B-X
modifications	B-X
mediating	B-X
resistance	B-X
to	B-X
the	B-X
antibiotic	B-X
polymyxin	B-X
B.	B-X
Wild-type	B-X
Salmonella	B-X
grown	B-X
at	B-X
pH	B-X
5.8	B-X
were	B-X
>	B-X
100	B-X
000-fold	B-X
more	B-X
resistant	B-X
to	B-X
polymyxin	B-X
B	B-X
than	B-X
organisms	B-X
grown	B-X
at	B-X
pH	B-X
7.7	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
protonation	B-X
of	B-X
the	B-X
PmrB	B-X
periplasmic	B-X
histidine	B-X
and/or	B-X
of	B-X
the	B-X
glutamic	B-X
acid	B-X
residues	B-X
activate	B-X
the	B-X
PmrA	B-X
protein	B-X
,	B-X
and	B-X
that	B-X
mild	B-X
acid	B-X
promotes	B-X
cellular	B-X
changes	B-X
resulting	B-X
in	B-X
polymyxin	B-X
B	B-X
resistance	B-X
.	B-X

Substitution	O
of	O
a	O
conserved	O
histidine	O
or	O
of	O
either	O
one	O
of	O
four	O
conserved	O
glutamic	O
acid	O
residues	O
in	O
the	O
periplasmic	O
domain	O
of	O
PmrB	O
severely	O
decreased	O
or	O
abolished	O
the	O
mild	O
acid	O
-	O
promoted	O
transcription	O
of	O
PmrA	O
-	O
activated	O
genes	O
.	O
<EOS>	B-X
The	B-X
Gram-negative	B-X
pathogen	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
experiences	B-X
a	B-X
number	B-X
of	B-X
acidic	B-X
environments	B-X
both	B-X
inside	B-X
and	B-X
outside	B-X
animal	B-X
hosts	B-X
.	B-X
Growth	B-X
in	B-X
mild	B-X
acid	B-X
(	B-X
pH	B-X
5.8	B-X
)	B-X
promotes	B-X
transcription	B-X
of	B-X
genes	B-X
activated	B-X
by	B-X
the	B-X
response	B-X
regulator	B-X
PmrA	B-X
,	B-X
but	B-X
the	B-X
signalling	B-X
pathway	B-X
(	B-X
s	B-X
)	B-X
that	B-X
mediates	B-X
this	B-X
response	B-X
has	B-X
thus	B-X
far	B-X
remained	B-X
unexplored	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
this	B-X
activation	B-X
requires	B-X
both	B-X
PmrA	B-X
's	B-X
cognate	B-X
sensor	B-X
kinase	B-X
PmrB	B-X
,	B-X
which	B-X
had	B-X
been	B-X
previously	B-X
shown	B-X
to	B-X
respond	B-X
to	B-X
Fe	B-X
(	B-X
3+	B-X
)	B-X
and	B-X
Al	B-X
(	B-X
3+	B-X
)	B-X
,	B-X
and	B-X
PmrA	B-X
's	B-X
post-translational	B-X
activator	B-X
PmrD	B-X
.	B-X
Substitution	B-X
of	B-X
a	B-X
conserved	B-X
histidine	B-X
or	B-X
of	B-X
either	B-X
one	B-X
of	B-X
four	B-X
conserved	B-X
glutamic	B-X
acid	B-X
residues	B-X
in	B-X
the	B-X
periplasmic	B-X
domain	B-X
of	B-X
PmrB	B-X
severely	B-X
decreased	B-X
or	B-X
abolished	B-X
the	B-X
mild	B-X
acid-promoted	B-X
transcription	B-X
of	B-X
PmrA-activated	B-X
genes	B-X
.	B-X
The	B-X
PmrA/PmrB	B-X
system	B-X
controls	B-X
lipopolysaccharide	B-X
modifications	B-X
mediating	B-X
resistance	B-X
to	B-X
the	B-X
antibiotic	B-X
polymyxin	B-X
B.	B-X
Wild-type	B-X
Salmonella	B-X
grown	B-X
at	B-X
pH	B-X
5.8	B-X
were	B-X
>	B-X
100	B-X
000-fold	B-X
more	B-X
resistant	B-X
to	B-X
polymyxin	B-X
B	B-X
than	B-X
organisms	B-X
grown	B-X
at	B-X
pH	B-X
7.7	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
protonation	B-X
of	B-X
the	B-X
PmrB	B-X
periplasmic	B-X
histidine	B-X
and/or	B-X
of	B-X
the	B-X
glutamic	B-X
acid	B-X
residues	B-X
activate	B-X
the	B-X
PmrA	B-X
protein	B-X
,	B-X
and	B-X
that	B-X
mild	B-X
acid	B-X
promotes	B-X
cellular	B-X
changes	B-X
resulting	B-X
in	B-X
polymyxin	B-X
B	B-X
resistance	B-X
.	B-X

The	O
PmrA	O
/	O
PmrB	O
system	O
controls	O
lipopolysaccharide	O
modifications	O
mediating	O
resistance	O
to	O
the	O
antibiotic	O
polymyxin	O
B	O
.	O

Wild	O
-	O
type	O
Salmonella	B-Organism
grown	O
at	O
pH	O
5	O
.	O
8	O
were	O
>	O
100	O
000	O
-	O
fold	O
more	O
resistant	O
to	O
polymyxin	O
B	O
than	O
organisms	O
grown	O
at	O
pH	O
7	O
.	O
7	O
.	O
<EOS>	B-X
Acid	B-X
pH	B-X
often	B-X
triggers	B-X
changes	B-X
in	B-X
gene	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
the	B-X
identity	B-X
of	B-X
the	B-X
gene	B-X
products	B-X
that	B-X
sense	B-X
fluctuations	B-X
in	B-X
extracytoplasmic	B-X
pH	B-X
.	B-X
The	B-X
Gram-negative	B-X
pathogen	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
experiences	B-X
a	B-X
number	B-X
of	B-X
acidic	B-X
environments	B-X
both	B-X
inside	B-X
and	B-X
outside	B-X
animal	B-X
hosts	B-X
.	B-X
Growth	B-X
in	B-X
mild	B-X
acid	B-X
(	B-X
pH	B-X
5.8	B-X
)	B-X
promotes	B-X
transcription	B-X
of	B-X
genes	B-X
activated	B-X
by	B-X
the	B-X
response	B-X
regulator	B-X
PmrA	B-X
,	B-X
but	B-X
the	B-X
signalling	B-X
pathway	B-X
(	B-X
s	B-X
)	B-X
that	B-X
mediates	B-X
this	B-X
response	B-X
has	B-X
thus	B-X
far	B-X
remained	B-X
unexplored	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
this	B-X
activation	B-X
requires	B-X
both	B-X
PmrA	B-X
's	B-X
cognate	B-X
sensor	B-X
kinase	B-X
PmrB	B-X
,	B-X
which	B-X
had	B-X
been	B-X
previously	B-X
shown	B-X
to	B-X
respond	B-X
to	B-X
Fe	B-X
(	B-X
3+	B-X
)	B-X
and	B-X
Al	B-X
(	B-X
3+	B-X
)	B-X
,	B-X
and	B-X
PmrA	B-X
's	B-X
post-translational	B-X
activator	B-X
PmrD	B-X
.	B-X
Substitution	B-X
of	B-X
a	B-X
conserved	B-X
histidine	B-X
or	B-X
of	B-X
either	B-X
one	B-X
of	B-X
four	B-X
conserved	B-X
glutamic	B-X
acid	B-X
residues	B-X
in	B-X
the	B-X
periplasmic	B-X
domain	B-X
of	B-X
PmrB	B-X
severely	B-X
decreased	B-X
or	B-X
abolished	B-X
the	B-X
mild	B-X
acid-promoted	B-X
transcription	B-X
of	B-X
PmrA-activated	B-X
genes	B-X
.	B-X
The	B-X
PmrA/PmrB	B-X
system	B-X
controls	B-X
lipopolysaccharide	B-X
modifications	B-X
mediating	B-X
resistance	B-X
to	B-X
the	B-X
antibiotic	B-X
polymyxin	B-X
B.	B-X
Wild-type	B-X
Salmonella	B-X
grown	B-X
at	B-X
pH	B-X
5.8	B-X
were	B-X
>	B-X
100	B-X
000-fold	B-X
more	B-X
resistant	B-X
to	B-X
polymyxin	B-X
B	B-X
than	B-X
organisms	B-X
grown	B-X
at	B-X
pH	B-X
7.7	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
protonation	B-X
of	B-X
the	B-X
PmrB	B-X
periplasmic	B-X
histidine	B-X
and/or	B-X
of	B-X
the	B-X
glutamic	B-X
acid	B-X
residues	B-X
activate	B-X
the	B-X
PmrA	B-X
protein	B-X
,	B-X
and	B-X
that	B-X
mild	B-X
acid	B-X
promotes	B-X
cellular	B-X
changes	B-X
resulting	B-X
in	B-X
polymyxin	B-X
B	B-X
resistance	B-X
.	B-X

Our	O
results	O
suggest	O
that	O
protonation	O
of	O
the	O
PmrB	O
periplasmic	O
histidine	O
and	O
/	O
or	O
of	O
the	O
glutamic	O
acid	O
residues	O
activate	O
the	O
PmrA	O
protein	O
,	O
and	O
that	O
mild	O
acid	O
promotes	O
cellular	O
changes	O
resulting	O
in	O
polymyxin	O
B	O
resistance	O
.	O
<EOS>	B-X
Acid	B-X
pH	B-X
often	B-X
triggers	B-X
changes	B-X
in	B-X
gene	B-X
expression	B-X
.	B-X
The	B-X
Gram-negative	B-X
pathogen	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
experiences	B-X
a	B-X
number	B-X
of	B-X
acidic	B-X
environments	B-X
both	B-X
inside	B-X
and	B-X
outside	B-X
animal	B-X
hosts	B-X
.	B-X
Growth	B-X
in	B-X
mild	B-X
acid	B-X
(	B-X
pH	B-X
5.8	B-X
)	B-X
promotes	B-X
transcription	B-X
of	B-X
genes	B-X
activated	B-X
by	B-X
the	B-X
response	B-X
regulator	B-X
PmrA	B-X
,	B-X
but	B-X
the	B-X
signalling	B-X
pathway	B-X
(	B-X
s	B-X
)	B-X
that	B-X
mediates	B-X
this	B-X
response	B-X
has	B-X
thus	B-X
far	B-X
remained	B-X
unexplored	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
this	B-X
activation	B-X
requires	B-X
both	B-X
PmrA	B-X
's	B-X
cognate	B-X
sensor	B-X
kinase	B-X
PmrB	B-X
,	B-X
which	B-X
had	B-X
been	B-X
previously	B-X
shown	B-X
to	B-X
respond	B-X
to	B-X
Fe	B-X
(	B-X
3+	B-X
)	B-X
and	B-X
Al	B-X
(	B-X
3+	B-X
)	B-X
,	B-X
and	B-X
PmrA	B-X
's	B-X
post-translational	B-X
activator	B-X
PmrD	B-X
.	B-X
Substitution	B-X
of	B-X
a	B-X
conserved	B-X
histidine	B-X
or	B-X
of	B-X
either	B-X
one	B-X
of	B-X
four	B-X
conserved	B-X
glutamic	B-X
acid	B-X
residues	B-X
in	B-X
the	B-X
periplasmic	B-X
domain	B-X
of	B-X
PmrB	B-X
severely	B-X
decreased	B-X
or	B-X
abolished	B-X
the	B-X
mild	B-X
acid-promoted	B-X
transcription	B-X
of	B-X
PmrA-activated	B-X
genes	B-X
.	B-X
The	B-X
PmrA/PmrB	B-X
system	B-X
controls	B-X
lipopolysaccharide	B-X
modifications	B-X
mediating	B-X
resistance	B-X
to	B-X
the	B-X
antibiotic	B-X
polymyxin	B-X
B.	B-X
Wild-type	B-X
Salmonella	B-X
grown	B-X
at	B-X
pH	B-X
5.8	B-X
were	B-X
>	B-X
100	B-X
000-fold	B-X
more	B-X
resistant	B-X
to	B-X
polymyxin	B-X
B	B-X
than	B-X
organisms	B-X
grown	B-X
at	B-X
pH	B-X
7.7	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
protonation	B-X
of	B-X
the	B-X
PmrB	B-X
periplasmic	B-X
histidine	B-X
and/or	B-X
of	B-X
the	B-X
glutamic	B-X
acid	B-X
residues	B-X
activate	B-X
the	B-X
PmrA	B-X
protein	B-X
,	B-X
and	B-X
that	B-X
mild	B-X
acid	B-X
promotes	B-X
cellular	B-X
changes	B-X
resulting	B-X
in	B-X
polymyxin	B-X
B	B-X
resistance	B-X
.	B-X

Introduction	O

Free	O
-	O
living	O
organisms	O
often	O
encounter	O
wide	O
variations	O
in	O
the	O
pH	O
of	O
their	O
surroundings	O
.	O

Thus	O
,	O
pH	O
may	O
act	O
as	O
a	O
signal	O
that	O
triggers	O
cellular	O
responses	O
designed	O
to	O
cope	O
with	O
a	O
new	O
environment	O
.	O

The	O
Gram	O
-	O
negative	O
bacterium	O
Salmonella	B-Organism
enterica	I-Organism
serovar	I-Organism
Typhimurium	I-Organism
,	O
for	O
example	O
,	O
experiences	O
a	O
number	O
of	O
acidic	O
environments	O
both	O
inside	O
and	O
outside	O
animal	O
hosts	O
.	O

During	O
infection	O
of	O
a	O
mammalian	O
host	O
,	O
Salmonella	B-Organism
is	O
exposed	O
to	O
severe	O
acidity	O
in	O
the	O
stomach	O
(	O
Rychlik	O
and	O
Barrow	O
,	O
2005	O
)	O
and	O
mild	O
acidification	O
in	O
the	O
endocytic	O
vacuoles	O
of	O
intestinal	O
epithelia	O
and	O
macrophages	O
(	O
Brumell	O
and	O
Grinstein	O
,	O
2004	O
)	O
.	O

Moreover	O
,	O
Salmonella	B-Organism
has	O
been	O
recovered	O
from	O
soil	O
and	O
water	O
(	O
Winfield	O
and	O
Groisman	O
,	O
2003	O
)	O
where	O
the	O
pH	O
can	O
be	O
significantly	O
low	O
.	O

While	O
growth	O
in	O
acidic	O
conditions	O
has	O
been	O
shown	O
to	O
promote	O
changes	O
in	O
the	O
gene	O
expression	O
profiles	O
of	O
several	O
bacterial	O
species	O
(	O
Tucker	O
et	O
al	O
.	O
,	O
2002	O
;	O
McGowan	O
et	O
al	O
.	O
,	O
2003	O
;	O
Weinrick	O
et	O
al	O
.	O
,	O
2004	O
;	O
Leaphart	O
et	O
al	O
.	O
,	O
2006	O
)	O
,	O
less	O
is	O
known	O
about	O
the	O
identity	O
of	O
the	O
molecule	O
(	O
s	O
)	O
that	O
sense	O
extracytoplasmic	O
fluctuations	O
in	O
pH	O
and	O
the	O
mechanisms	O
by	O
which	O
such	O
sensors	O
promote	O
changes	O
in	O
gene	O
expression	O
.	O

Previous	O
studies	O
have	O
revealed	O
that	O
Salmonella	B-Organism
responds	O
to	O
acidic	O
challenges	O
through	O
an	O
adaptive	O
system	O
called	O
the	O
acid	O
tolerance	O
response	O
in	O
which	O
adaptation	O
to	O
mild	O
acid	O
conditions	O
enables	O
the	O
organism	O
to	O
survive	O
periods	O
of	O
severe	O
acid	O
stress	O
(	O
Foster	O
and	O
Hall	O
,	O
1990	O
;	O
Foster	O
,	O
1995	O
)	O
.	O

The	O
acid	O
tolerance	O
response	O
of	O
Salmonella	B-Organism
results	O
in	O
the	O
synthesis	O
of	O
over	O
50	O
acid	O
shock	O
proteins	O
(	O
Bearson	O
et	O
al	O
.	O
,	O
1998	O
)	O
that	O
are	O
likely	O
to	O
function	O
primarily	O
when	O
variations	O
in	O
internal	O
pH	O
occur	O
,	O
i	O
.	O
e	O
.	O
when	O
Salmonella	B-Organism
experiences	O
severe	O
acidic	O
conditions	O
(	O
pH	O
approximately3	O
)	O
(	O
Foster	O
,	O
2004	O
)	O
.	O

Growth	O
of	O
Salmonella	B-Organism
in	O
mild	O
acid	O
(	O
pH	O
5	O
.	O
8	O
)	O
also	O
promotes	O
transcription	O
of	O
genes	O
regulated	O
by	O
the	O
response	O
regulator	O
PmrA	O
(	O
Soncini	O
and	O
Groisman	O
,	O
1996	O
)	O
.	O

The	O
expression	O
of	O
these	O
genes	O
has	O
been	O
shown	O
to	O
be	O
dispensable	O
for	O
the	O
acid	O
tolerance	O
response	O
(	O
Bearson	O
et	O
al	O
.	O
,	O
1998	O
)	O
which	O
suggests	O
that	O
there	O
are	O
still	O
uncharacterized	O
cellular	O
function	O
(	O
s	O
)	O
that	O
Salmonella	B-Organism
needs	O
to	O
regulate	O
in	O
acidic	O
environments	O
.	O

The	O
PmrA	O
protein	O
and	O
its	O
cognate	O
sensor	O
kinase	O
PmrB	O
form	O
a	O
two	O
-	O
component	O
regulatory	O
system	O
that	O
is	O
required	O
for	O
virulence	O
in	O
mice	B-Organism
(	O
Gunn	O
et	O
al	O
.	O
,	O
2000	O
)	O
,	O
infection	O
of	O
chicken	B-Organism
macrophages	O
(	O
Zhao	O
et	O
al	O
.	O
,	O
2002	O
)	O
,	O
growth	O
in	O
soil	O
(	O
Chamnongpol	O
et	O
al	O
.	O
,	O
2002	O
)	O
,	O
resistance	O
to	O
the	O
cationic	O
peptide	O
antibiotic	O
polymyxin	O
B	O
(	O
Roland	O
et	O
al	O
.	O
,	O
1993	O
)	O
and	O
resistance	O
to	O
Fe3	O
+	O
-	O
(	O
Wosten	O
et	O
al	O
.	O
,	O
2000	O
)	O
and	O
Al3	O
+	O
-	O
mediated	O
killing	O
(	O
Nishino	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

The	O
PmrA	O
-	O
regulated	O
products	O
characterized	O
thus	O
far	O
mediate	O
modifications	O
to	O
the	O
various	O
components	O
of	O
the	O
lipopolysacharide	O
(	O
LPS	O
)	O
structure	O
including	O
the	O
lipid	O
A	O
(	O
Gunn	O
et	O
al	O
.	O
,	O
1998	O
;	O
Trent	O
et	O
al	O
.	O
,	O
2001	O
;	O
Zhou	O
et	O
al	O
.	O
,	O
2001	O
;	O
Breazeale	O
et	O
al	O
.	O
,	O
2003	O
;	O
Lee	O
et	O
al	O
.	O
,	O
2004	O
)	O
,	O
the	O
core	O
region	O
(	O
Nishino	O
et	O
al	O
.	O
,	O
2006	O
)	O
and	O
the	O
O	O
-	O
antigen	O
(	O
Delgado	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

While	O
other	O
PmrA	O
-	O
regulated	O
genes	O
have	O
been	O
identified	O
(	O
Marchal	O
et	O
al	O
.	O
,	O
2004	O
;	O
Tamayo	O
et	O
al	O
.	O
,	O
2005	O
)	O
,	O
their	O
biochemical	O
activities	O
and	O
the	O
role	O
(	O
s	O
)	O
that	O
they	O
play	O
in	O
Salmonella	B-Organism
'	O
s	O
life	O
remain	O
unknown	O
.	O

Besides	O
mild	O
acid	O
pH	O
,	O
two	O
other	O
stimuli	O
are	O
known	O
to	O
promote	O
expression	O
of	O
PmrA	O
-	O
activated	O
genes	O
:	O
(	O
i	O
)	O
submillimolar	O
levels	O
of	O
extracellular	O
Fe3	O
+	O
or	O
Al3	O
+	O
,	O
which	O
are	O
directly	O
sensed	O
by	O
the	O
PmrB	O
protein	O
(	O
Wosten	O
et	O
al	O
.	O
,	O
2000	O
)	O
,	O
and	O
(	O
ii	O
)	O
low	O
concentrations	O
of	O
extracellular	O
Mg2	O
+	O
(	O
Soncini	O
and	O
Groisman	O
,	O
1996	O
)	O
(	O
Fig	O
.	O
1	O
)	O
.	O

The	O
low	O
Mg2	O
+	O
activation	O
of	O
the	O
PmrA	O
protein	O
requires	O
PhoQ	O
,	O
a	O
protein	O
that	O
senses	O
extracellular	O
Mg2	O
+	O
levels	O
(	O
Vescovi	O
et	O
al	O
.	O
,	O
1996	O
)	O
,	O
PhoQ	O
'	O
s	O
cognate	O
regulator	O
PhoP	O
,	O
and	O
the	O
PhoP	O
-	O
activated	O
protein	O
PmrD	O
(	O
Kox	O
et	O
al	O
.	O
,	O
2000	O
;	O
Kato	O
and	O
Groisman	O
,	O
2004	O
)	O
.	O

PmrD	O
binds	O
to	O
the	O
phosphorylated	O
form	O
of	O
PmrA	O
protecting	O
it	O
from	O
dephosphorylation	O
by	O
PmrB	O
(	O
Kato	O
and	O
Groisman	O
,	O
2004	O
)	O
.	O

Here	O
we	O
show	O
that	O
PmrA	O
'	O
s	O
cognate	O
sensor	O
kinase	O
PmrB	O
is	O
required	O
for	O
responding	O
to	O
external	O
changes	O
in	O
pH	O
through	O
a	O
mechanism	O
that	O
requires	O
a	O
histidine	O
and	O
several	O
glutamic	O
acid	O
residues	O
located	O
in	O
its	O
periplasmic	O
domain	O
,	O
as	O
well	O
as	O
the	O
post	O
-	O
translational	O
activator	O
PmrD	O
protein	O
.	O

Results	O

Mild	O
acid	O
pH	O
induces	O
transcription	O
of	O
PmrA	O
-	O
regulated	O
genes	O
To	O
examine	O
the	O
mild	O
acid	O
pH	O
induction	O
of	O
PmrA	O
-	O
activated	O
genes	O
,	O
we	O
grew	O
Salmonella	B-Organism
cells	O
harbouring	O
chromosomal	O
lacZYA	O
transcriptional	O
fusions	O
to	O
the	O
PmrA	O
-	O
regulated	O
genes	O
pbgP	O
,	O
pmrC	O
and	O
ugd	O
(	O
Wosten	O
and	O
Groisman	O
,	O
1999	O
)	O
in	O
N	O
-	O
minimal	O
media	O
buffered	O
at	O
pH	O
5	O
.	O
8	O
or	O
7	O
.	O
7	O
.	O
<EOS>	B-X
Maturation	B-X
of	B-X
the	B-X
adrenal	B-X
medulla	B-X
--	B-X
IV	B-X
.	B-X
Effects	B-X
of	B-X
morphine	B-X
.	B-X

This	O
medium	O
lacked	O
Fe3	O
+	O
or	O
Al3	O
+	O
,	O
the	O
only	O
known	O
PmrB	O
ligands	O
(	O
Wosten	O
et	O
al	O
.	O
,	O
2000	O
)	O
,	O
and	O
contained	O
10	O
mM	O
MgCl2	O
,	O
which	O
represses	O
expression	O
of	O
PmrA	O
-	O
activated	O
genes	O
(	O
Soncini	O
and	O
Groisman	O
,	O
1996	O
;	O
Kox	O
et	O
al	O
.	O
,	O
2000	O
)	O
.	O
<EOS>	B-X
Roles	B-X
of	B-X
the	B-X
EnvZ/OmpR	B-X
Two-Component	B-X
System	B-X
and	B-X
Porins	B-X
in	B-X
Iron	B-X
Acquisition	B-X
in	B-X
The	B-X
aromatic	B-X
heterocyclic	B-X
compound	B-X
indole	B-X
is	B-X
widely	B-X
spread	B-X
in	B-X
nature	B-X
.	B-X
Due	B-X
to	B-X
its	B-X
floral	B-X
odor	B-X
indole	B-X
finds	B-X
application	B-X
in	B-X
dairy	B-X
,	B-X
flavor	B-X
,	B-X
and	B-X
fragrance	B-X
products	B-X
.	B-X
Indole	B-X
is	B-X
an	B-X
inter-	B-X
and	B-X
intracellular	B-X
signaling	B-X
molecule	B-X
influencing	B-X
cell	B-X
division	B-X
,	B-X
sporulation	B-X
,	B-X
or	B-X
virulence	B-X
in	B-X
some	B-X
bacteria	B-X
that	B-X
synthesize	B-X
it	B-X
from	B-X
tryptophan	B-X
by	B-X
tryptophanase	B-X
.	B-X

All	O
three	O
genes	O
were	O
expressed	O
when	O
cells	O
were	O
grown	O
in	O
media	O
buffered	O
at	O
pH	O
5	O
.	O
8	O
but	O
not	O
at	O
pH	O
7	O
.	O
7	O
(	O
Fig	O
.	O
2A	O
-	O
C	O
)	O
,	O
in	O
agreement	O
with	O
previous	O
results	O
(	O
Soncini	O
and	O
Groisman	O
,	O
1996	O
)	O
.	O

A	O
similar	O
induction	O
of	O
pbgP	O
transcription	O
was	O
found	O
when	O
MES	O
was	O
used	O
as	O
the	O
buffering	O
agent	O
in	O
the	O
media	O
at	O
pH	O
5	O
.	O
8	O
instead	O
of	O
Bis	O
-	O
Tris	O
(	O
data	O
not	O
shown	O
)	O
,	O
indicating	O
that	O
the	O
mild	O
acid	O
effect	O
on	O
gene	O
expression	O
was	O
not	O
due	O
to	O
a	O
particular	O
buffering	O
system	O
.	O

The	O
transcriptional	O
activation	O
of	O
PmrA	O
-	O
regulated	O
genes	O
taking	O
place	O
at	O
pH	O
5	O
.	O
8	O
could	O
be	O
due	O
to	O
trace	O
amounts	O
of	O
metals	O
such	O
as	O
Fe3	O
+	O
,	O
which	O
is	O
more	O
soluble	O
at	O
acidic	O
pH	O
.	O

To	O
rule	O
out	O
this	O
possibility	O
,	O
we	O
treated	O
the	O
culture	O
medium	O
with	O
Chelex	O
100	O
resin	O
,	O
an	O
agent	O
known	O
to	O
chelate	O
polyvalent	O
metal	O
ions	O
that	O
does	O
not	O
affect	O
Salmonella	B-Organism
growth	O
.	O

We	O
determined	O
that	O
Chelex	O
100	O
was	O
effective	O
at	O
chelating	O
iron	O
because	O
expression	O
of	O
the	O
pmrA	O
-	O
independent	O
iron	O
-	O
repressed	O
iroA	O
gene	O
(	O
Hall	O
and	O
Foster	O
,	O
1996	O
)	O
was	O
induced	O
to	O
higher	O
levels	O
in	O
cultures	O
treated	O
with	O
Chelex	O
100	O
(	O
Fig	O
.	O
2D	O
)	O
.	O

Expression	O
of	O
pbgP	O
was	O
still	O
induced	O
when	O
Salmonella	B-Organism
was	O
grown	O
in	O
the	O
Chelex	O
-	O
treated	O
medium	O
(	O
Fig	O
.	O
2D	O
)	O
or	O
in	O
media	O
containing	O
the	O
specific	O
Fe3	O
+	O
chelator	O
deferoxamine	O
mesylate	O
(	O
data	O
not	O
shown	O
)	O
supporting	O
the	O
notion	O
that	O
mild	O
acid	O
pH	O
is	O
responsible	O
for	O
the	O
observed	O
induction	O
.	O

We	O
determined	O
that	O
the	O
regulatory	O
protein	O
PmrA	O
is	O
required	O
for	O
the	O
transcriptional	O
activation	O
in	O
response	O
to	O
mild	O
acid	O
pH	O
because	O
there	O
was	O
no	O
induction	O
of	O
the	O
three	O
investigated	O
genes	O
in	O
a	O
pmrA	O
mutant	O
(	O
Fig	O
.	O
2A	O
-	O
C	O
)	O
.	O

Moreover	O
,	O
a	O
mutant	O
expressing	O
a	O
derivative	O
of	O
the	O
PmrA	O
protein	O
that	O
cannot	O
be	O
phosphorylated	O
due	O
to	O
substitution	O
of	O
the	O
putative	O
phosphorylation	O
residue	O
aspartate	O
51	O
by	O
alanine	O
(	O
Kato	O
and	O
Groisman	O
,	O
2004	O
)	O
completely	O
failed	O
to	O
promote	O
transcription	O
of	O
PmrA	O
-	O
activated	O
genes	O
in	O
response	O
to	O
pH	O
5	O
.	O
8	O
,	O
in	O
a	O
similar	O
fashion	O
to	O
the	O
pmrA	O
strain	O
(	O
A	O
.	O
Kato	O
and	O
E	O
.	O
A	O
.	O
Groisman	O
,	O
unpubl	O
.	O
results	O
)	O
.	O

From	O
these	O
results	O
we	O
conclude	O
that	O
Salmonella	B-Organism
harbours	O
a	O
signalling	O
pathway	O
that	O
responds	O
to	O
mild	O
acid	O
pH	O
by	O
activating	O
the	O
PmrA	O
protein	O
through	O
phosphorylation	O
.	O

The	O
PmrB	O
protein	O
is	O
necessary	O
for	O
the	O
mild	O
acid	O
activation	O
of	O
PmrA	O

The	O
PmrB	O
protein	O
is	O
necessary	O
for	O
activation	O
of	O
the	O
PmrA	O
protein	O
in	O
low	O
Mg2	O
+	O
(	O
Kox	O
et	O
al	O
.	O
,	O
2000	O
;	O
Kato	O
and	O
Groisman	O
,	O
2004	O
)	O
and	O
in	O
the	O
presence	O
of	O
Fe3	O
+	O
(	O
Wosten	O
et	O
al	O
.	O
,	O
2000	O
)	O
,	O
consistent	O
with	O
the	O
notion	O
that	O
PmrB	O
is	O
the	O
major	O
phosphodonor	O
for	O
PmrA	O
.	O

We	O
investigated	O
whether	O
PmrB	O
was	O
also	O
required	O
for	O
the	O
pH	O
-	O
dependent	O
induction	O
of	O
pbgP	O
,	O
which	O
was	O
chosen	O
as	O
a	O
prototypical	O
PmrA	O
-	O
activated	O
gene	O
because	O
the	O
PmrA	O
protein	O
binds	O
to	O
the	O
pbgP	O
promoter	O
in	O
vitro	O
(	O
Wosten	O
and	O
Groisman	O
,	O
1999	O
)	O
and	O
in	O
vivo	O
(	O
Shin	O
and	O
Groisman	O
,	O
2005	O
)	O
.	O

Thus	O
,	O
we	O
determined	O
the	O
beta	O
-	O
galactosidase	O
activity	O
of	O
isogenic	O
pmrB	O
strains	O
harbouring	O
a	O
chromosomal	O
pbgP	O
-	O
lac	O
transcriptional	O
fusion	O
:	O
expression	O
was	O
approximately	O
sixfold	O
lower	O
in	O
a	O
pmrB	O
mutant	O
than	O
in	O
the	O
pmrB	O
+	O
strain	O
following	O
growth	O
at	O
pH	O
5	O
.	O
8	O
(	O
Fig	O
.	O
3	O
)	O
,	O
indicating	O
that	O
a	O
functional	O
pmrB	O
gene	O
is	O
necessary	O
for	O
a	O
normal	O
response	O
to	O
mild	O
acid	O
pH	O
.	O

There	O
was	O
residual	O
pbgP	O
expression	O
in	O
the	O
pmrB	O
mutant	O
induced	O
with	O
mild	O
acid	O
pH	O
(	O
Fig	O
.	O
3	O
)	O
,	O
which	O
was	O
in	O
contrast	O
to	O
the	O
absence	O
of	O
pbgP	O
transcription	O
in	O
the	O
pmrA	O
mutant	O
(	O
Fig	O
.	O
2	O
)	O
.	O

This	O
suggested	O
that	O
PmrA	O
could	O
become	O
phosphorylated	O
from	O
another	O
phosphodonor	O
(	O
s	O
)	O
when	O
PmrB	O
is	O
not	O
present	O
.	O

We	O
considered	O
the	O
possibility	O
of	O
PmrA	O
being	O
phosphorylated	O
from	O
acetyl	O
phosphate	O
because	O
acetyl	O
phosphate	O
has	O
been	O
shown	O
to	O
serve	O
as	O
phosphoryl	O
donor	O
to	O
several	O
response	O
regulators	O
when	O
their	O
cognate	O
sensors	O
are	O
absent	O
(	O
see	O
Wolfe	O
,	O
2005	O
for	O
a	O
review	O
)	O
.	O

Consistent	O
with	O
this	O
notion	O
,	O
pbgP	O
transcription	O
was	O
abrogated	O
in	O
the	O
pmrB	O
mutant	O
upon	O
deletion	O
of	O
the	O
pta	O
and	O
ackA	O
genes	O
(	O
Fig	O
.	O
3	O
)	O
,	O
which	O
encode	O
the	O
two	O
enzymes	O
that	O
are	O
required	O
for	O
the	O
production	O
of	O
acetyl	O
phosphate	O
(	O
Wolfe	O
,	O
2005	O
)	O
(	O
Fig	O
.	O
1	O
)	O
.	O

In	O
contrast	O
,	O
a	O
strain	O
lacking	O
the	O
ability	O
to	O
synthesize	O
acetyl	O
phosphate	O
but	O
with	O
a	O
functional	O
pmrB	O
gene	O
exhibited	O
wild	O
-	O
type	O
pbgP	O
expression	O
levels	O
(	O
Fig	O
.	O
3	O
)	O
,	O
implying	O
that	O
under	O
normal	O
conditions	O
(	O
i	O
.	O
e	O
.	O
when	O
a	O
functional	O
pmrB	O
gene	O
is	O
present	O
)	O
acetyl	O
phosphate	O
does	O
not	O
contribute	O
to	O
PmrA	O
phosphorylation	O
.	O

The	O
PmrD	O
protein	O
is	O
necessary	O
for	O
normal	O
PmrA	O
activation	O
at	O
pH	O
5	O
.	O
8	O

The	O
PhoP	O
-	O
activated	O
PmrD	O
protein	O
favours	O
the	O
phosphorylated	O
state	O
of	O
the	O
PmrA	O
protein	O
(	O
Fig	O
.	O
1	O
)	O
(	O
Kato	O
and	O
Groisman	O
,	O
2004	O
)	O
.	O

Thus	O
,	O
we	O
tested	O
the	O
possibility	O
of	O
PmrD	O
participating	O
in	O
the	O
PmrA	O
-	O
dependent	O
response	O
to	O
acidic	O
conditions	O
,	O
and	O
thus	O
contributing	O
to	O
the	O
pbgP	O
transcription	O
remaining	O
in	O
a	O
pmrB	O
mutant	O
.	O

Expression	O
of	O
the	O
pbgP	O
gene	O
was	O
abolished	O
in	O
a	O
pmrB	O
pmrD	O
double	O
mutant	O
(	O
Fig	O
.	O
3	O
)	O
indicating	O
that	O
both	O
genes	O
are	O
necessary	O
to	O
activate	O
PmrA	O
under	O
acidic	O
conditions	O
.	O

In	O
contrast	O
to	O
the	O
phenotype	O
of	O
the	O
pta	O
ackA	O
double	O
mutant	O
,	O
pbgP	O
transcription	O
was	O
reduced	O
in	O
the	O
pmrD	O
mutant	O
(	O
Fig	O
.	O
3	O
)	O
.	O

These	O
results	O
imply	O
that	O
the	O
pmrD	O
gene	O
was	O
being	O
expressed	O
even	O
though	O
the	O
media	O
contained	O
10	O
mM	O
MgCl2	O
,	O
a	O
concentration	O
known	O
to	O
repress	O
transcription	O
of	O
PhoP	O
-	O
activated	O
genes	O
(	O
Soncini	O
et	O
al	O
.	O
,	O
1996	O
)	O
.	O

We	O
examined	O
transcription	O
of	O
the	O
pmrD	O
gene	O
using	O
RNA	O
isolated	O
from	O
organisms	O
grown	O
at	O
pH	O
5	O
.	O
8	O
or	O
7	O
.	O
7	O
.	O
<EOS>	B-X
Maturation	B-X
of	B-X
the	B-X
adrenal	B-X
medulla	B-X
--	B-X
IV	B-X
.	B-X
Effects	B-X
of	B-X
morphine	B-X
.	B-X

Growth	O
at	O
pH	O
5	O
.	O
8	O
resulted	O
in	O
pmrD	O
transcript	O
levels	O
that	O
were	O
approximately3	O
.	O
5	O
-	O
fold	O
higher	O
than	O
in	O
organisms	O
grown	O
at	O
pH	O
7	O
.	O
7	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

This	O
acid	O
pH	O
-	O
promoted	O
increase	O
appears	O
to	O
be	O
specific	O
to	O
a	O
subset	O
of	O
PhoP	O
-	O
activated	O
genes	O
(	O
our	O
unpublished	O
results	O
)	O
that	O
includes	O
pmrD	O
because	O
expression	O
of	O
the	O
PhoP	O
-	O
regulated	O
slyA	O
gene	O
and	O
the	O
PhoP	O
-	O
independent	O
corA	O
gene	O
was	O
not	O
affected	O
by	O
the	O
pH	O
of	O
the	O
medium	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

In	O
agreement	O
with	O
the	O
gene	O
transcription	O
data	O
,	O
Western	O
blot	O
analysis	O
of	O
crude	O
extracts	O
using	O
anti	O
-	O
PmrD	O
antibodies	O
showed	O
that	O
the	O
PmrD	O
protein	O
was	O
produced	O
in	O
cells	O
grown	O
in	O
N	O
-	O
minimal	O
medium	O
pH	O
5	O
.	O
8	O
and	O
10	O
mM	O
MgCl2	O
but	O
not	O
in	O
cells	O
grown	O
in	O
the	O
same	O
medium	O
buffered	O
at	O
pH	O
7	O
.	O
7	O
(	O
Fig	O
.	O
4B	O
)	O
.	O

The	O
acid	O
-	O
promoted	O
expression	O
of	O
the	O
PmrD	O
protein	O
was	O
phoPQ	O
-	O
dependent	O
,	O
which	O
is	O
in	O
agreement	O
with	O
the	O
fact	O
that	O
PhoP	O
is	O
the	O
only	O
known	O
direct	O
transcriptional	O
activator	O
of	O
pmrD	O
(	O
Kox	O
et	O
al	O
.	O
,	O
2000	O
)	O
.	O

Conserved	O
histidine	O
and	O
glutamic	O
acid	O
residues	O
in	O
the	O
periplasmic	O
domain	O
of	O
PmrB	O
are	O
required	O
for	O
signalling	O
in	O
response	O
to	O
mild	O
acid	O
pH	O
<EOS>	B-X
Acid	B-X
pH	B-X
often	B-X
triggers	B-X
changes	B-X
in	B-X
gene	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
the	B-X
identity	B-X
of	B-X
the	B-X
gene	B-X
products	B-X
that	B-X
sense	B-X
fluctuations	B-X
in	B-X
extracytoplasmic	B-X
pH	B-X
.	B-X
The	B-X
Gram-negative	B-X
pathogen	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
experiences	B-X
a	B-X
number	B-X
of	B-X
acidic	B-X
environments	B-X
both	B-X
inside	B-X
and	B-X
outside	B-X
animal	B-X
hosts	B-X
.	B-X
Growth	B-X
in	B-X
mild	B-X
acid	B-X
(	B-X
pH	B-X
5.8	B-X
)	B-X
promotes	B-X
transcription	B-X
of	B-X
genes	B-X
activated	B-X
by	B-X
the	B-X
response	B-X
regulator	B-X
PmrA	B-X
,	B-X
but	B-X
the	B-X
signalling	B-X
pathway	B-X
(	B-X
s	B-X
)	B-X
that	B-X
mediates	B-X
this	B-X
response	B-X
has	B-X
thus	B-X
far	B-X
remained	B-X
unexplored	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
this	B-X
activation	B-X
requires	B-X
both	B-X
PmrA	B-X
's	B-X
cognate	B-X
sensor	B-X
kinase	B-X
PmrB	B-X
,	B-X
which	B-X
had	B-X
been	B-X
previously	B-X
shown	B-X
to	B-X
respond	B-X
to	B-X
Fe	B-X
(	B-X
3+	B-X
)	B-X
and	B-X
Al	B-X
(	B-X
3+	B-X
)	B-X
,	B-X
and	B-X
PmrA	B-X
's	B-X
post-translational	B-X
activator	B-X
PmrD	B-X
.	B-X
Substitution	B-X
of	B-X
a	B-X
conserved	B-X
histidine	B-X
or	B-X
of	B-X
either	B-X
one	B-X
of	B-X
four	B-X
conserved	B-X
glutamic	B-X
acid	B-X
residues	B-X
in	B-X
the	B-X
periplasmic	B-X
domain	B-X
of	B-X
PmrB	B-X
severely	B-X
decreased	B-X
or	B-X
abolished	B-X
the	B-X
mild	B-X
acid-promoted	B-X
transcription	B-X
of	B-X
PmrA-activated	B-X
genes	B-X
.	B-X
The	B-X
PmrA/PmrB	B-X
system	B-X
controls	B-X
lipopolysaccharide	B-X
modifications	B-X
mediating	B-X
resistance	B-X
to	B-X
the	B-X
antibiotic	B-X
polymyxin	B-X
B.	B-X
Wild-type	B-X
Salmonella	B-X
grown	B-X
at	B-X
pH	B-X
5.8	B-X
were	B-X
>	B-X
100	B-X
000-fold	B-X
more	B-X
resistant	B-X
to	B-X
polymyxin	B-X
B	B-X
than	B-X
organisms	B-X
grown	B-X
at	B-X
pH	B-X
7.7	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
protonation	B-X
of	B-X
the	B-X
PmrB	B-X
periplasmic	B-X
histidine	B-X
and/or	B-X
of	B-X
the	B-X
glutamic	B-X
acid	B-X
residues	B-X
activate	B-X
the	B-X
PmrA	B-X
protein	B-X
,	B-X
and	B-X
that	B-X
mild	B-X
acid	B-X
promotes	B-X
cellular	B-X
changes	B-X
resulting	B-X
in	B-X
polymyxin	B-X
B	B-X
resistance	B-X
.	B-X

The	O
results	O
described	O
above	O
established	O
that	O
PmrB	O
is	O
required	O
for	O
activation	O
of	O
PmrA	O
in	O
response	O
to	O
mild	O
acid	O
pH	O
.	O

This	O
could	O
be	O
because	O
PmrB	O
is	O
directly	O
involved	O
in	O
sensing	O
extracytoplasmic	O
pH	O
in	O
a	O
way	O
analogous	O
to	O
its	O
sensing	O
of	O
Fe3	O
+	O
and	O
Al3	O
+	O
(	O
Wosten	O
et	O
al	O
.	O
,	O
2000	O
)	O
,	O
or	O
because	O
PmrB	O
plays	O
an	O
indirect	O
role	O
in	O
its	O
capacity	O
of	O
main	O
(	O
if	O
not	O
sole	O
)	O
phosphodonor	O
for	O
PmrA	O
.	O

In	O
fact	O
,	O
PmrB	O
is	O
required	O
for	O
the	O
activation	O
of	O
PmrA	O
-	O
regulated	O
genes	O
in	O
response	O
to	O
the	O
low	O
Mg2	O
+	O
signal	O
,	O
which	O
is	O
sensed	O
by	O
the	O
PhoQ	O
protein	O
(	O
Kato	O
and	O
Groisman	O
,	O
2004	O
)	O
(	O
Fig	O
.	O
1	O
)	O
.	O

Thus	O
,	O
we	O
reasoned	O
that	O
if	O
PmrB	O
senses	O
extracytoplasmic	O
pH	O
directly	O
,	O
its	O
periplasmic	O
domain	O
(	O
Fig	O
.	O
5A	O
)	O
was	O
likely	O
to	O
be	O
required	O
for	O
the	O
response	O
to	O
this	O
signal	O
.	O

To	O
examine	O
this	O
hypothesis	O
,	O
we	O
tested	O
a	O
Salmonella	B-Organism
strain	O
with	O
a	O
chromosomal	O
pbgP	O
-	O
lac	O
fusion	O
,	O
deleted	O
for	O
the	O
chromosomal	O
copy	O
of	O
the	O
pmrB	O
gene	O
and	O
harbouring	O
a	O
plasmid	O
expressing	O
a	O
PmrB	O
protein	O
lacking	O
its	O
periplasmic	O
domain	O
for	O
its	O
ability	O
to	O
promote	O
pbgP	O
expression	O
in	O
response	O
to	O
different	O
signals	O
.	O

There	O
was	O
no	O
pbgP	O
expression	O
in	O
cells	O
grown	O
at	O
pH	O
5	O
.	O
8	O
(	O
Fig	O
.	O
5B	O
)	O
or	O
in	O
the	O
presence	O
of	O
Fe3	O
+	O
(	O
Fig	O
.	O
5D	O
)	O
,	O
which	O
is	O
in	O
contrast	O
to	O
the	O
normal	O
activation	O
in	O
response	O
to	O
low	O
Mg2	O
+	O
(	O
Fig	O
.	O
5C	O
)	O
.	O

Together	O
,	O
these	O
results	O
argue	O
in	O
favour	O
of	O
the	O
notion	O
that	O
PmrB	O
senses	O
extracellular	O
pH	O
besides	O
its	O
previously	O
described	O
ligands	O
Fe3	O
+	O
and	O
Al3	O
+	O
(	O
Wosten	O
et	O
al	O
.	O
,	O
2000	O
)	O
.	O

An	O
alignment	O
of	O
the	O
amino	O
acid	O
sequences	O
corresponding	O
to	O
the	O
putative	O
periplasmic	O
domain	O
of	O
the	O
PmrB	O
proteins	O
from	O
six	O
enteric	O
species	O
revealed	O
that	O
nine	O
residues	O
are	O
highly	O
conserved	O
(	O
Fig	O
.	O
6A	O
)	O
.	O

Interestingly	O
,	O
one	O
of	O
these	O
conserved	O
residues	O
was	O
a	O
histidine	O
at	O
position	O
35	O
.	O

Because	O
the	O
pKa	O
of	O
free	O
histidine	O
is	O
approximately6	O
,	O
the	O
pH	O
at	O
which	O
PmrA	O
-	O
activated	O
genes	O
are	O
induced	O
,	O
we	O
hypothesized	O
that	O
this	O
residue	O
might	O
be	O
required	O
for	O
pH	O
sensing	O
.	O

To	O
test	O
this	O
hypothesis	O
,	O
we	O
constructed	O
a	O
plasmid	O
that	O
produced	O
a	O
PmrB	O
protein	O
containing	O
a	O
single	O
histidine	O
to	O
alanine	O
substitution	O
at	O
position	O
35	O
.	O

While	O
this	O
mutation	O
severely	O
diminished	O
the	O
ability	O
of	O
Salmonella	B-Organism
to	O
respond	O
to	O
mild	O
acid	O
pH	O
,	O
there	O
still	O
was	O
some	O
residual	O
pbgP	O
expression	O
(	O
Fig	O
.	O
6B	O
)	O
suggesting	O
that	O
other	O
residues	O
might	O
also	O
be	O
required	O
for	O
pH	O
sensing	O
.	O

We	O
considered	O
the	O
possibility	O
that	O
a	O
second	O
histidine	O
at	O
position	O
57	O
could	O
be	O
involved	O
in	O
sensing	O
acid	O
despite	O
the	O
fact	O
that	O
this	O
residue	O
was	O
only	O
partially	O
conserved	O
across	O
species	O
(	O
Fig	O
.	O
6A	O
)	O
.	O

However	O
,	O
the	O
substitution	O
of	O
this	O
residue	O
by	O
alanine	O
had	O
no	O
effect	O
on	O
the	O
response	O
to	O
mild	O
acid	O
pH	O
(	O
Fig	O
.	O
6B	O
)	O
.	O

Four	O
of	O
the	O
nine	O
conserved	O
amino	O
acids	O
in	O
the	O
periplasmic	O
domain	O
of	O
PmrB	O
are	O
glutamic	O
acid	O
residues	O
,	O
which	O
also	O
could	O
be	O
subjected	O
to	O
changes	O
in	O
protonation	O
upon	O
variations	O
in	O
the	O
pH	O
of	O
their	O
surroundings	O
.	O

Although	O
the	O
pKa	O
of	O
free	O
glutamic	O
acid	O
is	O
approximately4	O
,	O
which	O
is	O
well	O
below	O
the	O
range	O
of	O
pH	O
at	O
which	O
PmrA	O
-	O
activated	O
genes	O
are	O
induced	O
,	O
the	O
folding	O
of	O
a	O
protein	O
can	O
dramatically	O
change	O
the	O
pKa	O
of	O
its	O
residues	O
.	O

For	O
instance	O
,	O
the	O
pKa	O
of	O
one	O
of	O
the	O
glutamic	O
acid	O
residues	O
of	O
the	O
regulatory	O
protein	O
TraM	O
is	O
approximately7	O
.	O
7	O
(	O
Lu	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

Therefore	O
,	O
we	O
hypothesized	O
that	O
one	O
or	O
more	O
of	O
the	O
glutamates	O
might	O
be	O
required	O
for	O
pH	O
sensing	O
.	O
<EOS>	B-X
HARKing	B-X
is	B-X
defined	B-X
as	B-X
presenting	B-X
a	B-X
post	B-X
hoc	B-X
hypothesis	B-X
(	B-X
i.e.	B-X
,	B-X
one	B-X
based	B-X
on	B-X
or	B-X
informed	B-X
by	B-X
one	B-X
's	B-X
results	B-X
)	B-X
in	B-X
one	B-X
's	B-X
research	B-X
report	B-X
as	B-X
i	B-X
f	B-X
it	B-X
were	B-X
,	B-X
in	B-X
fact	B-X
,	B-X
an	B-X
a	B-X
priori	B-X
hypotheses	B-X
.	B-X
I	B-X
identify	B-X
several	B-X
reasons	B-X
why	B-X
scientists	B-X
might	B-X
HARK	B-X
.	B-X
It	B-X
is	B-X
conceded	B-X
that	B-X
the	B-X
question	B-X
of	B-X
whether	B-X
HARKing	B-X
'	B-X
s	B-X
costs	B-X
exceed	B-X
its	B-X
benefits	B-X
is	B-X
a	B-X
complex	B-X
one	B-X
that	B-X
ought	B-X
to	B-X
be	B-X
addressed	B-X
through	B-X
research	B-X
,	B-X
open	B-X
discussion	B-X
,	B-X
and	B-X
debate	B-X
.	B-X
Two	B-X
alternative	B-X
hypothese	B-X
are	B-X
also	B-X
discussed	B-X
,	B-X
one	B-X
based	B-X
on	B-X
eye	B-X
movements	B-X
,	B-X
the	B-X
other	B-X
based	B-X
on	B-X
continuous	B-X
coupling	B-X
between	B-X
perception	B-X
and	B-X
action	B-X
.	B-X

To	O
test	O
this	O
hypothesis	O
,	O
we	O
used	O
plasmids	O
that	O
produced	O
PmrB	O
proteins	O
containing	O
single	O
-	O
amino	O
-	O
acid	O
replacements	O
in	O
the	O
conserved	O
glutamic	O
acid	O
residues	O
.	O

When	O
either	O
one	O
of	O
the	O
four	O
conserved	O
glutamates	O
was	O
substituted	O
by	O
alanine	O
Salmonella	B-Organism
could	O
no	O
longer	O
respond	O
to	O
mild	O
acid	O
pH	O
(	O
Fig	O
.	O
6B	O
)	O
.	O

Strains	O
expressing	O
the	O
mutant	O
PmrB	O
proteins	O
could	O
express	O
pbgP	O
normally	O
in	O
response	O
to	O
the	O
low	O
Mg2	O
+	O
signal	O
(	O
Fig	O
.	O
6C	O
)	O
(	O
Wosten	O
et	O
al	O
.	O
,	O
2000	O
)	O
,	O
indicating	O
that	O
mutations	O
in	O
residues	O
of	O
the	O
periplasmic	O
domain	O
of	O
PmrB	O
do	O
not	O
impair	O
the	O
enzymatic	O
activity	O
of	O
the	O
cytoplasmic	O
domain	O
of	O
the	O
PmrB	O
protein	O
.	O

These	O
results	O
indicate	O
that	O
the	O
periplasmic	O
glutamates	O
are	O
required	O
for	O
responding	O
to	O
mild	O
acid	O
pH	O
.	O

Mild	O
acid	O
pH	O
induces	O
resistance	O
to	O
the	O
antimicrobial	O
peptide	O
polymyxin	O
B	O

What	O
role	O
could	O
the	O
mild	O
acid	O
pH	O
-	O
dependent	O
activation	O
of	O
PmrA	O
-	O
regulated	O
genes	O
play	O
in	O
Salmonella	B-Organism
'	O
s	O
lifestyle	O
?	O

Because	O
the	O
PmrA	O
/	O
PmrB	O
system	O
is	O
required	O
for	O
resistance	O
to	O
the	O
antimicrobial	O
peptide	O
polymyxin	O
B	O
(	O
Roland	O
et	O
al	O
.	O
,	O
1993	O
)	O
,	O
we	O
hypothesized	O
that	O
mild	O
acid	O
pH	O
could	O
induce	O
this	O
resistance	O
.	O

In	O
fact	O
,	O
the	O
survival	O
of	O
wild	O
-	O
type	O
cells	O
to	O
a	O
challenge	O
with	O
polymyxin	O
B	O
was	O
100	O
000	O
-	O
fold	O
higher	O
when	O
they	O
were	O
grown	O
at	O
pH	O
5	O
.	O
8	O
than	O
when	O
grown	O
at	O
pH	O
7	O
.	O
7	O
(	O
Fig	O
.	O
7	O
)	O
.	O

This	O
resistance	O
was	O
PmrA	O
-	O
dependent	O
because	O
a	O
strain	O
deficient	O
in	O
the	O
pmrA	O
gene	O
was	O
approximately	O
100	O
000	O
-	O
fold	O
more	O
sensitive	O
to	O
polymyxin	O
B	O
than	O
the	O
wild	O
-	O
type	O
strain	O
when	O
grown	O
pH	O
5	O
.	O
8	O
(	O
Fig	O
.	O
7	O
)	O
.	O

Discussion	O
<EOS>	B-X
Discussion	B-X
structures	B-X
are	B-X
argumentation-theoretical	B-X
tools	B-X
that	B-X
can	B-X
be	B-X
employed	B-X
to	B-X
tackle	B-X
three	B-X
barriers	B-X
that	B-X
separate	B-X
lay	B-X
stakeholders	B-X
from	B-X
policy	B-X
debates	B-X
:	B-X
difficulty	B-X
,	B-X
magnitude	B-X
,	B-X
and	B-X
complexity	B-X
.	B-X
Discussions	B-X
about	B-X
preventive	B-X
behaviors	B-X
were	B-X
assessed	B-X
before	B-X
testing	B-X
and	B-X
1	B-X
and	B-X
6	B-X
months	B-X
post-testing	B-X
.	B-X
Discussion	B-X
of	B-X
preventive	B-X
behaviors	B-X
declined	B-X
following	B-X
test	B-X
reporting	B-X
,	B-X
with	B-X
more	B-X
rapid	B-X
decline	B-X
reported	B-X
by	B-X
noncarriers	B-X
.	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X

We	O
have	O
established	O
that	O
the	O
sensor	O
kinase	O
PmrB	O
is	O
the	O
primary	O
sensor	O
that	O
activates	O
the	O
PmrA	O
protein	O
when	O
Salmonella	B-Organism
experiences	O
mild	O
acid	O
pH	O
,	O
resulting	O
in	O
transcription	O
of	O
PmrA	O
-	O
activated	O
genes	O
(	O
Fig	O
.	O
1	O
)	O
.	O

That	O
PmrB	O
is	O
likely	O
to	O
sense	O
changes	O
in	O
pH	O
directly	O
is	O
supported	O
by	O
three	O
findings	O
:	O
(	O
i	O
)	O
the	O
mild	O
acid	O
pH	O
-	O
dependent	O
activation	O
of	O
the	O
PmrA	O
-	O
regulated	O
gene	O
pbgP	O
was	O
dramatically	O
reduced	O
in	O
a	O
strain	O
lacking	O
pmrB	O
(	O
Fig	O
.	O
3	O
)	O
,	O
(	O
ii	O
)	O
the	O
periplasmic	O
domain	O
of	O
PmrB	O
was	O
necessary	O
for	O
activation	O
of	O
pbgP	O
under	O
mild	O
acid	O
conditions	O
(	O
Fig	O
.	O
5	O
)	O
,	O
and	O
(	O
iii	O
)	O
single	O
amino	O
acid	O
substitutions	O
in	O
conserved	O
histidine	O
and	O
glutamic	O
acid	O
residues	O
located	O
in	O
the	O
periplasmic	O
domain	O
of	O
PmrB	O
abolished	O
its	O
ability	O
to	O
stimulate	O
pbgP	O
transcription	O
at	O
pH	O
5	O
.	O
8	O
(	O
Fig	O
.	O
6	O
)	O
.	O

The	O
periplasmic	O
histidine	O
and	O
glutamates	O
are	O
conserved	O
in	O
the	O
PmrB	O
periplasmic	O
domain	O
of	O
other	O
enteric	O
species	O
,	O
raising	O
the	O
possibility	O
that	O
the	O
signalling	O
pathway	O
described	O
in	O
this	O
article	O
may	O
be	O
operating	O
in	O
other	O
organisms	O
in	O
addition	O
to	O
S	B-Organism
.	I-Organism
enterica	I-Organism
.	O

The	O
requirement	O
of	O
periplasmic	O
PmrB	O
residues	O
in	O
the	O
mild	O
acid	O
pH	O
activation	O
of	O
PmrA	O
-	O
regulated	O
genes	O
suggests	O
that	O
this	O
signalling	O
pathway	O
responds	O
to	O
changes	O
in	O
extracytoplasmic	O
pH	O
.	O
<EOS>	B-X
Acid	B-X
pH	B-X
often	B-X
triggers	B-X
changes	B-X
in	B-X
gene	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
the	B-X
identity	B-X
of	B-X
the	B-X
gene	B-X
products	B-X
that	B-X
sense	B-X
fluctuations	B-X
in	B-X
extracytoplasmic	B-X
pH	B-X
.	B-X
The	B-X
Gram-negative	B-X
pathogen	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
experiences	B-X
a	B-X
number	B-X
of	B-X
acidic	B-X
environments	B-X
both	B-X
inside	B-X
and	B-X
outside	B-X
animal	B-X
hosts	B-X
.	B-X
Growth	B-X
in	B-X
mild	B-X
acid	B-X
(	B-X
pH	B-X
5.8	B-X
)	B-X
promotes	B-X
transcription	B-X
of	B-X
genes	B-X
activated	B-X
by	B-X
the	B-X
response	B-X
regulator	B-X
PmrA	B-X
,	B-X
but	B-X
the	B-X
signalling	B-X
pathway	B-X
(	B-X
s	B-X
)	B-X
that	B-X
mediates	B-X
this	B-X
response	B-X
has	B-X
thus	B-X
far	B-X
remained	B-X
unexplored	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
this	B-X
activation	B-X
requires	B-X
both	B-X
PmrA	B-X
's	B-X
cognate	B-X
sensor	B-X
kinase	B-X
PmrB	B-X
,	B-X
which	B-X
had	B-X
been	B-X
previously	B-X
shown	B-X
to	B-X
respond	B-X
to	B-X
Fe	B-X
(	B-X
3+	B-X
)	B-X
and	B-X
Al	B-X
(	B-X
3+	B-X
)	B-X
,	B-X
and	B-X
PmrA	B-X
's	B-X
post-translational	B-X
activator	B-X
PmrD	B-X
.	B-X
Substitution	B-X
of	B-X
a	B-X
conserved	B-X
histidine	B-X
or	B-X
of	B-X
either	B-X
one	B-X
of	B-X
four	B-X
conserved	B-X
glutamic	B-X
acid	B-X
residues	B-X
in	B-X
the	B-X
periplasmic	B-X
domain	B-X
of	B-X
PmrB	B-X
severely	B-X
decreased	B-X
or	B-X
abolished	B-X
the	B-X
mild	B-X
acid-promoted	B-X
transcription	B-X
of	B-X
PmrA-activated	B-X
genes	B-X
.	B-X
The	B-X
PmrA/PmrB	B-X
system	B-X
controls	B-X
lipopolysaccharide	B-X
modifications	B-X
mediating	B-X
resistance	B-X
to	B-X
the	B-X
antibiotic	B-X
polymyxin	B-X
B.	B-X
Wild-type	B-X
Salmonella	B-X
grown	B-X
at	B-X
pH	B-X
5.8	B-X
were	B-X
>	B-X
100	B-X
000-fold	B-X
more	B-X
resistant	B-X
to	B-X
polymyxin	B-X
B	B-X
than	B-X
organisms	B-X
grown	B-X
at	B-X
pH	B-X
7.7	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
protonation	B-X
of	B-X
the	B-X
PmrB	B-X
periplasmic	B-X
histidine	B-X
and/or	B-X
of	B-X
the	B-X
glutamic	B-X
acid	B-X
residues	B-X
activate	B-X
the	B-X
PmrA	B-X
protein	B-X
,	B-X
and	B-X
that	B-X
mild	B-X
acid	B-X
promotes	B-X
cellular	B-X
changes	B-X
resulting	B-X
in	B-X
polymyxin	B-X
B	B-X
resistance	B-X
.	B-X

Moreover	O
,	O
under	O
the	O
experimental	O
conditions	O
used	O
in	O
this	O
study	O
it	O
is	O
unlikely	O
that	O
the	O
cytoplasmic	O
pH	O
varied	O
significantly	O
because	O
:	O
first	O
,	O
bacterial	O
cells	O
can	O
maintain	O
an	O
internal	O
pH	O
of	O
up	O
to	O
2	O
units	O
higher	O
than	O
the	O
external	O
pH	O
(	O
Foster	O
,	O
2004	O
)	O
;	O
in	O
fact	O
,	O
Slonczewski	O
et	O
al	O
.	O

(	O
1981	O
)	O
determined	O
that	O
the	O
intracellular	O
pH	O
in	O
Escherichia	B-Organism
coli	I-Organism
cells	O
was	O
7	O
.	O
4	O
even	O
when	O
the	O
external	O
pH	O
was	O
5	O
.	O
5	O
.	O

Second	O
,	O
acid	O
stress	O
can	O
become	O
a	O
severe	O
challenge	O
for	O
bacterial	O
cells	O
when	O
organic	O
acids	O
such	O
as	O
acetate	O
or	O
products	O
of	O
fermentation	O
are	O
present	O
in	O
the	O
medium	O
(	O
Bearson	O
et	O
al	O
.	O
,	O
1998	O
)	O
;	O
and	O
in	O
our	O
experiments	O
we	O
used	O
a	O
non	O
-	O
fermentable	O
sugar	O
(	O
glycerol	O
)	O
and	O
inorganic	O
acids	O
which	O
are	O
not	O
expected	O
to	O
cause	O
such	O
acid	O
stress	O
.	O

Structural	O
changes	O
driven	O
by	O
a	O
relatively	O
narrow	O
variation	O
in	O
pH	O
(	O
1	O
-	O
2	O
units	O
)	O
have	O
been	O
reported	O
for	O
several	O
cytosolic	O
bacterial	O
proteins	O
(	O
Tews	O
et	O
al	O
.	O
,	O
2005	O
;	O
Lu	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

This	O
is	O
in	O
contrast	O
to	O
the	O
few	O
membrane	O
proteins	O
(	O
other	O
than	O
ion	O
channels	O
)	O
that	O
have	O
been	O
shown	O
to	O
respond	O
to	O
changes	O
in	O
extracellular	O
pH	O
of	O
a	O
similar	O
magnitude	O
.	O

For	O
example	O
,	O
the	O
eukaryotic	O
G	O
-	O
protein	O
coupled	O
receptor	O
OGR1	O
is	O
inactive	O
at	O
pH	O
7	O
.	O
8	O
and	O
fully	O
active	O
at	O
pH	O
6	O
.	O
8	O
suggesting	O
that	O
the	O
pH	O
sensing	O
mechanism	O
involves	O
protonation	O
of	O
several	O
extracytoplasmic	O
histidines	O
(	O
Ludwig	O
et	O
al	O
.	O
,	O
2003	O
)	O
,	O
which	O
is	O
in	O
agreement	O
with	O
the	O
pKa	O
of	O
free	O
histidine	O
of	O
approximately6	O
.	O

In	O
the	O
case	O
of	O
PmrB	O
,	O
a	O
normal	O
response	O
to	O
mild	O
acid	O
pH	O
requires	O
not	O
only	O
a	O
periplasmic	O
histidine	O
but	O
also	O
several	O
glutamic	O
acid	O
residues	O
.	O

Therefore	O
,	O
regulation	O
of	O
PmrB	O
activity	O
may	O
involve	O
protonation	O
of	O
one	O
or	O
more	O
of	O
these	O
amino	O
acids	O
.	O
<EOS>	B-X
The	B-X
major	B-X
processes	B-X
discussed	B-X
below	B-X
are	B-X
protein	B-X
turnover	B-X
(	B-X
degradation	B-X
and	B-X
synthesis	B-X
)	B-X
,	B-X
degradation	B-X
into	B-X
urea	B-X
,	B-X
or	B-X
conversion	B-X
into	B-X
glucose	B-X
(	B-X
gluconeogenesis	B-X
,	B-X
Figure	B-X
1	B-X
)	B-X
.	B-X
Daily	B-X
protein	B-X
turnover	B-X
is	B-X
a	B-X
dynamic	B-X
process	B-X
characterized	B-X
by	B-X
a	B-X
double	B-X
flux	B-X
of	B-X
amino	B-X
acids	B-X
:	B-X
the	B-X
amino	B-X
acids	B-X
released	B-X
by	B-X
endogenous	B-X
(	B-X
body	B-X
)	B-X
protein	B-X
breakdown	B-X
can	B-X
be	B-X
reutilized	B-X
and	B-X
reconverted	B-X
to	B-X
protein	B-X
synthesis	B-X
,	B-X
with	B-X
very	B-X
little	B-X
loss	B-X
.	B-X
The	B-X
metabolic	B-X
need	B-X
for	B-X
amino	B-X
acids	B-X
is	B-X
essentially	B-X
to	B-X
maintain	B-X
stores	B-X
of	B-X
endogenous	B-X
tissue	B-X
proteins	B-X
within	B-X
an	B-X
appropriate	B-X
range	B-X
,	B-X
allowing	B-X
protein	B-X
homeostasis	B-X
to	B-X
be	B-X
maintained	B-X
.	B-X
Thanks	B-X
to	B-X
a	B-X
dynamic	B-X
,	B-X
free	B-X
amino	B-X
acid	B-X
pool	B-X
,	B-X
this	B-X
demand	B-X
for	B-X
amino	B-X
acids	B-X
can	B-X
be	B-X
continuously	B-X
supplied	B-X
.	B-X
The	B-X
size	B-X
of	B-X
the	B-X
free	B-X
amino	B-X
acid	B-X
pool	B-X
remains	B-X
limited	B-X
and	B-X
is	B-X
regulated	B-X
within	B-X
narrow	B-X
limits	B-X
.	B-X
The	B-X
supply	B-X
of	B-X
amino	B-X
acids	B-X
to	B-X
cover	B-X
physiological	B-X
needs	B-X
can	B-X
be	B-X
derived	B-X
from	B-X
3	B-X
sources	B-X
:	B-X
1	B-X
.	B-X
Exogenous	B-X
proteins	B-X
that	B-X
release	B-X
amino	B-X
acids	B-X
after	B-X
digestion	B-X
and	B-X
absorption	B-X
2	B-X
.	B-X
De	B-X
novo	B-X
synthesis	B-X
,	B-X
including	B-X
amino	B-X
acids	B-X
(	B-X
as	B-X
well	B-X
as	B-X
ammonia	B-X
)	B-X
derived	B-X
from	B-X
the	B-X
process	B-X
of	B-X
urea	B-X
salvage	B-X
,	B-X
following	B-X
hydrolysis	B-X
and	B-X
microflora	B-X
metabolism	B-X
in	B-X
the	B-X
hind	B-X
gut	B-X
.	B-X
When	B-X
protein	B-X
intake	B-X
surpasses	B-X
the	B-X
physiological	B-X
needs	B-X
of	B-X
amino	B-X
acids	B-X
,	B-X
the	B-X
excess	B-X
amino	B-X
acids	B-X
are	B-X
disposed	B-X
of	B-X
by	B-X
three	B-X
major	B-X
processes	B-X
:	B-X
1	B-X
.	B-X
Gluconeogenesis	B-X
,	B-X
i.	B-X
e.	B-X
de	B-X
novo	B-X
synthesis	B-X
of	B-X
glucose	B-X
.	B-X
Most	B-X
of	B-X
the	B-X
amino	B-X
groups	B-X
of	B-X
the	B-X
excess	B-X
amino	B-X
acids	B-X
are	B-X
converted	B-X
into	B-X
urea	B-X
through	B-X
the	B-X
urea	B-X
cycle	B-X
,	B-X
whereas	B-X
their	B-X
carbon	B-X
skeletons	B-X
are	B-X
transformed	B-X
into	B-X
other	B-X
intermediates	B-X
,	B-X
mostly	B-X
glucose	B-X
.	B-X
This	B-X
is	B-X
one	B-X
of	B-X
the	B-X
mechanisms	B-X
,	B-X
essential	B-X
for	B-X
life	B-X
,	B-X
developed	B-X
by	B-X
the	B-X
body	B-X
to	B-X
maintain	B-X
blood	B-X
glucose	B-X
within	B-X
a	B-X
narrow	B-X
range	B-X
,	B-X
(	B-X
i.	B-X
e.	B-X
glucose	B-X
homeostasis	B-X
)	B-X
.	B-X
It	B-X
includes	B-X
the	B-X
process	B-X
of	B-X
gluconeogenesis	B-X
,	B-X
i.	B-X
e.	B-X
de	B-X
novo	B-X
synthesis	B-X
of	B-X
glucose	B-X
from	B-X
non-glycogenic	B-X
precursors	B-X
;	B-X
in	B-X
particular	B-X
certain	B-X
specific	B-X
amino	B-X
acids	B-X
(	B-X
for	B-X
example	B-X
,	B-X
alanine	B-X
)	B-X
,	B-X
as	B-X
well	B-X
as	B-X
glycerol	B-X
(	B-X
derived	B-X
from	B-X
fat	B-X
breakdown	B-X
)	B-X
and	B-X
lactate	B-X
(	B-X
derived	B-X
from	B-X
muscles	B-X
)	B-X
.	B-X
The	B-X
gluconeogenetic	B-X
pathway	B-X
progressively	B-X
takes	B-X
over	B-X
when	B-X
the	B-X
supply	B-X
of	B-X
glucose	B-X
from	B-X
exogenous	B-X
or	B-X
endogenous	B-X
sources	B-X
(	B-X
glycogenolysis	B-X
)	B-X
becomes	B-X
insufficient	B-X
.	B-X

Even	O
though	O
protonation	O
of	O
the	O
glutamic	O
acid	O
residues	O
may	O
seem	O
unlikely	O
given	O
the	O
fact	O
that	O
the	O
pKa	O
of	O
free	O
glutamic	O
acid	O
is	O
approximately4	O
,	O
protein	O
folding	O
can	O
change	O
the	O
pKa	O
of	O
its	O
residues	O
(	O
Tanford	O
and	O
Roxby	O
,	O
1972	O
)	O
.	O

Indeed	O
,	O
the	O
pKa	O
of	O
one	O
of	O
the	O
glutamic	O
acid	O
residues	O
of	O
the	O
regulatory	O
protein	O
TraM	O
is	O
approximately7	O
.	O
7	O
in	O
the	O
folded	O
protein	O
(	O
Lu	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

Therefore	O
,	O
it	O
is	O
plausible	O
that	O
protonation	O
/	O
deprotonation	O
of	O
one	O
or	O
more	O
of	O
the	O
glutamic	O
acids	O
in	O
the	O
periplasmic	O
domain	O
of	O
PmrB	O
could	O
occur	O
at	O
pH	O
approximately5	O
.	O
8	O
.	O
<EOS>	B-X
The	B-X
substrates	B-X
were	B-X
divided	B-X
into	B-X
three	B-X
main	B-X
groups	B-X
:	B-X
molecular	B-X
oxygen	B-X
,	B-X
quinones	B-X
,	B-X
and	B-X
one-electron	B-X
acceptors	B-X
.	B-X
There	B-X
are	B-X
two	B-X
proposed	B-X
mechanisms	B-X
for	B-X
the	B-X
reductive	B-X
half-reaction	B-X
:	B-X
hydride	B-X
abstraction	B-X
and	B-X
nucleophilic	B-X
attack	B-X
followed	B-X
by	B-X
deprotonation	B-X
.	B-X
The	B-X
former	B-X
mechanism	B-X
appears	B-X
plausible	B-X
;	B-X
here	B-X
,	B-X
beta-D-glucose	B-X
is	B-X
oxidized	B-X
to	B-X
glucono-delta-lactone	B-X
by	B-X
a	B-X
concerted	B-X
transfer	B-X
of	B-X
a	B-X
proton	B-X
from	B-X
its	B-X
C1-hydroxyl	B-X
to	B-X
a	B-X
basic	B-X
group	B-X
on	B-X
the	B-X
enzyme	B-X
(	B-X
His516	B-X
)	B-X
and	B-X
a	B-X
direct	B-X
hydride	B-X
transfer	B-X
from	B-X
its	B-X
C1	B-X
position	B-X
to	B-X
the	B-X
N5	B-X
position	B-X
in	B-X
FAD	B-X
.	B-X
The	B-X
oxidative	B-X
half-reaction	B-X
proceeds	B-X
via	B-X
one-	B-X
or	B-X
two-electron	B-X
transfer	B-X
mechanisms	B-X
,	B-X
depending	B-X
on	B-X
the	B-X
type	B-X
of	B-X
the	B-X
oxidizing	B-X
substrate	B-X
.	B-X
The	B-X
active	B-X
site	B-X
of	B-X
the	B-X
enzyme	B-X
contains	B-X
,	B-X
in	B-X
addition	B-X
to	B-X
FAD	B-X
,	B-X
three	B-X
amino	B-X
acid	B-X
side	B-X
chains	B-X
that	B-X
are	B-X
intimately	B-X
involved	B-X
in	B-X
catalysis	B-X
:	B-X
His516	B-X
with	B-X
a	B-X
pK	B-X
(	B-X
a	B-X
)	B-X
=6.9	B-X
,	B-X
and	B-X
Glu412	B-X
with	B-X
pK	B-X
(	B-X
a	B-X
)	B-X
=3.4	B-X
which	B-X
is	B-X
hydrogen	B-X
bonded	B-X
to	B-X
His559	B-X
,	B-X
with	B-X
pK	B-X
(	B-X
a	B-X
)	B-X
>	B-X
8	B-X
.	B-X
The	B-X
protonation	B-X
of	B-X
each	B-X
of	B-X
these	B-X
residues	B-X
has	B-X
a	B-X
strong	B-X
influence	B-X
on	B-X
all	B-X
rate	B-X
constants	B-X
in	B-X
the	B-X
catalytic	B-X
mechanism	B-X
.	B-X

Integral	O
membrane	O
proteins	O
that	O
recognize	O
signals	O
in	O
addition	O
to	O
extracytoplasmic	O
pH	O
,	O
such	O
as	O
PmrB	O
,	O
have	O
been	O
identified	O
both	O
in	O
prokaryotes	O
and	O
in	O
eukaryotes	O
.	O

The	O
CadC	O
protein	O
of	O
E	B-Organism
.	I-Organism
coli	I-Organism
,	O
for	O
example	O
,	O
is	O
activated	O
by	O
exogenous	O
lysine	O
besides	O
acid	O
pH	O
(	O
Dell	O
et	O
al	O
.	O
,	O
1994	O
)	O
.	O

Likewise	O
,	O
the	O
human	B-Organism
receptor	O
OGR1	O
responds	O
to	O
both	O
pH	O
and	O
sphingosylphosphorylcholine	O
(	O
Ludwig	O
et	O
al	O
.	O
,	O
2003	O
)	O
.	O

The	O
fact	O
that	O
the	O
PmrB	O
H35A	O
and	O
the	O
E64A	O
mutant	O
proteins	O
displayed	O
partial	O
activity	O
in	O
response	O
to	O
ferric	O
iron	O
but	O
were	O
severely	O
impaired	O
in	O
their	O
ability	O
to	O
respond	O
to	O
acid	O
pH	O
(	O
compare	O
Fig	O
.	O
6B	O
and	O
D	O
)	O
supports	O
the	O
notion	O
that	O
these	O
signals	O
are	O
sensed	O
independently	O
.	O

Similarly	O
,	O
cadC	O
mutants	O
have	O
been	O
isolated	O
that	O
are	O
impaired	O
in	O
the	O
ability	O
to	O
sense	O
only	O
one	O
of	O
its	O
two	O
inducing	O
signals	O
(	O
Dell	O
et	O
al	O
.	O
,	O
1994	O
)	O
.	O

Furthermore	O
,	O
the	O
ability	O
to	O
sense	O
two	O
different	O
compounds	O
has	O
also	O
recently	O
been	O
shown	O
to	O
be	O
genetically	O
distinguishable	O
in	O
the	O
bacterial	O
chemoreceptor	O
Tcp	O
(	O
Iwama	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

The	O
PmrB	O
protein	O
plays	O
the	O
primary	O
role	O
in	O
the	O
pH	O
-	O
dependent	O
activation	O
of	O
PmrA	O
,	O
but	O
full	O
activation	O
also	O
requires	O
PmrD	O
,	O
the	O
post	O
-	O
translational	O
activator	O
of	O
the	O
PmrA	O
protein	O
(	O
Fig	O
.	O
3	O
)	O
.	O

The	O
levels	O
of	O
phosphorylated	O
PmrA	O
are	O
determined	O
by	O
the	O
balance	O
of	O
the	O
autokinase	O
+	O
phosphotransferase	O
activity	O
of	O
PmrB	O
and	O
PmrB	O
'	O
s	O
phosphatase	O
activity	O
towards	O
phospho	O
-	O
PmrA	O
.	O

Thus	O
,	O
PmrD	O
may	O
be	O
necessary	O
to	O
ensure	O
that	O
the	O
amount	O
of	O
phosphorylated	O
PmrA	O
is	O
such	O
to	O
promote	O
transcription	O
of	O
its	O
regulated	O
genes	O
.	O

Consistent	O
with	O
its	O
role	O
in	O
acid	O
pH	O
activation	O
,	O
expression	O
of	O
the	O
pmrD	O
gene	O
was	O
promoted	O
in	O
media	O
of	O
mild	O
acid	O
pH	O
(	O
Fig	O
.	O
4	O
)	O
.	O

The	O
mechanism	O
(	O
s	O
)	O
by	O
which	O
acid	O
pH	O
leads	O
to	O
an	O
increase	O
in	O
the	O
levels	O
of	O
the	O
pmrD	O
transcript	O
,	O
however	O
,	O
remains	O
unclear	O
.	O

Although	O
it	O
has	O
been	O
suggested	O
that	O
the	O
Salmonella	B-Organism
PhoQ	O
protein	O
senses	O
acid	O
pH	O
(	O
Aranda	O
et	O
al	O
.	O
,	O
1992	O
)	O
or	O
responds	O
to	O
both	O
pH	O
and	O
Mg2	O
+	O
(	O
Bearson	O
et	O
al	O
.	O
,	O
1998	O
)	O
,	O
a	O
direct	O
role	O
for	O
PhoQ	O
in	O
responding	O
to	O
acid	O
pH	O
appears	O
unlikely	O
because	O
not	O
all	O
PhoP	O
-	O
regulated	O
genes	O
are	O
activated	O
under	O
these	O
conditions	O
,	O
which	O
is	O
in	O
contrast	O
to	O
low	O
Mg2	O
+	O
activating	O
the	O
whole	O
PhoP	O
regulon	O
(	O
see	O
Groisman	O
and	O
Mouslim	O
,	O
2006	O
for	O
a	O
review	O
)	O
.	O

What	O
role	O
could	O
the	O
pH	O
-	O
dependent	O
activation	O
of	O
PmrA	O
-	O
regulated	O
genes	O
play	O
in	O
Salmonella	B-Organism
'	O
s	O
lifestyle	O
?	O

Because	O
several	O
PmrA	O
-	O
activated	O
gene	O
products	O
are	O
responsible	O
for	O
remodelling	O
the	O
LPS	O
structure	O
and	O
these	O
modifications	O
are	O
required	O
for	O
resistance	O
to	O
certain	O
antimicrobial	O
peptides	O
and	O
toxic	O
metals	O
,	O
one	O
possibility	O
is	O
that	O
acidic	O
environments	O
provide	O
a	O
means	O
to	O
induce	O
the	O
cell	O
envelope	O
changes	O
resulting	O
in	O
resistance	O
.	O

Indeed	O
,	O
when	O
grown	O
at	O
pH	O
5	O
.	O
8	O
wild	O
-	O
type	O
Salmonella	B-Organism
were	O
100	O
000	O
-	O
fold	O
more	O
resistant	O
to	O
polymyxin	O
B	O
than	O
when	O
grown	O
at	O
pH	O
7	O
.	O
7	O
(	O
Fig	O
.	O
7	O
)	O
.	O

This	O
may	O
be	O
particularly	O
important	O
for	O
Salmonella	B-Organism
living	O
in	O
soil	O
due	O
to	O
the	O
fact	O
that	O
the	O
antimicrobial	O
peptide	O
polymyxin	O
B	O
is	O
produced	O
by	O
the	O
soil	O
bacterium	O
Paenibacillus	B-Organism
polymyxa	I-Organism
(	O
Paulus	O
and	O
Gray	O
,	O
1964	O
)	O
and	O
because	O
the	O
solubility	O
of	O
metals	O
such	O
as	O
Fe3	O
+	O
increases	O
in	O
acid	O
pH	O
.	O

On	O
the	O
other	O
hand	O
,	O
although	O
mild	O
acid	O
(	O
pH	O
6	O
.	O
0	O
)	O
per	O
se	O
,	O
i	O
.	O
e	O
.	O
even	O
in	O
the	O
presence	O
of	O
high	O
Mg2	O
+	O
,	O
promotes	O
LPS	O
modifications	O
(	O
Gibbons	O
et	O
al	O
.	O
,	O
2005	O
)	O
,	O
the	O
low	O
pH	O
signal	O
may	O
also	O
act	O
synergistically	O
with	O
the	O
low	O
Mg2	O
+	O
signal	O
in	O
vivo	O
because	O
Mg2	O
+	O
deprivation	O
alone	O
is	O
not	O
sufficient	O
to	O
provide	O
all	O
the	O
LPS	O
modifications	O
seen	O
in	O
Salmonella	B-Organism
when	O
present	O
inside	O
macrophages	O
(	O
Gibbons	O
et	O
al	O
.	O
,	O
2005	O
)	O
.	O

Finally	O
,	O
while	O
a	O
role	O
for	O
the	O
PmrA	O
-	O
dependent	O
LPS	O
modifications	O
in	O
the	O
previously	O
described	O
acid	O
tolerance	O
response	O
is	O
unlikely	O
because	O
survival	O
to	O
acid	O
stress	O
(	O
pH	O
approximately3	O
)	O
was	O
not	O
reduced	O
in	O
cells	O
deficient	O
in	O
pmrA	O
(	O
data	O
not	O
shown	O
and	O
Bearson	O
et	O
al	O
.	O
,	O
1998	O
)	O
,	O
some	O
of	O
the	O
PmrA	O
-	O
regulated	O
genes	O
to	O
which	O
no	O
function	O
has	O
been	O
ascribed	O
yet	O
could	O
mediate	O
other	O
cellular	O
responses	O
to	O
acid	O
pH	O
.	O

Mlc	O
regulation	O
of	O
Salmonella	B-Organism
pathogenicity	O
island	O
I	O
gene	O
expression	O
via	O
hilE	O
repression	O
<EOS>	B-X
The	B-X
global	B-X
regulator	B-X
Mlc	B-X
is	B-X
a	B-X
repressor	B-X
of	B-X
several	B-X
genes	B-X
and	B-X
operons	B-X
that	B-X
are	B-X
involved	B-X
in	B-X
sugar	B-X
uptake	B-X
and	B-X
metabolism	B-X
.	B-X
A	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
mlc	B-X
mutant	B-X
showed	B-X
reduced	B-X
levels	B-X
of	B-X
invasion	B-X
and	B-X
cytotoxicity	B-X
compared	B-X
to	B-X
the	B-X
wild-type	B-X
,	B-X
and	B-X
exhibited	B-X
reduced	B-X
expression	B-X
levels	B-X
of	B-X
hilD	B-X
,	B-X
hilA	B-X
and	B-X
invF	B-X
,	B-X
which	B-X
are	B-X
regulatory	B-X
genes	B-X
in	B-X
the	B-X
Salmonella	B-X
pathogenicity	B-X
island	B-X
1	B-X
(	B-X
SPI1	B-X
)	B-X
.	B-X
However	B-X
,	B-X
the	B-X
effects	B-X
of	B-X
Mlc	B-X
on	B-X
hilD	B-X
expression	B-X
and	B-X
bacterial	B-X
invasiveness	B-X
were	B-X
not	B-X
seen	B-X
in	B-X
the	B-X
hilE	B-X
mutant	B-X
,	B-X
and	B-X
hilE	B-X
expression	B-X
was	B-X
increased	B-X
in	B-X
the	B-X
mlc	B-X
mutant	B-X
,	B-X
which	B-X
suggests	B-X
that	B-X
Mlc	B-X
exerts	B-X
positive	B-X
effects	B-X
on	B-X
the	B-X
expression	B-X
of	B-X
SPI1	B-X
genes	B-X
by	B-X
reducing	B-X
the	B-X
expression	B-X
of	B-X
HilE	B-X
,	B-X
which	B-X
is	B-X
known	B-X
to	B-X
down-regulate	B-X
the	B-X
expression	B-X
of	B-X
SPI1	B-X
genes	B-X
through	B-X
direct	B-X
interaction	B-X
with	B-X
HilD	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
two	B-X
known	B-X
promoters	B-X
of	B-X
hilE	B-X
were	B-X
not	B-X
modulated	B-X
by	B-X
Mlc	B-X
,	B-X
and	B-X
we	B-X
identified	B-X
a	B-X
third	B-X
promoter	B-X
,	B-X
designated	B-X
P3	B-X
,	B-X
which	B-X
was	B-X
repressed	B-X
by	B-X
Mlc	B-X
.	B-X
The	B-X
gel	B-X
mobility	B-X
shift	B-X
assay	B-X
and	B-X
footprinting	B-X
analysis	B-X
revealed	B-X
that	B-X
Mlc	B-X
repressed	B-X
hilE	B-X
in	B-X
a	B-X
direct	B-X
manner	B-X
by	B-X
binding	B-X
to	B-X
two	B-X
distinct	B-X
sites	B-X
in	B-X
the	B-X
hilE	B-X
P3	B-X
promoter	B-X
region	B-X
.	B-X
The	B-X
specific	B-X
down-regulation	B-X
of	B-X
hilD	B-X
observed	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
Mlc	B-X
regulon-inducible	B-X
sugars	B-X
,	B-X
such	B-X
as	B-X
glucose	B-X
and	B-X
mannose	B-X
,	B-X
could	B-X
not	B-X
be	B-X
detected	B-X
in	B-X
the	B-X
mlc	B-X
mutant	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
results	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
Mlc	B-X
functions	B-X
to	B-X
sense	B-X
the	B-X
availability	B-X
of	B-X
sugars	B-X
and	B-X
is	B-X
linked	B-X
to	B-X
virulence	B-X
gene	B-X
regulation	B-X
by	B-X
its	B-X
ability	B-X
to	B-X
control	B-X
hilE	B-X
expression	B-X
in	B-X
Salmonella	B-X
.	B-X

The	O
global	O
regulator	O
Mlc	O
is	O
a	O
repressor	O
of	O
several	O
genes	O
and	O
operons	O
that	O
are	O
involved	O
in	O
sugar	O
uptake	O
and	O
metabolism	O
.	O
<EOS>	B-X
The	B-X
global	B-X
regulator	B-X
Mlc	B-X
is	B-X
a	B-X
repressor	B-X
of	B-X
several	B-X
genes	B-X
and	B-X
operons	B-X
that	B-X
are	B-X
involved	B-X
in	B-X
sugar	B-X
uptake	B-X
and	B-X
metabolism	B-X
.	B-X
A	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
mlc	B-X
mutant	B-X
showed	B-X
reduced	B-X
levels	B-X
of	B-X
invasion	B-X
and	B-X
cytotoxicity	B-X
compared	B-X
to	B-X
the	B-X
wild-type	B-X
,	B-X
and	B-X
exhibited	B-X
reduced	B-X
expression	B-X
levels	B-X
of	B-X
hilD	B-X
,	B-X
hilA	B-X
and	B-X
invF	B-X
,	B-X
which	B-X
are	B-X
regulatory	B-X
genes	B-X
in	B-X
the	B-X
Salmonella	B-X
pathogenicity	B-X
island	B-X
1	B-X
(	B-X
SPI1	B-X
)	B-X
.	B-X
However	B-X
,	B-X
the	B-X
effects	B-X
of	B-X
Mlc	B-X
on	B-X
hilD	B-X
expression	B-X
and	B-X
bacterial	B-X
invasiveness	B-X
were	B-X
not	B-X
seen	B-X
in	B-X
the	B-X
hilE	B-X
mutant	B-X
,	B-X
and	B-X
hilE	B-X
expression	B-X
was	B-X
increased	B-X
in	B-X
the	B-X
mlc	B-X
mutant	B-X
,	B-X
which	B-X
suggests	B-X
that	B-X
Mlc	B-X
exerts	B-X
positive	B-X
effects	B-X
on	B-X
the	B-X
expression	B-X
of	B-X
SPI1	B-X
genes	B-X
by	B-X
reducing	B-X
the	B-X
expression	B-X
of	B-X
HilE	B-X
,	B-X
which	B-X
is	B-X
known	B-X
to	B-X
down-regulate	B-X
the	B-X
expression	B-X
of	B-X
SPI1	B-X
genes	B-X
through	B-X
direct	B-X
interaction	B-X
with	B-X
HilD	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
two	B-X
known	B-X
promoters	B-X
of	B-X
hilE	B-X
were	B-X
not	B-X
modulated	B-X
by	B-X
Mlc	B-X
,	B-X
and	B-X
we	B-X
identified	B-X
a	B-X
third	B-X
promoter	B-X
,	B-X
designated	B-X
P3	B-X
,	B-X
which	B-X
was	B-X
repressed	B-X
by	B-X
Mlc	B-X
.	B-X
The	B-X
gel	B-X
mobility	B-X
shift	B-X
assay	B-X
and	B-X
footprinting	B-X
analysis	B-X
revealed	B-X
that	B-X
Mlc	B-X
repressed	B-X
hilE	B-X
in	B-X
a	B-X
direct	B-X
manner	B-X
by	B-X
binding	B-X
to	B-X
two	B-X
distinct	B-X
sites	B-X
in	B-X
the	B-X
hilE	B-X
P3	B-X
promoter	B-X
region	B-X
.	B-X
The	B-X
specific	B-X
down-regulation	B-X
of	B-X
hilD	B-X
observed	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
Mlc	B-X
regulon-inducible	B-X
sugars	B-X
,	B-X
such	B-X
as	B-X
glucose	B-X
and	B-X
mannose	B-X
,	B-X
could	B-X
not	B-X
be	B-X
detected	B-X
in	B-X
the	B-X
mlc	B-X
mutant	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
results	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
Mlc	B-X
functions	B-X
to	B-X
sense	B-X
the	B-X
availability	B-X
of	B-X
sugars	B-X
and	B-X
is	B-X
linked	B-X
to	B-X
virulence	B-X
gene	B-X
regulation	B-X
by	B-X
its	B-X
ability	B-X
to	B-X
control	B-X
hilE	B-X
expression	B-X
in	B-X
Salmonella	B-X
.	B-X

A	O
Salmonella	O
enterica	O
serovar	O
Typhimurium	O
mlc	O
mutant	O
showed	O
reduced	O
levels	O
of	O
invasion	O
and	O
cytotoxicity	O
compared	O
to	O
the	O
wild	O
-	O
type	O
,	O
and	O
exhibited	O
reduced	O
expression	O
levels	O
of	O
hilD	O
,	O
hilA	O
and	O
invF	O
,	O
which	O
are	O
regulatory	O
genes	O
in	O
the	O
Salmonella	B-Organism
pathogenicity	O
island	O
1	O
(	O
SPI1	O
)	O
.	O

However	O
,	O
the	O
effects	O
of	O
Mlc	O
on	O
hilD	O
expression	O
and	O
bacterial	O
invasiveness	O
were	O
not	O
seen	O
in	O
the	O
hilE	O
mutant	O
,	O
and	O
hilE	O
expression	O
was	O
increased	O
in	O
the	O
mlc	O
mutant	O
,	O
which	O
suggests	O
that	O
Mlc	O
exerts	O
positive	O
effects	O
on	O
the	O
expression	O
of	O
SPI1	O
genes	O
by	O
reducing	O
the	O
expression	O
of	O
HilE	O
,	O
which	O
is	O
known	O
to	O
down	O
-	O
regulate	O
the	O
expression	O
of	O
SPI1	O
genes	O
through	O
direct	O
interaction	O
with	O
HilD	O
.	O

We	O
found	O
that	O
the	O
two	O
known	O
promoters	O
of	O
hilE	O
were	O
not	O
modulated	O
by	O
Mlc	O
,	O
and	O
we	O
identified	O
a	O
third	O
promoter	O
,	O
designated	O
P3	O
,	O
which	O
was	O
repressed	O
by	O
Mlc	O
.	O

The	O
gel	O
mobility	O
shift	O
assay	O
and	O
footprinting	O
analysis	O
revealed	O
that	O
Mlc	O
repressed	O
hilE	O
in	O
a	O
direct	O
manner	O
by	O
binding	O
to	O
two	O
distinct	O
sites	O
in	O
the	O
hilE	O
P3	O
promoter	O
region	O
.	O

The	O
specific	O
down	O
-	O
regulation	O
of	O
hilD	O
observed	O
in	O
the	O
presence	O
of	O
Mlc	O
regulon	O
-	O
inducible	O
sugars	O
,	O
such	O
as	O
glucose	O
and	O
mannose	O
,	O
could	O
not	O
be	O
detected	O
in	O
the	O
mlc	O
mutant	O
.	O

Based	O
on	O
these	O
results	O
,	O
we	O
propose	O
that	O
Mlc	O
functions	O
to	O
sense	O
the	O
availability	O
of	O
sugars	O
and	O
is	O
linked	O
to	O
virulence	O
gene	O
regulation	O
by	O
its	O
ability	O
to	O
control	O
hilE	O
expression	O
in	O
Salmonella	B-Organism
.	O
<EOS>	B-X
The	B-X
global	B-X
regulator	B-X
Mlc	B-X
is	B-X
a	B-X
repressor	B-X
of	B-X
several	B-X
genes	B-X
and	B-X
operons	B-X
that	B-X
are	B-X
involved	B-X
in	B-X
sugar	B-X
uptake	B-X
and	B-X
metabolism	B-X
.	B-X
A	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
mlc	B-X
mutant	B-X
showed	B-X
reduced	B-X
levels	B-X
of	B-X
invasion	B-X
and	B-X
cytotoxicity	B-X
compared	B-X
to	B-X
the	B-X
wild-type	B-X
,	B-X
and	B-X
exhibited	B-X
reduced	B-X
expression	B-X
levels	B-X
of	B-X
hilD	B-X
,	B-X
hilA	B-X
and	B-X
invF	B-X
,	B-X
which	B-X
are	B-X
regulatory	B-X
genes	B-X
in	B-X
the	B-X
Salmonella	B-X
pathogenicity	B-X
island	B-X
1	B-X
(	B-X
SPI1	B-X
)	B-X
.	B-X
However	B-X
,	B-X
the	B-X
effects	B-X
of	B-X
Mlc	B-X
on	B-X
hilD	B-X
expression	B-X
and	B-X
bacterial	B-X
invasiveness	B-X
were	B-X
not	B-X
seen	B-X
in	B-X
the	B-X
hilE	B-X
mutant	B-X
,	B-X
and	B-X
hilE	B-X
expression	B-X
was	B-X
increased	B-X
in	B-X
the	B-X
mlc	B-X
mutant	B-X
,	B-X
which	B-X
suggests	B-X
that	B-X
Mlc	B-X
exerts	B-X
positive	B-X
effects	B-X
on	B-X
the	B-X
expression	B-X
of	B-X
SPI1	B-X
genes	B-X
by	B-X
reducing	B-X
the	B-X
expression	B-X
of	B-X
HilE	B-X
,	B-X
which	B-X
is	B-X
known	B-X
to	B-X
down-regulate	B-X
the	B-X
expression	B-X
of	B-X
SPI1	B-X
genes	B-X
through	B-X
direct	B-X
interaction	B-X
with	B-X
HilD	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
two	B-X
known	B-X
promoters	B-X
of	B-X
hilE	B-X
were	B-X
not	B-X
modulated	B-X
by	B-X
Mlc	B-X
,	B-X
and	B-X
we	B-X
identified	B-X
a	B-X
third	B-X
promoter	B-X
,	B-X
designated	B-X
P3	B-X
,	B-X
which	B-X
was	B-X
repressed	B-X
by	B-X
Mlc	B-X
.	B-X
The	B-X
gel	B-X
mobility	B-X
shift	B-X
assay	B-X
and	B-X
footprinting	B-X
analysis	B-X
revealed	B-X
that	B-X
Mlc	B-X
repressed	B-X
hilE	B-X
in	B-X
a	B-X
direct	B-X
manner	B-X
by	B-X
binding	B-X
to	B-X
two	B-X
distinct	B-X
sites	B-X
in	B-X
the	B-X
hilE	B-X
P3	B-X
promoter	B-X
region	B-X
.	B-X
The	B-X
specific	B-X
down-regulation	B-X
of	B-X
hilD	B-X
observed	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
Mlc	B-X
regulon-inducible	B-X
sugars	B-X
,	B-X
such	B-X
as	B-X
glucose	B-X
and	B-X
mannose	B-X
,	B-X
could	B-X
not	B-X
be	B-X
detected	B-X
in	B-X
the	B-X
mlc	B-X
mutant	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
results	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
Mlc	B-X
functions	B-X
to	B-X
sense	B-X
the	B-X
availability	B-X
of	B-X
sugars	B-X
and	B-X
is	B-X
linked	B-X
to	B-X
virulence	B-X
gene	B-X
regulation	B-X
by	B-X
its	B-X
ability	B-X
to	B-X
control	B-X
hilE	B-X
expression	B-X
in	B-X
Salmonella	B-X
.	B-X

INTRODUCTION	O

Salmonella	B-Organism
enterica	I-Organism
serovar	I-Organism
Typhimurium	I-Organism
is	O
a	O
facultative	O
intracellular	O
pathogen	O
that	O
initiates	O
disease	O
,	O
which	O
is	O
normally	O
limited	O
to	O
gastroenteritis	O
in	O
humans	B-Organism
.	O

However	O
,	O
this	O
bacterium	O
causes	O
systemic	O
disease	O
in	O
mice	B-Organism
and	O
has	O
been	O
used	O
as	O
an	O
animal	O
model	O
of	O
typhoid	O
fever	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
discuss	B-X
work	B-X
on	B-X
the	B-X
mouse	B-X
model	B-X
of	B-X
human	B-X
typhoid	B-X
fever	B-X
caused	B-X
by	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
.	B-X
This	B-X
has	B-X
revealed	B-X
the	B-X
use	B-X
of	B-X
several	B-X
routes	B-X
of	B-X
systemic	B-X
dissemination	B-X
that	B-X
result	B-X
in	B-X
colonization	B-X
and	B-X
growth	B-X
within	B-X
the	B-X
spleen	B-X
and	B-X
liver	B-X
,	B-X
the	B-X
major	B-X
sites	B-X
of	B-X
bacterial	B-X
proliferation	B-X
.	B-X
Efforts	B-X
to	B-X
understand	B-X
molecular	B-X
mechanisms	B-X
of	B-X
pathogenesis	B-X
of	B-X
the	B-X
human-restricted	B-X
pathogen	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhi	B-X
,	B-X
the	B-X
causative	B-X
agent	B-X
of	B-X
typhoid	B-X
fever	B-X
,	B-X
have	B-X
been	B-X
hampered	B-X
by	B-X
the	B-X
lack	B-X
of	B-X
a	B-X
tractable	B-X
small	B-X
animal	B-X
model	B-X
.	B-X
This	B-X
obstacle	B-X
has	B-X
been	B-X
surmounted	B-X
by	B-X
a	B-X
humanized	B-X
mouse	B-X
model	B-X
in	B-X
which	B-X
genetically	B-X
modified	B-X
mice	B-X
are	B-X
engrafted	B-X
with	B-X
purified	B-X
CD34+	B-X
stem	B-X
cells	B-X
from	B-X
human	B-X
umbilical	B-X
cord	B-X
blood	B-X
,	B-X
designated	B-X
CD34+	B-X
Hu-NSG	B-X
(	B-X
formerly	B-X
hu-SRC-SCID	B-X
)	B-X
mice	B-X
.	B-X
We	B-X
have	B-X
shown	B-X
that	B-X
these	B-X
mice	B-X
develop	B-X
a	B-X
lethal	B-X
systemic	B-X
infection	B-X
with	B-X
S.	B-X
Typhi	B-X
that	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
presence	B-X
of	B-X
engrafted	B-X
human	B-X
hematopoietic	B-X
cells	B-X
.	B-X
Immunological	B-X
and	B-X
pathological	B-X
features	B-X
of	B-X
human	B-X
typhoid	B-X
are	B-X
recapitulated	B-X
in	B-X
this	B-X
model	B-X
,	B-X
which	B-X
has	B-X
been	B-X
successfully	B-X
employed	B-X
for	B-X
the	B-X
identification	B-X
of	B-X
bacterial	B-X
genetic	B-X
determinants	B-X
of	B-X
S.	B-X
Typhi	B-X
virulence	B-X
.	B-X
Here	B-X
we	B-X
describe	B-X
the	B-X
methods	B-X
used	B-X
to	B-X
infect	B-X
CD34+	B-X
Hu-NSG	B-X
mice	B-X
with	B-X
S.	B-X
Typhi	B-X
in	B-X
humanized	B-X
mice	B-X
and	B-X
to	B-X
construct	B-X
and	B-X
analyze	B-X
a	B-X
transposon-directed	B-X
insertion	B-X
site	B-X
sequencing	B-X
S.	B-X
Typhi	B-X
library	B-X
,	B-X
and	B-X
provide	B-X
general	B-X
considerations	B-X
for	B-X
the	B-X
use	B-X
of	B-X
humanized	B-X
mice	B-X
for	B-X
the	B-X
study	B-X
of	B-X
a	B-X
human-restricted	B-X
pathogen	B-X
.	B-X

Since	O
Salmonella	B-Organism
is	O
acquired	O
usually	O
by	O
oral	O
ingestion	O
of	O
contaminated	O
materials	O
,	O
a	O
key	O
step	O
in	O
the	O
infection	O
process	O
is	O
passage	O
across	O
the	O
intestinal	O
epithelium	O
by	O
invasion	O
of	O
M	O
cells	O
in	O
Peyer	O
'	O
s	O
patches	O
(	O
1	O
)	O
.	O

Many	O
of	O
the	O
genes	O
required	O
for	O
intestinal	O
penetration	O
and	O
invasion	O
of	O
host	O
cells	O
are	O
carried	O
on	O
the	O
40	O
-	O
kb	O
region	O
at	O
centisome	O
63	O
,	O
which	O
is	O
called	O
Salmonella	B-Organism
pathogenicity	O
island	O
1	O
(	O
SPI1	O
)	O
(	O
2	O
)	O
.	O

SPI1	O
contains	O
at	O
least	O
37	O
genes	O
,	O
which	O
encode	O
various	O
components	O
of	O
the	O
type	O
III	O
secretion	O
systems	O
(	O
T3SSs	O
)	O
,	O
its	O
regulators	O
and	O
its	O
secreted	O
effectors	O
(	O
3	O
)	O
.	O

The	O
effector	O
proteins	O
mediate	O
actin	O
cytoskeleton	O
rearrangement	O
,	O
in	O
the	O
form	O
of	O
large	O
membrane	O
ruffles	O
,	O
which	O
engulf	O
the	O
bacteria	O
into	O
the	O
host	O
cell	O
(	O
4	O
,	O
5	O
)	O
.	O

The	O
expression	O
of	O
SPI1	O
is	O
controlled	O
in	O
response	O
to	O
a	O
specific	O
combination	O
of	O
environmental	O
signals	O
,	O
including	O
pH	O
,	O
oxygen	O
tension	O
,	O
medium	O
osmolarity	O
,	O
bile	O
,	O
Mg2	O
+	O
concentration	O
,	O
short	O
-	O
chain	O
fatty	O
acids	O
(	O
SCFAS	O
)	O
,	O
and	O
growth	O
stage	O
of	O
the	O
bacteria	O
(	O
3	O
,	O
6	O
)	O
.	O

Although	O
many	O
factors	O
and	O
a	O
complex	O
mechanism	O
related	O
to	O
environmental	O
stimuli	O
are	O
involved	O
in	O
the	O
modulation	O
of	O
SPI1	O
genes	O
,	O
they	O
are	O
thought	O
to	O
converge	O
on	O
the	O
activation	O
of	O
several	O
transcriptional	O
regulators	O
encoded	O
within	O
SPI1	O
,	O
such	O
as	O
HilA	O
,	O
HilC	O
,	O
HilD	O
and	O
InvF	O
(	O
7	O
-	O
9	O
)	O
.	O

HilA	O
plays	O
a	O
crucial	O
role	O
in	O
the	O
expression	O
of	O
genes	O
that	O
encode	O
the	O
SPI1	O
-	O
T3SS	O
apparatus	O
,	O
the	O
prg	O
and	O
inv	O
/	O
spa	O
operons	O
,	O
by	O
binding	O
upstream	O
of	O
prgH	O
and	O
invF	O
(	O
10	O
)	O
.	O

The	O
expression	O
of	O
invF	O
leads	O
to	O
the	O
induction	O
of	O
several	O
effector	O
genes	O
encoded	O
both	O
within	O
SPI1	O
(	O
sic	O
/	O
sip	O
operon	O
)	O
and	O
outside	O
SPI1	O
(	O
sigD	O
/	O
sopB	O
and	O
sopE	O
)	O
,	O
with	O
SicA	O
as	O
a	O
co	O
-	O
factor	O
(	O
11	O
)	O
.	O

HilC	O
and	O
HilD	O
,	O
which	O
are	O
members	O
of	O
the	O
AraC	O
/	O
XylS	O
family	O
,	O
have	O
been	O
postulated	O
to	O
act	O
as	O
a	O
derepressor	O
of	O
hilA	O
expression	O
by	O
counteracting	O
the	O
action	O
of	O
negative	O
regulatory	O
elements	O
at	O
the	O
hilA	O
promoter	O
(	O
12	O
,	O
13	O
)	O
.	O

However	O
,	O
it	O
has	O
been	O
shown	O
that	O
HilD	O
provides	O
an	O
essential	O
activating	O
function	O
for	O
hilA	O
in	O
the	O
absence	O
of	O
negative	O
regulators	O
(	O
14	O
)	O
.	O

HilC	O
and	O
HilD	O
also	O
directly	O
activate	O
the	O
alternative	O
promoter	O
of	O
the	O
invF	O
operon	O
,	O
which	O
is	O
independent	O
of	O
HilA	O
(	O
15	O
,	O
16	O
)	O
.	O

Similar	O
to	O
HilC	O
and	O
HilD	O
,	O
RtsA	O
activates	O
the	O
expression	O
of	O
SPI1	O
genes	O
by	O
binding	O
upstream	O
of	O
the	O
master	O
regulatory	O
gene	O
,	O
hilA	O
,	O
to	O
induce	O
its	O
expression	O
(	O
9	O
,	O
17	O
)	O
.	O

Recently	O
,	O
Baxter	O
and	O
Jones	O
(	O
18	O
)	O
have	O
shown	O
that	O
HilE	O
is	O
an	O
important	O
Salmonella	B-Organism
-	O
specific	O
regulator	O
of	O
hilA	O
expression	O
.	O

A	O
null	O
mutation	O
in	O
hilE	O
causes	O
an	O
increase	O
in	O
hilA	O
expression	O
and	O
invasion	O
.	O

Using	O
two	O
-	O
hybrid	O
analysis	O
,	O
it	O
has	O
been	O
shown	O
that	O
HilE	O
interacts	O
with	O
HilD	O
,	O
which	O
suggests	O
that	O
HilE	O
represses	O
hilA	O
expression	O
by	O
inhibiting	O
the	O
activity	O
of	O
HilD	O
through	O
a	O
protein	O
-	O
protein	O
interaction	O
(	O
19	O
,	O
20	O
)	O
.	O

Several	O
other	O
genes	O
have	O
been	O
identified	O
that	O
exert	O
positive	O
or	O
negative	O
effects	O
on	O
these	O
direct	O
regulators	O
of	O
SPI1	O
in	O
response	O
to	O
the	O
changes	O
in	O
environmental	O
conditions	O
.	O
<EOS>	B-X
Progestogens	B-X
act	B-X
at	B-X
the	B-X
genomic	B-X
level	B-X
by	B-X
binding	B-X
to	B-X
the	B-X
nuclear	B-X
receptors	B-X
and	B-X
modulating	B-X
the	B-X
expression	B-X
of	B-X
some	B-X
target-genes	B-X
.	B-X
P4	B-X
produced	B-X
in	B-X
the	B-X
luteal	B-X
phase	B-X
of	B-X
the	B-X
menstrual	B-X
cycle	B-X
has	B-X
several	B-X
physiological	B-X
effects	B-X
regulating	B-X
menses	B-X
and	B-X
,	B-X
in	B-X
the	B-X
pregnant	B-X
uterus	B-X
,	B-X
controlling	B-X
the	B-X
development	B-X
of	B-X
endometrial	B-X
receptivity	B-X
preparing	B-X
the	B-X
endometrium	B-X
for	B-X
implantation	B-X
.	B-X
Extra-nuclear	B-X
,	B-X
non-classical	B-X
mechanisms	B-X
of	B-X
action	B-X
have	B-X
also	B-X
been	B-X
identified	B-X
,	B-X
including	B-X
steroid	B-X
interactions	B-X
with	B-X
some	B-X
membrane	B-X
receptors	B-X
[	B-X
oxytocin	B-X
receptors	B-X
and	B-X
-aminobutyric	B-X
acid	B-X
(	B-X
GABA	B-X
Mounting	B-X
evidence	B-X
shows	B-X
that	B-X
MicroRNAs	B-X
(	B-X
miRNAs	B-X
)	B-X
and	B-X
their	B-X
target	B-X
genes	B-X
are	B-X
aberrantly	B-X
expressed	B-X
in	B-X
many	B-X
cancers	B-X
and	B-X
are	B-X
linked	B-X
to	B-X
tumor	B-X
occurrence	B-X
and	B-X
progression	B-X
,	B-X
especially	B-X
in	B-X
esophageal	B-X
cancer	B-X
(	B-X
EC	B-X
)	B-X
.	B-X
We	B-X
identified	B-X
162	B-X
differentially	B-X
expressed	B-X
miRNAs	B-X
and	B-X
4555	B-X
differentially	B-X
expressed	B-X
mRNAs	B-X
in	B-X
EC	B-X
.	B-X
Furthermore	B-X
,	B-X
7	B-X
target	B-X
genes	B-X
(	B-X
Rho	B-X
GTPase-activating	B-X
protein	B-X
24	B-X
,	B-X
Chromobox	B-X
3	B-X
,	B-X
Contactin-associated	B-X
protein	B-X
2	B-X
,	B-X
ELOVL	B-X
fatty	B-X
acid	B-X
elongase	B-X
5	B-X
,	B-X
LIF	B-X
receptor	B-X
subunit	B-X
alpha	B-X
,	B-X
transmembrane	B-X
protein	B-X
44	B-X
,	B-X
and	B-X
transmembrane	B-X
protein	B-X
67	B-X
)	B-X
were	B-X
selected	B-X
for	B-X
Gene	B-X
Ontology	B-X
and	B-X
Kyoto	B-X
Encyclopedia	B-X
of	B-X
Genes	B-X
and	B-X
Genomes	B-X
analyses	B-X
to	B-X
reveal	B-X
their	B-X
potential	B-X
mechanisms	B-X
in	B-X
promoting	B-X
EC	B-X
progression	B-X
.	B-X
After	B-X
a	B-X
series	B-X
of	B-X
correlation	B-X
analyses	B-X
,	B-X
miRNA	B-X
target	B-X
genes	B-X
were	B-X
found	B-X
to	B-X
be	B-X
significantly	B-X
positively	B-X
or	B-X
negatively	B-X
associated	B-X
with	B-X
immune	B-X
infiltration	B-X
,	B-X
tumor	B-X
microenvironment	B-X
,	B-X
cancer	B-X
stemness	B-X
properties	B-X
,	B-X
and	B-X
tumor	B-X
mutation	B-X
burden	B-X
at	B-X
different	B-X
degrees	B-X
in	B-X
EC	B-X
.	B-X
To	B-X
further	B-X
elucidate	B-X
the	B-X
role	B-X
of	B-X
miRNA	B-X
signature	B-X
in	B-X
cancer	B-X
progression	B-X
,	B-X
we	B-X
performed	B-X
a	B-X
pan-cancer	B-X
analysis	B-X
to	B-X
determine	B-X
whether	B-X
these	B-X
genes	B-X
exert	B-X
similar	B-X
effects	B-X
on	B-X
other	B-X
tumors	B-X
.	B-X
Interestingly	B-X
,	B-X
the	B-X
miRNA	B-X
target	B-X
genes	B-X
altered	B-X
expression	B-X
on	B-X
tumor	B-X
immunity	B-X
;	B-X
however	B-X
,	B-X
pan-cancer	B-X
progression	B-X
was	B-X
the	B-X
same	B-X
as	B-X
that	B-X
of	B-X
EC	B-X
.	B-X
Thus	B-X
,	B-X
we	B-X
explored	B-X
the	B-X
immune	B-X
landscape	B-X
of	B-X
the	B-X
miRNA	B-X
signature	B-X
and	B-X
its	B-X
target	B-X
genes	B-X
in	B-X
EC	B-X
and	B-X
pan-cancer	B-X
.	B-X
These	B-X
findings	B-X
demonstrated	B-X
the	B-X
versatility	B-X
and	B-X
effectiveness	B-X
of	B-X
our	B-X
model	B-X
in	B-X
various	B-X
cancers	B-X
and	B-X
provided	B-X
a	B-X
new	B-X
direction	B-X
for	B-X
cancer	B-X
management	B-X
.	B-X

These	O
genes	O
include	O
those	O
that	O
encode	O
several	O
two	O
-	O
component	O
regulatory	O
systems	O
(	O
PhoP	O
/	O
Q	O
,	O
PhoBR	O
,	O
OmpR	O
/	O
EnvZ	O
and	O
SirA	O
/	O
BarA	O
)	O
,	O
post	O
-	O
transcriptional	O
systems	O
(	O
CsrAB	O
,	O
RNase	O
E	O
,	O
PNPase	O
and	O
Lon	O
)	O
,	O
nucleoid	O
proteins	O
(	O
HU	O
,	O
FIS	O
,	O
H	O
-	O
NS	O
and	O
Hha	O
)	O
,	O
signaling	O
molecules	O
(	O
ppGpp	O
and	O
NpnN	O
)	O
,	O
and	O
other	O
regulatory	O
proteins	O
(	O
FliZ	O
,	O
FadD	O
and	O
CpxA	O
)	O
(	O
6	O
,	O
7	O
,	O
19	O
,	O
21	O
,	O
22	O
)	O
.	O

The	O
phosphoenolpyruvate	O
:	O
sugar	O
phosphotransferase	O
system	O
(	O
PTS	O
)	O
is	O
the	O
major	O
sugar	O
transport	O
system	O
in	O
many	O
Gram	O
-	O
positive	O
and	O
Gram	O
-	O
negative	O
bacterial	O
species	O
.	O

In	O
the	O
animal	O
model	O
,	O
attenuation	O
of	O
virulence	O
has	O
been	O
noted	O
for	O
Salmonella	B-Organism
strains	O
that	O
carry	O
mutations	O
in	O
the	O
pts	O
,	O
crr	O
,	O
cya	O
or	O
crp	O
genes	O
,	O
which	O
encode	O
the	O
general	O
energy	O
-	O
coupling	O
enzymes	O
of	O
the	O
PTS	O
,	O
enzyme	O
IIAGlc	O
of	O
the	O
PTS	O
,	O
adenylate	O
cyclase	O
and	O
cyclic	O
AMP	O
receptor	O
protein	O
,	O
respectively	O
(	O
23	O
,	O
24	O
)	O
.	O

Mlc	O
is	O
a	O
global	O
regulator	O
of	O
carbohydrate	O
metabolism	O
and	O
controls	O
several	O
genes	O
involved	O
in	O
sugar	O
utilization	O
(	O
25	O
-	O
27	O
)	O
.	O

Therefore	O
,	O
it	O
seemed	O
possible	O
that	O
Mlc	O
also	O
affects	O
the	O
virulence	O
of	O
Salmonella	B-Organism
.	O

In	O
the	O
present	O
study	O
,	O
a	O
Salmonella	O
Typhimurium	O
mlc	O
mutant	O
was	O
constructed	O
to	O
investigate	O
the	O
contribution	O
of	O
Mlc	O
to	O
the	O
virulence	O
phenotype	O
.	O

We	O
have	O
found	O
that	O
Mlc	O
activates	O
SPI1	O
gene	O
expression	O
by	O
repressing	O
hilE	O
expression	O
.	O

RESULTS	O

Mutation	O
of	O
the	O
mlc	O
gene	O
reduces	O
Salmonella	B-Organism
invasiveness	O
The	O
process	O
of	O
invasion	O
into	O
non	O
-	O
phagocytic	O
epithelial	O
cells	O
,	O
which	O
is	O
known	O
to	O
be	O
mediated	O
by	O
proteins	O
secreted	O
by	O
the	O
SPI1	O
-	O
encoded	O
type	O
III	O
machinery	O
(	O
3	O
)	O
,	O
is	O
an	O
important	O
initial	O
step	O
in	O
the	O
pathogenesis	O
of	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
.	O
<EOS>	B-X
Salmonella	B-X
enterica	B-X
subspecies	B-X
I	B-X
,	B-X
serovar	B-X
Typhimurium	B-X
(	B-X
S.	B-X
typhimurium	B-X
)	B-X
,	B-X
is	B-X
a	B-X
leading	B-X
cause	B-X
of	B-X
human	B-X
gastroenteritis	B-X
,	B-X
and	B-X
is	B-X
used	B-X
as	B-X
a	B-X
mouse	B-X
model	B-X
of	B-X
human	B-X
typhoid	B-X
fever	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
focus	B-X
on	B-X
Salmonella	B-X
enterica	B-X
Typhimurium	B-X
(	B-X
S.	B-X
Typhimurium	B-X
)	B-X
,	B-X
a	B-X
frequent	B-X
cause	B-X
of	B-X
acute	B-X
,	B-X
self-limiting	B-X
food-borne	B-X
diarrhea	B-X
and	B-X
a	B-X
model	B-X
that	B-X
has	B-X
revealed	B-X
key	B-X
principles	B-X
of	B-X
enteropathogen	B-X
infection	B-X
.	B-X
We	B-X
review	B-X
the	B-X
steps	B-X
of	B-X
gut	B-X
infection	B-X
and	B-X
the	B-X
mucosal	B-X
innate-immune	B-X
defenses	B-X
limiting	B-X
pathogen	B-X
burdens	B-X
,	B-X
and	B-X
we	B-X
discuss	B-X
how	B-X
inflammation	B-X
boosts	B-X
gut	B-X
luminal	B-X
S.	B-X
Typhimurium	B-X
growth	B-X
.	B-X
We	B-X
also	B-X
discuss	B-X
how	B-X
S.	B-X
Typhimurium-induced	B-X
inflammation	B-X
accelerates	B-X
the	B-X
transfer	B-X
of	B-X
plasmids	B-X
and	B-X
phages	B-X
,	B-X
which	B-X
may	B-X
promote	B-X
the	B-X
transmission	B-X
of	B-X
antibiotic	B-X
resistance	B-X
and	B-X
facilitate	B-X
emergence	B-X
of	B-X
pathobionts	B-X
and	B-X
pathogens	B-X
with	B-X
enhanced	B-X
virulence	B-X
.	B-X

We	O
examined	O
the	O
ability	O
of	O
an	O
mlc	O
mutant	O
,	O
SR1304	B-Organism
,	O
to	O
invade	O
cultured	O
HEp	B-Organism
-	I-Organism
2	I-Organism
and	O
HeLa	O
epithelial	O
cells	O
.	O

SL1344	B-Organism
was	O
used	O
as	O
the	O
control	O
strain	O
,	O
and	O
the	O
invasiveness	O
of	O
this	O
strain	O
was	O
arbitrarily	O
set	O
at	O
100	O
%	O
.	O

When	O
the	O
Salmonella	B-Organism
bacteria	O
were	O
grown	O
in	O
static	O
cultures	O
to	O
the	O
exponential	O
phase	O
(	O
SPI1	O
-	O
inducing	O
condition	O
)	O
,	O
the	O
invasiveness	O
of	O
SR1304	B-Organism
for	O
both	O
epithelial	O
cell	O
lines	O
was	O
reduced	O
by	O
about	O
3	O
-	O
fold	O
,	O
compared	O
to	O
that	O
of	O
SL1344	B-Organism
(	O
Figure	O
1A	O
and	O
B	O
)	O
.	O

S	B-Organism
.	I-Organism
<EOS>	B-X
Finkelstein	B-X
's	B-X
Test	B-X
Is	B-X
Superior	B-X
to	B-X
Eichhoff	B-X
's	B-X
Test	B-X
in	B-X
the	B-X
Investigation	B-X
of	B-X
de	B-X
Quervain	B-X
's	B-X
Disease	B-X
.	B-X
Protein	B-X
S	B-X
deficiency	B-X
.	B-X
Letter	B-X
:	B-X
Craniometrics	B-X
and	B-X
Ventricular	B-X
Access	B-X
:	B-X
A	B-X
Review	B-X
of	B-X
Kocher	B-X
's	B-X
,	B-X
Kaufman	B-X
's	B-X
,	B-X
Paine	B-X
's	B-X
,	B-X
Menovksy	B-X
's	B-X
,	B-X
Tubbs	B-X
'	B-X
,	B-X
Keen	B-X
's	B-X
,	B-X
Frazier	B-X
's	B-X
,	B-X
Dandy	B-X
's	B-X
,	B-X
and	B-X
Sanchez	B-X
's	B-X
Points	B-X
.	B-X

Typhimurium	B-Organism
induces	O
the	O
apoptosis	O
of	O
infected	O
macrophages	O
.	O
<EOS>	B-X
Recent	B-X
studies	B-X
have	B-X
highlighted	B-X
mechanistic	B-X
overlaps	B-X
and	B-X
extensive	B-X
,	B-X
multifaceted	B-X
crosstalk	B-X
between	B-X
pyroptosis	B-X
,	B-X
apoptosis	B-X
,	B-X
and	B-X
necroptosis	B-X
,	B-X
three	B-X
programmed	B-X
cell	B-X
death	B-X
pathways	B-X
traditionally	B-X
considered	B-X
autonomous	B-X
.	B-X
During	B-X
PANoptosis	B-X
,	B-X
inflammatory	B-X
cell	B-X
death	B-X
occurs	B-X
through	B-X
the	B-X
collective	B-X
activation	B-X
of	B-X
pyroptosis	B-X
,	B-X
apoptosis	B-X
,	B-X
and	B-X
necroptosis	B-X
,	B-X
which	B-X
can	B-X
circumvent	B-X
pathogen-mediated	B-X
inhibition	B-X
of	B-X
individual	B-X
death	B-X
pathways	B-X
.	B-X
Infection	B-X
of	B-X
macrophages	B-X
with	B-X
influenza	B-X
A	B-X
virus	B-X
,	B-X
vesicular	B-X
stomatitis	B-X
virus	B-X
,	B-X
SIRT3-mediated	B-X
deacetylation	B-X
of	B-X
NLRC4	B-X
promotes	B-X
inflammasome	B-X
activation	B-X
.	B-X

This	O
process	O
is	O
rapid	O
,	O
specific	O
and	O
depends	O
on	O
the	O
T3SS	O
encoded	O
within	O
SPI1	O
(	O
33	O
,	O
34	O
)	O
.	O

To	O
discover	O
whether	O
the	O
mlc	O
mutant	O
grown	O
under	O
the	O
SPI1	O
-	O
inducing	O
condition	O
affects	O
the	O
capacity	O
to	O
induce	O
apoptosis	O
in	O
macrophages	O
,	O
the	O
release	O
of	O
the	O
cytoplasmic	O
enzyme	O
LDH	O
was	O
determined	O
in	O
a	O
cytotoxicity	O
assay	O
(	O
33	O
)	O
.	O

Figure	O
1C	O
shows	O
that	O
SL1344	B-Organism
killed	O
42	O
%	O
of	O
the	O
macrophages	O
,	O
whereas	O
SR1304	B-Organism
killed	O
only	O
16	O
%	O
of	O
the	O
macrophages	O
4h	O
after	O
infection	O
,	O
which	O
demonstrates	O
that	O
the	O
mlc	O
gene	O
plays	O
an	O
important	O
role	O
in	O
the	O
expression	O
of	O
genes	O
involved	O
in	O
cytotoxicity	O
.	O

We	O
also	O
tested	O
the	O
effect	O
of	O
the	O
mlc	O
mutation	O
on	O
the	O
ability	O
to	O
replicate	O
within	O
the	O
RAW264	O
.	O
7	O
macrophage	O
cell	O
line	O
.	O

After	O
cultivation	O
to	O
the	O
stationary	O
phase	O
with	O
aeration	O
,	O
the	O
bacteria	O
were	O
opsonized	O
with	O
10	O
%	O
normal	O
mouse	B-Organism
serum	O
and	O
added	O
to	O
the	O
cell	O
monolayer	O
(	O
30	O
)	O
.	O

When	O
the	O
number	O
of	O
intracellular	O
bacteria	O
were	O
measured	O
at	O
2	O
and	O
18h	O
post	O
-	O
infection	O
,	O
the	O
degree	O
of	O
replication	O
was	O
similar	O
for	O
SL1344	B-Organism
and	O
SR1304	B-Organism
(	O
Figure	O
1D	O
)	O
.	O

Collectively	O
,	O
these	O
results	O
suggest	O
that	O
the	O
main	O
target	O
of	O
Mlc	O
action	O
in	O
Salmonella	B-Organism
virulence	O
is	O
SPI1	O
,	O
which	O
is	O
known	O
to	O
encode	O
various	O
genes	O
that	O
are	O
required	O
for	O
Salmonella	B-Organism
invasion	O
of	O
host	O
cells	O
.	O

The	O
expression	O
levels	O
of	O
hilA	O
,	O
invF	O
and	O
hilD	O
,	O
but	O
not	O
of	O
hilC	O
,	O
are	O
decreased	O
in	O
the	O
mlc	O
mutant	O
<EOS>	B-X
DNA	B-X
adenine	B-X
methylase	B-X
(	B-X
Dam	B-X
(	B-X
-	B-X
)	B-X
)	B-X
mutants	B-X
of	B-X
Salmonella	B-X
enterica	B-X
are	B-X
attenuated	B-X
in	B-X
the	B-X
mouse	B-X
model	B-X
and	B-X
present	B-X
multiple	B-X
virulence-related	B-X
defects	B-X
.	B-X
Impaired	B-X
interaction	B-X
of	B-X
Salmonella	B-X
Dam	B-X
(	B-X
-	B-X
)	B-X
mutants	B-X
with	B-X
the	B-X
intestinal	B-X
epithelium	B-X
has	B-X
been	B-X
tentatively	B-X
correlated	B-X
with	B-X
reduced	B-X
secretion	B-X
of	B-X
pathogenicity	B-X
island	B-X
1	B-X
(	B-X
SPI-1	B-X
)	B-X
effectors	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
show	B-X
that	B-X
S.	B-X
enterica	B-X
Dam	B-X
(	B-X
-	B-X
)	B-X
mutants	B-X
contain	B-X
lowered	B-X
levels	B-X
of	B-X
the	B-X
SPI-1	B-X
transcriptional	B-X
regulators	B-X
HilA	B-X
,	B-X
HilC	B-X
,	B-X
HilD	B-X
,	B-X
and	B-X
InvF	B-X
.	B-X
A	B-X
transcriptional	B-X
hilDlac	B-X
fusion	B-X
is	B-X
expressed	B-X
at	B-X
similar	B-X
levels	B-X
in	B-X
Dam	B-X
(	B-X
+	B-X
)	B-X
and	B-X
Dam	B-X
(	B-X
-	B-X
)	B-X
hosts	B-X
.	B-X
However	B-X
,	B-X
lower	B-X
levels	B-X
of	B-X
hilD	B-X
mRNA	B-X
are	B-X
found	B-X
in	B-X
a	B-X
Dam	B-X
(	B-X
-	B-X
)	B-X
background	B-X
,	B-X
thus	B-X
providing	B-X
unsuspected	B-X
evidence	B-X
that	B-X
Dam	B-X
methylation	B-X
might	B-X
exert	B-X
post-transcriptional	B-X
regulation	B-X
of	B-X
hilD	B-X
expression	B-X
.	B-X
This	B-X
hypothesis	B-X
is	B-X
supported	B-X
by	B-X
the	B-X
following	B-X
lines	B-X
of	B-X
evidence	B-X
:	B-X
(	B-X
i	B-X
)	B-X
lowered	B-X
levels	B-X
of	B-X
hilD	B-X
mRNA	B-X
are	B-X
found	B-X
in	B-X
Salmonella	B-X
Dam	B-X
(	B-X
-	B-X
)	B-X
mutants	B-X
when	B-X
hilD	B-X
is	B-X
transcribed	B-X
from	B-X
a	B-X
heterologous	B-X
promoter	B-X
;	B-X
(	B-X
ii	B-X
)	B-X
increased	B-X
hilD	B-X
mRNA	B-X
turnover	B-X
is	B-X
observed	B-X
in	B-X
Dam	B-X
(	B-X
-	B-X
)	B-X
mutants	B-X
;	B-X
(	B-X
iii	B-X
)	B-X
lack	B-X
of	B-X
the	B-X
Hfq	B-X
RNA	B-X
chaperone	B-X
enhances	B-X
hilD	B-X
mRNA	B-X
instability	B-X
in	B-X
Dam	B-X
(	B-X
-	B-X
)	B-X
mutants	B-X
;	B-X
and	B-X
(	B-X
iv	B-X
)	B-X
lack	B-X
of	B-X
the	B-X
RNA	B-X
degradosome	B-X
components	B-X
polynucleotide	B-X
phosphorylase	B-X
and	B-X
ribonuclease	B-X
E	B-X
suppresses	B-X
hilD	B-X
mRNA	B-X
instability	B-X
in	B-X
a	B-X
Dam	B-X
(	B-X
-	B-X
)	B-X
background	B-X
.	B-X
Our	B-X
report	B-X
of	B-X
Dam-dependent	B-X
control	B-X
of	B-X
hilD	B-X
mRNA	B-X
stability	B-X
suggests	B-X
that	B-X
DNA	B-X
adenine	B-X
methylation	B-X
plays	B-X
hitherto	B-X
unknown	B-X
roles	B-X
in	B-X
post-transcriptional	B-X
control	B-X
of	B-X
gene	B-X
expression	B-X
.	B-X

To	O
identify	O
the	O
target	O
gene	O
in	O
SPI1	O
that	O
is	O
regulated	O
by	O
Mlc	O
,	O
the	O
expression	O
patterns	O
of	O
the	O
SPI1	O
-	O
regulatory	O
genes	O
,	O
which	O
include	O
hilA	O
,	O
invF	O
,	O
hilC	O
and	O
hilD	O
,	O
were	O
examined	O
by	O
primer	O
extension	O
analysis	O
of	O
total	O
RNA	O
from	O
SL1344	B-Organism
and	O
SR1304	B-Organism
grown	O
statically	O
to	O
the	O
exponential	O
phase	O
.	O

The	O
transcriptional	O
start	O
sites	O
of	O
these	O
genes	O
have	O
been	O
reported	O
previously	O
(	O
12	O
,	O
16	O
,	O
35	O
,	O
36	O
)	O
.	O
<EOS>	B-X
During	B-X
retinal	B-X
development	B-X
,	B-X
post-mitotic	B-X
neural	B-X
progenitor	B-X
cells	B-X
must	B-X
activate	B-X
thousands	B-X
of	B-X
genes	B-X
to	B-X
complete	B-X
synaptogenesis	B-X
and	B-X
terminal	B-X
maturation	B-X
.	B-X
While	B-X
many	B-X
of	B-X
these	B-X
genes	B-X
are	B-X
known	B-X
,	B-X
others	B-X
remain	B-X
beyond	B-X
the	B-X
sensitivity	B-X
of	B-X
expression	B-X
microarray	B-X
analysis	B-X
.	B-X
Some	B-X
of	B-X
these	B-X
elusive	B-X
gene	B-X
activation	B-X
events	B-X
can	B-X
be	B-X
detected	B-X
by	B-X
mapping	B-X
changes	B-X
in	B-X
RNA	B-X
polymerase-II	B-X
(	B-X
Pol-II	B-X
)	B-X
association	B-X
around	B-X
transcription	B-X
start	B-X
sites	B-X
.	B-X

SR1304	B-Organism
exhibited	O
a	O
>	O
10	O
-	O
fold	O
reduction	O
in	O
hilA	O
and	O
HilA	O
-	O
dependent	O
invF	O
(	O
invFA	O
)	O
expression	O
,	O
and	O
about	O
a	O
3	O
-	O
fold	O
reduction	O
in	O
hilD	O
and	O
HilC	O
/	O
D	O
-	O
dependent	O
invF	O
(	O
invFD	O
)	O
expression	O
,	O
compared	O
to	O
SL1344	B-Organism
.	O

However	O
,	O
hilC	O
expression	O
was	O
unchanged	O
(	O
Figure	O
2A	O
)	O
.	O

We	O
also	O
observed	O
reduced	O
expression	O
of	O
the	O
prgH	O
and	O
sigD	O
genes	O
,	O
which	O
are	O
known	O
to	O
be	O
regulated	O
by	O
HilA	O
and	O
InvF	O
(	O
10	O
,	O
11	O
,	O
29	O
,	O
35	O
)	O
,	O
in	O
SR1304	B-Organism
(	O
Figure	O
2B	O
)	O
.	O

The	O
expression	O
levels	O
of	O
hilA	O
and	O
invF	O
were	O
previously	O
shown	O
to	O
be	O
affected	O
by	O
both	O
HilC	O
and	O
HilD	O
(	O
8	O
,	O
9	O
,	O
16	O
)	O
but	O
since	O
hilC	O
levels	O
are	O
unaffected	O
by	O
the	O
mlc	O
mutation	O
(	O
Figure	O
2A	O
)	O
we	O
speculated	O
that	O
Mlc	O
was	O
regulating	O
hilA	O
and	O
invF	O
expression	O
indirectly	O
probably	O
by	O
modulating	O
the	O
expression	O
of	O
hilD	O
or	O
the	O
higher	O
regulator	O
of	O
hilD	O
.	O
<EOS>	B-X
The	B-X
hilA	B-X
gene	B-X
on	B-X
the	B-X
Salmonella	B-X
enterica	B-X
pathogenicity	B-X
island-1	B-X
encodes	B-X
the	B-X
key	B-X
transcriptional	B-X
regulator	B-X
of	B-X
host	B-X
cell	B-X
invasion	B-X
.	B-X
Transcription	B-X
of	B-X
hilA	B-X
is	B-X
regulated	B-X
by	B-X
numerous	B-X
physiological	B-X
signals	B-X
,	B-X
including	B-X
repression	B-X
under	B-X
low	B-X
osmolarity	B-X
conditions	B-X
.	B-X
To	B-X
investigate	B-X
the	B-X
osmotic	B-X
control	B-X
of	B-X
hilA	B-X
transcription	B-X
,	B-X
promoter	B-X
truncations	B-X
that	B-X
remove	B-X
sequences	B-X
flanking	B-X
the	B-X
hilA	B-X
promoter	B-X
were	B-X
examined	B-X
.	B-X
Expression	B-X
of	B-X
the	B-X
minimal	B-X
hilA	B-X
core	B-X
promoter	B-X
(	B-X
-55	B-X
to	B-X
+90	B-X
,	B-X
relative	B-X
to	B-X
the	B-X
transcription	B-X
start	B-X
site	B-X
)	B-X
was	B-X
57-times	B-X
higher	B-X
than	B-X
the	B-X
intact	B-X
promoter	B-X
(	B-X
-242	B-X
to	B-X
+505	B-X
)	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
osmotic	B-X
stress	B-X
.	B-X
Either	B-X
flanking	B-X
region	B-X
depressed	B-X
expression	B-X
when	B-X
it	B-X
was	B-X
placed	B-X
downstream	B-X
of	B-X
the	B-X
lacUV5	B-X
promoter	B-X
,	B-X
and	B-X
this	B-X
inhibition	B-X
was	B-X
increased	B-X
when	B-X
the	B-X
other	B-X
flanking	B-X
sequence	B-X
was	B-X
present	B-X
upstream	B-X
of	B-X
the	B-X
promoter	B-X
.	B-X
These	B-X
results	B-X
show	B-X
that	B-X
the	B-X
hilA	B-X
promoter	B-X
is	B-X
highly	B-X
active	B-X
without	B-X
other	B-X
transcription	B-X
regulators	B-X
.	B-X
The	B-X
hilA	B-X
activators	B-X
,	B-X
HilD	B-X
and	B-X
HilC	B-X
appear	B-X
to	B-X
overcome	B-X
effects	B-X
of	B-X
downstream	B-X
silencing	B-X
region	B-X
and	B-X
disrupt	B-X
repressive	B-X
DNA	B-X
loop	B-X
.	B-X
Action	B-X
of	B-X
activators	B-X
requires	B-X
contact	B-X
with	B-X
RNA	B-X
polymerase	B-X
from	B-X
their	B-X
DNA	B-X
binding	B-X
site	B-X
,	B-X
centered	B-X
at	B-X
position	B-X
-77	B-X
,	B-X
relative	B-X
to	B-X
the	B-X
hilA	B-X
transcription	B-X
start	B-X
site	B-X
.	B-X

Mlc	O
modulates	O
the	O
expression	O
of	O
SPI1	O
genes	O
by	O
repressing	O
hilE	O
<EOS>	B-X
The	B-X
global	B-X
regulator	B-X
Mlc	B-X
is	B-X
a	B-X
repressor	B-X
of	B-X
several	B-X
genes	B-X
and	B-X
operons	B-X
that	B-X
are	B-X
involved	B-X
in	B-X
sugar	B-X
uptake	B-X
and	B-X
metabolism	B-X
.	B-X
A	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
mlc	B-X
mutant	B-X
showed	B-X
reduced	B-X
levels	B-X
of	B-X
invasion	B-X
and	B-X
cytotoxicity	B-X
compared	B-X
to	B-X
the	B-X
wild-type	B-X
,	B-X
and	B-X
exhibited	B-X
reduced	B-X
expression	B-X
levels	B-X
of	B-X
hilD	B-X
,	B-X
hilA	B-X
and	B-X
invF	B-X
,	B-X
which	B-X
are	B-X
regulatory	B-X
genes	B-X
in	B-X
the	B-X
Salmonella	B-X
pathogenicity	B-X
island	B-X
1	B-X
(	B-X
SPI1	B-X
)	B-X
.	B-X
However	B-X
,	B-X
the	B-X
effects	B-X
of	B-X
Mlc	B-X
on	B-X
hilD	B-X
expression	B-X
and	B-X
bacterial	B-X
invasiveness	B-X
were	B-X
not	B-X
seen	B-X
in	B-X
the	B-X
hilE	B-X
mutant	B-X
,	B-X
and	B-X
hilE	B-X
expression	B-X
was	B-X
increased	B-X
in	B-X
the	B-X
mlc	B-X
mutant	B-X
,	B-X
which	B-X
suggests	B-X
that	B-X
Mlc	B-X
exerts	B-X
positive	B-X
effects	B-X
on	B-X
the	B-X
expression	B-X
of	B-X
SPI1	B-X
genes	B-X
by	B-X
reducing	B-X
the	B-X
expression	B-X
of	B-X
HilE	B-X
,	B-X
which	B-X
is	B-X
known	B-X
to	B-X
down-regulate	B-X
the	B-X
expression	B-X
of	B-X
SPI1	B-X
genes	B-X
through	B-X
direct	B-X
interaction	B-X
with	B-X
HilD	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
two	B-X
known	B-X
promoters	B-X
of	B-X
hilE	B-X
were	B-X
not	B-X
modulated	B-X
by	B-X
Mlc	B-X
,	B-X
and	B-X
we	B-X
identified	B-X
a	B-X
third	B-X
promoter	B-X
,	B-X
designated	B-X
P3	B-X
,	B-X
which	B-X
was	B-X
repressed	B-X
by	B-X
Mlc	B-X
.	B-X
The	B-X
gel	B-X
mobility	B-X
shift	B-X
assay	B-X
and	B-X
footprinting	B-X
analysis	B-X
revealed	B-X
that	B-X
Mlc	B-X
repressed	B-X
hilE	B-X
in	B-X
a	B-X
direct	B-X
manner	B-X
by	B-X
binding	B-X
to	B-X
two	B-X
distinct	B-X
sites	B-X
in	B-X
the	B-X
hilE	B-X
P3	B-X
promoter	B-X
region	B-X
.	B-X
The	B-X
specific	B-X
down-regulation	B-X
of	B-X
hilD	B-X
observed	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
Mlc	B-X
regulon-inducible	B-X
sugars	B-X
,	B-X
such	B-X
as	B-X
glucose	B-X
and	B-X
mannose	B-X
,	B-X
could	B-X
not	B-X
be	B-X
detected	B-X
in	B-X
the	B-X
mlc	B-X
mutant	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
results	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
Mlc	B-X
functions	B-X
to	B-X
sense	B-X
the	B-X
availability	B-X
of	B-X
sugars	B-X
and	B-X
is	B-X
linked	B-X
to	B-X
virulence	B-X
gene	B-X
regulation	B-X
by	B-X
its	B-X
ability	B-X
to	B-X
control	B-X
hilE	B-X
expression	B-X
in	B-X
Salmonella	B-X
.	B-X

Subsequently	O
,	O
we	O
studied	O
whether	O
hilE	O
expression	O
was	O
affected	O
by	O
Mlc	O
.	O

Baxter	O
et	O
al	O
.	O
<EOS>	B-X
Size-selected	B-X
supported	B-X
clusters	B-X
of	B-X
transition	B-X
metals	B-X
can	B-X
be	B-X
remarkable	B-X
and	B-X
highly	B-X
tunable	B-X
catalysts	B-X
.	B-X
A	B-X
particular	B-X
example	B-X
is	B-X
Pt	B-X
clusters	B-X
deposited	B-X
on	B-X
alumina	B-X
,	B-X
which	B-X
have	B-X
been	B-X
shown	B-X
to	B-X
dehydrogenate	B-X
hydrocarbons	B-X
in	B-X
a	B-X
size-specific	B-X
manner	B-X
.	B-X

(	O
20	O
)	O
have	O
found	O
that	O
HilE	O
plays	O
an	O
important	O
regulatory	O
role	O
in	O
the	O
expression	O
of	O
the	O
Salmonella	B-Organism
-	O
invasive	O
phenotype	O
by	O
affecting	O
hilA	O
transcription	O
through	O
direct	O
interaction	O
with	O
HilD	O
.	O

To	O
study	O
the	O
effect	O
of	O
Mlc	O
on	O
hilE	O
expression	O
,	O
we	O
measured	O
the	O
expression	O
of	O
hilE	O
-	O
lacZY	O
on	O
the	O
low	O
-	O
copy	O
plasmid	O
pMAB69	O
,	O
which	O
contains	O
the	O
hilE	O
promoter	O
region	O
from	O
-	O
886	O
to	O
+	O
121	O
,	O
relative	O
to	O
the	O
translation	O
start	O
site	O
.	O

When	O
these	O
cells	O
were	O
grown	O
in	O
static	O
cultures	O
to	O
exponential	O
phase	O
,	O
SL1344	B-Organism
-	I-Organism
pMAB69	I-Organism
expressed	O
28	O
.	O
9	O
+	O
/	O
-	O
3	O
.	O
5	O
Miller	O
units	O
of	O
beta	O
-	O
galactosidase	O
,	O
whereas	O
SR1304	B-Organism
-	I-Organism
pMAB69	I-Organism
expressed	O
49	O
.	O
5	O
+	O
/	O
-	O
5	O
.	O
3	O
Miller	O
units	O
of	O
beta	O
-	O
galactosidase	O
;	O
the	O
level	O
of	O
hilE	O
expression	O
in	O
the	O
mlc	O
mutant	O
was	O
almost	O
1	O
.	O
8	O
-	O
fold	O
higher	O
than	O
that	O
in	O
the	O
wild	O
-	O
type	O
strain	O
.	O

The	O
hilE	O
mRNA	O
level	O
measured	O
by	O
real	O
-	O
time	O
PCR	O
also	O
revealed	O
that	O
hilE	O
expression	O
was	O
increased	O
in	O
SR1304	B-Organism
by	O
about	O
2	O
-	O
fold	O
(	O
Figure	O
3A	O
)	O
.	O

These	O
results	O
suggest	O
that	O
Mlc	O
can	O
act	O
as	O
a	O
negative	O
regulator	O
of	O
hilE	O
.	O

The	O
role	O
of	O
HilE	O
in	O
the	O
regulation	O
of	O
SPI1	O
gene	O
expression	O
by	O
Mlc	O
was	O
further	O
studied	O
by	O
comparing	O
the	O
invasive	O
abilities	O
of	O
the	O
hilE	O
and	O
hilE	O
/	O
mlc	O
mutant	O
strains	O
of	O
Salmonella	B-Organism
.	O

Invasiveness	O
for	O
HEp	O
-	O
2	O
cells	O
was	O
reduced	O
to	O
39	O
.	O
1	O
%	O
of	O
the	O
wild	O
-	O
type	O
level	O
by	O
mlc	O
mutation	O
,	O
whereas	O
it	O
was	O
increased	O
by	O
1	O
.	O
57	O
-	O
fold	O
by	O
hilE	O
mutation	O
(	O
Figure	O
3B	O
)	O
.	O

However	O
,	O
the	O
hilE	O
/	O
mlc	O
double	O
mutant	O
showed	O
an	O
almost	O
similar	O
invasion	O
ability	O
to	O
that	O
of	O
the	O
hilE	O
mutant	O
(	O
Figure	O
3B	O
)	O
,	O
which	O
suggests	O
that	O
the	O
effect	O
of	O
the	O
mlc	O
mutation	O
on	O
the	O
invasive	O
phenotype	O
is	O
mainly	O
dependent	O
upon	O
HilE	O
function	O
.	O

The	O
requirement	O
of	O
hilE	O
for	O
Mlc	O
function	O
was	O
reflected	O
in	O
the	O
levels	O
of	O
hilD	O
transcription	O
.	O

While	O
hilD	O
expression	O
was	O
reduced	O
in	O
the	O
mlc	O
mutant	O
,	O
it	O
was	O
slightly	O
higher	O
than	O
the	O
wild	O
-	O
type	O
level	O
in	O
both	O
the	O
hilE	O
and	O
hilE	O
/	O
mlc	O
mutant	O
strains	O
(	O
Figure	O
3C	O
)	O
.	O

Additionally	O
,	O
the	O
over	O
-	O
expression	O
of	O
HilD	O
from	O
the	O
plasmid	O
pJB3	O
containing	O
hilD	O
gene	O
under	O
the	O
control	O
of	O
a	O
lac	O
promoter	O
caused	O
the	O
induction	O
of	O
hilA	O
by	O
approximately2	O
-	O
fold	O
and	O
invF	O
by	O
approximately6	O
-	O
fold	O
irrespective	O
of	O
hilE	O
or	O
mlc	O
mutation	O
when	O
real	O
-	O
time	O
PCR	O
was	O
used	O
to	O
compare	O
the	O
expression	O
levels	O
(	O
data	O
not	O
shown	O
)	O
.	O

Since	O
HilD	O
activates	O
the	O
transcription	O
of	O
hilA	O
(	O
14	O
)	O
,	O
which	O
in	O
turn	O
can	O
activate	O
HilA	O
-	O
dependent	O
invFA	O
expression	O
(	O
10	O
)	O
,	O
and	O
directly	O
activates	O
HilC	O
/	O
D	O
-	O
dependent	O
invFD	O
expression	O
(	O
16	O
)	O
,	O
these	O
results	O
establish	O
that	O
the	O
mlc	O
mutation	O
exerts	O
a	O
negative	O
effect	O
on	O
SPI1	O
gene	O
expression	O
,	O
mainly	O
by	O
increasing	O
the	O
level	O
of	O
hilE	O
expression	O
.	O

The	O
low	O
level	O
of	O
hilD	O
expression	O
in	O
the	O
mlc	O
mutant	O
can	O
be	O
explained	O
by	O
the	O
fact	O
that	O
the	O
increased	O
level	O
of	O
HilE	O
in	O
the	O
mlc	O
mutant	O
can	O
repress	O
the	O
activity	O
of	O
HilD	O
,	O
which	O
is	O
known	O
to	O
act	O
as	O
an	O
activator	O
of	O
its	O
own	O
expression	O
(	O
9	O
,	O
36	O
)	O
.	O

The	O
hilE	O
P3	O
promoter	O
is	O
repressed	O
by	O
Mlc	O
<EOS>	B-X
The	B-X
global	B-X
regulator	B-X
Mlc	B-X
is	B-X
a	B-X
repressor	B-X
of	B-X
several	B-X
genes	B-X
and	B-X
operons	B-X
that	B-X
are	B-X
involved	B-X
in	B-X
sugar	B-X
uptake	B-X
and	B-X
metabolism	B-X
.	B-X
However	B-X
,	B-X
the	B-X
effects	B-X
of	B-X
Mlc	B-X
on	B-X
hilD	B-X
expression	B-X
and	B-X
bacterial	B-X
invasiveness	B-X
were	B-X
not	B-X
seen	B-X
in	B-X
the	B-X
hilE	B-X
mutant	B-X
,	B-X
and	B-X
hilE	B-X
expression	B-X
was	B-X
increased	B-X
in	B-X
the	B-X
mlc	B-X
mutant	B-X
,	B-X
which	B-X
suggests	B-X
that	B-X
Mlc	B-X
exerts	B-X
positive	B-X
effects	B-X
on	B-X
the	B-X
expression	B-X
of	B-X
SPI1	B-X
genes	B-X
by	B-X
reducing	B-X
the	B-X
expression	B-X
of	B-X
HilE	B-X
,	B-X
which	B-X
is	B-X
known	B-X
to	B-X
down-regulate	B-X
the	B-X
expression	B-X
of	B-X
SPI1	B-X
genes	B-X
through	B-X
direct	B-X
interaction	B-X
with	B-X
HilD	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
two	B-X
known	B-X
promoters	B-X
of	B-X
hilE	B-X
were	B-X
not	B-X
modulated	B-X
by	B-X
Mlc	B-X
,	B-X
and	B-X
we	B-X
identified	B-X
a	B-X
third	B-X
promoter	B-X
,	B-X
designated	B-X
P3	B-X
,	B-X
which	B-X
was	B-X
repressed	B-X
by	B-X
Mlc	B-X
.	B-X
The	B-X
gel	B-X
mobility	B-X
shift	B-X
assay	B-X
and	B-X
footprinting	B-X
analysis	B-X
revealed	B-X
that	B-X
Mlc	B-X
repressed	B-X
hilE	B-X
in	B-X
a	B-X
direct	B-X
manner	B-X
by	B-X
binding	B-X
to	B-X
two	B-X
distinct	B-X
sites	B-X
in	B-X
the	B-X
hilE	B-X
P3	B-X
promoter	B-X
region	B-X
.	B-X
The	B-X
specific	B-X
down-regulation	B-X
of	B-X
hilD	B-X
observed	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
Mlc	B-X
regulon-inducible	B-X
sugars	B-X
,	B-X
such	B-X
as	B-X
glucose	B-X
and	B-X
mannose	B-X
,	B-X
could	B-X
not	B-X
be	B-X
detected	B-X
in	B-X
the	B-X
mlc	B-X
mutant	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
results	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
Mlc	B-X
functions	B-X
to	B-X
sense	B-X
the	B-X
availability	B-X
of	B-X
sugars	B-X
and	B-X
is	B-X
linked	B-X
to	B-X
virulence	B-X
gene	B-X
regulation	B-X
by	B-X
its	B-X
ability	B-X
to	B-X
control	B-X
hilE	B-X
expression	B-X
in	B-X
Salmonella	B-X
.	B-X

Baxter	O
and	O
Jones	O
(	O
18	O
)	O
have	O
identified	O
two	O
independent	O
hilE	O
promoters	O
,	O
P1	O
and	O
P2	O
.	O

We	O
performed	O
a	O
primer	O
extension	O
assay	O
of	O
total	O
RNA	O
isolated	O
from	O
SL1344	B-Organism
grown	O
to	O
exponential	O
phase	O
in	O
static	O
culture	O
,	O
using	O
the	O
primer	O
described	O
by	O
Baxter	O
and	O
Jones	O
(	O
18	O
)	O
,	O
to	O
discover	O
which	O
promoter	O
is	O
regulated	O
by	O
Mlc	O
.	O

The	O
transcriptional	O
start	O
site	O
of	O
one	O
transcript	O
,	O
designated	O
P1	O
,	O
agreed	O
with	O
the	O
previous	O
report	O
,	O
although	O
the	O
promoter	O
activity	O
was	O
very	O
low	O
under	O
the	O
conditions	O
used	O
in	O
our	O
experiment	O
(	O
Figure	O
4A	O
)	O
.	O

We	O
detected	O
a	O
stronger	O
transcript	O
,	O
designated	O
P2	O
,	O
upstream	O
of	O
P1	O
,	O
although	O
the	O
transcription	O
start	O
site	O
of	O
P2	O
was	O
mapped	O
12	O
nucleotides	O
upstream	O
of	O
that	O
reported	O
by	O
Baxter	O
and	O
Jones	O
(	O
18	O
)	O
(	O
Figures	O
4A	O
and	O
5C	O
)	O
.	O

This	O
difference	O
could	O
be	O
attributed	O
to	O
differences	O
in	O
the	O
experimental	O
model	O
conditions	O
;	O
in	O
our	O
study	O
,	O
total	O
RNA	O
from	O
a	O
Salmonella	B-Organism
strain	O
was	O
used	O
in	O
the	O
primer	O
extension	O
assay	O
,	O
whereas	O
Baxter	O
and	O
Jones	O
(	O
18	O
)	O
used	O
total	O
RNA	O
prepared	O
from	O
E	B-Organism
.	I-Organism
coli	I-Organism
harboring	O
the	O
hilE	O
reporter	O
plasmid	O
pMAB69	O
.	O
<EOS>	B-X
In	B-X
vitro	B-X
models	B-X
of	B-X
osteoarthritis	B-X
are	B-X
vital	B-X
to	B-X
advance	B-X
research	B-X
into	B-X
the	B-X
causes	B-X
of	B-X
the	B-X
disease	B-X
,	B-X
and	B-X
the	B-X
subsequent	B-X
design	B-X
and	B-X
testing	B-X
of	B-X
potential	B-X
therapeutics	B-X
.	B-X
However	B-X
,	B-X
a	B-X
plethora	B-X
of	B-X
in	B-X
vitro	B-X
models	B-X
have	B-X
been	B-X
used	B-X
by	B-X
researchers	B-X
but	B-X
with	B-X
no	B-X
consensus	B-X
on	B-X
the	B-X
most	B-X
appropriate	B-X
model	B-X
.	B-X
Models	B-X
attempt	B-X
to	B-X
mimic	B-X
factors	B-X
and	B-X
conditions	B-X
which	B-X
initiate	B-X
OA	B-X
,	B-X
or	B-X
dissect	B-X
the	B-X
pathways	B-X
active	B-X
in	B-X
the	B-X
disease	B-X
.	B-X
Underlying	B-X
uncertainty	B-X
as	B-X
to	B-X
the	B-X
cause	B-X
of	B-X
OA	B-X
and	B-X
the	B-X
different	B-X
attributes	B-X
of	B-X
isolated	B-X
cells	B-X
and	B-X
tissues	B-X
used	B-X
mean	B-X
that	B-X
similar	B-X
models	B-X
may	B-X
produce	B-X
differing	B-X
results	B-X
and	B-X
can	B-X
differ	B-X
from	B-X
the	B-X
naturally	B-X
occurring	B-X
disease	B-X
.	B-X
This	B-X
review	B-X
article	B-X
assesses	B-X
a	B-X
selection	B-X
of	B-X
the	B-X
in	B-X
vitro	B-X
models	B-X
currently	B-X
used	B-X
in	B-X
OA	B-X
research	B-X
,	B-X
and	B-X
considers	B-X
the	B-X
merits	B-X
of	B-X
each	B-X
.	B-X
Particular	B-X
focus	B-X
is	B-X
placed	B-X
on	B-X
the	B-X
more	B-X
prevalent	B-X
cytokine	B-X
stimulation	B-X
and	B-X
load-based	B-X
models	B-X
.	B-X
A	B-X
brief	B-X
review	B-X
of	B-X
the	B-X
mechanism	B-X
of	B-X
these	B-X
models	B-X
is	B-X
given	B-X
,	B-X
with	B-X
their	B-X
relevance	B-X
to	B-X
the	B-X
naturally	B-X
occurring	B-X
disease	B-X
.	B-X
Most	B-X
in	B-X
vitro	B-X
models	B-X
have	B-X
used	B-X
supraphysiological	B-X
loads	B-X
or	B-X
cytokine	B-X
concentrations	B-X
(	B-X
compared	B-X
with	B-X
the	B-X
natural	B-X
disease	B-X
)	B-X
in	B-X
order	B-X
to	B-X
impart	B-X
a	B-X
timely	B-X
response	B-X
from	B-X
the	B-X
cells	B-X
or	B-X
tissue	B-X
assessed	B-X
.	B-X
Whilst	B-X
models	B-X
inducing	B-X
OA-like	B-X
pathology	B-X
with	B-X
a	B-X
single	B-X
stimulus	B-X
can	B-X
answer	B-X
important	B-X
biological	B-X
questions	B-X
about	B-X
the	B-X
behaviour	B-X
of	B-X
cells	B-X
and	B-X
tissues	B-X
,	B-X
the	B-X
development	B-X
of	B-X
combinatorial	B-X
models	B-X
encompassing	B-X
different	B-X
physiological	B-X
and	B-X
molecular	B-X
aspects	B-X
of	B-X
the	B-X
disease	B-X
should	B-X
more	B-X
accurately	B-X
reflect	B-X
the	B-X
pathogenesis	B-X
of	B-X
the	B-X
naturally	B-X
occurring	B-X
disease	B-X
.	B-X

However	O
,	O
the	O
activities	O
of	O
the	O
two	O
promoters	O
were	O
not	O
changed	O
by	O
mlc	O
mutation	O
.	O
<EOS>	B-X
However	B-X
,	B-X
understanding	B-X
the	B-X
role	B-X
of	B-X
physical	B-X
activity	B-X
in	B-X
modern	B-X
society	B-X
and	B-X
creating	B-X
an	B-X
awareness	B-X
in	B-X
the	B-X
general	B-X
population	B-X
is	B-X
one	B-X
of	B-X
the	B-X
most	B-X
important	B-X
tasks	B-X
of	B-X
health	B-X
and	B-X
recreation	B-X
promoters	B-X
.	B-X
The	B-X
current	B-X
review	B-X
will	B-X
focus	B-X
on	B-X
the	B-X
health	B-X
benefits	B-X
of	B-X
the	B-X
two	B-X
most	B-X
widely	B-X
studied	B-X
modifiable	B-X
lifestyle	B-X
risk	B-X
factors	B-X
,	B-X
physical	B-X
activity	B-X
and	B-X
diet	B-X
,	B-X
focusing	B-X
particularly	B-X
on	B-X
the	B-X
Mediterranean	B-X
diet	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
well-documented	B-X
therapeutic	B-X
actions	B-X
of	B-X
repeated	B-X
physical	B-X
activities	B-X
over	B-X
human	B-X
lifespan	B-X
are	B-X
mediated	B-X
by	B-X
the	B-X
rapidly	B-X
turning	B-X
over	B-X
proto-oncogenic	B-X
Myc	B-X
(	B-X
myelocytomatosis	B-X
)	B-X
network	B-X
of	B-X
transcription	B-X
factors	B-X
.	B-X
This	B-X
transcription	B-X
factor	B-X
network	B-X
is	B-X
unique	B-X
in	B-X
utilizing	B-X
promoter	B-X
and	B-X
epigenomic	B-X
(	B-X
acetylation/deacetylation	B-X
,	B-X
methylation/demethylation	B-X
)	B-X
mechanisms	B-X
for	B-X
controlling	B-X
genes	B-X
that	B-X
include	B-X
those	B-X
encoding	B-X
intermediary	B-X
metabolism	B-X
(	B-X
the	B-X
primary	B-X
source	B-X
of	B-X
acetyl	B-X
groups	B-X
)	B-X
,	B-X
mitochondrial	B-X
functions	B-X
and	B-X
biogenesis	B-X
,	B-X
and	B-X
coupling	B-X
their	B-X
expression	B-X
with	B-X
regulation	B-X
of	B-X
cell	B-X
growth	B-X
and	B-X
proliferation	B-X
.	B-X
We	B-X
further	B-X
propose	B-X
that	B-X
remote	B-X
functioning	B-X
of	B-X
the	B-X
network	B-X
occurs	B-X
because	B-X
there	B-X
are	B-X
two	B-X
arms	B-X
of	B-X
this	B-X
network	B-X
,	B-X
which	B-X
consists	B-X
of	B-X
driver	B-X
cells	B-X
(	B-X
e.g.	B-X
,	B-X
working	B-X
myocytes	B-X
)	B-X
that	B-X
metabolize	B-X
carbohydrates	B-X
,	B-X
fats	B-X
,	B-X
proteins	B-X
,	B-X
and	B-X
oxygen	B-X
and	B-X
produce	B-X
redox-modulating	B-X
metabolites	B-X
such	B-X
as	B-X
HO	B-X
,	B-X
NAD	B-X
,	B-X
and	B-X
lactate	B-X
.	B-X
The	B-X
exercise-induced	B-X
products	B-X
represent	B-X
autocrine	B-X
,	B-X
paracrine	B-X
,	B-X
or	B-X
endocrine	B-X
signals	B-X
for	B-X
target	B-X
recipient	B-X
cells	B-X
(	B-X
e.g.	B-X
,	B-X
aortic	B-X
endothelium	B-X
,	B-X
hepatocytes	B-X
,	B-X
and	B-X
pancreatic	B-X
-cells	B-X
)	B-X
in	B-X
which	B-X
the	B-X
metabolic	B-X
signals	B-X
are	B-X
coupled	B-X
with	B-X
genomic	B-X
networks	B-X
and	B-X
interorgan	B-X
signaling	B-X
is	B-X
activated	B-X
.	B-X
And	B-X
finally	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
lactate	B-X
,	B-X
the	B-X
major	B-X
metabolite	B-X
released	B-X
from	B-X
working	B-X
muscles	B-X
and	B-X
transported	B-X
into	B-X
recipient	B-X
cells	B-X
,	B-X
links	B-X
the	B-X
two	B-X
arms	B-X
of	B-X
the	B-X
signaling	B-X
pathway	B-X
.	B-X
Recently	B-X
discovered	B-X
contributions	B-X
of	B-X
the	B-X
Myc	B-X
network	B-X
in	B-X
stem	B-X
cell	B-X
development	B-X
and	B-X
maintenance	B-X
further	B-X
suggest	B-X
that	B-X
regular	B-X
physical	B-X
activity	B-X
may	B-X
prevent	B-X
age-related	B-X
diseases	B-X
such	B-X
as	B-X
cardiovascular	B-X
pathologies	B-X
,	B-X
cancers	B-X
,	B-X
diabetes	B-X
,	B-X
and	B-X
neurological	B-X
functions	B-X
through	B-X
prevention	B-X
of	B-X
stem	B-X
cell	B-X
dysfunctions	B-X
and	B-X
depletion	B-X
with	B-X
aging	B-X
.	B-X
Hence	B-X
,	B-X
regular	B-X
physical	B-X
activities	B-X
may	B-X
attenuate	B-X
the	B-X
various	B-X
deleterious	B-X
effects	B-X
of	B-X
the	B-X
Myc	B-X
network	B-X
on	B-X
health	B-X
,	B-X
the	B-X
wild	B-X
side	B-X
of	B-X
the	B-X
Myc-network	B-X
,	B-X
through	B-X
modulating	B-X
transcription	B-X
of	B-X
genes	B-X
associated	B-X
with	B-X
glucose	B-X
and	B-X
energy	B-X
metabolism	B-X
and	B-X
maintain	B-X
a	B-X
healthy	B-X
human	B-X
status	B-X
.	B-X

Using	O
a	O
primer	O
extension	O
assay	O
with	O
the	O
hilE5	O
primer	O
(	O
Table	O
2	O
)	O
,	O
the	O
promoter	O
of	O
hilE	O
,	O
which	O
is	O
designated	O
as	O
P3	O
,	O
was	O
newly	O
identified	O
;	O
this	O
promoter	O
initiates	O
335	O
nucleotides	O
upstream	O
of	O
the	O
translation	O
start	O
site	O
of	O
hilE	O
(	O
Figure	O
4B	O
,	O
lane	O
1	O
)	O
.	O

We	O
observed	O
putative	O
-	O
10	O
(	O
TTAAAT	O
)	O
and	O
-	O
35	O
(	O
ATAACA	O
)	O
motifs	O
for	O
hilE	O
P3	O
(	O
Figure	O
4C	O
)	O
(	O
37	O
)	O
.	O

Transcription	O
from	O
the	O
P3	O
promoter	O
was	O
increased	O
substantially	O
by	O
mlc	O
mutation	O
(	O
Figure	O
4B	O
,	O
lane	O
2	O
)	O
.	O

The	O
specificity	O
of	O
the	O
Mlc	O
effect	O
was	O
verified	O
by	O
complementation	O
,	O
as	O
the	O
plasmid	O
pKB	O
,	O
which	O
expresses	O
mlc	O
,	O
restored	O
the	O
transcriptional	O
level	O
of	O
hilE	O
in	O
SR1304	B-Organism
almost	O
to	O
that	O
of	O
the	O
wild	O
-	O
type	O
strain	O
(	O
Figure	O
4B	O
,	O
lane	O
4	O
)	O
.	O

Mlc	O
directly	O
represses	O
hilE	O
by	O
binding	O
to	O
the	O
P3	O
promoter	O

A	O
gel	O
mobility	O
shift	O
assay	O
was	O
performed	O
with	O
purified	O
Mlc	O
,	O
to	O
test	O
whether	O
Mlc	O
directly	O
represses	O
the	O
hilE	O
P3	O
promoter	O
.	O

The	O
Mlc	O
-	O
His6	O
protein	O
was	O
produced	O
in	O
E	B-Organism
.	I-Organism
coli	I-Organism
and	O
purified	O
to	O
>	O
90	O
%	O
homogeneity	O
by	O
Ni2	O
+	O
affinity	O
chromatography	O
.	O

The	O
activity	O
of	O
the	O
purified	O
Mlc	O
-	O
His6	O
protein	O
was	O
verified	O
with	O
the	O
control	O
gel	O
mobility	O
shift	O
experiment	O
employing	O
the	O
Salmonella	B-Organism
ptsG	O
DNA	O
fragment	O
that	O
contains	O
the	O
known	O
Mlc	O
-	O
binding	O
site	O
(	O
data	O
not	O
shown	O
)	O
.	O

When	O
the	O
labeled	O
hilE	O
promoter	O
DNA	O
was	O
incubated	O
with	O
2	O
-	O
fold	O
dilutions	O
of	O
the	O
purified	O
Mlc	O
-	O
His6	O
protein	O
(	O
100	O
-	O
800nM	O
)	O
in	O
the	O
presence	O
of	O
the	O
non	O
-	O
specific	O
DNA	O
competitor	O
poly	O
dI	O
-	O
dC	O
,	O
the	O
concentration	O
-	O
dependent	O
formation	O
of	O
protein	O
-	O
DNA	O
complexes	O
was	O
observed	O
(	O
Figure	O
5A	O
)	O
.	O

The	O
addition	O
of	O
cold	O
probe	O
released	O
the	O
labeled	O
probe	O
from	O
the	O
retarded	O
complex	O
(	O
Figure	O
5A	O
,	O
right	O
panel	O
)	O
,	O
which	O
indicates	O
specific	O
binding	O
of	O
Mlc	O
to	O
the	O
hilE	O
P3	O
promoter	O
DNA	O
.	O

The	O
precise	O
locations	O
of	O
the	O
Mlc	O
-	O
binding	O
sites	O
were	O
determined	O
by	O
DNase	O
I	O
footprinting	O
with	O
His	O
-	O
tagged	O
Mlc	O
.	O

Two	O
Mlc	O
-	O
binding	O
sites	O
,	O
one	O
at	O
position	O
-	O
10	O
to	O
+	O
12	O
(	O
Mlc	O
1	O
)	O
and	O
the	O
other	O
at	O
position	O
-	O
86	O
to	O
-	O
108	O
(	O
Mlc	O
2	O
)	O
with	O
respect	O
to	O
the	O
transcriptional	O
start	O
site	O
of	O
hilE	O
P3	O
,	O
were	O
identified	O
(	O
Figure	O
5B	O
)	O
.	O

Inspection	O
of	O
the	O
DNA	O
sequences	O
at	O
these	O
sites	O
showed	O
high	O
-	O
level	O
homology	O
with	O
the	O
known	O
consensus	O
Mlc	O
-	O
binding	O
sequence	O
,	O
which	O
has	O
the	O
conserved	O
TT	O
-	O
9bp	O
-	O
AA	O
motif	O
and	O
an	O
AT	O
-	O
rich	O
region	O
at	O
positions	O
+	O
/	O
-	O
7	O
to	O
+	O
/	O
-	O
11	O
,	O
showing	O
imperfect	O
dyad	O
symmetry	O
(	O
38	O
)	O
(	O
Figure	O
5C	O
)	O
.	O

These	O
results	O
clearly	O
demonstrate	O
that	O
Mlc	O
can	O
regulate	O
directly	O
the	O
hilE	O
P3	O
promoter	O
by	O
binding	O
to	O
the	O
promoter	O
.	O

Sugars	O
that	O
induce	O
the	O
Mlc	O
regulon	O
repress	O
hilD	O
expression	O
by	O
activating	O
hilE	O

Sequestration	O
of	O
Mlc	O
by	O
the	O
unphosphorylated	O
form	O
of	O
glucose	O
permease	O
,	O
enzyme	O
IICBGlc	O
,	O
is	O
known	O
to	O
displace	O
Mlc	O
from	O
its	O
DNA	O
-	O
binding	O
sites	O
,	O
thereby	O
allowing	O
transcription	O
of	O
its	O
target	O
genes	O
(	O
25	O
-	O
27	O
)	O
.	O

The	O
Mlc	O
regulon	O
can	O
be	O
induced	O
by	O
glucose	O
and	O
,	O
to	O
a	O
lesser	O
extent	O
,	O
by	O
mannose	O
(	O
39	O
)	O
.	O

The	O
effects	O
of	O
various	O
carbon	O
sources	O
on	O
the	O
expression	O
of	O
hilE	O
and	O
hilD	O
were	O
studied	O
with	O
two	O
Mlc	O
regulon	O
-	O
inducing	O
sugars	O
,	O
glucose	O
and	O
mannose	O
,	O
and	O
two	O
Mlc	O
regulon	O
-	O
non	O
-	O
inducing	O
carbohydrates	O
,	O
arabinose	O
and	O
glycerol	O
.	O

SL1344	B-Organism
and	O
SR1304	B-Organism
carrying	O
either	O
pMAB69	O
(	O
hilE	O
-	O
lacZY	O
)	O
or	O
pJB5	O
(	O
hilD	O
-	O
lacZY	O
)	O
were	O
cultivated	O
in	O
TB	O
that	O
was	O
buffered	O
to	O
pH	O
7	O
.	O
0	O
with	O
0	O
.	O
1M	O
MOPS	O
,	O
to	O
minimize	O
pH	O
effects	O
arising	O
from	O
growth	O
in	O
the	O
presence	O
of	O
the	O
various	O
carbon	O
sources	O
.	O

In	O
the	O
wild	O
-	O
type	O
strain	O
,	O
glucose	O
and	O
mannose	O
increased	O
hilE	O
expression	O
2	O
-	O
fold	O
and	O
hilE	O
activation	O
reduced	O
hilD	O
expression	O
(	O
Figure	O
6	O
)	O
.	O

The	O
expression	O
levels	O
of	O
hilE	O
and	O
hilD	O
remained	O
almost	O
unaffected	O
in	O
the	O
presence	O
of	O
glycerol	O
.	O

Interestingly	O
,	O
arabinose	O
also	O
activated	O
hilE	O
,	O
albeit	O
to	O
a	O
lesser	O
degree	O
than	O
either	O
glucose	O
or	O
mannose	O
.	O
<EOS>	B-X
A	B-X
potential	B-X
approach	B-X
is	B-X
administration	B-X
of	B-X
D-mannose	B-X
,	B-X
an	B-X
inert	B-X
monosaccharide	B-X
that	B-X
is	B-X
metabolised	B-X
and	B-X
excreted	B-X
in	B-X
urine	B-X
and	B-X
acts	B-X
by	B-X
inhibiting	B-X
bacterial	B-X
adhesion	B-X
to	B-X
the	B-X
urothelium	B-X
.	B-X
We	B-X
performed	B-X
a	B-X
systematic	B-X
review	B-X
to	B-X
assess	B-X
the	B-X
effect	B-X
of	B-X
D-mannose	B-X
in	B-X
the	B-X
prevention	B-X
of	B-X
recurrent	B-X
UTIs	B-X
.	B-X
Of	B-X
the	B-X
eight	B-X
studies	B-X
reporting	B-X
on	B-X
D-mannose	B-X
in	B-X
this	B-X
context	B-X
,	B-X
six	B-X
were	B-X
clinical	B-X
and	B-X
included	B-X
695	B-X
individuals	B-X
.	B-X
Three	B-X
studies	B-X
reported	B-X
that	B-X
time	B-X
to	B-X
UTI	B-X
recurrence	B-X
was	B-X
longer	B-X
with	B-X
D-mannose	B-X
.	B-X
It	B-X
also	B-X
leads	B-X
to	B-X
a	B-X
longer	B-X
duration	B-X
between	B-X
episodes	B-X
of	B-X
recurrences	B-X
and	B-X
consequently	B-X
improves	B-X
patient	B-X
quality	B-X
of	B-X
life	B-X
.	B-X

Nevertheless	O
,	O
this	O
caused	O
a	O
minute	O
increase	O
in	O
hilD	O
expression	O
.	O

In	O
the	O
absence	O
of	O
sugars	O
,	O
the	O
mlc	O
mutation	O
increased	O
hilE	O
expression	O
1	O
.	O
5	O
-	O
fold	O
,	O
with	O
a	O
concomitant	O
reduction	O
in	O
hilD	O
expression	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
expression	O
in	O
SR1304	B-Organism
of	O
both	O
hilE	O
and	O
hilD	O
was	O
increased	O
in	O
the	O
presence	O
of	O
glucose	O
,	O
mannose	O
or	O
arabinose	O
.	O
<EOS>	B-X
A	B-X
key	B-X
plant	B-X
sugar	B-X
that	B-X
is	B-X
present	B-X
throughout	B-X
the	B-X
plantae	B-X
,	B-X
even	B-X
before	B-X
the	B-X
divergence	B-X
of	B-X
the	B-X
land	B-X
plant	B-X
lineage	B-X
,	B-X
but	B-X
is	B-X
not	B-X
found	B-X
in	B-X
animals	B-X
,	B-X
is	B-X
l-arabinose	B-X
(	B-X
l-Ara	B-X
)	B-X
.	B-X
We	B-X
also	B-X
discuss	B-X
the	B-X
biological	B-X
function	B-X
of	B-X
l-Ara	B-X
in	B-X
a	B-X
context-focused	B-X
manner	B-X
,	B-X
mainly	B-X
addressing	B-X
cell	B-X
wall-related	B-X
functions	B-X
that	B-X
are	B-X
conferred	B-X
by	B-X
the	B-X
basic	B-X
physical	B-X
properties	B-X
of	B-X
arabinose-containing	B-X
polymers/compounds	B-X
.	B-X
Over	B-X
forty	B-X
years	B-X
of	B-X
research	B-X
on	B-X
the	B-X
L-arabinose	B-X
operon	B-X
of	B-X
Escherichia	B-X
coli	B-X
have	B-X
provided	B-X
insights	B-X
into	B-X
the	B-X
mechanism	B-X
of	B-X
positive	B-X
regulation	B-X
of	B-X
gene	B-X
activity	B-X
.	B-X
This	B-X
research	B-X
also	B-X
discovered	B-X
DNA	B-X
looping	B-X
and	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
the	B-X
regulatory	B-X
protein	B-X
changes	B-X
its	B-X
DNA-binding	B-X
properties	B-X
in	B-X
response	B-X
to	B-X
the	B-X
presence	B-X
of	B-X
arabinose	B-X
.	B-X

These	O
results	O
imply	O
that	O
multiple	O
regulatory	O
pathways	O
are	O
involved	O
in	O
the	O
regulation	O
of	O
hilE	O
and	O
hilD	O
by	O
carbohydrates	O
.	O

DISCUSSION	O

Analysis	O
of	O
the	O
Salmonella	O
mlc	O
mutant	O
revealed	O
that	O
invasiveness	O
for	O
epithelial	O
cells	O
was	O
impaired	O
by	O
the	O
mlc	O
mutation	O
(	O
Figure	O
1	O
)	O
.	O

It	O
is	O
well	O
known	O
that	O
SPI1	O
is	O
required	O
for	O
the	O
invasion	O
of	O
host	O
cells	O
and	O
induction	O
of	O
macrophage	O
apoptosis	O
(	O
2	O
,	O
3	O
,	O
40	O
)	O
.	O

The	O
genetic	O
evidence	O
to	O
date	O
is	O
consistent	O
with	O
a	O
regulatory	O
cascade	O
of	O
transcriptional	O
activation	O
,	O
in	O
which	O
HilD	O
,	O
HilA	O
and	O
InvF	O
act	O
sequentially	O
to	O
activate	O
SPI1	O
expression	O
.	O

In	O
brief	O
,	O
HilD	O
binds	O
directly	O
to	O
sites	O
upstream	O
of	O
hilA	O
and	O
invFD	O
and	O
acts	O
as	O
an	O
activator	O
(	O
14	O
,	O
16	O
,	O
36	O
)	O
.	O

HilA	O
activates	O
the	O
transcription	O
of	O
invFA	O
and	O
SPI1	O
-	O
T3SS	O
apparatus	O
genes	O
required	O
for	O
the	O
secretion	O
of	O
effector	O
proteins	O
,	O
whereas	O
the	O
expression	O
of	O
effector	O
proteins	O
is	O
regulated	O
by	O
InvF	O
(	O
10	O
,	O
11	O
)	O
.	O

This	O
regulatory	O
cascade	O
implies	O
that	O
the	O
reduced	O
invasive	O
phenotype	O
of	O
mlc	O
mutant	O
is	O
the	O
result	O
of	O
hilD	O
repression	O
,	O
which	O
affects	O
both	O
hilA	O
and	O
invF	O
expression	O
(	O
Figures	O
1	O
and	O
2	O
)	O
.	O

The	O
2	O
-	O
3	O
-	O
fold	O
decrease	O
in	O
hilD	O
expression	O
caused	O
by	O
the	O
mlc	O
mutation	O
is	O
sufficient	O
to	O
account	O
for	O
the	O
nearly	O
10	O
-	O
fold	O
decrease	O
in	O
hilA	O
and	O
invFA	O
transcription	O
,	O
owing	O
to	O
the	O
nature	O
of	O
the	O
feed	O
-	O
forward	O
regulatory	O
loop	O
,	O
in	O
that	O
moderate	O
effects	O
on	O
HilD	O
production	O
are	O
amplified	O
(	O
9	O
)	O
.	O

Although	O
the	O
Salmonella	O
mlc	O
mutant	O
was	O
less	O
invasive	O
for	O
epithelial	O
cells	O
than	O
the	O
wild	O
-	O
type	O
strain	O
,	O
the	O
extent	O
of	O
the	O
reduction	O
in	O
invasiveness	O
and	O
cytotoxicity	O
of	O
the	O
mlc	O
mutant	O
was	O
not	O
as	O
great	O
as	O
we	O
had	O
expected	O
,	O
considering	O
the	O
observed	O
reduction	O
in	O
SPI1	O
gene	O
expression	O
(	O
Figure	O
2	O
)	O
.	O

This	O
may	O
be	O
partly	O
due	O
to	O
the	O
expression	O
of	O
hilC	O
,	O
a	O
de	O
-	O
repressor	O
of	O
hilA	O
,	O
which	O
was	O
not	O
reduced	O
in	O
the	O
mlc	O
mutant	O
(	O
Figure	O
2A	O
)	O
.	O

The	O
hilC	O
mutation	O
had	O
little	O
effect	O
on	O
SPI1	O
gene	O
expression	O
or	O
the	O
invasive	O
phenotype	O
,	O
whereas	O
the	O
over	O
-	O
expression	O
of	O
hilC	O
suppressed	O
the	O
hilD	O
mutation	O
,	O
thereby	O
promoting	O
high	O
levels	O
of	O
hilA	O
and	O
invF	O
expression	O
,	O
which	O
suggests	O
that	O
HilC	O
can	O
partially	O
compensate	O
for	O
the	O
loss	O
of	O
function	O
of	O
HilD	O
and	O
the	O
invasive	O
phenotype	O
(	O
8	O
,	O
9	O
,	O
15	O
)	O
.	O
<EOS>	B-X
Sequences	B-X
between	B-X
-332	B-X
and	B-X
-39	B-X
upstream	B-X
of	B-X
the	B-X
hilA	B-X
promoter	B-X
are	B-X
required	B-X
for	B-X
repression	B-X
of	B-X
hilA	B-X
.	B-X
An	B-X
unidentified	B-X
repressor	B-X
is	B-X
thought	B-X
to	B-X
bind	B-X
these	B-X
upstream	B-X
repressing	B-X
sequences	B-X
(	B-X
URS	B-X
)	B-X
to	B-X
inhibit	B-X
hilA	B-X
expression	B-X
.	B-X
Two	B-X
AraC-like	B-X
transcriptional	B-X
regulators	B-X
encoded	B-X
on	B-X
Salmonella	B-X
pathogenicity	B-X
island	B-X
1	B-X
(	B-X
SPI1	B-X
)	B-X
,	B-X
HilC	B-X
and	B-X
HilD	B-X
,	B-X
bind	B-X
to	B-X
the	B-X
URS	B-X
to	B-X
counteract	B-X
the	B-X
repression	B-X
of	B-X
hilA	B-X
.	B-X
The	B-X
URS	B-X
is	B-X
required	B-X
for	B-X
regulation	B-X
of	B-X
hilA	B-X
by	B-X
osmolarity	B-X
,	B-X
oxygen	B-X
,	B-X
PhoP/PhoQ	B-X
,	B-X
and	B-X
SirA/BarA	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
FadD	B-X
,	B-X
FliZ	B-X
,	B-X
PhoB	B-X
,	B-X
and	B-X
EnvZ/OmpR	B-X
also	B-X
require	B-X
the	B-X
URS	B-X
to	B-X
regulate	B-X
hilA	B-X
.	B-X
These	B-X
environmental	B-X
and	B-X
regulatory	B-X
factors	B-X
may	B-X
affect	B-X
hilA	B-X
expression	B-X
by	B-X
altering	B-X
the	B-X
expression	B-X
or	B-X
activity	B-X
of	B-X
HilC	B-X
,	B-X
HilD	B-X
,	B-X
or	B-X
the	B-X
unknown	B-X
repressor	B-X
.	B-X
To	B-X
begin	B-X
investigating	B-X
these	B-X
possibilities	B-X
,	B-X
we	B-X
tested	B-X
the	B-X
effects	B-X
of	B-X
environmental	B-X
and	B-X
regulatory	B-X
factors	B-X
on	B-X
hilC	B-X
and	B-X
hilD	B-X
expression	B-X
.	B-X
We	B-X
also	B-X
examined	B-X
hilA	B-X
regulation	B-X
when	B-X
hilC	B-X
or	B-X
hilD	B-X
was	B-X
disrupted	B-X
or	B-X
expressed	B-X
to	B-X
a	B-X
high	B-X
level	B-X
.	B-X
Although	B-X
hilC	B-X
is	B-X
regulated	B-X
by	B-X
all	B-X
environmental	B-X
conditions	B-X
and	B-X
regulatory	B-X
factors	B-X
that	B-X
modulate	B-X
hilA	B-X
expression	B-X
,	B-X
hilC	B-X
is	B-X
not	B-X
required	B-X
for	B-X
the	B-X
regulation	B-X
of	B-X
hilA	B-X
by	B-X
any	B-X
conditions	B-X
or	B-X
factors	B-X
except	B-X
EnvZ/OmpR	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
hilD	B-X
is	B-X
absolutely	B-X
required	B-X
for	B-X
hilA	B-X
expression	B-X
,	B-X
but	B-X
environmental	B-X
conditions	B-X
and	B-X
regulatory	B-X
factors	B-X
have	B-X
little	B-X
or	B-X
no	B-X
effect	B-X
on	B-X
hilD	B-X
expression	B-X
.	B-X
We	B-X
speculate	B-X
that	B-X
EnvZ/OmpR	B-X
regulates	B-X
hilA	B-X
by	B-X
altering	B-X
the	B-X
expression	B-X
and/or	B-X
activity	B-X
of	B-X
hilC	B-X
,	B-X
while	B-X
all	B-X
other	B-X
regulatory	B-X
conditions	B-X
and	B-X
mutations	B-X
regulate	B-X
hilA	B-X
by	B-X
modulating	B-X
hilD	B-X
posttranscriptionally	B-X
.	B-X
We	B-X
also	B-X
discuss	B-X
models	B-X
in	B-X
which	B-X
the	B-X
regulation	B-X
of	B-X
hilA	B-X
expression	B-X
is	B-X
mediated	B-X
by	B-X
modulation	B-X
of	B-X
the	B-X
expression	B-X
or	B-X
activity	B-X
of	B-X
one	B-X
or	B-X
more	B-X
repressors	B-X
.	B-X

We	O
have	O
reported	O
previously	O
that	O
there	O
may	O
be	O
an	O
independent	O
hilC	O
regulatory	O
pathway	O
that	O
is	O
not	O
applicable	O
to	O
hilA	O
or	O
invFA	O
regulation	O
when	O
bacteria	O
respond	O
to	O
changes	O
in	O
osmolarity	O
(	O
29	O
)	O
.	O
<EOS>	B-X
In	B-X
their	B-X
natural	B-X
habitats	B-X
,	B-X
microorganisms	B-X
are	B-X
often	B-X
exposed	B-X
to	B-X
osmolality	B-X
changes	B-X
in	B-X
the	B-X
environment	B-X
.	B-X
On	B-X
the	B-X
basis	B-X
of	B-X
the	B-X
available	B-X
literature	B-X
,	B-X
we	B-X
conclude	B-X
that	B-X
representative	B-X
gram-negative	B-X
and	B-X
gram-positive	B-X
bacteria	B-X
use	B-X
different	B-X
strategies	B-X
to	B-X
respond	B-X
to	B-X
osmotic	B-X
stress	B-X
.	B-X
The	B-X
main	B-X
focus	B-X
of	B-X
this	B-X
paper	B-X
is	B-X
on	B-X
the	B-X
initial	B-X
response	B-X
of	B-X
bacteria	B-X
to	B-X
hyper-	B-X
and	B-X
hypo-osmotic	B-X
conditions	B-X
,	B-X
and	B-X
in	B-X
particular	B-X
the	B-X
osmosensing	B-X
devices	B-X
that	B-X
allow	B-X
the	B-X
cell	B-X
to	B-X
rapidly	B-X
activate	B-X
and/or	B-X
to	B-X
synthesize	B-X
the	B-X
transport	B-X
systems	B-X
necessary	B-X
for	B-X
uptake	B-X
and	B-X
excretion	B-X
of	B-X
compatible	B-X
solutes	B-X
.	B-X
This	B-X
bacterium	B-X
exhibits	B-X
a	B-X
complex	B-X
life	B-X
cycle	B-X
,	B-X
including	B-X
one	B-X
symbiotic	B-X
stage	B-X
characterized	B-X
by	B-X
colonization	B-X
of	B-X
the	B-X
upper	B-X
nematode	B-X
gut	B-X
,	B-X
and	B-X
a	B-X
pathogenic	B-X
stage	B-X
,	B-X
characterized	B-X
by	B-X
release	B-X
from	B-X
the	B-X
nematode	B-X
into	B-X
the	B-X
hemocoel	B-X
of	B-X
insect	B-X
larvae	B-X
,	B-X
resulting	B-X
in	B-X
rapid	B-X
insect	B-X
death	B-X
caused	B-X
by	B-X
bacterial	B-X
toxins	B-X
.	B-X

Our	O
data	O
clearly	O
demonstrate	O
that	O
Mlc	O
directly	O
regulates	O
hilE	O
expression	O
by	O
binding	O
to	O
the	O
hilE	O
P3	O
promoter	O
(	O
Figure	O
5	O
)	O
.	O

The	O
two	O
Mlc	O
-	O
binding	O
sites	O
in	O
hilE	O
P3	O
identified	O
by	O
the	O
gel	O
mobility	O
shift	O
assay	O
and	O
DNase	O
I	O
footprinting	O
analysis	O
show	O
high	O
-	O
level	O
homology	O
with	O
the	O
known	O
consensus	O
Mlc	O
-	O
binding	O
sequences	O
;	O
additionally	O
,	O
the	O
two	O
Mlc	O
-	O
binding	O
sites	O
are	O
separated	O
by	O
98nt	O
,	O
as	O
is	O
the	O
case	O
for	O
other	O
promoters	O
that	O
have	O
two	O
Mlc	O
-	O
binding	O
sites	O
(	O
41	O
)	O
.	O

The	O
transcriptional	O
start	O
site	O
of	O
the	O
hilE	O
P3	O
promoter	O
lies	O
335nt	O
upstream	O
of	O
the	O
ATG	O
start	O
codon	O
of	O
hilE	O
(	O
Figures	O
4B	O
and	O
5C	O
)	O
.	O

It	O
is	O
unusual	O
that	O
the	O
5	O
'	O
-	O
untranslated	O
region	O
(	O
UTR	O
)	O
of	O
mRNA	O
is	O
more	O
than	O
300nt	O
in	O
bacteria	O
(	O
42	O
)	O
.	O

However	O
,	O
this	O
length	O
of	O
5	O
'	O
-	O
UTR	O
has	O
been	O
observed	O
in	O
other	O
SPI1	O
regulators	O
.	O

The	O
HilC	O
/	O
D	O
-	O
dependent	O
transcriptional	O
start	O
site	O
of	O
the	O
invFD	O
promoter	O
is	O
631bp	O
upstream	O
of	O
the	O
invF	O
open	O
reading	O
frame	O
(	O
16	O
)	O
.	O

The	O
UTR	O
of	O
the	O
hilA	O
gene	O
is	O
also	O
up	O
to	O
350nt	O
in	O
length	O
,	O
and	O
is	O
suggested	O
to	O
be	O
involved	O
in	O
the	O
complex	O
regulation	O
of	O
hilA	O
in	O
response	O
to	O
environmental	O
signals	O
(	O
8	O
,	O
12	O
)	O
.	O

It	O
has	O
been	O
demonstrated	O
that	O
the	O
region	O
190	O
-	O
270	O
-	O
bp	O
upstream	O
of	O
the	O
hilE	O
promoter	O
is	O
required	O
for	O
the	O
activation	O
of	O
hilE	O
P2	O
expression	O
by	O
FimYZ	O
,	O
which	O
is	O
a	O
response	O
regulator	O
that	O
is	O
involved	O
in	O
the	O
expression	O
of	O
type	O
1	O
fimbriae	O
and	O
motility	O
genes	O
(	O
18	O
,	O
Figure	O
5C	O
)	O
.	O

Therefore	O
,	O
we	O
cannot	O
rule	O
out	O
the	O
possibility	O
that	O
additional	O
cis	O
-	O
or	O
trans	O
-	O
acting	O
regulatory	O
elements	O
,	O
which	O
have	O
not	O
yet	O
been	O
characterized	O
,	O
are	O
involved	O
in	O
hilE	O
expression	O
.	O
<EOS>	B-X
Most	B-X
protein-coding	B-X
mRNAs	B-X
are	B-X
exported	B-X
into	B-X
the	B-X
cytoplasm	B-X
for	B-X
protein	B-X
synthesis	B-X
,	B-X
while	B-X
some	B-X
mRNA	B-X
species	B-X
,	B-X
long	B-X
noncoding	B-X
RNAs	B-X
,	B-X
and	B-X
some	B-X
regulatory	B-X
element-associated	B-X
unstable	B-X
transcripts	B-X
tend	B-X
to	B-X
be	B-X
retained	B-X
in	B-X
the	B-X
nucleus	B-X
,	B-X
where	B-X
they	B-X
function	B-X
as	B-X
a	B-X
regulatory	B-X
unit	B-X
and/or	B-X
are	B-X
regulated	B-X
by	B-X
nuclear	B-X
surveillance	B-X
pathways	B-X
.	B-X
The	B-X
phenomenon	B-X
of	B-X
internal	B-X
initiation	B-X
of	B-X
translation	B-X
was	B-X
discovered	B-X
in	B-X
1988	B-X
on	B-X
poliovirus	B-X
mRNA	B-X
.	B-X
Aberrant	B-X
expression	B-X
of	B-X
long	B-X
non-coding	B-X
RNA	B-X
(	B-X
lncRNA	B-X
)	B-X
,	B-X
micro	B-X
RNA	B-X
(	B-X
miRNA	B-X
)	B-X
,	B-X
and	B-X
circular	B-X
RNA	B-X
(	B-X
circRNA	B-X
)	B-X
in	B-X
tumors	B-X
compared	B-X
to	B-X
their	B-X
normal	B-X
counterparts	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
recurrent	B-X
mutations	B-X
in	B-X
functional	B-X
regulatory	B-X
In	B-X
humans	B-X
,	B-X
25	B-X
selenoprotein	B-X
genes	B-X
have	B-X
been	B-X
characterized	B-X
.	B-X
The	B-X
most	B-X
remarkable	B-X
trait	B-X
of	B-X
selenoprotein	B-X
biosynthesis	B-X
is	B-X
the	B-X
cotranslational	B-X
insertion	B-X
of	B-X
selenocysteine	B-X
by	B-X
the	B-X
recoding	B-X
of	B-X
a	B-X
UGA	B-X
codon	B-X
,	B-X
normally	B-X
decoded	B-X
as	B-X
a	B-X
stop	B-X
signal	B-X
.	B-X

Glucose	O
and	O
mannose	O
induce	O
the	O
Mlc	O
regulon	O
(	O
39	O
)	O
by	O
dephosphorylating	O
EIICBGlc	O
,	O
which	O
then	O
sequesters	O
Mlc	O
from	O
its	O
binding	O
sites	O
(	O
27	O
,	O
43	O
)	O
.	O

It	O
has	O
been	O
suggested	O
that	O
glucose	O
plays	O
a	O
negative	O
role	O
in	O
the	O
expression	O
of	O
invasion	O
-	O
associated	O
genes	O
in	O
Salmonella	B-Organism
.	O

The	O
addition	O
of	O
excess	O
glucose	O
to	O
the	O
culture	O
medium	O
results	O
in	O
the	O
reduction	O
of	O
cell	O
association	O
by	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
(	O
44	O
)	O
.	O
<EOS>	B-X
In	B-X
this	B-X
week	B-X
s	B-X
issue	B-X
of	B-X
Eurosurveillance	B-X
,	B-X
four	B-X
European	B-X
countries	B-X
present	B-X
recent	B-X
outbreaks	B-X
of	B-X
Salmonella	B-X
Typhimurium	B-X
.	B-X
This	B-X
dose	B-X
response	B-X
assessment	B-X
combines	B-X
data	B-X
from	B-X
6	B-X
human	B-X
challenge	B-X
studies	B-X
and	B-X
44	B-X
outbreaks	B-X
to	B-X
determine	B-X
infectivity	B-X
and	B-X
pathogenicity	B-X
of	B-X
several	B-X
serotypes	B-X
of	B-X
nontyphoid	B-X
Salmonella	B-X
.	B-X
Outcomes	B-X
focus	B-X
on	B-X
the	B-X
major	B-X
serotypes	B-X
Salmonella	B-X
Enteritidis	B-X
and	B-X
Typhimurium	B-X
,	B-X
showing	B-X
that	B-X
Typhimurium	B-X
is	B-X
less	B-X
infectious	B-X
and	B-X
has	B-X
a	B-X
lower	B-X
probability	B-X
of	B-X
causing	B-X
acute	B-X
illness	B-X
in	B-X
infected	B-X
subjects	B-X
.	B-X
The	B-X
dose	B-X
response	B-X
relation	B-X
of	B-X
Salmonella	B-X
Enteritidis	B-X
is	B-X
less	B-X
steep	B-X
than	B-X
that	B-X
of	B-X
Typhimurium	B-X
,	B-X
indicating	B-X
greater	B-X
heterogeneity	B-X
in	B-X
infectivity	B-X
and	B-X
pathogenicity	B-X
.	B-X

The	O
glucose	O
present	O
in	O
DLB	O
(	O
LB	O
broth	O
diluted	O
1	O
:	O
5	O
)	O
decreased	O
hilA	O
expression	O
2	O
.	O
5	O
-	O
fold	O
,	O
as	O
compared	O
to	O
DLB	O
without	O
glucose	O
,	O
while	O
lactose	O
and	O
arabinose	O
had	O
little	O
effect	O
on	O
hilA	O
expression	O
(	O
45	O
)	O
.	O

The	O
results	O
presented	O
in	O
this	O
study	O
support	O
the	O
notion	O
that	O
hilE	O
expression	O
is	O
activated	O
as	O
a	O
result	O
of	O
Mlc	O
sequestration	O
by	O
unphosphorylated	O
EIICBGlc	O
in	O
the	O
presence	O
of	O
glucose	O
.	O

We	O
observed	O
a	O
2	O
-	O
fold	O
activation	O
of	O
hilE	O
and	O
concomitant	O
repression	O
of	O
hilD	O
in	O
the	O
presence	O
of	O
glucose	O
or	O
mannose	O
,	O
which	O
are	O
known	O
inducers	O
of	O
the	O
Mlc	O
regulon	O
,	O
when	O
TB	O
was	O
used	O
(	O
Figure	O
6	O
)	O
.	O

However	O
,	O
the	O
effect	O
of	O
the	O
sugar	O
was	O
not	O
seen	O
when	O
LB	O
was	O
used	O
(	O
data	O
not	O
shown	O
)	O
.	O
<EOS>	B-X
In	B-X
animal	B-X
studies	B-X
,	B-X
sugar	B-X
has	B-X
been	B-X
found	B-X
to	B-X
produce	B-X
more	B-X
symptoms	B-X
than	B-X
is	B-X
required	B-X
to	B-X
be	B-X
considered	B-X
an	B-X
addictive	B-X
substance	B-X
.	B-X
Animal	B-X
data	B-X
has	B-X
shown	B-X
significant	B-X
overlap	B-X
between	B-X
the	B-X
consumption	B-X
of	B-X
added	B-X
sugars	B-X
and	B-X
drug-like	B-X
effects	B-X
,	B-X
including	B-X
bingeing	B-X
,	B-X
craving	B-X
,	B-X
tolerance	B-X
,	B-X
withdrawal	B-X
,	B-X
cross-sensitisation	B-X
,	B-X
cross-tolerance	B-X
,	B-X
cross-dependence	B-X
,	B-X
reward	B-X
and	B-X
opioid	B-X
effects	B-X
.	B-X
Sugar	B-X
addiction	B-X
seems	B-X
to	B-X
be	B-X
dependence	B-X
to	B-X
the	B-X
natural	B-X
endogenous	B-X
opioids	B-X
that	B-X
get	B-X
released	B-X
upon	B-X
sugar	B-X
intake	B-X
.	B-X
In	B-X
both	B-X
animals	B-X
and	B-X
humans	B-X
,	B-X
the	B-X
evidence	B-X
in	B-X
the	B-X
literature	B-X
shows	B-X
substantial	B-X
parallels	B-X
and	B-X
overlap	B-X
between	B-X
drugs	B-X
of	B-X
abuse	B-X
and	B-X
sugar	B-X
,	B-X
from	B-X
the	B-X
standpoint	B-X
of	B-X
brain	B-X
neurochemistry	B-X
as	B-X
well	B-X
as	B-X
behaviour	B-X
.	B-X

We	O
speculate	O
that	O
the	O
nutrient	O
-	O
rich	O
LB	O
broth	O
may	O
mask	O
the	O
effect	O
of	O
the	O
sugar	O
on	O
hilE	O
expression	O
because	O
the	O
effect	O
of	O
sugar	O
addition	O
on	O
hilA	O
expression	O
was	O
more	O
distinct	O
in	O
DLB	O
than	O
LB	O
(	O
45	O
)	O
.	O

In	O
addition	O
,	O
hilE	O
expression	O
was	O
also	O
increased	O
in	O
the	O
presence	O
of	O
arabinose	O
,	O
which	O
suggests	O
an	O
additional	O
regulatory	O
mechanism	O
mediated	O
by	O
arabinose	O
.	O

Interestingly	O
,	O
carbohydrate	O
regulation	O
of	O
hilE	O
and	O
hilD	O
expression	O
in	O
the	O
mlc	O
mutant	O
created	O
a	O
different	O
story	O
.	O

All	O
of	O
the	O
carbohydrates	O
tested	O
in	O
this	O
study	O
,	O
with	O
the	O
exception	O
of	O
glycerol	O
,	O
increased	O
hilD	O
expression	O
by	O
approximately1	O
.	O
1	O
-	O
1	O
.	O
2	O
-	O
fold	O
,	O
even	O
though	O
hilE	O
expression	O
in	O
the	O
mlc	O
mutant	O
was	O
increased	O
by	O
approximately30	O
%	O
in	O
the	O
presence	O
of	O
the	O
sugars	O
tested	O
(	O
Figure	O
6	O
)	O
.	O

These	O
results	O
suggest	O
that	O
the	O
presence	O
of	O
complex	O
regulatory	O
mechanisms	O
for	O
hilE	O
is	O
required	O
for	O
optimal	O
regulation	O
of	O
the	O
SPI1	O
genes	O
,	O
as	O
can	O
be	O
expected	O
from	O
the	O
complex	O
regulatory	O
networks	O
identified	O
in	O
Salmonella	B-Organism
(	O
46	O
)	O
.	O

It	O
has	O
been	O
suggested	O
that	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
PhoR	O
-	O
PhoB	O
leads	O
to	O
increased	O
hilE	O
P2	O
expression	O
and	O
subsequent	O
repression	O
of	O
hilA	O
and	O
invasion	O
genes	O
(	O
7	O
,	O
18	O
)	O
.	O

The	O
PhoR	O
sensor	O
kinase	O
phosphorylates	O
PhoB	O
when	O
extracellular	O
Pi	O
levels	O
are	O
low	O
,	O
and	O
the	O
phosphorylated	O
PhoB	O
then	O
binds	O
and	O
activates	O
the	O
promoters	O
in	O
the	O
Pho	O
regulon	O
.	O

However	O
,	O
even	O
in	O
the	O
absence	O
of	O
PhoR	O
,	O
many	O
carbon	O
sources	O
are	O
known	O
to	O
activate	O
the	O
Pho	O
regulon	O
via	O
CreC	O
,	O
which	O
is	O
a	O
PhoR	O
homolog	O
(	O
47	O
)	O
.	O

Thus	O
,	O
carbon	O
metabolism	O
sensed	O
by	O
PhoB	O
/	O
R	O
may	O
also	O
affect	O
hilE	O
expression	O
(	O
22	O
)	O
,	O
and	O
this	O
may	O
be	O
one	O
of	O
the	O
reasons	O
for	O
the	O
elevated	O
hilE	O
expression	O
in	O
the	O
presence	O
of	O
carbohydrates	O
in	O
the	O
mlc	O
mutant	O
(	O
Figure	O
6A	O
)	O
.	O

Recently	O
,	O
Teplitski	O
et	O
al	O
.	O

(	O
48	O
)	O
have	O
reported	O
that	O
the	O
expression	O
of	O
sirA	O
,	O
which	O
is	O
a	O
response	O
regulator	O
for	O
BarA	O
(	O
49	O
)	O
,	O
is	O
decreased	O
in	O
the	O
presence	O
of	O
50mM	O
glucose	O
.	O

The	O
repressive	O
effect	O
of	O
glucose	O
was	O
also	O
observed	O
for	O
the	O
downstream	O
members	O
of	O
the	O
SirA	O
regulon	O
,	O
such	O
as	O
csrB	O
,	O
csrC	O
and	O
hilA	O
(	O
48	O
,	O
49	O
)	O
.	O

Collectively	O
,	O
these	O
results	O
show	O
that	O
SPI1	O
is	O
not	O
activated	O
when	O
Salmonella	B-Organism
is	O
grown	O
in	O
the	O
presence	O
of	O
glucose	O
(	O
Figure	O
6	O
;	O
44	O
,	O
45	O
,	O
48	O
)	O
.	O
<EOS>	B-X
Mechanistically	B-X
,	B-X
PRDM1	B-X
enhances	B-X
USP22	B-X
transcription	B-X
,	B-X
thus	B-X
reducing	B-X
SPI1	B-X
protein	B-X
degradation	B-X
through	B-X
deubiquitination	B-X
,	B-X
which	B-X
enhances	B-X
PD-L1	B-X
transcription	B-X
.	B-X
Collectively	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
the	B-X
PRDM1-USP22-SPI1	B-X
axis	B-X
regulates	B-X
PD-L1	B-X
levels	B-X
,	B-X
resulting	B-X
in	B-X
infiltrated	B-X
CD8	B-X
To	B-X
clarify	B-X
whether	B-X
cuproptosis	B-X
was	B-X
involved	B-X
in	B-X
AGEs-induced	B-X
cardiotoxicity	B-X
,	B-X
we	B-X
analyzed	B-X
the	B-X
toxicity	B-X
of	B-X
AGEs	B-X
and	B-X
copper	B-X
in	B-X
AC16	B-X
cardiomyocytes	B-X
and	B-X
in	B-X
STZ-induced	B-X
or	B-X
db/db-diabetic	B-X
mouse	B-X
models	B-X
.	B-X
The	B-X
results	B-X
showed	B-X
that	B-X
copper	B-X
ionophore	B-X
elesclomol	B-X
induced	B-X
cuproptosis	B-X
in	B-X
cardiomyocytes	B-X
.	B-X

Since	O
the	O
environmental	O
conditions	O
faced	O
by	O
Salmonella	B-Organism
change	O
constantly	O
during	O
passage	O
through	O
the	O
intestine	O
of	O
the	O
animal	O
host	O
,	O
this	O
bacterium	O
should	O
use	O
multiple	O
signals	O
to	O
modulate	O
the	O
virulence	O
genes	O
needed	O
for	O
survival	O
.	O

It	O
is	O
known	O
that	O
S	B-Organism
.	I-Organism
<EOS>	B-X
Unfortunately	B-X
,	B-X
comparatively	B-X
little	B-X
is	B-X
known	B-X
about	B-X
the	B-X
contribution	B-X
of	B-X
the	B-X
immune	B-X
system	B-X
once	B-X
the	B-X
trajectory	B-X
has	B-X
been	B-X
set	B-X
,	B-X
and	B-X
chronic	B-X
HF	B-X
has	B-X
been	B-X
established-which	B-X
clinically	B-X
represents	B-X
the	B-X
majority	B-X
of	B-X
patients	B-X
.	B-X
It	B-X
is	B-X
known	B-X
that	B-X
chronic	B-X
HF	B-X
is	B-X
associated	B-X
with	B-X
circulating	B-X
inflammatory	B-X
cytokines	B-X
that	B-X
can	B-X
predict	B-X
clinical	B-X
outcomes	B-X
,	B-X
yet	B-X
the	B-X
causative	B-X
role	B-X
inflammation	B-X
plays	B-X
in	B-X
disease	B-X
progression	B-X
is	B-X
not	B-X
well	B-X
defined	B-X
,	B-X
and	B-X
the	B-X
majority	B-X
of	B-X
clinical	B-X
trials	B-X
that	B-X
target	B-X
aspects	B-X
of	B-X
inflammation	B-X
in	B-X
patients	B-X
with	B-X
chronic	B-X
HF	B-X
have	B-X
largely	B-X
been	B-X
negative	B-X
.	B-X
This	B-X
review	B-X
will	B-X
present	B-X
what	B-X
is	B-X
currently	B-X
known	B-X
about	B-X
inflammation	B-X
in	B-X
chronic	B-X
HF	B-X
in	B-X
both	B-X
humans	B-X
and	B-X
animal	B-X
models	B-X
as	B-X
a	B-X
means	B-X
to	B-X
highlight	B-X
the	B-X
gap	B-X
in	B-X
our	B-X
knowledge	B-X
base	B-X
that	B-X
requires	B-X
further	B-X
examination	B-X
.	B-X
However	B-X
,	B-X
despite	B-X
LAG3	B-X
's	B-X
role	B-X
in	B-X
immune	B-X
exhaustion	B-X
and	B-X
the	B-X
great	B-X
potential	B-X
of	B-X
LAG3	B-X
inhibition	B-X
as	B-X
treatment	B-X
,	B-X
much	B-X
remains	B-X
unknown	B-X
about	B-X
its	B-X
biology	B-X
,	B-X
particularly	B-X
its	B-X
mechanism	B-X
of	B-X
action	B-X
.	B-X
This	B-X
review	B-X
describes	B-X
the	B-X
knowns	B-X
,	B-X
unknowns	B-X
and	B-X
controversies	B-X
surrounding	B-X
LAG3	B-X
.	B-X

Typhimurium	B-Organism
uses	O
bile	O
or	O
SCFAs	O
including	O
acetate	O
,	O
propionate	O
and	O
butyrate	O
,	O
as	O
environmental	O
signals	O
to	O
modulate	O
its	O
invasion	O
of	O
the	O
gastrointestinal	O
tract	O
(	O
50	O
-	O
52	O
)	O
.	O
<EOS>	B-X
Milk	B-X
thistle	B-X
extracts	B-X
have	B-X
been	B-X
used	B-X
as	B-X
medicinal	B-X
herbs	B-X
in	B-X
the	B-X
treatment	B-X
of	B-X
liver	B-X
cirrhosis	B-X
,	B-X
chronic	B-X
hepatitis	B-X
(	B-X
liver	B-X
inflammation	B-X
)	B-X
,	B-X
and	B-X
gallbladder	B-X
disorders	B-X
.	B-X
Other	B-X
reported	B-X
uses	B-X
of	B-X
milk	B-X
thistle	B-X
in	B-X
folk	B-X
medicine	B-X
include	B-X
as	B-X
a	B-X
treatment	B-X
for	B-X
malarial	B-X
fever	B-X
,	B-X
bronchitis	B-X
,	B-X
gallstones	B-X
,	B-X
jaundice	B-X
,	B-X
peritonitis	B-X
,	B-X
uterine	B-X
congestion	B-X
,	B-X
varicose	B-X
veins	B-X
,	B-X
and	B-X
as	B-X
a	B-X
milk	B-X
production	B-X
stimulant	B-X
for	B-X
nursing	B-X
mothers	B-X
.	B-X
Milk	B-X
thistle	B-X
extract	B-X
was	B-X
nominated	B-X
for	B-X
study	B-X
by	B-X
the	B-X
National	B-X
Institute	B-X
of	B-X
Environmental	B-X
Health	B-X
Sciences	B-X
because	B-X
it	B-X
is	B-X
one	B-X
of	B-X
the	B-X
most	B-X
widely	B-X
used	B-X
herbs	B-X
in	B-X
the	B-X
United	B-X
States	B-X
.	B-X
Male	B-X
and	B-X
female	B-X
F344/N	B-X
rats	B-X
and	B-X
B6C3F1	B-X
mice	B-X
were	B-X
exposed	B-X
to	B-X
an	B-X
ethanol/water	B-X
extract	B-X
of	B-X
milk	B-X
thistle	B-X
fruit	B-X
(	B-X
milk	B-X
thistle	B-X
extract	B-X
)	B-X
containing	B-X
approximately	B-X
65	B-X
%	B-X
silymarin	B-X
in	B-X
feed	B-X
for	B-X
3	B-X
months	B-X
or	B-X
2	B-X
years	B-X
.	B-X
3-MONTH	B-X
STUDY	B-X
IN	B-X
RATS	B-X
:	B-X
Groups	B-X
of	B-X
10	B-X
male	B-X
and	B-X
10	B-X
female	B-X
rats	B-X
were	B-X
fed	B-X
diets	B-X
containing	B-X
0	B-X
,	B-X
3,125	B-X
,	B-X
6,250	B-X
,	B-X
12,500	B-X
,	B-X
25,000	B-X
,	B-X
or	B-X
50,000	B-X
ppm	B-X
milk	B-X
thistle	B-X
extract	B-X
(	B-X
equivalent	B-X
to	B-X
average	B-X
daily	B-X
doses	B-X
of	B-X
approximately	B-X
260	B-X
,	B-X
525	B-X
,	B-X
1,050	B-X
,	B-X
2,180	B-X
,	B-X
or	B-X
4,500	B-X
mg	B-X
milk	B-X
thistle	B-X
extract/kilogram	B-X
body	B-X
weight	B-X
to	B-X
males	B-X
and	B-X
260	B-X
,	B-X
510	B-X
,	B-X
1,050	B-X
,	B-X
2,150	B-X
,	B-X
or	B-X
4,550	B-X
mg/kg	B-X
to	B-X
females	B-X
)	B-X
for	B-X
14	B-X
weeks	B-X
.	B-X
The	B-X
sperm	B-X
motility	B-X
in	B-X
12,500	B-X
,	B-X
25,000	B-X
,	B-X
and	B-X
50,000	B-X
ppm	B-X
males	B-X
was	B-X
decreased	B-X
by	B-X
5	B-X
%	B-X
,	B-X
11	B-X
%	B-X
,	B-X
and	B-X
9	B-X
%	B-X
,	B-X
respectively	B-X
,	B-X
relative	B-X
to	B-X
that	B-X
of	B-X
the	B-X
controls	B-X
;	B-X
the	B-X
total	B-X
number	B-X
of	B-X
spermatid	B-X
heads	B-X
per	B-X
testis	B-X
decreased	B-X
by	B-X
11	B-X
%	B-X
,	B-X
21	B-X
%	B-X
,	B-X
and	B-X
9	B-X
%	B-X
in	B-X
12,500	B-X
,	B-X
25,000	B-X
,	B-X
and	B-X
50,000	B-X
ppm	B-X
males	B-X
.	B-X
3-MONTH	B-X
STUDY	B-X
IN	B-X
MICE	B-X
:	B-X
Groups	B-X
of	B-X
10	B-X
male	B-X
and	B-X
10	B-X
female	B-X
mice	B-X
were	B-X
fed	B-X
diets	B-X
containing	B-X
0	B-X
,	B-X
3,125	B-X
,	B-X
6,250	B-X
,	B-X
12,500	B-X
,	B-X
25,000	B-X
,	B-X
or	B-X
50,000	B-X
ppm	B-X
milk	B-X
thistle	B-X
extract	B-X
(	B-X
equivalent	B-X
to	B-X
average	B-X
daily	B-X
doses	B-X
of	B-X
approximately	B-X
640	B-X
,	B-X
1,340	B-X
,	B-X
2,500	B-X
,	B-X
5,280	B-X
,	B-X
or	B-X
11,620	B-X
mg/kg	B-X
to	B-X
males	B-X
and	B-X
580	B-X
,	B-X
1,180	B-X
,	B-X
2,335	B-X
,	B-X
4,800	B-X
,	B-X
or	B-X
9,680	B-X
mg/kg	B-X
to	B-X
females	B-X
)	B-X
for	B-X
14	B-X
weeks	B-X
.	B-X
Absolute	B-X
and	B-X
relative	B-X
thymus	B-X
weights	B-X
were	B-X
significantly	B-X
decreased	B-X
in	B-X
25,000	B-X
and	B-X
50,000	B-X
ppm	B-X
males	B-X
.	B-X
No	B-X
significant	B-X
differences	B-X
were	B-X
observed	B-X
between	B-X
exposed	B-X
and	B-X
control	B-X
groups	B-X
,	B-X
for	B-X
sperm	B-X
parameters	B-X
of	B-X
male	B-X
mice	B-X
,	B-X
for	B-X
estrous	B-X
cyclicity	B-X
of	B-X
female	B-X
mice	B-X
,	B-X
or	B-X
for	B-X
reproductive	B-X
organ	B-X
weights	B-X
of	B-X
male	B-X
or	B-X
female	B-X
mice	B-X
,	B-X
when	B-X
mice	B-X
were	B-X
administered	B-X
milk	B-X
thistle	B-X
extract	B-X
in	B-X
feed	B-X
at	B-X
12,500	B-X
,	B-X
25,000	B-X
,	B-X
or	B-X
50,000	B-X
ppm	B-X
.	B-X
2-YEAR	B-X
STUDY	B-X
IN	B-X
RATS	B-X
:	B-X
Groups	B-X
of	B-X
50	B-X
male	B-X
and	B-X
50	B-X
female	B-X
rats	B-X
were	B-X
fed	B-X
diets	B-X
containing	B-X
0	B-X
,	B-X
12,500	B-X
,	B-X
25,000	B-X
,	B-X
or	B-X
50,000	B-X
ppm	B-X
milk	B-X
thistle	B-X
extract	B-X
(	B-X
equivalent	B-X
to	B-X
average	B-X
daily	B-X
doses	B-X
of	B-X
approximately	B-X
570	B-X
,	B-X
1,180	B-X
,	B-X
or	B-X
2,520	B-X
mg/kg	B-X
to	B-X
males	B-X
and	B-X
630	B-X
,	B-X
1,300	B-X
,	B-X
or	B-X
2,750	B-X
mg/kg	B-X
to	B-X
females	B-X
)	B-X
for	B-X
105	B-X
to	B-X
106	B-X
weeks	B-X
.	B-X
Exposure	B-X
to	B-X
milk	B-X
thistle	B-X
extract	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
survival	B-X
of	B-X
male	B-X
or	B-X
female	B-X
rats	B-X
.	B-X
Significantly	B-X
decreased	B-X
incidences	B-X
of	B-X
mammary	B-X
gland	B-X
fibroadenoma	B-X
,	B-X
adenoma	B-X
,	B-X
or	B-X
carcinoma	B-X
(	B-X
combined	B-X
)	B-X
occurred	B-X
in	B-X
females	B-X
exposed	B-X
to	B-X
25,000	B-X
or	B-X
50,000	B-X
ppm	B-X
.	B-X
Significantly	B-X
increased	B-X
incidences	B-X
of	B-X
clear	B-X
cell	B-X
and	B-X
mixed	B-X
cell	B-X
focus	B-X
of	B-X
the	B-X
liver	B-X
occurred	B-X
in	B-X
25,000	B-X
and	B-X
50,000	B-X
ppm	B-X
females	B-X
.	B-X
The	B-X
incidences	B-X
of	B-X
bile	B-X
duct	B-X
hyperplasia	B-X
were	B-X
significantly	B-X
decreased	B-X
in	B-X
50,000	B-X
ppm	B-X
males	B-X
and	B-X
in	B-X
all	B-X
exposed	B-X
groups	B-X
of	B-X
females	B-X
,	B-X
and	B-X
the	B-X
incidence	B-X
of	B-X
mixed	B-X
inflammatory	B-X
cell	B-X
infiltration	B-X
was	B-X
significantly	B-X
decreased	B-X
in	B-X
50,000	B-X
ppm	B-X
males	B-X
.	B-X
2-YEAR	B-X
STUDY	B-X
IN	B-X
MICE	B-X
:	B-X
Groups	B-X
of	B-X
50	B-X
male	B-X
and	B-X
50	B-X
female	B-X
mice	B-X
were	B-X
fed	B-X
diets	B-X
containing	B-X
0	B-X
,	B-X
12,500	B-X
,	B-X
25,000	B-X
,	B-X
or	B-X
50,000	B-X
ppm	B-X
milk	B-X
thistle	B-X
extract	B-X
(	B-X
equivalent	B-X
to	B-X
average	B-X
daily	B-X
doses	B-X
of	B-X
approximately	B-X
1,610	B-X
,	B-X
3,530	B-X
,	B-X
or	B-X
7,770	B-X
mg/kg	B-X
to	B-X
males	B-X
and	B-X
1,500	B-X
,	B-X
3,175	B-X
,	B-X
or	B-X
7,180	B-X
mg/kg	B-X
to	B-X
females	B-X
)	B-X
for	B-X
105	B-X
to	B-X
106	B-X
weeks	B-X
.	B-X
Exposure	B-X
to	B-X
milk	B-X
thistle	B-X
extract	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
survival	B-X
of	B-X
male	B-X
or	B-X
female	B-X
mice	B-X
.	B-X
The	B-X
mean	B-X
body	B-X
weights	B-X
of	B-X
the	B-X
25,000	B-X
ppm	B-X
groups	B-X
were	B-X
less	B-X
than	B-X
those	B-X
of	B-X
controls	B-X
after	B-X
week	B-X
25	B-X
;	B-X
mean	B-X
body	B-X
weights	B-X
of	B-X
50,000	B-X
ppm	B-X
groups	B-X
were	B-X
less	B-X
than	B-X
those	B-X
of	B-X
controls	B-X
after	B-X
week	B-X
12	B-X
.	B-X
Significantly	B-X
decreased	B-X
incidences	B-X
of	B-X
hepatocellular	B-X
adenoma	B-X
and	B-X
hepatocellular	B-X
carcinoma	B-X
occurred	B-X
in	B-X
50,000	B-X
ppm	B-X
males	B-X
,	B-X
and	B-X
decreased	B-X
incidences	B-X
of	B-X
hepatocellular	B-X
adenoma	B-X
or	B-X
carcinoma	B-X
(	B-X
combined	B-X
)	B-X
occurred	B-X
in	B-X
25,000	B-X
and	B-X
50,000	B-X
ppm	B-X
males	B-X
.	B-X

We	O
propose	O
that	O
Salmonella	B-Organism
can	O
use	O
the	O
glucose	O
concentration	O
of	O
the	O
mammalian	O
intestinal	O
tract	O
as	O
one	O
of	O
many	O
signals	O
for	O
the	O
regulation	O
of	O
invasion	O
genes	O
.	O

Salmonella	B-Organism
may	O
use	O
Mlc	O
to	O
sense	O
the	O
availability	O
of	O
sugars	O
,	O
thereby	O
allowing	O
decisions	O
as	O
to	O
when	O
and	O
where	O
to	O
initiate	O
the	O
expression	O
of	O
genes	O
involved	O
in	O
invasion	O
.	O

S	B-Organism
.	I-Organism
<EOS>	B-X
Finkelstein	B-X
's	B-X
Test	B-X
Is	B-X
Superior	B-X
to	B-X
Eichhoff	B-X
's	B-X
Test	B-X
in	B-X
the	B-X
Investigation	B-X
of	B-X
de	B-X
Quervain	B-X
's	B-X
Disease	B-X
.	B-X
Protein	B-X
S	B-X
deficiency	B-X
.	B-X
Letter	B-X
:	B-X
Craniometrics	B-X
and	B-X
Ventricular	B-X
Access	B-X
:	B-X
A	B-X
Review	B-X
of	B-X
Kocher	B-X
's	B-X
,	B-X
Kaufman	B-X
's	B-X
,	B-X
Paine	B-X
's	B-X
,	B-X
Menovksy	B-X
's	B-X
,	B-X
Tubbs	B-X
'	B-X
,	B-X
Keen	B-X
's	B-X
,	B-X
Frazier	B-X
's	B-X
,	B-X
Dandy	B-X
's	B-X
,	B-X
and	B-X
Sanchez	B-X
's	B-X
Points	B-X
.	B-X

Typhimurium	B-Organism
typically	O
invades	O
the	O
distal	O
small	O
intestine	O
(	O
ileum	O
)	O
of	O
the	O
mammalian	O
upper	O
gastrointestinal	O
tract	O
(	O
53	O
)	O
.	O

Simple	O
sugars	O
,	O
such	O
as	O
glucose	O
,	O
are	O
rarely	O
encountered	O
in	O
the	O
distal	O
ileum	O
,	O
as	O
most	O
are	O
absorbed	O
in	O
the	O
proximal	O
portion	O
of	O
the	O
small	O
intestine	O
(	O
54	O
)	O
.	O

The	O
relatively	O
high	O
glucose	O
concentration	O
in	O
the	O
proximal	O
small	O
intestine	O
may	O
repress	O
SPI1	O
gene	O
expression	O
through	O
Mlc	O
,	O
perhaps	O
together	O
with	O
PhoR	O
-	O
PhoB	O
and	O
/	O
or	O
SirA	O
,	O
whereas	O
upon	O
transit	O
to	O
the	O
distal	O
ileum	O
,	O
the	O
glucose	O
concentration	O
becomes	O
low	O
enough	O
to	O
activate	O
the	O
invasion	O
genes	O
of	O
SPI1	O
.	O

The	O
effects	O
of	O
various	O
sugars	O
on	O
the	O
differential	O
regulation	O
of	O
SPI1	O
genes	O
require	O
further	O
investigation	O
to	O
understand	O
their	O
roles	O
in	O
Salmonella	B-Organism
pathogenesis	O
.	O

SalK	O
/	O
SalR	O
,	O
a	O
Two	O
-	O
Component	O
Signal	O
Transduction	O
System	O
,	O
Is	O
Essential	O
for	O
Full	O
Virulence	O
of	O
Highly	O
Invasive	O
Streptococcus	B-Organism
suis	I-Organism
Serotype	I-Organism
2	I-Organism
<EOS>	B-X
Streptococcus	B-X
suis	B-X
serotype	B-X
2	B-X
(	B-X
S.	B-X
suis	B-X
2	B-X
,	B-X
SS2	B-X
)	B-X
has	B-X
evolved	B-X
into	B-X
a	B-X
highly	B-X
infectious	B-X
entity	B-X
,	B-X
which	B-X
caused	B-X
the	B-X
two	B-X
recent	B-X
large-scale	B-X
outbreaks	B-X
of	B-X
human	B-X
SS2	B-X
epidemic	B-X
in	B-X
China	B-X
,	B-X
and	B-X
is	B-X
characterized	B-X
by	B-X
a	B-X
toxic	B-X
shock-like	B-X
syndrome	B-X
.	B-X

Background	O
Streptococcus	B-Organism
suis	I-Organism
serotype	I-Organism
2	I-Organism
(	O
S	B-Organism
.	I-Organism
suis	I-Organism
2	I-Organism
,	O
SS2	B-Organism
)	O
has	O
evolved	O
into	O
a	O
highly	O
infectious	O
entity	O
,	O
which	O
caused	O
the	O
two	O
recent	O
large	O
-	O
scale	O
outbreaks	O
of	O
human	B-Organism
SS2	B-Organism
epidemic	O
in	O
China	O
,	O
and	O
is	O
characterized	O
by	O
a	O
toxic	O
shock	O
-	O
like	O
syndrome	O
.	O
<EOS>	B-X
Streptococcus	B-X
suis	B-X
serotype	B-X
2	B-X
(	B-X
S.	B-X
suis	B-X
2	B-X
,	B-X
SS2	B-X
)	B-X
has	B-X
evolved	B-X
into	B-X
a	B-X
highly	B-X
infectious	B-X
entity	B-X
,	B-X
which	B-X
caused	B-X
the	B-X
two	B-X
recent	B-X
large-scale	B-X
outbreaks	B-X
of	B-X
human	B-X
SS2	B-X
epidemic	B-X
in	B-X
China	B-X
,	B-X
and	B-X
is	B-X
characterized	B-X
by	B-X
a	B-X
toxic	B-X
shock-like	B-X
syndrome	B-X
.	B-X

However	O
,	O
the	O
molecular	O
pathogenesis	O
of	O
this	O
new	O
emerging	O
pathogen	O
is	O
still	O
poorly	O
understood	O
.	O
<EOS>	B-X
To	B-X
date	B-X
,	B-X
cellular	B-X
and	B-X
molecular	B-X
mechanisms	B-X
governing	B-X
CNS	B-X
invasion	B-X
are	B-X
still	B-X
poorly	B-X
understood	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
known	B-X
MeV	B-X
entry	B-X
receptors	B-X
are	B-X
not	B-X
expressed	B-X
in	B-X
the	B-X
CNS	B-X
and	B-X
how	B-X
MeV	B-X
enters	B-X
and	B-X
spreads	B-X
in	B-X
the	B-X
brain	B-X
is	B-X
not	B-X
fully	B-X
understood	B-X
.	B-X
Almost	B-X
exclusively	B-X
studied	B-X
in	B-X
the	B-X
light	B-X
of	B-X
their	B-X
interactions	B-X
with	B-X
RNA	B-X
ligands	B-X
and	B-X
the	B-X
associated	B-X
functional	B-X
events	B-X
,	B-X
they	B-X
are	B-X
still	B-X
poorly	B-X
understood	B-X
as	B-X
evolutionary	B-X
units	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
offer	B-X
a	B-X
new	B-X
perspective	B-X
in	B-X
which	B-X
FinO/ProQ-family	B-X
regulators	B-X
emerge	B-X
as	B-X
active	B-X
evolutionary	B-X
players	B-X
with	B-X
both	B-X
negative	B-X
and	B-X
positive	B-X
roles	B-X
,	B-X
significantly	B-X
impacting	B-X
the	B-X
evolutionary	B-X
modes	B-X
and	B-X
trajectories	B-X
of	B-X
their	B-X
bacterial	B-X
hosts	B-X
.	B-X

Methodology	O
/	O
Principal	O
Findings	O
89K	O
is	O
a	O
newly	O
predicted	O
pathogenicity	O
island	O
(	O
PAI	O
)	O
which	O
is	O
specific	O
to	O
Chinese	O
epidemic	O
strains	O
isolated	O
from	O
these	O
two	O
SS2	B-Organism
outbreaks	O
.	O
<EOS>	B-X
Streptococcus	B-X
suis	B-X
serotype	B-X
2	B-X
(	B-X
S.	B-X
suis	B-X
2	B-X
,	B-X
SS2	B-X
)	B-X
has	B-X
evolved	B-X
into	B-X
a	B-X
highly	B-X
infectious	B-X
entity	B-X
,	B-X
which	B-X
caused	B-X
the	B-X
two	B-X
recent	B-X
large-scale	B-X
outbreaks	B-X
of	B-X
human	B-X
SS2	B-X
epidemic	B-X
in	B-X
China	B-X
,	B-X
and	B-X
is	B-X
characterized	B-X
by	B-X
a	B-X
toxic	B-X
shock-like	B-X
syndrome	B-X
.	B-X

Further	O
bioinformatics	O
analysis	O
revealed	O
a	O
unique	O
two	O
-	O
component	O
signal	O
transduction	O
system	O
(	O
TCSTS	O
)	O
located	O
in	O
the	O
candidate	O
89K	O
PAI	O
,	O
which	O
is	O
orthologous	O
to	O
the	O
SalK	O
/	O
SalR	O
regulatory	O
system	O
of	O
Streptococcus	B-Organism
salivarius	I-Organism
.	O

Knockout	O
of	O
salKR	O
eliminated	O
the	O
lethality	O
of	O
SS2	B-Organism
in	O
experimental	O
infection	O
of	O
piglets	B-Organism
.	O
<EOS>	B-X
Streptococcus	B-X
suis	B-X
serotype	B-X
2	B-X
(	B-X
S.	B-X
suis	B-X
2	B-X
,	B-X
SS2	B-X
)	B-X
has	B-X
evolved	B-X
into	B-X
a	B-X
highly	B-X
infectious	B-X
entity	B-X
,	B-X
which	B-X
caused	B-X
the	B-X
two	B-X
recent	B-X
large-scale	B-X
outbreaks	B-X
of	B-X
human	B-X
SS2	B-X
epidemic	B-X
in	B-X
China	B-X
,	B-X
and	B-X
is	B-X
characterized	B-X
by	B-X
a	B-X
toxic	B-X
shock-like	B-X
syndrome	B-X
.	B-X

Functional	O
complementation	O
of	O
salKR	O
into	O
the	O
isogenic	O
mutant	O
DeltasalKR	O
restored	O
its	O
soaring	O
pathogenicity	O
.	O

Colonization	O
experiments	O
showed	O
that	O
the	O
DeltasalKR	O
mutant	O
could	O
not	O
colonize	O
any	O
susceptible	O
tissue	O
of	O
piglets	B-Organism
when	O
administered	O
alone	O
.	O

Bactericidal	O
assays	O
demonstrated	O
that	O
resistance	O
of	O
the	O
mutant	O
to	O
polymorphonuclear	O
leukocyte	O
(	O
PMN	O
)	O
-	O
mediated	O
killing	O
was	O
greatly	O
decreased	O
.	O

Expression	O
microarray	O
analysis	O
exhibited	O
a	O
transcription	O
profile	O
alteration	O
of	O
26	O
various	O
genes	O
down	O
-	O
regulated	O
in	O
the	O
DeltasalKR	O
mutant	O
.	O
<EOS>	B-X
However	B-X
,	B-X
the	B-X
molecular	B-X
pathogenesis	B-X
of	B-X
this	B-X
new	B-X
emerging	B-X
pathogen	B-X
is	B-X
still	B-X
poorly	B-X
understood	B-X
.	B-X

Conclusions	O
/	O
Significance	O
These	O
findings	O
suggest	O
that	O
SalK	O
/	O
SalR	O
is	O
requisite	O
for	O
the	O
full	O
virulence	O
of	O
ethnic	O
Chinese	O
isolates	O
of	O
highly	O
pathogenic	O
SS2	B-Organism
,	O
thus	O
providing	O
experimental	O
evidence	O
for	O
the	O
validity	O
of	O
this	O
bioinformatically	O
predicted	O
PAI	O
.	O
<EOS>	B-X
Streptococcus	B-X
suis	B-X
serotype	B-X
2	B-X
(	B-X
S.	B-X
suis	B-X
2	B-X
,	B-X
SS2	B-X
)	B-X
has	B-X
evolved	B-X
into	B-X
a	B-X
highly	B-X
infectious	B-X
entity	B-X
,	B-X
which	B-X
caused	B-X
the	B-X
two	B-X
recent	B-X
large-scale	B-X
outbreaks	B-X
of	B-X
human	B-X
SS2	B-X
epidemic	B-X
in	B-X
China	B-X
,	B-X
and	B-X
is	B-X
characterized	B-X
by	B-X
a	B-X
toxic	B-X
shock-like	B-X
syndrome	B-X
.	B-X

Introduction	O

Streptococcus	B-Organism
suis	I-Organism
(	O
S	B-Organism
.	I-Organism
suis	I-Organism
)	O
is	O
considered	O
an	O
important	O
zoonotic	O
pathogen	O
causing	O
a	O
variety	O
of	O
life	O
-	O
threatening	O
infections	O
that	O
include	O
meningitis	O
,	O
arthritis	O
,	O
septicaemia	O
and	O
even	O
sudden	O
death	O
in	O
pigs	B-Organism
and	O
humans	B-Organism
[	O
1	O
]	O
,	O
[	O
2	O
]	O
.	O

Among	O
the	O
known	O
35	O
serotypes	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
,	O
S	B-Organism
.	I-Organism
suis	I-Organism
serotype	I-Organism
2	I-Organism
(	O
S	B-Organism
.	I-Organism
suis	I-Organism
2	I-Organism
or	O
SS2	B-Organism
)	O
is	O
the	O
most	O
virulent	O
and	O
the	O
most	O
frequently	O
isolated	O
serotype	O
.	O
<EOS>	B-X
Infections	B-X
caused	B-X
by	B-X
Streptococcus	B-X
suis	B-X
are	B-X
considered	B-X
a	B-X
global	B-X
problem	B-X
in	B-X
the	B-X
swine	B-X
industry	B-X
.	B-X
In	B-X
this	B-X
animal	B-X
species	B-X
,	B-X
S.	B-X
suis	B-X
is	B-X
associated	B-X
with	B-X
septicemia	B-X
,	B-X
meningitis	B-X
,	B-X
endocarditis	B-X
,	B-X
arthritis	B-X
and	B-X
,	B-X
occasionally	B-X
,	B-X
other	B-X
infections	B-X
.	B-X
Although	B-X
sporadic	B-X
cases	B-X
of	B-X
S.	B-X
suis	B-X
infection	B-X
in	B-X
humans	B-X
have	B-X
been	B-X
reported	B-X
,	B-X
a	B-X
large	B-X
outbreak	B-X
due	B-X
to	B-X
S.	B-X
suis	B-X
serotype	B-X
2	B-X
emerged	B-X
in	B-X
the	B-X
summer	B-X
of	B-X
2005	B-X
in	B-X
Sichuan	B-X
,	B-X
China	B-X
.	B-X
A	B-X
similar	B-X
outbreak	B-X
was	B-X
observed	B-X
in	B-X
another	B-X
Chinese	B-X
province	B-X
in	B-X
1998	B-X
.	B-X
The	B-X
increased	B-X
severity	B-X
of	B-X
S.	B-X
suis	B-X
infections	B-X
in	B-X
humans	B-X
,	B-X
such	B-X
as	B-X
a	B-X
shorter	B-X
incubation	B-X
time	B-X
,	B-X
more	B-X
rapid	B-X
disease	B-X
progression	B-X
and	B-X
higher	B-X
rate	B-X
of	B-X
mortality	B-X
,	B-X
underscores	B-X
the	B-X
critical	B-X
need	B-X
to	B-X
better	B-X
understand	B-X
the	B-X
factors	B-X
associated	B-X
with	B-X
pathogenesis	B-X
of	B-X
S.	B-X
suis	B-X
infection	B-X
.	B-X
From	B-X
the	B-X
35	B-X
capsular	B-X
serotypes	B-X
currently	B-X
known	B-X
,	B-X
serotype	B-X
2	B-X
is	B-X
considered	B-X
the	B-X
most	B-X
virulent	B-X
and	B-X
frequently	B-X
isolated	B-X
in	B-X
both	B-X
swine	B-X
and	B-X
humans	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
review	B-X
the	B-X
epidemiological	B-X
,	B-X
clinical	B-X
and	B-X
immunopathological	B-X
features	B-X
of	B-X
S.	B-X
suis	B-X
infection	B-X
in	B-X
humans	B-X
.	B-X

It	O
was	O
previously	O
thought	O
that	O
SS2	B-Organism
caused	O
only	O
sporadic	O
cases	O
of	O
meningitis	O
and	O
sepsis	O
in	O
humans	B-Organism
[	O
1	O
]	O
,	O
[	O
2	O
]	O
.	O

However	O
,	O
two	O
major	O
emerging	O
infectious	O
disease	O
outbreaks	O
of	O
SS2	B-Organism
in	O
China	O
(	O
one	O
in	O
Jiangsu	O
Province	O
,	O
1998	O
,	O
and	O
the	O
other	O
in	O
Sichuan	O
Province	O
,	O
2005	O
)	O
,	O
raised	O
considerable	O
international	O
concerns	O
among	O
the	O
public	O
health	O
professionals	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
.	O

A	O
key	O
feature	O
of	O
these	O
two	O
Chinese	O
outbreaks	O
is	O
the	O
prevalence	O
of	O
a	O
toxic	O
shock	O
-	O
like	O
syndrome	O
manifesting	O
itself	O
as	O
acute	O
high	O
fever	O
,	O
multiple	O
organ	O
failures	O
,	O
short	O
course	O
of	O
disease	O
and	O
high	O
lethality	O
[	O
5	O
]	O
.	O

Despite	O
the	O
growing	O
significance	O
of	O
such	O
infections	O
,	O
little	O
is	O
known	O
about	O
the	O
factors	O
that	O
govern	O
the	O
physiological	O
responses	O
of	O
this	O
emerging	O
organism	O
,	O
especially	O
the	O
genetic	O
repertoire	O
that	O
the	O
streptococcus	O
employs	O
to	O
cause	O
the	O
toxic	O
shock	O
-	O
like	O
syndrome	O
.	O

To	O
shed	O
light	O
on	O
the	O
mystery	O
of	O
high	O
virulence	O
of	O
the	O
epidemic	O
outbreak	O
strains	O
of	O
SS2	B-Organism
,	O
our	O
joint	O
research	O
group	O
completed	O
a	O
comprehensive	O
study	O
of	O
comparative	O
genomics	O
,	O
decoding	O
the	O
whole	O
genome	O
sequences	O
of	O
two	O
virulent	O
SS2	B-Organism
strains	O
(	O
98HAH12	B-Organism
and	O
05ZYH33	B-Organism
)	O
isolated	O
from	O
Chinese	O
infected	O
patients	B-Organism
[	O
6	O
]	O
.	O

A	O
candidate	O
pathogenicity	O
island	O
(	O
PAI	O
)	O
called	O
89K	O
was	O
predicted	O
,	O
which	O
is	O
only	O
present	O
in	O
the	O
epidemic	O
strains	O
in	O
these	O
two	O
SS2	B-Organism
outbtreaks	O
but	O
not	O
in	O
other	O
domestic	O
clinical	O
isolates	O
or	O
international	O
virulent	O
strains	O
[	O
6	O
]	O
.	O
<EOS>	B-X
Since	B-X
its	B-X
appearance	B-X
,	B-X
strains	B-X
capable	B-X
of	B-X
producing	B-X
higher	B-X
mortality	B-X
rates	B-X
as	B-X
well	B-X
as	B-X
greater	B-X
severity	B-X
in	B-X
clinical	B-X
signs	B-X
and	B-X
lesions	B-X
than	B-X
classical	B-X
strains	B-X
have	B-X
been	B-X
identified	B-X
.	B-X
However	B-X
,	B-X
since	B-X
the	B-X
first	B-X
reports	B-X
of	B-X
these	B-X
``	B-X
virulent	B-X
''	B-X
PRRSV	B-X
outbreaks	B-X
,	B-X
no	B-X
homogeneity	B-X
and	B-X
consensus	B-X
in	B-X
their	B-X
description	B-X
have	B-X
been	B-X
established	B-X
.	B-X
Moreover	B-X
,	B-X
to	B-X
the	B-X
authors	B-X
'	B-X
knowledge	B-X
,	B-X
there	B-X
is	B-X
no	B-X
published	B-X
information	B-X
related	B-X
to	B-X
the	B-X
criteria	B-X
that	B-X
a	B-X
PRRSV	B-X
strain	B-X
should	B-X
fulfil	B-X
to	B-X
be	B-X
considered	B-X
as	B-X
a	B-X
``	B-X
virulent	B-X
''	B-X
strain	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
revise	B-X
the	B-X
terminology	B-X
used	B-X
and	B-X
gather	B-X
the	B-X
information	B-X
related	B-X
to	B-X
the	B-X
main	B-X
characteristics	B-X
and	B-X
differences	B-X
in	B-X
clinical	B-X
signs	B-X
,	B-X
lesions	B-X
,	B-X
viral	B-X
replication	B-X
and	B-X
tropism	B-X
as	B-X
well	B-X
as	B-X
immunological	B-X
parameters	B-X
between	B-X
virulent	B-X
and	B-X
classical	B-X
PRRSV	B-X
strains	B-X
and	B-X
propose	B-X
a	B-X
first	B-X
approximation	B-X
to	B-X
the	B-X
criteria	B-X
to	B-X
define	B-X
a	B-X
virulent	B-X
PRRSV	B-X
strain	B-X
.	B-X

However	O
,	O
this	O
bioinformatically	O
predicted	O
candidate	O
PAI	O
needs	O
experimental	O
validation	O
and	O
its	O
linkage	O
to	O
SS2	B-Organism
-	O
related	O
high	O
pathogenicity	O
remains	O
unknown	O
.	O

As	O
a	O
subgroup	O
of	O
genomic	O
islands	O
(	O
GIs	O
)	O
,	O
PAI	O
usually	O
contains	O
some	O
distinct	O
genetic	O
elements	O
acquired	O
by	O
horizontal	O
gene	O
transfer	O
[	O
7	O
]	O
,	O
[	O
8	O
]	O
.	O

A	O
wide	O
range	O
of	O
molecular	O
machineries	O
such	O
as	O
quorum	O
sensing	O
,	O
TCSTS	O
,	O
and	O
ABC	O
transporters	O
,	O
are	O
often	O
involved	O
in	O
a	O
putative	O
PAI	O
,	O
whereby	O
the	O
PAI	O
responds	O
to	O
environmental	O
signals	O
and	O
fulfills	O
its	O
critical	O
functions	O
contributing	O
to	O
the	O
virulence	O
in	O
pathogens	O
[	O
8	O
]	O
-	O
[	O
10	O
]	O
.	O

Further	O
bioinformatics	O
analysis	O
of	O
the	O
89K	O
island	O
revealed	O
a	O
distinct	O
two	O
-	O
component	O
signal	O
transduction	O
system	O
(	O
TCSTS	O
)	O
encoded	O
therein	O
appears	O
to	O
be	O
orthologous	O
to	O
the	O
SalK	O
/	O
SalR	O
system	O
of	O
S	B-Organism
.	I-Organism
salivarius	I-Organism
,	O
a	O
salivaricin	O
regulated	O
TCSTS	O
[	O
11	O
]	O
.	O

TCSTS	O
,	O
composed	O
of	O
a	O
membrane	O
sensor	O
(	O
histidine	O
kinase	O
,	O
HK	O
)	O
and	O
a	O
cytoplasmic	O
response	O
regulator	O
(	O
RR	O
)	O
,	O
is	O
an	O
important	O
mechanism	O
used	O
by	O
bacteria	O
to	O
adapt	O
to	O
and	O
survive	O
in	O
the	O
changing	O
environments	O
.	O

In	O
pathogens	O
,	O
various	O
members	O
of	O
TCSTSs	O
have	O
been	O
shown	O
to	O
play	O
critical	O
roles	O
in	O
both	O
metabolism	O
and	O
pathogenesis	O
[	O
12	O
]	O
-	O
[	O
23	O
]	O
.	O

Up	O
until	O
now	O
,	O
only	O
one	O
orphan	O
response	O
regulator	O
,	O
RevS	O
,	O
has	O
been	O
found	O
to	O
be	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
SS2	B-Organism
[	O
24	O
]	O
.	O

To	O
date	O
,	O
SalK	O
/	O
SalR	O
is	O
still	O
a	O
little	O
-	O
reported	O
TCSTS	O
in	O
the	O
fast	O
-	O
growing	O
field	O
of	O
bacterial	O
pathogenesis	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
attempted	O
to	O
generate	O
the	O
deletion	O
mutant	O
of	O
salKR	O
and	O
assess	O
the	O
contribution	O
of	O
this	O
TCSTS	O
to	O
the	O
high	O
pathogenicity	O
of	O
Chinese	O
SS2	B-Organism
strains	O
.	O

Virulence	O
assays	O
together	O
with	O
a	O
series	O
of	O
experiments	O
enabled	O
us	O
to	O
identify	O
a	O
novel	O
genetic	O
determinant	O
which	O
is	O
required	O
for	O
the	O
overall	O
virulence	O
of	O
Chinese	O
isolates	O
of	O
highly	O
pathogenic	O
SS2	B-Organism
.	O

Results	O

Discovery	O
and	O
Characterization	O
of	O
SalK	O
/	O
SalR	O
The	O
newly	O
decoded	O
genomic	O
sequence	O
of	O
S	B-Organism
.	I-Organism
suis	I-Organism
05ZYH33	I-Organism
makes	O
it	O
possible	O
to	O
systematically	O
investigate	O
the	O
genetic	O
basis	O
of	O
streptococcal	O
pathogenicity	O
.	O

We	O
focused	O
on	O
the	O
putative	O
89K	O
PAI	O
to	O
perform	O
further	O
molecular	O
analysis	O
.	O

On	O
the	O
negative	O
strand	O
of	O
89K	O
,	O
peptides	O
encoded	O
by	O
05SSU0944	O
and	O
05SSU0943	O
exhibit	O
27	O
%	O
and	O
41	O
%	O
amino	O
acid	O
sequence	O
identity	O
with	O
the	O
SalK	O
and	O
the	O
SalR	O
proteins	O
of	O
Streptococcus	B-Organism
salivarius	I-Organism
,	O
respectively	O
,	O
forming	O
a	O
TCSTS	O
belonging	O
to	O
the	O
Nar	O
/	O
LuxR	O
family	O
.	O

05SSU0944	O
and	O
05SSU0943	O
were	O
accordingly	O
renamed	O
salK	O
and	O
salR	O
(	O
Fig	O
.	O
1	O
)	O
.	O

Notably	O
,	O
the	O
average	O
GC	O
content	O
of	O
salKR	O
,	O
29	O
.	O
9	O
%	O
,	O
is	O
much	O
less	O
than	O
that	O
of	O
both	O
89K	O
and	O
the	O
whole	O
genome	O
of	O
05ZYH33	B-Organism
(	O
36	O
.	O
8	O
%	O
and	O
41	O
.	O
1	O
%	O
,	O
respectively	O
)	O
(	O
Fig	O
.	O
1B	O
)	O
.	O

The	O
results	O
of	O
bioinformatics	O
analysis	O
indicated	O
that	O
the	O
response	O
regulator	O
,	O
SalR	O
,	O
contains	O
199	O
amino	O
acids	O
(	O
aa	O
)	O
with	O
the	O
three	O
N	O
-	O
terminal	O
invariant	O
aa	O
residues	O
(	O
D30	O
,	O
D54	O
and	O
K107	O
)	O
of	O
the	O
receiver	O
domain	O
of	O
response	O
regulators	O
from	O
Gram	O
-	O
positive	O
bacteria	O
[	O
25	O
]	O
.	O

In	O
the	O
C	O
-	O
terminal	O
domain	O
,	O
it	O
contains	O
two	O
residues	O
(	O
E142	O
,	O
G152	O
)	O
that	O
are	O
absolutely	O
conserved	O
in	O
the	O
winged	O
helix	O
-	O
turn	O
-	O
helix	O
DNA	O
-	O
binding	O
domains	O
of	O
response	O
regulators	O
belonging	O
to	O
the	O
LuxR	O
family	O
[	O
26	O
]	O
.	O

salK	O
encodes	O
a	O
396	O
aa	O
long	O
protein	O
,	O
with	O
five	O
N	O
-	O
terminal	O
transmembrane	O
domains	O
and	O
a	O
transmitter	O
domain	O
signature	O
motif	O
in	O
the	O
C	O
-	O
terminal	O
-	O
typical	O
of	O
sensor	O
histidine	O
protein	O
kinases	O
of	O
TCSTSs	O
[	O
25	O
]	O
.	O

As	O
some	O
TCSTS	O
gene	O
pairs	O
are	O
adjacent	O
to	O
the	O
genes	O
that	O
they	O
control	O
,	O
the	O
genetic	O
structure	O
of	O
the	O
salKR	O
locus	O
and	O
its	O
flanking	O
genes	O
was	O
defined	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

The	O
salK	O
coding	O
region	O
overlaps	O
that	O
of	O
salR	O
by	O
20	O
base	O
pairs	O
(	O
bp	O
)	O
,	O
and	O
no	O
putative	O
promoter	O
or	O
transcriptional	O
terminator	O
could	O
be	O
identified	O
within	O
either	O
gene	O
.	O
<EOS>	B-X
The	B-X
-thalassemias	B-X
are	B-X
characterized	B-X
by	B-X
a	B-X
quantitative	B-X
deficiency	B-X
of	B-X
-globin	B-X
chains	B-X
underlaid	B-X
by	B-X
a	B-X
striking	B-X
heterogeneity	B-X
of	B-X
molecular	B-X
defects	B-X
.	B-X
Although	B-X
most	B-X
of	B-X
the	B-X
molecular	B-X
lesions	B-X
involve	B-X
the	B-X
structural	B-X
	B-X
gene	B-X
directly	B-X
,	B-X
some	B-X
down-regulate	B-X
the	B-X
gene	B-X
through	B-X
distal	B-X
cis	B-X
effects	B-X
,	B-X
and	B-X
rare	B-X
trans-acting	B-X
mutations	B-X
have	B-X
also	B-X
been	B-X
identified	B-X
.	B-X
Unraveling	B-X
the	B-X
molecular	B-X
basis	B-X
of	B-X
-thalassemia	B-X
has	B-X
provided	B-X
a	B-X
paradigm	B-X
for	B-X
understanding	B-X
of	B-X
much	B-X
of	B-X
human	B-X
genetics	B-X
.	B-X
This	B-X
study	B-X
describes	B-X
comprehensive	B-X
polling	B-X
of	B-X
transcription	B-X
start	B-X
and	B-X
termination	B-X
sites	B-X
and	B-X
analysis	B-X
of	B-X
previously	B-X
unidentified	B-X
full-length	B-X
complementary	B-X
DNAs	B-X
derived	B-X
from	B-X
the	B-X
mouse	B-X
genome	B-X
.	B-X
We	B-X
identify	B-X
the	B-X
5	B-X
'	B-X
and	B-X
3	B-X
'	B-X
boundaries	B-X
of	B-X
181,047	B-X
transcripts	B-X
with	B-X
extensive	B-X
variation	B-X
in	B-X
transcripts	B-X
arising	B-X
from	B-X
alternative	B-X
promoter	B-X
usage	B-X
,	B-X
splicing	B-X
,	B-X
and	B-X
polyadenylation	B-X
.	B-X
There	B-X
are	B-X
16,247	B-X
new	B-X
mouse	B-X
protein-coding	B-X
transcripts	B-X
,	B-X
including	B-X
5154	B-X
encoding	B-X
previously	B-X
unidentified	B-X
proteins	B-X
.	B-X
Genomic	B-X
mapping	B-X
of	B-X
the	B-X
transcriptome	B-X
reveals	B-X
transcriptional	B-X
forests	B-X
,	B-X
with	B-X
overlapping	B-X
transcription	B-X
on	B-X
both	B-X
strands	B-X
,	B-X
separated	B-X
by	B-X
deserts	B-X
in	B-X
which	B-X
few	B-X
transcripts	B-X
are	B-X
observed	B-X
.	B-X
The	B-X
data	B-X
provide	B-X
a	B-X
comprehensive	B-X
platform	B-X
for	B-X
the	B-X
comparative	B-X
analysis	B-X
of	B-X
mammalian	B-X
transcriptional	B-X
regulation	B-X
in	B-X
differentiation	B-X
and	B-X
development	B-X
.	B-X

A	O
putative	O
promoter	O
located	O
approximately	O
50	O
bp	O
upstream	O
from	O
the	O
TTG	O
initiation	O
codon	O
of	O
salK	O
,	O
was	O
predicted	O
using	O
the	O
online	O
server	O
of	O
Neutral	O
Network	O
Promoter	O
Prediction	O
.	O

Further	O
sequence	O
analysis	O
revealed	O
a	O
palindrome	O
of	O
55	O
bp	O
with	O
the	O
potential	O
to	O
form	O
a	O
stem	O
-	O
loop	O
structure	O
situated	O
in	O
the	O
intergenic	O
region	O
between	O
salR	O
and	O
05SSU0942	O
,	O
which	O
may	O
function	O
as	O
a	O
transcriptional	O
terminator	O
.	O

05SSU0945	O
,	O
situated	O
upstream	O
(	O
729	O
bp	O
long	O
intergenic	O
region	O
)	O
of	O
the	O
salKR	O
locus	O
,	O
encodes	O
a	O
94	O
aa	O
polypeptide	O
for	O
which	O
there	O
were	O
no	O
significant	O
database	O
matches	O
.	O

Downstream	O
of	O
salKR	O
,	O
the	O
05SSU0942	O
,	O
05SSU0941	O
,	O
05SSU0940	O
,	O
05SSU0939	O
,	O
05SSU0938	O
genes	O
were	O
predicted	O
to	O
encode	O
peptides	O
with	O
significant	O
identities	O
to	O
the	O
orthologues	O
of	O
Streptococcus	B-Organism
agalactiae	I-Organism
.	O

The	O
function	O
of	O
these	O
downstream	O
gene	O
products	O
are	O
unknown	O
except	O
for	O
05SSU0941	O
,	O
which	O
encodes	O
a	O
predicted	O
DNA	O
primase	O
that	O
might	O
be	O
involed	O
in	O
DNA	O
replication	O
.	O

The	O
genetic	O
organization	O
of	O
this	O
locus	O
indicates	O
that	O
salK	O
might	O
be	O
cotranscribed	O
with	O
salR	O
initiating	O
from	O
the	O
PsalK	O
promoter	O
.	O

Transcriptional	O
Analysis	O
of	O
the	O
salKR	O
Locus	O
and	O
its	O
Flanking	O
Sequences	O

To	O
confirm	O
the	O
predicted	O
transcripts	O
of	O
salKR	O
and	O
the	O
flanking	O
genes	O
,	O
RNA	O
extracted	O
from	O
S	B-Organism
.	I-Organism
suis	I-Organism
05ZYH33	I-Organism
cells	O
was	O
subjected	O
to	O
RT	O
-	O
PCR	O
analysis	O
by	O
using	O
primers	O
amplifying	O
each	O
intergenic	O
region	O
of	O
salKR	O
and	O
the	O
flanking	O
genes	O
.	O

As	O
shown	O
in	O
Fig	O
.	O
<EOS>	B-X
Fig	B-X
plants	B-X
appear	B-X
to	B-X
have	B-X
discriminatively	B-X
enforced	B-X
fig	B-X
wasps	B-X
to	B-X
evolve	B-X
``	B-X
adaptation	B-X
characteristics	B-X
''	B-X
that	B-X
provide	B-X
greater	B-X
benefit	B-X
to	B-X
the	B-X
fig	B-X
,	B-X
and	B-X
fig	B-X
wasps	B-X
appear	B-X
to	B-X
have	B-X
diversified	B-X
their	B-X
evolutionary	B-X
strategies	B-X
in	B-X
response	B-X
to	B-X
discriminative	B-X
enforcement	B-X
by	B-X
figs	B-X
and	B-X
competition	B-X
among	B-X
different	B-X
fig	B-X
wasp	B-X
species	B-X
.	B-X
Unenhanced	B-X
(	B-X
Fig	B-X
1	B-X
)	B-X
and	B-X
multiphasic	B-X
contrast-enhanced	B-X
CT	B-X
imaging	B-X
was	B-X
performed	B-X
in	B-X
arterial	B-X
(	B-X
Fig	B-X
2A	B-X
)	B-X
,	B-X
portal	B-X
venous	B-X
(	B-X
Fig	B-X
2B	B-X
)	B-X
,	B-X
and	B-X
delayed	B-X
(	B-X
3	B-X
minutes	B-X
after	B-X
injection	B-X
)	B-X
(	B-X
Fig	B-X
2C	B-X
)	B-X
phases	B-X
.	B-X
Axial	B-X
and	B-X
coronal	B-X
maximum	B-X
intensity	B-X
projection	B-X
reconstructed	B-X
CT	B-X
images	B-X
were	B-X
obtained	B-X
in	B-X
the	B-X
arterial	B-X
(	B-X
Fig	B-X
3	B-X
)	B-X
and	B-X
portal	B-X
venous	B-X
(	B-X
Fig	B-X
4	B-X
)	B-X
phases	B-X
.	B-X
The	B-X
patient	B-X
also	B-X
underwent	B-X
whole-body	B-X
iodine	B-X
131	B-X
scintigraphy	B-X
(	B-X
Fig	B-X
5	B-X
)	B-X
.	B-X

2B	O
,	O
RT	O
-	O
PCR	O
products	O
were	O
obtained	O
with	O
five	O
pairs	O
of	O
the	O
primers	O
(	O
P3	O
/	O
P4	O
,	O
P5	O
/	O
P6	O
,	O
P7	O
/	O
P8	O
,	O
P9	O
/	O
P10	O
and	O
P13	O
/	O
P14	O
)	O
,	O
but	O
not	O
with	O
the	O
other	O
three	O
primer	O
pairs	O
(	O
P1	O
/	O
P2	O
,	O
P11	O
/	O
P12	O
and	O
P15	O
/	O
P16	O
)	O
.	O

On	O
the	O
other	O
hand	O
,	O
when	O
genomic	O
DNA	O
was	O
used	O
as	O
a	O
template	O
,	O
all	O
these	O
primer	O
pairs	O
yielded	O
the	O
expected	O
PCR	O
products	O
(	O
Fig	O
.	O
2B	O
,	O
PCR	O
)	O
.	O

These	O
results	O
suggested	O
that	O
salK	O
and	O
salR	O
are	O
transcriptionally	O
coupled	O
,	O
and	O
the	O
five	O
downstream	O
(	O
05SSU0942	O
-	O
05SSU0938	O
)	O
genes	O
are	O
co	O
-	O
transcribed	O
from	O
a	O
promoter	O
positioned	O
immediately	O
upstream	O
of	O
05SSU0942	O
and	O
that	O
their	O
transcription	O
ends	O
between	O
the	O
05SSU0938	O
-	O
05SSU0937	O
intergenic	O
region	O
which	O
contains	O
a	O
terminator	O
-	O
like	O
inverted	O
repeat	O
sequence	O
.	O

Construction	O
of	O
DeltasalKR	O

To	O
test	O
the	O
role	O
of	O
SalK	O
/	O
SalR	O
in	O
the	O
pathogenesis	O
of	O
SS2	B-Organism
,	O
we	O
constructed	O
a	O
homologous	O
suicide	O
plasmid	O
,	O
pUC	O
:	O
:	O
salKR	O
with	O
a	O
SpcR	O
cassette	O
(	O
Fig	O
.	O
3A	O
)	O
,	O
and	O
electrotransformed	O
the	O
competent	O
cells	O
of	O
05ZYH33	B-Organism
.	O

Positive	O
transformants	O
were	O
first	O
screened	O
on	O
THB	O
agar	O
plates	O
under	O
the	O
selective	O
pressure	O
of	O
spectinomycin	O
.	O

Colony	O
PCR	O
-	O
based	O
assays	O
were	O
performed	O
to	O
detect	O
whether	O
salKR	O
was	O
still	O
present	O
in	O
the	O
genome	O
or	O
not	O
.	O

One	O
candidate	O
mutant	O
in	O
which	O
salKR	O
failed	O
to	O
be	O
amplified	O
was	O
obtained	O
.	O

To	O
check	O
this	O
suspected	O
mutant	O
,	O
Southern	O
hybridization	O
analyses	O
were	O
employed	O
using	O
probes	O
of	O
SpcR	O
gene	O
,	O
an	O
internal	O
fragment	O
of	O
salKR	O
,	O
and	O
pUC18	O
,	O
respectively	O
.	O

In	O
wild	O
type	O
strain	O
05ZYH33	B-Organism
,	O
the	O
internal	O
fragment	O
of	O
salKR	O
probe	O
hybridized	O
with	O
a	O
single	O
4	O
.	O
0	O
kb	O
Cla	O
I	O
fragment	O
(	O
Fig	O
.	O
3C	O
,	O
lane	O
1	O
)	O
,	O
whereas	O
the	O
SpcR	O
and	O
pUC18	O
probes	O
did	O
not	O
hybridized	O
with	O
the	O
genomic	O
DNA	O
(	O
Fig	O
.	O
3B	O
and	O
3D	O
,	O
lane	O
1	O
)	O
.	O

In	O
the	O
suspected	O
mutant	O
,	O
a	O
3	O
.	O
6	O
kb	O
restriction	O
fragment	O
hybridized	O
with	O
the	O
SpcR	O
probe	O
(	O
Fig	O
.	O
3B	O
,	O
lane	O
2	O
)	O
,	O
while	O
no	O
hybridization	O
signal	O
was	O
detected	O
when	O
the	O
internal	O
fragment	O
of	O
salKR	O
and	O
pUC18	O
served	O
as	O
the	O
probes	O
(	O
Fig	O
.	O
3C	O
and	O
3D	O
,	O
lane	O
2	O
)	O
.	O

In	O
a	O
single	O
cross	O
-	O
over	O
mutant	O
which	O
was	O
set	O
as	O
the	O
reference	O
,	O
both	O
the	O
SpcR	O
and	O
pUC18	O
probe	O
hybridized	O
with	O
a	O
6	O
.	O
1	O
kb	O
Cla	O
I	O
restriction	O
fragment	O
(	O
Fig	O
.	O
3B	O
and	O
3D	O
,	O
lane	O
3	O
)	O
,	O
and	O
the	O
salKR	O
probe	O
hybridized	O
with	O
a	O
4	O
.	O
0	O
kb	O
fragment	O
(	O
Fig	O
.	O
3C	O
,	O
lane	O
3	O
)	O
,	O
indicating	O
that	O
this	O
strain	O
had	O
pUC	O
:	O
:	O
salKR	O
integrated	O
into	O
its	O
chromosome	O
by	O
a	O
single	O
cross	O
-	O
over	O
event	O
at	O
the	O
3	O
'	O
-	O
flanking	O
region	O
of	O
the	O
salKR	O
genes	O
(	O
Fig	O
.	O
3A	O
,	O
III	O
)	O
.	O

Additionally	O
,	O
the	O
allelic	O
replacement	O
of	O
the	O
wild	O
-	O
type	O
salKR	O
genes	O
by	O
the	O
SpcR	O
cassette	O
in	O
the	O
suspected	O
mutant	O
was	O
also	O
confirmed	O
by	O
multiple	O
-	O
PCR	O
analysis	O
and	O
sequencing	O
with	O
primers	O
specific	O
to	O
genomic	O
regions	O
lying	O
out	O
the	O
homologous	O
left	O
and	O
right	O
arms	O
(	O
Fig	O
.	O
3A	O
and	O
3E	O
)	O
.	O

All	O
these	O
results	O
demonstrate	O
that	O
an	O
isogenic	O
knockout	O
mutant	O
of	O
salKR	O
(	O
namely	O
DeltasalKR	O
)	O
was	O
successfully	O
constructed	O
.	O

RT	O
-	O
PCR	O
experiments	O
later	O
also	O
showed	O
that	O
neither	O
salK	O
nor	O
salR	O
could	O
be	O
transcribed	O
in	O
DeltasalKR	O
(	O
data	O
not	O
shown	O
)	O
,	O
which	O
further	O
confirmed	O
that	O
salKR	O
had	O
been	O
deleted	O
from	O
the	O
bacterial	O
chromosome	O
.	O

Role	O
of	O
SalK	O
/	O
SalR	O
in	O
Virulence	O
<EOS>	B-X
To	B-X
determine	B-X
the	B-X
role	B-X
of	B-X
the	B-X
two-component	B-X
regulatory	B-X
system	B-X
(	B-X
TCS	B-X
)	B-X
SalK/SalR	B-X
in	B-X
the	B-X
resistance	B-X
of	B-X
Streptococcus	B-X
suis	B-X
serotype	B-X
2	B-X
(	B-X
SS2	B-X
)	B-X
phagocytosed	B-X
by	B-X
THP-1-derived	B-X
macrophages	B-X
(	B-X
THP-Mphi	B-X
)	B-X
.	B-X

Given	O
the	O
multiple	O
roles	O
of	O
TCSTS	O
in	O
bacteria	O
,	O
we	O
evaluated	O
the	O
effect	O
of	O
salKR	O
deletion	O
on	O
the	O
general	O
biological	O
characteristics	O
of	O
SS2	B-Organism
prior	O
to	O
in	O
vivo	O
work	O
.	O

First	O
,	O
the	O
ability	O
of	O
the	O
mutant	O
strain	O
to	O
retain	O
spectinomycin	O
resistance	O
was	O
assessed	O
.	O

The	O
spectinomycin	O
resistance	O
phenotype	O
was	O
stable	O
in	O
DeltasalKR	O
during	O
in	O
vitro	O
culture	O
(	O
data	O
not	O
shown	O
)	O
.	O

Next	O
,	O
the	O
growth	O
kinetics	O
curves	O
of	O
DeltasalKR	O
were	O
compared	O
with	O
that	O
of	O
WT	O
,	O
and	O
no	O
obvious	O
distinctions	O
were	O
observed	O
.	O

When	O
streaked	O
on	O
THB	O
plates	O
with	O
5	O
%	O
sheep	O
blood	O
,	O
DeltasalKR	O
and	O
WT	O
colonies	O
displayed	O
a	O
similar	O
haemolytic	O
phenotype	O
.	O

Finally	O
,	O
cell	O
morphology	O
and	O
ultrastructure	O
of	O
these	O
two	O
strains	O
were	O
examined	O
under	O
light	O
microscope	O
and	O
transmission	O
electron	O
microscope	O
respectively	O
,	O
however	O
,	O
no	O
significant	O
differences	O
were	O
found	O
(	O
Fig	O
.	O
4	O
)	O
.	O

An	O
experimental	O
infection	O
model	O
in	O
piglets	B-Organism
was	O
designed	O
to	O
assess	O
the	O
role	O
of	O
SalK	O
/	O
SalR	O
in	O
virulence	O
.	O

As	O
shown	O
in	O
Figure	O
5	O
,	O
all	O
six	O
SPF	O
-	O
piglets	B-Organism
inoculated	O
intravenously	O
with	O
WT	O
developed	O
most	O
of	O
the	O
typical	O
disease	O
symptoms	O
,	O
including	O
high	O
fever	O
,	O
limping	O
,	O
swollen	O
joints	O
,	O
shivering	O
,	O
CNS	O
failure	O
and	O
respiratory	O
failure	O
within	O
24	O
hrs	O
.	O

Five	O
of	O
them	O
died	O
on	O
day	O
2	O
post	O
-	O
infection	O
,	O
and	O
the	O
last	O
one	O
on	O
day	O
3	O
.	O
<EOS>	B-X
Pirfenidone	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
slow	B-X
disease	B-X
progression	B-X
in	B-X
patients	B-X
with	B-X
idiopathic	B-X
pulmonary	B-X
fibrosis	B-X
(	B-X
IPF	B-X
)	B-X
.	B-X
In	B-X
view	B-X
of	B-X
the	B-X
pathomechanistic	B-X
and	B-X
clinical	B-X
similarities	B-X
between	B-X
IPF	B-X
and	B-X
other	B-X
progressive	B-X
fibrotic	B-X
ILDs	B-X
,	B-X
we	B-X
aimed	B-X
to	B-X
assess	B-X
the	B-X
efficacy	B-X
and	B-X
safety	B-X
of	B-X
pirfenidone	B-X
in	B-X
patients	B-X
with	B-X
four	B-X
non-IPF	B-X
progressive	B-X
fibrotic	B-X
ILDs	B-X
.	B-X
The	B-X
purpose	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
describe	B-X
the	B-X
clinical	B-X
characteristics	B-X
and	B-X
in-hospital	B-X
and	B-X
post-discharge	B-X
outcomes	B-X
of	B-X
respiratory	B-X
syncytial	B-X
virus	B-X
(	B-X
RSV	B-X
)	B-X
infection	B-X
among	B-X
adults	B-X
hospitalised	B-X
with	B-X
influenza-like	B-X
illness	B-X
(	B-X
ILI	B-X
)	B-X
and	B-X
compared	B-X
against	B-X
patients	B-X
admitted	B-X
for	B-X
influenza	B-X
.	B-X
The	B-X
present	B-X
study	B-X
analyzed	B-X
whether	B-X
the	B-X
pattern	B-X
of	B-X
maternal	B-X
mortality	B-X
has	B-X
changed	B-X
over	B-X
the	B-X
last	B-X
five	B-X
decades	B-X
at	B-X
the	B-X
Department	B-X
of	B-X
Obstetrics	B-X
and	B-X
Gynecology	B-X
of	B-X
the	B-X
Medical	B-X
University	B-X
of	B-X
Graz	B-X
.	B-X

In	O
contrast	O
,	O
six	O
infected	O
piglets	B-Organism
with	O
an	O
avirulent	O
strain	O
,	O
05HAS68	B-Organism
(	O
as	O
negative	O
control	O
)	O
,	O
survived	O
nearly	O
without	O
any	O
obvious	O
symptoms	O
until	O
the	O
end	O
of	O
the	O
experiment	O
(	O
14	O
days	O
after	O
infection	O
)	O
.	O

Wherein	O
the	O
six	O
piglets	B-Organism
challenged	O
with	O
the	O
DeltasalKR	O
mutant	O
were	O
all	O
alive	O
and	O
symptom	O
-	O
free	O
during	O
the	O
entire	O
course	O
monitored	O
.	O

This	O
was	O
similar	O
to	O
those	O
observed	O
in	O
the	O
negative	O
control	O
group	O
,	O
indicating	O
that	O
DeltasalKR	O
totally	O
loses	O
its	O
lethality	O
.	O

The	O
experiments	O
of	O
functional	O
complementation	O
with	O
the	O
complemented	O
strain	O
CDeltasalKR	O
showed	O
clearly	O
that	O
the	O
reintroduction	O
of	O
salKR	O
into	O
DeltasalKR	O
restored	O
its	O
high	O
pathogenicity	O
.	O

Five	O
out	O
of	O
six	O
piglets	B-Organism
succumbed	O
to	O
the	O
lethal	O
infections	O
of	O
CDeltasalKR	O
and	O
died	O
,	O
with	O
median	O
survival	O
times	O
of	O
2	O
to	O
3	O
days	O
.	O

The	O
last	O
one	O
recovered	O
from	O
serious	O
clinical	O
symptoms	O
and	O
survived	O
at	O
the	O
experiments	O
end	O
.	O

All	O
these	O
results	O
strongly	O
suggest	O
that	O
SalK	O
/	O
SalR	O
plays	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
Chinese	O
isolates	O
of	O
highly	O
invasive	O
SS2	B-Organism
.	O

To	O
better	O
evaluate	O
the	O
virulence	O
attenuation	O
of	O
DeltasalKR	O
,	O
colonization	O
experiments	O
were	O
carried	O
out	O
.	O

As	O
shown	O
in	O
Table	O
1	O
,	O
wild	O
-	O
type	O
bacteria	O
were	O
found	O
in	O
all	O
of	O
the	O
SS2	B-Organism
specific	O
tissues	O
of	O
WT	O
-	O
infected	O
piglets	B-Organism
,	O
including	O
heart	O
,	O
lung	O
,	O
liver	O
,	O
kidney	O
,	O
spleen	O
,	O
tonsil	O
,	O
brain	O
,	O
blood	O
,	O
joints	O
and	O
so	O
on	O
.	O

In	O
contrast	O
,	O
in	O
the	O
mutant	O
-	O
inoculated	O
group	O
,	O
no	O
mutant	O
bacteria	O
could	O
be	O
recovered	O
from	O
any	O
of	O
the	O
examined	O
tissue	O
specimens	O
.	O

Obviously	O
,	O
lack	O
of	O
SalK	O
/	O
SalR	O
badly	O
impaired	O
the	O
capability	O
of	O
05ZYH33	B-Organism
to	O
colonize	O
the	O
various	O
tissues	O
of	O
piglets	B-Organism
.	O

In	O
the	O
WT	O
/	O
DeltasalKR	O
coinfection	O
group	O
,	O
besides	O
the	O
detection	O
of	O
wild	O
-	O
type	O
bacteria	O
in	O
all	O
the	O
specimens	O
,	O
DeltasalKR	O
mutant	O
bacteria	O
could	O
also	O
be	O
isolated	O
from	O
some	O
susceptible	O
tissues	O
(	O
such	O
as	O
heart	O
,	O
kidney	O
,	O
tonsil	O
and	O
brain	O
)	O
at	O
a	O
lower	O
degree	O
than	O
the	O
wild	O
-	O
type	O
strain	O
.	O

We	O
anticipated	O
that	O
the	O
DeltasalKR	O
mutant	O
is	O
still	O
able	O
to	O
colonize	O
these	O
organs	O
,	O
is	O
just	O
due	O
to	O
the	O
WT	O
-	O
mediated	O
impairment	O
of	O
host	O
defense	O
against	O
SS2	B-Organism
infection	O
in	O
these	O
tissues	O
.	O

Decreased	O
Resistance	O
of	O
DeltasalKR	O
to	O
PMN	O
-	O
Mediated	O
Killing	O

Together	O
with	O
the	O
wild	O
type	O
strain	O
,	O
DeltasalKR	O
was	O
subjected	O
to	O
PMN	O
-	O
mediated	O
killing	O
assays	O
.	O

We	O
found	O
that	O
the	O
mortality	O
rate	O
of	O
both	O
strains	O
(	O
WT	O
and	O
DeltasalKR	O
)	O
increased	O
coordinately	O
with	O
the	O
extension	O
of	O
the	O
co	O
-	O
culture	O
time	O
with	O
PMN	O
cells	O
(	O
Fig	O
.	O
6	O
)	O
.	O

However	O
,	O
DeltasalKR	O
had	O
a	O
higher	O
mortality	O
rate	O
than	O
that	O
of	O
WT	O
,	O
which	O
means	O
that	O
DeltasalKR	O
was	O
less	O
able	O
to	O
resist	O
killing	O
by	O
PMNs	O
,	O
key	O
mediators	O
of	O
innate	O
immunity	O
.	O

This	O
result	O
may	O
account	O
partially	O
,	O
if	O
not	O
most	O
of	O
all	O
,	O
for	O
the	O
virulence	O
loss	O
in	O
DeltasalKR	O
.	O
<EOS>	B-X
To	B-X
some	B-X
extent	B-X
,	B-X
the	B-X
use	B-X
of	B-X
implants	B-X
with	B-X
a	B-X
microrough	B-X
surface	B-X
and	B-X
rigid	B-X
splinting	B-X
may	B-X
compensate	B-X
for	B-X
suboptimal	B-X
stability	B-X
.	B-X
It	B-X
is	B-X
important	B-X
to	B-X
avoid	B-X
fracture	B-X
of	B-X
the	B-X
provisional	B-X
restoration	B-X
at	B-X
all	B-X
times	B-X
as	B-X
this	B-X
may	B-X
result	B-X
in	B-X
local	B-X
overloading	B-X
and	B-X
implant	B-X
failure	B-X
.	B-X
Also	B-X
,	B-X
unevenly	B-X
distributed	B-X
occlusal	B-X
contacts	B-X
may	B-X
contribute	B-X
to	B-X
failure	B-X
and	B-X
therefore	B-X
occlusion	B-X
ought	B-X
to	B-X
be	B-X
evaluated	B-X
at	B-X
every	B-X
occasion	B-X
,	B-X
especially	B-X
during	B-X
the	B-X
early	B-X
phase	B-X
of	B-X
healing	B-X
.	B-X
Taking	B-X
these	B-X
aspects	B-X
into	B-X
account	B-X
,	B-X
immediate	B-X
loading	B-X
in	B-X
the	B-X
fully	B-X
edentulous	B-X
mandible	B-X
by	B-X
means	B-X
of	B-X
an	B-X
overdenture	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
predictable	B-X
in	B-X
terms	B-X
of	B-X
implant	B-X
survival	B-X
(	B-X
94.4-100	B-X
%	B-X
)	B-X
.	B-X
However	B-X
,	B-X
the	B-X
procedure	B-X
may	B-X
result	B-X
in	B-X
additional	B-X
costs	B-X
as	B-X
a	B-X
result	B-X
of	B-X
the	B-X
need	B-X
for	B-X
repeated	B-X
relining	B-X
.	B-X
With	B-X
at	B-X
least	B-X
four	B-X
implants	B-X
a	B-X
failure	B-X
rate	B-X
of	B-X
0-3.3	B-X
%	B-X
may	B-X
be	B-X
expected	B-X
.	B-X
Increasing	B-X
the	B-X
number	B-X
of	B-X
implants	B-X
may	B-X
reduce	B-X
implant	B-X
failure	B-X
to	B-X
3.3	B-X
%	B-X
.	B-X
However	B-X
,	B-X
this	B-X
finding	B-X
may	B-X
not	B-X
imply	B-X
that	B-X
a	B-X
provisional	B-X
implant	B-X
crown	B-X
becomes	B-X
redundant	B-X
when	B-X
soft-tissue	B-X
conditioning	B-X
is	B-X
deemed	B-X
necessary	B-X
.	B-X
Taking	B-X
into	B-X
account	B-X
earlier	B-X
factors	B-X
for	B-X
success	B-X
,	B-X
immediate	B-X
loading	B-X
in	B-X
the	B-X
partially	B-X
edentulous	B-X
jaw	B-X
by	B-X
means	B-X
of	B-X
a	B-X
fixed	B-X
prosthesis	B-X
seems	B-X
predictable	B-X
in	B-X
terms	B-X
of	B-X
implant	B-X
survival	B-X
(	B-X
95.5-100	B-X
%	B-X
)	B-X
.	B-X

Expression	O
Microarray	O
Analysis	O
of	O
the	O
Mutant	O
Strain	O
DeltasalKR	O

To	O
gain	O
further	O
insights	O
into	O
the	O
network	O
/	O
circuit	O
mediated	O
by	O
SalK	O
/	O
SalR	O
,	O
whole	O
-	O
genome	O
DNA	O
microarray	O
was	O
applied	O
to	O
reveal	O
the	O
differential	O
transcription	O
profiles	O
between	O
DeltasalKR	O
and	O
WT	O
[	O
13	O
]	O
,	O
[	O
19	O
]	O
.	O

For	O
identifying	O
genes	O
whose	O
expression	O
was	O
significantly	O
different	O
,	O
the	O
threshold	O
for	O
the	O
expression	O
ratio	O
between	O
the	O
mutant	O
and	O
wild	O
type	O
strain	O
was	O
set	O
at	O
2	O
.	O

In	O
total	O
,	O
the	O
absence	O
of	O
SalK	O
/	O
SalR	O
led	O
to	O
decreased	O
expression	O
of	O
26	O
genes	O
spread	O
throughout	O
the	O
genome	O
(	O
i	O
.	O
e	O
.	O
1	O
.	O
2	O
%	O
of	O
the	O
2194	O
tested	O
)	O
.	O

These	O
down	O
-	O
regulated	O
genes	O
can	O
be	O
roughly	O
categorized	O
into	O
the	O
3	O
groups	O
,	O
which	O
can	O
be	O
found	O
in	O
Table	O
2	O
.	O

Genes	O
involved	O
in	O
substance	O
transport	O
and	O
metabolism	O
In	O
the	O
DeltasalKR	O
mutant	O
,	O
transcripts	O
of	O
several	O
ABC	O
-	O
transporters	O
are	O
less	O
abundant	O
.	O

As	O
learned	O
,	O
ABC	O
-	O
transporters	O
and	O
permeases	O
are	O
usually	O
involved	O
in	O
controlling	O
influx	O
and	O
efflux	O
of	O
small	O
molecules	O
through	O
metabolic	O
pathways	O
in	O
response	O
to	O
environmental	O
changes	O
in	O
bacteria	O
[	O
27	O
]	O
.	O

Multidrug	O
resistance	O
[	O
28	O
]	O
,	O
[	O
29	O
]	O
and	O
pathogenicity	O
[	O
10	O
]	O
can	O
also	O
be	O
attributed	O
to	O
ABC	O
-	O
transporters	O
.	O

It	O
is	O
widely	O
accepted	O
that	O
over	O
-	O
expression	O
of	O
ABC	O
-	O
type	O
multidrug	O
transporters	O
can	O
efficiently	O
evade	O
the	O
pressure	O
of	O
drugs	O
and	O
enhance	O
the	O
invasion	O
ability	O
of	O
pathogens	O
[	O
28	O
]	O
-	O
[	O
30	O
]	O
.	O

Furthermore	O
,	O
orotidine	O
-	O
5	O
-	O
phosphate	O
decarboxylase	O
(	O
05SSU1009	O
)	O
,	O
a	O
newly	O
identified	O
pathogenesis	O
-	O
related	O
protein	O
in	O
Vibrio	B-Organism
vulnificus	I-Organism
[	O
31	O
]	O
,	O
was	O
also	O
found	O
to	O
be	O
repressed	O
greatly	O
in	O
DeltasalKR	O
.	O

Daigle	O
et	O
al	O
.	O
<EOS>	B-X
Development	B-X
of	B-X
novel	B-X
antibacterial	B-X
strategies	B-X
is	B-X
required	B-X
to	B-X
tackle	B-X
the	B-X
alarming	B-X
threat	B-X
for	B-X
global	B-X
health	B-X
due	B-X
to	B-X
antimicrobial	B-X
resistance	B-X
.	B-X
Among	B-X
377,561	B-X
female	B-X
Medicare	B-X
beneficiaries	B-X
who	B-X
sustained	B-X
a	B-X
fracture	B-X
,	B-X
10	B-X
%	B-X
had	B-X
another	B-X
fracture	B-X
within	B-X
1	B-X
year	B-X
,	B-X
18	B-X
%	B-X
within	B-X
2	B-X
years	B-X
,	B-X
and	B-X
31	B-X
%	B-X
within	B-X
5	B-X
years	B-X
.	B-X
Timely	B-X
management	B-X
to	B-X
reduce	B-X
risk	B-X
of	B-X
subsequent	B-X
fracture	B-X
is	B-X
warranted	B-X
following	B-X
all	B-X
nontraumatic	B-X
fractures	B-X
,	B-X
including	B-X
nonhip	B-X
nonvertebral	B-X
fractures	B-X
,	B-X
in	B-X
older	B-X
women	B-X
.	B-X
As	B-X
mathematical	B-X
models	B-X
and	B-X
computational	B-X
tools	B-X
become	B-X
more	B-X
sophisticated	B-X
and	B-X
powerful	B-X
to	B-X
accurately	B-X
depict	B-X
system	B-X
dynamics	B-X
,	B-X
numerical	B-X
methods	B-X
that	B-X
were	B-X
previously	B-X
considered	B-X
computationally	B-X
impractical	B-X
started	B-X
being	B-X
utilized	B-X
for	B-X
large-scale	B-X
simulations	B-X
.	B-X
Methods	B-X
that	B-X
characterize	B-X
a	B-X
rare	B-X
event	B-X
in	B-X
biochemical	B-X
systems	B-X
are	B-X
part	B-X
of	B-X
such	B-X
phenomenon	B-X
,	B-X
as	B-X
many	B-X
of	B-X
them	B-X
are	B-X
computationally	B-X
expensive	B-X
and	B-X
require	B-X
high-performance	B-X
computing	B-X
.	B-X
In	B-X
this	B-X
paper	B-X
,	B-X
we	B-X
introduce	B-X
an	B-X
enhanced	B-X
version	B-X
of	B-X
the	B-X
doubly	B-X
weighted	B-X
stochastic	B-X
simulation	B-X
algorithm	B-X
(	B-X
dwSSA	B-X
)	B-X
(	B-X
Daigle	B-X
et	B-X
al	B-X
.	B-X
in	B-X
J	B-X
Chem	B-X
Phys	B-X
134:044110	B-X
,	B-X
2011	B-X
)	B-X
,	B-X
called	B-X
dwSSA	B-X
[	B-X
Formula	B-X
:	B-X
see	B-X
text	B-X
]	B-X
,	B-X
that	B-X
significantly	B-X
improves	B-X
the	B-X
speed	B-X
of	B-X
convergence	B-X
to	B-X
the	B-X
rare	B-X
event	B-X
of	B-X
interest	B-X
when	B-X
the	B-X
conventional	B-X
multilevel	B-X
cross-entropy	B-X
method	B-X
in	B-X
dwSSA	B-X
is	B-X
either	B-X
unable	B-X
to	B-X
converge	B-X
or	B-X
converges	B-X
very	B-X
slowly	B-X
.	B-X
This	B-X
achievement	B-X
is	B-X
enabled	B-X
by	B-X
a	B-X
novel	B-X
polynomial	B-X
leaping	B-X
method	B-X
that	B-X
uses	B-X
past	B-X
data	B-X
to	B-X
detect	B-X
slow	B-X
convergence	B-X
and	B-X
attempts	B-X
to	B-X
push	B-X
the	B-X
system	B-X
toward	B-X
the	B-X
rare	B-X
event	B-X
.	B-X
We	B-X
demonstrate	B-X
the	B-X
performance	B-X
of	B-X
dwSSA	B-X
[	B-X
Formula	B-X
:	B-X
see	B-X
text	B-X
]	B-X
on	B-X
two	B-X
systems-a	B-X
susceptible-infectious-recovered-susceptible	B-X
disease	B-X
dynamics	B-X
model	B-X
and	B-X
a	B-X
yeast	B-X
polarization	B-X
model-and	B-X
compare	B-X
its	B-X
computational	B-X
efficiency	B-X
to	B-X
that	B-X
of	B-X
dwSSA	B-X
.	B-X

[	O
32	O
]	O
has	O
shown	O
that	O
mutation	O
of	O
phosphotransferase	O
system	O
(	O
PST	O
)	O
in	O
extraintestinal	B-Organism
pathogenic	I-Organism
E	I-Organism
.	I-Organism
coli	I-Organism
(	O
ExPEC	B-Organism
)	O
can	O
cause	O
the	O
loss	O
of	O
its	O
colonization	O
ability	O
in	O
extraintestinal	O
organs	O
,	O
and	O
bacteria	O
are	O
cleared	O
rapidly	O
from	O
the	O
bloodstream	O
.	O

Similarly	O
,	O
we	O
observed	O
that	O
pst	O
(	O
05SSU0451	O
)	O
is	O
down	O
-	O
regulated	O
in	O
DeltasalKR	O
whose	O
survival	O
in	O
the	O
bloodstream	O
is	O
drastically	O
affected	O
(	O
Fig	O
.	O
6	O
)	O
.	O

Genes	O
revolved	O
in	O
recombination	O
/	O
repair	O
and	O
transcription	O

Together	O
with	O
some	O
elements	O
of	O
DNA	O
recombination	O
/	O
repair	O
(	O
05SSU0063	O
,	O
05SSU0588	O
and	O
05SSU0953	O
)	O
,	O
two	O
transcription	O
regulators	O
(	O
05SSU0503	O
and	O
05SSU1233	O
)	O
were	O
also	O
under	O
the	O
regulation	O
of	O
SalK	O
/	O
SalR	O
.	O

Although	O
these	O
genes	O
were	O
found	O
to	O
be	O
down	O
-	O
regulated	O
in	O
the	O
mutant	O
,	O
it	O
is	O
not	O
understood	O
how	O
they	O
are	O
associated	O
with	O
the	O
attenuation	O
of	O
DeltasalKR	O
.	O
<EOS>	B-X
An	B-X
unusual	B-X
flower	B-X
and	B-X
tendril	B-X
(	B-X
uft	B-X
)	B-X
mutant	B-X
in	B-X
cucumber	B-X
was	B-X
caused	B-X
by	B-X
a	B-X
mutation	B-X
in	B-X
Csa1G056950	B-X
encoding	B-X
an	B-X
F-box	B-X
protein	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
identified	B-X
an	B-X
unusual	B-X
flower	B-X
and	B-X
tendril	B-X
(	B-X
uft	B-X
)	B-X
mutant	B-X
from	B-X
an	B-X
ethyl	B-X
methanesulfonate	B-X
(	B-X
EMS	B-X
)	B-X
mutagenesis	B-X
population	B-X
.	B-X
Genetic	B-X
analysis	B-X
revealed	B-X
that	B-X
the	B-X
phenotype	B-X
of	B-X
the	B-X
uft	B-X
mutant	B-X
was	B-X
regulated	B-X
by	B-X
a	B-X
single	B-X
recessive	B-X
nuclear	B-X
gene	B-X
.	B-X
Transcriptomics	B-X
is	B-X
one	B-X
powerful	B-X
tool	B-X
that	B-X
has	B-X
been	B-X
used	B-X
to	B-X
identify	B-X
novel	B-X
genes	B-X
that	B-X
are	B-X
up-	B-X
or	B-X
down-regulated	B-X
in	B-X
the	B-X
PG	B-X
which	B-X
may	B-X
contribute	B-X
to	B-X
20E	B-X
regulation	B-X
.	B-X
Additional	B-X
functional	B-X
characterization	B-X
of	B-X
putative	B-X
regulatory	B-X
candidate	B-X
genes	B-X
typically	B-X
involves	B-X
qRT-PCR	B-X
and/or	B-X
RNAi	B-X
mediated	B-X
knockdown	B-X
of	B-X
the	B-X
candidate	B-X
mRNA	B-X
in	B-X
the	B-X
PG	B-X
to	B-X
assess	B-X
whether	B-X
the	B-X
gene	B-X
's	B-X
expression	B-X
shows	B-X
temporal	B-X
regulation	B-X
in	B-X
the	B-X
PG	B-X
and	B-X
whether	B-X
its	B-X
expression	B-X
is	B-X
essential	B-X
for	B-X
proper	B-X
20E	B-X
production	B-X
and	B-X
the	B-X
correct	B-X
timing	B-X
of	B-X
developmental	B-X
transitions	B-X
.	B-X
While	B-X
these	B-X
methods	B-X
have	B-X
proved	B-X
fruitful	B-X
for	B-X
identifying	B-X
novel	B-X
regulators	B-X
of	B-X
20E	B-X
production	B-X
,	B-X
characterizing	B-X
the	B-X
null	B-X
phenotype	B-X
of	B-X
putative	B-X
regulatory	B-X
genes	B-X
is	B-X
the	B-X
gold	B-X
standard	B-X
for	B-X
assigning	B-X
gene	B-X
function	B-X
since	B-X
RNAi	B-X
is	B-X
known	B-X
to	B-X
generate	B-X
various	B-X
types	B-X
of	B-X
``	B-X
off	B-X
target	B-X
''	B-X
effects	B-X
.	B-X
Here	B-X
we	B-X
describe	B-X
the	B-X
genetic	B-X
null	B-X
mutant	B-X
phenotype	B-X
of	B-X
the	B-X

Genes	O
encoding	O
proteins	O
of	O
unknown	O
function	O
<EOS>	B-X
Twenty-two	B-X
of	B-X
these	B-X
genes	B-X
were	B-X
up-regulated	B-X
and	B-X
half	B-X
of	B-X
them	B-X
encode	B-X
small	B-X
secreted	B-X
proteins	B-X
(	B-X
SSPs	B-X
)	B-X
with	B-X
unknown	B-X
functions	B-X
.	B-X
Seven	B-X
of	B-X
the	B-X
SSP	B-X
genes	B-X
and	B-X
two	B-X
other	B-X
genes	B-X
that	B-X
are	B-X
over-expressed	B-X
in	B-X
the	B-X
rep1	B-X
SG200	B-X
strain	B-X
encode	B-X
proteins	B-X
that	B-X
can	B-X
be	B-X
classified	B-X
as	B-X
secreted	B-X
cysteine-rich	B-X
proteins	B-X
(	B-X
SCRPs	B-X
)	B-X
.	B-X
Plant	B-X
nucleotide-binding	B-X
leucine-rich	B-X
repeat	B-X
(	B-X
NB-LRR	B-X
)	B-X
proteins	B-X
serve	B-X
as	B-X
intracellular	B-X
sensors	B-X
to	B-X
detect	B-X
pathogen	B-X
effectors	B-X
and	B-X
trigger	B-X
immune	B-X
responses	B-X
.	B-X
Transcription	B-X
of	B-X
the	B-X
NB-LRR-encoding	B-X
Resistance	B-X
(	B-X
R	B-X
)	B-X
genes	B-X
needs	B-X
to	B-X
be	B-X
tightly	B-X
controlled	B-X
to	B-X
avoid	B-X
inappropriate	B-X
defense	B-X
activation	B-X
.	B-X
The	B-X
Arabidopsis	B-X
(	B-X
Arabidopsis	B-X
thaliana	B-X
)	B-X
suppressor	B-X
of	B-X
npr1-1	B-X
,	B-X
constitutive	B-X
1	B-X
(	B-X
snc1	B-X
)	B-X
mutant	B-X
carries	B-X
a	B-X
gain-of-function	B-X
mutation	B-X
in	B-X
a	B-X
Toll/Interleukin1	B-X
receptor-like	B-X
(	B-X
TIR	B-X
)	B-X
-NB-LRR-encoding	B-X
gene	B-X
,	B-X
resulting	B-X
in	B-X
the	B-X
constitutive	B-X
activation	B-X
of	B-X
plant	B-X
defense	B-X
responses	B-X
.	B-X
Positional	B-X
cloning	B-X
revealed	B-X
that	B-X
MOS9	B-X
encodes	B-X
a	B-X
plant-specific	B-X
protein	B-X
of	B-X
unknown	B-X
function	B-X
.	B-X
Expression	B-X
analysis	B-X
showed	B-X
that	B-X
MOS9	B-X
is	B-X
required	B-X
for	B-X
the	B-X
full	B-X
expression	B-X
of	B-X
TIR-NB-LRR	B-X
protein-encoding	B-X
RECOGNITION	B-X
OF	B-X
PERONOSPORA	B-X
PARASITICA	B-X
4	B-X
(	B-X
RPP4	B-X
)	B-X
and	B-X
SNC1	B-X
,	B-X
both	B-X
of	B-X
which	B-X
reside	B-X
in	B-X
the	B-X
RPP4	B-X
cluster	B-X
.	B-X
Our	B-X
data	B-X
suggest	B-X
that	B-X
MOS9	B-X
functions	B-X
together	B-X
with	B-X
ATXR7	B-X
to	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
SNC1	B-X
and	B-X
RPP4	B-X
through	B-X
H3K4	B-X
methylation	B-X
,	B-X
which	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
fine-tuning	B-X
their	B-X
transcription	B-X
levels	B-X
and	B-X
functions	B-X
in	B-X
plant	B-X
defense	B-X
.	B-X

Several	O
membrane	O
proteins	O
such	O
as	O
05SSU0677	O
and	O
05SSU1912	O
were	O
also	O
repressed	O
in	O
DeltasalKR	O
.	O

It	O
is	O
well	O
documented	O
that	O
surface	O
proteins	O
or	O
cell	O
wall	O
-	O
anchored	O
proteins	O
are	O
usually	O
thought	O
to	O
contribute	O
to	O
the	O
immunogenicity	O
[	O
33	O
]	O
,	O
[	O
34	O
]	O
,	O
invasiveness	O
[	O
35	O
]	O
-	O
[	O
37	O
]	O
,	O
and	O
even	O
pathogenesis	O
[	O
38	O
]	O
,	O
[	O
39	O
]	O
of	O
pathogens	O
.	O
<EOS>	B-X
Secretion	B-X
of	B-X
cellular	B-X
components	B-X
across	B-X
the	B-X
plasma	B-X
membrane	B-X
is	B-X
an	B-X
essential	B-X
process	B-X
that	B-X
enables	B-X
organisms	B-X
to	B-X
interact	B-X
with	B-X
their	B-X
environments	B-X
.	B-X
Production	B-X
of	B-X
extracellular	B-X
vesicles	B-X
in	B-X
bacteria	B-X
is	B-X
a	B-X
well-documented	B-X
but	B-X
poorly	B-X
understood	B-X
process	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
their	B-X
roles	B-X
in	B-X
pathogenesis	B-X
,	B-X
cell-to-cell	B-X
communication	B-X
,	B-X
and	B-X
stress	B-X
responses	B-X
,	B-X
OMVs	B-X
play	B-X
important	B-X
roles	B-X
in	B-X
immunomodulation	B-X
and	B-X
the	B-X
establishment	B-X
and	B-X
balance	B-X
of	B-X
the	B-X
gut	B-X
microbiota	B-X
.	B-X
While	B-X
the	B-X
detrimental	B-X
effects	B-X
of	B-X
STING	B-X
during	B-X
sepsis	B-X
had	B-X
been	B-X
well	B-X
documented	B-X
,	B-X
the	B-X
exact	B-X
mechanism	B-X
by	B-X
which	B-X
STING	B-X
causes	B-X
lethal	B-X
sepsis	B-X
remains	B-X
obscure	B-X
.	B-X
Through	B-X
single-cell	B-X
RNA	B-X
sequence	B-X
,	B-X
genetic	B-X
approaches	B-X
,	B-X
and	B-X
mass	B-X
spectrometry	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
STING	B-X
promotes	B-X
sepsis-induced	B-X
multiple	B-X
organ	B-X
injury	B-X
by	B-X
inducing	B-X
macrophage	B-X
ferroptosis	B-X
in	B-X
a	B-X
cGAS-	B-X
and	B-X
interferon-independent	B-X
manner	B-X
.	B-X
Mechanistically	B-X
,	B-X
Q237	B-X
,	B-X
E316	B-X
,	B-X
and	B-X
S322	B-X
in	B-X
the	B-X
CBD	B-X
domain	B-X
of	B-X
STING	B-X
are	B-X
critical	B-X
binding	B-X
sites	B-X
for	B-X
the	B-X
interaction	B-X
with	B-X
the	B-X
coiled-coil	B-X
domain	B-X
of	B-X
NCOA4	B-X
.	B-X
Meanwhile	B-X
,	B-X
we	B-X
identified	B-X
HET0016	B-X
by	B-X
high	B-X
throughput	B-X
screening	B-X
,	B-X
a	B-X
selective	B-X
20-HETE	B-X
synthase	B-X
inhibitor	B-X
,	B-X
decreased	B-X
STING-induced	B-X
ferroptosis	B-X
in	B-X
peripheral	B-X
blood	B-X
mononuclear	B-X
cells	B-X
from	B-X
patients	B-X
with	B-X
sepsis	B-X
and	B-X
mortality	B-X
in	B-X
septic	B-X
mice	B-X
model	B-X
.	B-X

Moreover	O
,	O
it	O
should	O
be	O
noted	O
that	O
numerous	O
proteins	O
of	O
unknown	O
function	O
are	O
also	O
depressed	O
in	O
DeltasalKR	O
,	O
which	O
may	O
in	O
part	O
lead	O
to	O
the	O
virulence	O
loss	O
of	O
the	O
mutant	O
via	O
some	O
thus	O
-	O
far	O
-	O
unknown	O
mechanisms	O
.	O

Remarkably	O
,	O
no	O
gene	O
was	O
found	O
to	O
be	O
up	O
-	O
regulated	O
(	O
more	O
than	O
twice	O
)	O
in	O
DeltasalKR	O
.	O

To	O
examine	O
the	O
validity	O
of	O
the	O
microarray	O
data	O
,	O
we	O
performed	O
further	O
quantitative	O
real	O
-	O
time	O
PCR	O
analysis	O
on	O
42	O
genes	O
using	O
RNA	O
from	O
three	O
independent	O
cultures	O
of	O
each	O
strain	O
(	O
WT	O
,	O
the	O
DeltasalKR	O
mutant	O
and	O
the	O
complemented	O
strain	O
CDeltasalKR	O
)	O
.	O

These	O
genes	O
include	O
the	O
total	O
26	O
ones	O
that	O
are	O
down	O
-	O
regulated	O
in	O
the	O
DeltasalKR	O
mutant	O
,	O
four	O
virulence	O
factors	O
(	O
CPS	O
,	O
MRP	O
,	O
EF	O
,	O
SLY	O
)	O
coding	O
genes	O
[	O
40	O
]	O
-	O
[	O
44	O
]	O
,	O
genes	O
immediately	O
flanking	O
the	O
salKR	O
locus	O
(	O
05SSU0945	O
and	O
05SSU0942	O
)	O
,	O
and	O
10	O
genes	O
that	O
selected	O
from	O
the	O
chromosome	O
of	O
05ZYH33	B-Organism
every	O
200	O
ORFs	O
.	O

As	O
shown	O
in	O
Table	O
S1	O
,	O
the	O
quantitative	O
results	O
of	O
RT	O
-	O
PCR	O
were	O
highly	O
compatible	O
to	O
the	O
microarray	O
data	O
,	O
in	O
the	O
DeltasalKR	O
mutant	O
,	O
41	O
out	O
of	O
42	O
selected	O
genes	O
(	O
97	O
.	O
6	O
%	O
)	O
were	O
confirmed	O
to	O
have	O
similar	O
transcript	O
levels	O
using	O
these	O
two	O
different	O
techniques	O
,	O
thus	O
independently	O
confirming	O
the	O
microarray	O
results	O
.	O

The	O
discrepancies	O
of	O
target	O
genes	O
expression	O
between	O
microarray	O
data	O
and	O
real	O
-	O
time	O
quantitative	O
PCR	O
results	O
probably	O
best	O
reflects	O
differences	O
in	O
the	O
relative	O
sensitivity	O
and	O
specificity	O
of	O
the	O
two	O
methods	O
.	O

Among	O
the	O
26	O
down	O
-	O
regulated	O
genes	O
in	O
the	O
DeltasalKR	O
mutant	O
,	O
five	O
did	O
not	O
recover	O
to	O
expression	O
level	O
of	O
the	O
wild	O
-	O
type	O
strain	O
,	O
indicating	O
that	O
the	O
complemented	O
strain	O
does	O
not	O
imitate	O
completely	O
the	O
exact	O
tuning	O
of	O
gene	O
expression	O
as	O
in	O
the	O
wild	O
-	O
type	O
strain	O
.	O

Discussion	O
<EOS>	B-X
Discussion	B-X
structures	B-X
are	B-X
argumentation-theoretical	B-X
tools	B-X
that	B-X
can	B-X
be	B-X
employed	B-X
to	B-X
tackle	B-X
three	B-X
barriers	B-X
that	B-X
separate	B-X
lay	B-X
stakeholders	B-X
from	B-X
policy	B-X
debates	B-X
:	B-X
difficulty	B-X
,	B-X
magnitude	B-X
,	B-X
and	B-X
complexity	B-X
.	B-X
Discussions	B-X
about	B-X
preventive	B-X
behaviors	B-X
were	B-X
assessed	B-X
before	B-X
testing	B-X
and	B-X
1	B-X
and	B-X
6	B-X
months	B-X
post-testing	B-X
.	B-X
Discussion	B-X
of	B-X
preventive	B-X
behaviors	B-X
declined	B-X
following	B-X
test	B-X
reporting	B-X
,	B-X
with	B-X
more	B-X
rapid	B-X
decline	B-X
reported	B-X
by	B-X
noncarriers	B-X
.	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X

Since	O
the	O
first	O
description	O
of	O
human	B-Organism
infection	O
in	O
Denmark	O
in	O
1968	O
,	O
SS2	B-Organism
seems	O
to	O
have	O
developed	O
some	O
unknown	O
machinery	O
to	O
behave	O
much	O
more	O
invasively	O
,	O
which	O
is	O
supported	O
by	O
two	O
recent	O
large	O
-	O
scale	O
outbreaks	O
of	O
human	B-Organism
epidemics	O
in	O
China	O
(	O
one	O
had	O
25	O
cases	O
with	O
14	O
deaths	O
in	O
Jiangsu	O
in	O
1998	O
,	O
the	O
second	O
had	O
204	O
cases	O
with	O
38	O
deaths	O
in	O
Sichuan	O
in	O
2005	O
)	O
[	O
4	O
]	O
,	O
[	O
5	O
]	O
.	O

During	O
the	O
past	O
decades	O
,	O
a	O
series	O
of	O
virulence	O
determinants	O
of	O
SS2	B-Organism
involved	O
in	O
the	O
survival	O
,	O
spread	O
and	O
pathopoiesis	O
of	O
the	O
bacterium	O
within	O
the	O
host	O
have	O
been	O
identified	O
,	O
such	O
as	O
capsule	O
polysaccharide	O
(	O
CPS	O
)	O
,	O
muramidase	O
-	O
related	O
protein	O
(	O
MRP	O
)	O
,	O
suilysin	O
,	O
etc	O
.	O

Very	O
recently	O
,	O
Chen	O
et	O
al	O
.	O

[	O
6	O
]	O
reported	O
a	O
candidate	O
PAI	O
of	O
approximately89	O
kb	O
in	O
the	O
epidemic	O
outbreak	O
strains	O
of	O
SS2	B-Organism
infections	O
in	O
China	O
,	O
gave	O
some	O
genomic	O
clues	O
for	O
elucidating	O
molecular	O
pathways	O
by	O
which	O
SS2	B-Organism
behaved	O
so	O
aggressively	O
.	O

However	O
,	O
they	O
did	O
not	O
provide	O
sufficient	O
experimental	O
evidence	O
supporting	O
the	O
prediction	O
of	O
89K	O
PAI	O
which	O
was	O
largely	O
based	O
on	O
the	O
results	O
of	O
bioinformatical	O
analysis	O
,	O
and	O
the	O
functions	O
of	O
the	O
vast	O
majority	O
of	O
genes	O
encoding	O
within	O
the	O
89K	O
island	O
remain	O
largely	O
unknown	O
.	O

In	O
this	O
study	O
,	O
we	O
carried	O
out	O
a	O
detailed	O
structural	O
and	O
functional	O
analysis	O
of	O
a	O
unique	O
two	O
-	O
component	O
regulatory	O
system	O
designated	O
SalK	O
/	O
SalR	O
which	O
is	O
located	O
in	O
the	O
putative	O
89K	O
PAI	O
.	O

Bioinformatics	O
analysis	O
revealed	O
that	O
the	O
GC	O
content	O
of	O
salKR	O
is	O
far	O
less	O
than	O
that	O
of	O
89K	O
island	O
and	O
the	O
whole	O
genome	O
,	O
implying	O
that	O
this	O
TCSTS	O
is	O
of	O
foreign	O
origin	O
which	O
may	O
have	O
been	O
acquired	O
through	O
horizontal	O
gene	O
transfer	O
.	O

It	O
has	O
been	O
well	O
documented	O
that	O
horizontal	O
gene	O
transfer	O
events	O
occur	O
frequently	O
in	O
pathogens	O
[	O
45	O
]	O
-	O
[	O
47	O
]	O
,	O
and	O
some	O
of	O
them	O
have	O
been	O
implicated	O
in	O
high	O
pathogenicity	O
[	O
48	O
]	O
and	O
even	O
in	O
the	O
causation	O
of	O
severe	O
diseases	O
[	O
49	O
]	O
.	O

Suilysin	O
,	O
a	O
known	O
virulence	O
factor	O
,	O
was	O
believed	O
to	O
be	O
introduced	O
into	O
SS2	B-Organism
via	O
lateral	O
gene	O
transfer	O
[	O
43	O
]	O
.	O

Moreover	O
,	O
PCR	O
analysis	O
using	O
primers	O
amplifying	O
the	O
salKR	O
locus	O
also	O
demonstrated	O
that	O
this	O
TCSTS	O
is	O
specific	O
to	O
Chinese	O
epidemic	O
outbreak	O
strains	O
of	O
SS2	B-Organism
(	O
data	O
not	O
shown	O
)	O
,	O
implying	O
its	O
tight	O
linkage	O
to	O
the	O
virulence	O
of	O
this	O
new	O
emerging	O
pathogenic	O
species	O
.	O

In	O
order	O
to	O
define	O
the	O
role	O
of	O
SalK	O
/	O
SalR	O
in	O
SS2	B-Organism
infection	O
,	O
an	O
isogenic	O
SalK	O
/	O
SalR	O
-	O
deficient	O
mutant	O
was	O
generated	O
and	O
the	O
impact	O
of	O
salKR	O
deletion	O
on	O
virulence	O
of	O
SS2	B-Organism
was	O
assessed	O
.	O

Results	O
of	O
piglets	B-Organism
experimental	O
infections	O
clearly	O
showed	O
that	O
the	O
deletion	O
of	O
salKR	O
leads	O
to	O
elimination	O
of	O
the	O
lethality	O
of	O
this	O
important	O
pathogen	O
.	O

Colonization	O
analysis	O
also	O
revealed	O
the	O
incapability	O
of	O
the	O
DeltasalKR	O
mutant	O
to	O
colonize	O
any	O
susceptible	O
tissue	O
of	O
piglets	B-Organism
when	O
administered	O
alone	O
.	O

These	O
results	O
indicate	O
definitely	O
that	O
SalK	O
/	O
SalR	O
plays	O
a	O
critical	O
role	O
in	O
the	O
pathogenicity	O
of	O
SS2	B-Organism
.	O

The	O
reduction	O
in	O
virulence	O
was	O
mostly	O
restored	O
in	O
a	O
complemented	O
strain	O
upon	O
reintroduction	O
of	O
functional	O
copies	O
of	O
salK	O
and	O
salR	O
into	O
the	O
mutant	O
,	O
suggesting	O
that	O
it	O
did	O
not	O
result	O
from	O
polar	O
effects	O
on	O
expression	O
of	O
flanking	O
genes	O
.	O

We	O
consider	O
that	O
the	O
partial	O
complementation	O
observed	O
in	O
the	O
piglets	B-Organism
infection	O
model	O
is	O
inherent	O
to	O
the	O
pleiotropic	O
role	O
of	O
this	O
regulatory	O
system	O
which	O
makes	O
it	O
difficult	O
to	O
restore	O
the	O
fine	O
tuning	O
of	O
gene	O
expression	O
as	O
in	O
the	O
wild	O
-	O
type	O
strain	O
.	O

Results	O
of	O
real	O
-	O
time	O
quantitative	O
RT	O
-	O
PCR	O
also	O
confirmed	O
that	O
,	O
in	O
the	O
complemented	O
strain	O
CDeltasalKR	O
,	O
only	O
partial	O
genes	O
identified	O
as	O
down	O
-	O
regulated	O
in	O
the	O
mutant	O
rebounded	O
to	O
comparative	O
transcript	O
levels	O
of	O
the	O
wild	O
-	O
type	O
strain	O
.	O

Those	O
unrecovered	O
genes	O
were	O
probably	O
irrelavent	O
to	O
the	O
bacterial	O
virulence	O
of	O
SS2	B-Organism
.	O

It	O
is	O
known	O
that	O
TCSTSs	O
are	O
often	O
implicated	O
in	O
the	O
regulation	O
of	O
the	O
direct	O
downstream	O
genes	O
.	O

However	O
,	O
genes	O
immediately	O
flanking	O
the	O
salKR	O
locus	O
were	O
identified	O
as	O
transcriptionally	O
unaffected	O
by	O
the	O
disruption	O
of	O
the	O
salKR	O
genes	O
.	O

This	O
result	O
is	O
in	O
agreement	O
with	O
the	O
predicted	O
operon	O
organization	O
in	O
the	O
genome	O
,	O
which	O
suggests	O
that	O
salK	O
and	O
salR	O
are	O
a	O
single	O
co	O
-	O
transcriptional	O
unit	O
.	O

Among	O
the	O
26	O
target	O
genes	O
affected	O
by	O
SalK	O
/	O
SalR	O
,	O
17	O
of	O
them	O
(	O
65	O
.	O
4	O
%	O
)	O
were	O
predicted	O
to	O
be	O
monocistronically	O
transcribed	O
,	O
the	O
others	O
to	O
be	O
part	O
of	O
larger	O
transcriptional	O
units	O
(	O
Table	O
2	O
)	O
.	O

For	O
those	O
members	O
belonging	O
to	O
putative	O
transcriptional	O
operons	O
,	O
microarray	O
results	O
showed	O
that	O
most	O
of	O
those	O
genes	O
cotranscribed	O
with	O
them	O
were	O
also	O
down	O
-	O
regulated	O
to	O
a	O
various	O
degree	O
,	O
although	O
under	O
the	O
threshold	O
of	O
2	O
.	O

In	O
the	O
89K	O
island	O
,	O
transcripts	O
of	O
only	O
two	O
genes	O
designated	O
05SSU0935	O
and	O
05SSU0953	O
that	O
encode	O
a	O
hypothetical	O
protein	O
and	O
a	O
DNA	O
recombinase	O
respectively	O
,	O
were	O
decreased	O
in	O
DeltasalKR	O
,	O
their	O
contributions	O
to	O
the	O
attenuation	O
are	O
unknown	O
.	O

It	O
seems	O
that	O
SalK	O
/	O
SalR	O
may	O
control	O
the	O
full	O
virulence	O
of	O
SS2	B-Organism
by	O
regulating	O
distant	O
gene	O
expression	O
at	O
the	O
genome	O
-	O
wide	O
level	O
.	O

Further	O
investigation	O
of	O
other	O
transcriptional	O
alterations	O
observed	O
in	O
the	O
microarray	O
data	O
will	O
be	O
required	O
for	O
a	O
better	O
understanding	O
of	O
pathogenesis	O
of	O
this	O
highly	O
pathogenic	O
pathogen	O
.	O

Efforts	O
are	O
currently	O
being	O
made	O
in	O
order	O
to	O
address	O
functions	O
of	O
those	O
down	O
-	O
regulated	O
hypothetical	O
proteins	O
individually	O
.	O

It	O
has	O
been	O
described	O
that	O
genes	O
essential	O
for	O
viability	O
and	O
important	O
virulence	O
factors	O
are	O
often	O
under	O
the	O
regulation	O
of	O
TCSTS	O
.	O

However	O
,	O
in	O
our	O
study	O
,	O
neither	O
microarray	O
findings	O
nor	O
further	O
analysis	O
of	O
real	O
-	O
time	O
quantitative	O
RT	O
-	O
PCR	O
revealed	O
any	O
differences	O
in	O
level	O
of	O
transcription	O
of	O
the	O
known	O
virulence	O
factors	O
(	O
CPS	O
,	O
suilysin	O
,	O
MRP	O
and	O
EF	O
)	O
between	O
the	O
wild	O
type	O
and	O
mutant	O
strain	O
.	O

Several	O
possible	O
explanations	O
may	O
be	O
envisaged	O
.	O
<EOS>	B-X
Natural	B-X
selection	B-X
is	B-X
often	B-X
envisaged	B-X
as	B-X
the	B-X
ultimate	B-X
cause	B-X
of	B-X
the	B-X
apparent	B-X
rationality	B-X
exhibited	B-X
by	B-X
organisms	B-X
in	B-X
their	B-X
specific	B-X
habitat	B-X
.	B-X
as	B-X
non-conformity	B-X
of	B-X
a	B-X
given	B-X
behaviour	B-X
to	B-X
axioms	B-X
such	B-X
as	B-X
transitivity	B-X
or	B-X
independence	B-X
of	B-X
irrelevant	B-X
alternatives	B-X
,	B-X
we	B-X
propose	B-X
two	B-X
possible	B-X
families	B-X
of	B-X
Darwinian	B-X
explanations	B-X
that	B-X
may	B-X
account	B-X
for	B-X
these	B-X
apparent	B-X
irrationalities	B-X
.	B-X
First	B-X
,	B-X
we	B-X
consider	B-X
cases	B-X
where	B-X
natural	B-X
selection	B-X
may	B-X
have	B-X
been	B-X
an	B-X
indirect	B-X
cause	B-X
of	B-X
irrationality	B-X
.	B-X
Second	B-X
,	B-X
we	B-X
consider	B-X
putative	B-X
cases	B-X
where	B-X
violations	B-X
of	B-X
rationality	B-X
axioms	B-X
may	B-X
have	B-X
been	B-X
directly	B-X
favored	B-X
by	B-X
natural	B-X
selection	B-X
.	B-X

First	O
,	O
some	O
pathogenic	O
determinants	O
are	O
environmentally	O
regulated	O
and	O
induced	O
at	O
specific	O
stages	O
of	O
the	O
infection	O
process	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
.	O

Secondly	O
,	O
some	O
of	O
the	O
TCSTSs	O
of	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
were	O
suggested	O
to	O
be	O
involved	O
in	O
key	O
processes	O
of	O
pathogenesis	O
,	O
such	O
as	O
autolysis	O
and	O
cell	O
-	O
cell	O
signaling	O
[	O
52	O
]	O
,	O
SalK	O
/	O
SalR	O
might	O
regulate	O
similar	O
processes	O
in	O
Chinese	O
SS2	B-Organism
virulent	O
isolates	O
.	O

More	O
importantly	O
,	O
accumulated	O
evidence	O
suggests	O
that	O
some	O
of	O
the	O
known	O
virulent	O
factors	O
are	O
not	O
requisite	O
for	O
the	O
full	O
virulence	O
of	O
SS2	B-Organism
,	O
as	O
the	O
absence	O
of	O
one	O
or	O
more	O
of	O
these	O
proteins	O
in	O
isolates	O
from	O
infected	O
animals	O
cannot	O
necessarily	O
be	O
associated	O
with	O
a	O
lack	O
of	O
virulence	O
[	O
53	O
]	O
-	O
[	O
56	O
]	O
.	O
<EOS>	B-X
Enterovirus	B-X
71	B-X
(	B-X
EV71	B-X
)	B-X
recruits	B-X
various	B-X
cellular	B-X
factors	B-X
to	B-X
assist	B-X
in	B-X
the	B-X
replication	B-X
and	B-X
translation	B-X
of	B-X
its	B-X
genome	B-X
.	B-X
Identification	B-X
of	B-X
the	B-X
host	B-X
factors	B-X
involved	B-X
in	B-X
the	B-X
EV71	B-X
life	B-X
cycle	B-X
not	B-X
only	B-X
will	B-X
enable	B-X
a	B-X
better	B-X
understanding	B-X
of	B-X
the	B-X
infection	B-X
mechanism	B-X
but	B-X
also	B-X
has	B-X
the	B-X
potential	B-X
to	B-X
be	B-X
of	B-X
use	B-X
in	B-X
the	B-X
development	B-X
of	B-X
antiviral	B-X
therapeutics	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
demonstrated	B-X
that	B-X
the	B-X
cellular	B-X
factor	B-X
68-kDa	B-X
Src-associated	B-X
protein	B-X
in	B-X
mitosis	B-X
(	B-X
Sam68	B-X
)	B-X
acts	B-X
as	B-X
an	B-X
internal	B-X
ribosome	B-X
entry	B-X
site	B-X
(	B-X
IRES	B-X
)	B-X
trans-acting	B-X
factor	B-X
(	B-X
ITAF	B-X
)	B-X
that	B-X
binds	B-X
specifically	B-X
to	B-X
the	B-X
EV71	B-X
5	B-X
'	B-X
untranslated	B-X
region	B-X
(	B-X
5'UTR	B-X
)	B-X
.	B-X
More	B-X
importantly	B-X
,	B-X
dual-luciferase	B-X
(	B-X
firefly	B-X
)	B-X
reporter	B-X
analysis	B-X
suggested	B-X
that	B-X
overexpression	B-X
of	B-X
Sam68	B-X
positively	B-X
regulated	B-X
IRES-dependent	B-X
translation	B-X
of	B-X
virus	B-X
proteins	B-X
.	B-X
Moreover	B-X
,	B-X
Sam68	B-X
was	B-X
redistributed	B-X
from	B-X
the	B-X
nucleus	B-X
to	B-X
the	B-X
cytoplasm	B-X
and	B-X
interacts	B-X
with	B-X
cellular	B-X
factors	B-X
,	B-X
such	B-X
as	B-X
poly	B-X
(	B-X
rC	B-X
)	B-X
-binding	B-X
protein	B-X
2	B-X
(	B-X
PCBP2	B-X
)	B-X
and	B-X
poly	B-X
(	B-X
A	B-X
)	B-X
-binding	B-X
protein	B-X
(	B-X
PABP	B-X
)	B-X
,	B-X
during	B-X
EV71	B-X
infection	B-X
.	B-X
The	B-X
cytoplasmic	B-X
relocalization	B-X
of	B-X
Sam68	B-X
in	B-X
EV71-infected	B-X
cells	B-X
may	B-X
be	B-X
involved	B-X
in	B-X
the	B-X
enhancement	B-X
of	B-X
EV71	B-X
IRES-mediated	B-X
translation	B-X
.	B-X
Since	B-X
Sam68	B-X
is	B-X
known	B-X
to	B-X
be	B-X
a	B-X
RNA-binding	B-X
protein	B-X
,	B-X
these	B-X
results	B-X
provide	B-X
direct	B-X
evidence	B-X
that	B-X
Sam68	B-X
is	B-X
a	B-X
novel	B-X
ITAF	B-X
that	B-X
interacts	B-X
with	B-X
EV71	B-X
IRES	B-X
and	B-X
positively	B-X
regulates	B-X
viral	B-X
protein	B-X
translation	B-X
.	B-X

In	O
conclusion	O
,	O
a	O
unique	O
two	O
-	O
component	O
regulatory	O
system	O
SalK	O
/	O
SalR	O
has	O
been	O
identified	O
from	O
a	O
putative	O
89K	O
PAI	O
in	O
Chinese	O
isolates	O
of	O
highly	O
pathogenic	O
SS2	B-Organism
.	O

Prior	O
to	O
this	O
study	O
,	O
SalK	O
/	O
SalR	O
is	O
only	O
known	O
to	O
be	O
associated	O
with	O
the	O
production	O
of	O
a	O
kind	O
of	O
lantibiotic	O
peptide	O
named	O
salivaricin	O
A	O
(	O
SalA	O
)	O
in	O
S	B-Organism
.	I-Organism
salivarius	I-Organism
[	O
11	O
]	O
,	O
as	O
yet	O
,	O
this	O
TCSTS	O
has	O
not	O
been	O
linked	O
to	O
the	O
regulation	O
of	O
bacterial	O
virulence	O
.	O

Our	O
data	O
confirm	O
,	O
for	O
the	O
first	O
time	O
,	O
that	O
SalK	O
/	O
SalR	O
is	O
absolutely	O
indispensable	O
for	O
the	O
full	O
virulence	O
of	O
Chinese	O
highly	O
invasive	O
SS2	B-Organism
strains	O
,	O
although	O
we	O
fails	O
to	O
define	O
its	O
precise	O
regulatory	O
mechanism	O
.	O

Not	O
only	O
does	O
this	O
investigation	O
provide	O
experimental	O
evidence	O
for	O
the	O
validity	O
of	O
the	O
candidate	O
89K	O
PAI	O
,	O
but	O
it	O
adds	O
novel	O
insights	O
into	O
the	O
infectious	O
disease	O
pathogenesis	O
of	O
SS2	B-Organism
.	O

RpoE	O
fine	O
tunes	O
expression	O
of	O
a	O
subset	O
of	O
SsrB	O
-	O
regulated	O
virulence	O
factors	O
in	O
Salmonella	B-Organism
enterica	I-Organism
serovar	I-Organism
Typhimurium	I-Organism
<EOS>	B-X
The	B-X
survival	B-X
of	B-X
Salmonella	B-X
enterica	B-X
within	B-X
the	B-X
intracellular	B-X
host	B-X
niche	B-X
requires	B-X
highly	B-X
co-ordinated	B-X
expression	B-X
of	B-X
virulence	B-X
effectors	B-X
predominantly	B-X
regulated	B-X
by	B-X
the	B-X
SsrAB	B-X
two-component	B-X
regulatory	B-X
system	B-X
.	B-X
S.	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
mutants	B-X
lacking	B-X
the	B-X
ssrAB	B-X
genes	B-X
are	B-X
avirulent	B-X
in	B-X
mice	B-X
,	B-X
highlighting	B-X
the	B-X
importance	B-X
of	B-X
this	B-X
regulatory	B-X
system	B-X
in	B-X
vivo	B-X
.	B-X

Background	O
The	O
survival	O
of	O
Salmonella	B-Organism
enterica	I-Organism
within	O
the	O
intracellular	O
host	O
niche	O
requires	O
highly	O
co	O
-	O
ordinated	O
expression	O
of	O
virulence	O
effectors	O
predominantly	O
regulated	O
by	O
the	O
SsrAB	O
two	O
-	O
component	O
regulatory	O
system	O
.	O
<EOS>	B-X
The	B-X
survival	B-X
of	B-X
Salmonella	B-X
enterica	B-X
within	B-X
the	B-X
intracellular	B-X
host	B-X
niche	B-X
requires	B-X
highly	B-X
co-ordinated	B-X
expression	B-X
of	B-X
virulence	B-X
effectors	B-X
predominantly	B-X
regulated	B-X
by	B-X
the	B-X
SsrAB	B-X
two-component	B-X
regulatory	B-X
system	B-X
.	B-X
S.	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
mutants	B-X
lacking	B-X
the	B-X
ssrAB	B-X
genes	B-X
are	B-X
avirulent	B-X
in	B-X
mice	B-X
,	B-X
highlighting	B-X
the	B-X
importance	B-X
of	B-X
this	B-X
regulatory	B-X
system	B-X
in	B-X
vivo	B-X
.	B-X
Mutants	B-X
lacking	B-X
the	B-X
gene	B-X
encoding	B-X
the	B-X
alternative	B-X
sigma	B-X
factor	B-X
sigmaE	B-X
(	B-X
rpoE	B-X
)	B-X
are	B-X
also	B-X
highly	B-X
attenuated	B-X
for	B-X
intracellular	B-X
survival	B-X
,	B-X
pointing	B-X
to	B-X
a	B-X
potential	B-X
connection	B-X
with	B-X
the	B-X
SsrAB	B-X
regulatory	B-X
system	B-X
.	B-X

S	B-Organism
.	I-Organism
enterica	I-Organism
serovar	I-Organism
Typhimurium	I-Organism
mutants	I-Organism
lacking	O
the	O
ssrAB	O
genes	O
are	O
avirulent	O
in	O
mice	B-Organism
,	O
highlighting	O
the	O
importance	O
of	O
this	O
regulatory	O
system	O
in	O
vivo	O
.	O
<EOS>	B-X
The	B-X
survival	B-X
of	B-X
Salmonella	B-X
enterica	B-X
within	B-X
the	B-X
intracellular	B-X
host	B-X
niche	B-X
requires	B-X
highly	B-X
co-ordinated	B-X
expression	B-X
of	B-X
virulence	B-X
effectors	B-X
predominantly	B-X
regulated	B-X
by	B-X
the	B-X
SsrAB	B-X
two-component	B-X
regulatory	B-X
system	B-X
.	B-X
S.	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
mutants	B-X
lacking	B-X
the	B-X
ssrAB	B-X
genes	B-X
are	B-X
avirulent	B-X
in	B-X
mice	B-X
,	B-X
highlighting	B-X
the	B-X
importance	B-X
of	B-X
this	B-X
regulatory	B-X
system	B-X
in	B-X
vivo	B-X
.	B-X
Mutants	B-X
lacking	B-X
the	B-X
gene	B-X
encoding	B-X
the	B-X
alternative	B-X
sigma	B-X
factor	B-X
sigmaE	B-X
(	B-X
rpoE	B-X
)	B-X
are	B-X
also	B-X
highly	B-X
attenuated	B-X
for	B-X
intracellular	B-X
survival	B-X
,	B-X
pointing	B-X
to	B-X
a	B-X
potential	B-X
connection	B-X
with	B-X
the	B-X
SsrAB	B-X
regulatory	B-X
system	B-X
.	B-X

Mutants	O
lacking	O
the	O
gene	O
encoding	O
the	O
alternative	O
sigma	O
factor	O
sigmaE	O
(	O
rpoE	O
)	O
are	O
also	O
highly	O
attenuated	O
for	O
intracellular	O
survival	O
,	O
pointing	O
to	O
a	O
potential	O
connection	O
with	O
the	O
SsrAB	O
regulatory	O
system	O
.	O
<EOS>	B-X
The	B-X
survival	B-X
of	B-X
Salmonella	B-X
enterica	B-X
within	B-X
the	B-X
intracellular	B-X
host	B-X
niche	B-X
requires	B-X
highly	B-X
co-ordinated	B-X
expression	B-X
of	B-X
virulence	B-X
effectors	B-X
predominantly	B-X
regulated	B-X
by	B-X
the	B-X
SsrAB	B-X
two-component	B-X
regulatory	B-X
system	B-X
.	B-X
S.	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
mutants	B-X
lacking	B-X
the	B-X
ssrAB	B-X
genes	B-X
are	B-X
avirulent	B-X
in	B-X
mice	B-X
,	B-X
highlighting	B-X
the	B-X
importance	B-X
of	B-X
this	B-X
regulatory	B-X
system	B-X
in	B-X
vivo	B-X
.	B-X
Mutants	B-X
lacking	B-X
the	B-X
gene	B-X
encoding	B-X
the	B-X
alternative	B-X
sigma	B-X
factor	B-X
sigmaE	B-X
(	B-X
rpoE	B-X
)	B-X
are	B-X
also	B-X
highly	B-X
attenuated	B-X
for	B-X
intracellular	B-X
survival	B-X
,	B-X
pointing	B-X
to	B-X
a	B-X
potential	B-X
connection	B-X
with	B-X
the	B-X
SsrAB	B-X
regulatory	B-X
system	B-X
.	B-X

Results	O
In	O
this	O
study	O
we	O
demonstrate	O
that	O
RpoE	O
is	O
involved	O
in	O
fine	O
-	O
tuning	O
the	O
expression	O
of	O
a	O
subset	O
of	O
SsrB	O
-	O
regulated	O
genes	O
found	O
in	O
the	O
Salmonella	B-Organism
pathogenicity	O
island	O
-	O
2	O
(	O
SPI	O
-	O
2	O
)	O
genetic	O
locus	O
that	O
encodes	O
a	O
horizontally	O
acquired	O
type	O
III	O
secretion	O
system	O
,	O
and	O
unlinked	O
genes	O
integrated	O
into	O
this	O
regulon	O
that	O
are	O
required	O
for	O
virulence	O
in	O
host	O
animals	O
.	O
<EOS>	B-X
The	B-X
survival	B-X
of	B-X
Salmonella	B-X
enterica	B-X
within	B-X
the	B-X
intracellular	B-X
host	B-X
niche	B-X
requires	B-X
highly	B-X
co-ordinated	B-X
expression	B-X
of	B-X
virulence	B-X
effectors	B-X
predominantly	B-X
regulated	B-X
by	B-X
the	B-X
SsrAB	B-X
two-component	B-X
regulatory	B-X
system	B-X
.	B-X
S.	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
mutants	B-X
lacking	B-X
the	B-X
ssrAB	B-X
genes	B-X
are	B-X
avirulent	B-X
in	B-X
mice	B-X
,	B-X
highlighting	B-X
the	B-X
importance	B-X
of	B-X
this	B-X
regulatory	B-X
system	B-X
in	B-X
vivo	B-X
.	B-X
Mutants	B-X
lacking	B-X
the	B-X
gene	B-X
encoding	B-X
the	B-X
alternative	B-X
sigma	B-X
factor	B-X
sigmaE	B-X
(	B-X
rpoE	B-X
)	B-X
are	B-X
also	B-X
highly	B-X
attenuated	B-X
for	B-X
intracellular	B-X
survival	B-X
,	B-X
pointing	B-X
to	B-X
a	B-X
potential	B-X
connection	B-X
with	B-X
the	B-X
SsrAB	B-X
regulatory	B-X
system	B-X
.	B-X

Conclusion	O
These	O
data	O
point	O
to	O
a	O
potential	O
connection	O
between	O
the	O
virulence	O
phenotype	O
of	O
strains	O
lacking	O
ssrB	O
and	O
rpoE	O
,	O
and	O
highlight	O
new	O
transcriptional	O
regulation	O
that	O
might	O
be	O
essential	O
for	O
appropriate	O
temporal	O
and	O
spatial	O
control	O
of	O
the	O
virulence	O
-	O
associated	O
type	O
III	O
secretion	O
system	O
during	O
host	O
infection	O
.	O
<EOS>	B-X
The	B-X
survival	B-X
of	B-X
Salmonella	B-X
enterica	B-X
within	B-X
the	B-X
intracellular	B-X
host	B-X
niche	B-X
requires	B-X
highly	B-X
co-ordinated	B-X
expression	B-X
of	B-X
virulence	B-X
effectors	B-X
predominantly	B-X
regulated	B-X
by	B-X
the	B-X
SsrAB	B-X
two-component	B-X
regulatory	B-X
system	B-X
.	B-X
S.	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
mutants	B-X
lacking	B-X
the	B-X
ssrAB	B-X
genes	B-X
are	B-X
avirulent	B-X
in	B-X
mice	B-X
,	B-X
highlighting	B-X
the	B-X
importance	B-X
of	B-X
this	B-X
regulatory	B-X
system	B-X
in	B-X
vivo	B-X
.	B-X
Mutants	B-X
lacking	B-X
the	B-X
gene	B-X
encoding	B-X
the	B-X
alternative	B-X
sigma	B-X
factor	B-X
sigmaE	B-X
(	B-X
rpoE	B-X
)	B-X
are	B-X
also	B-X
highly	B-X
attenuated	B-X
for	B-X
intracellular	B-X
survival	B-X
,	B-X
pointing	B-X
to	B-X
a	B-X
potential	B-X
connection	B-X
with	B-X
the	B-X
SsrAB	B-X
regulatory	B-X
system	B-X
.	B-X

Background	O
<EOS>	B-X
Background	B-X
matching	B-X
is	B-X
the	B-X
most	B-X
familiar	B-X
and	B-X
widespread	B-X
camouflage	B-X
strategy	B-X
:	B-X
avoiding	B-X
detection	B-X
by	B-X
having	B-X
a	B-X
similar	B-X
colour	B-X
and	B-X
pattern	B-X
to	B-X
the	B-X
background	B-X
.	B-X
Background	B-X
is	B-X
thus	B-X
a	B-X
relatively	B-X
modest	B-X
correction	B-X
for	B-X
all	B-X
Z	B-X
opacity	B-X
data	B-X
published	B-X
to	B-X
date	B-X
.	B-X
Background	B-X
estimation	B-X
and	B-X
foreground	B-X
segmentation	B-X
are	B-X
important	B-X
steps	B-X
in	B-X
many	B-X
high-level	B-X
vision	B-X
tasks	B-X
.	B-X
Patient	B-X
Preference	B-X
for	B-X
Telehealth	B-X
Background	B-X
Shapes	B-X
Impressions	B-X
of	B-X
Physicians	B-X
and	B-X
Information	B-X
Recall	B-X
:	B-X
A	B-X
Randomized	B-X
Experiment	B-X
.	B-X

Salmonella	B-Organism
enterica	I-Organism
are	O
enteric	O
pathogens	O
that	O
acquired	O
a	O
type	O
III	O
secretion	O
system	O
(	O
T3SS	O
)	O
through	O
horizontal	O
gene	O
transfer	O
of	O
a	O
genomic	O
island	O
termed	O
Salmonella	O
Pathogenicity	O
Island	O
2	O
(	O
SPI	O
-	O
2	O
)	O
[	O
1	O
,	O
2	O
]	O
.	O

The	O
SPI	O
-	O
2	O
-	O
encoded	O
T3SS	O
and	O
its	O
translocated	O
effectors	O
modify	O
the	O
intracellular	O
host	O
niche	O
for	O
Salmonella	B-Organism
replication	O
[	O
3	O
-	O
5	O
]	O
.	O
<EOS>	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
(	B-X
S.	B-X
Typhimurium	B-X
)	B-X
is	B-X
a	B-X
Gram-negative	B-X
facultative	B-X
food-borne	B-X
pathogen	B-X
that	B-X
causes	B-X
gastroenteritis	B-X
in	B-X
humans	B-X
.	B-X
This	B-X
bacterium	B-X
has	B-X
evolved	B-X
a	B-X
sophisticated	B-X
machinery	B-X
to	B-X
alter	B-X
host	B-X
cell	B-X
function	B-X
critical	B-X
to	B-X
its	B-X
virulence	B-X
capabilities	B-X
.	B-X
Central	B-X
to	B-X
S.	B-X
Typhimurium	B-X
pathogenesis	B-X
are	B-X
two	B-X
Type	B-X
III	B-X
secretion	B-X
systems	B-X
(	B-X
T3SS	B-X
)	B-X
encoded	B-X
within	B-X
pathogenicity	B-X
islands	B-X
SPI-1	B-X
and	B-X
SPI-2	B-X
that	B-X
are	B-X
responsible	B-X
for	B-X
the	B-X
secretion	B-X
and	B-X
translocation	B-X
of	B-X
a	B-X
set	B-X
of	B-X
bacterial	B-X
proteins	B-X
termed	B-X
effectors	B-X
into	B-X
host	B-X
cells	B-X
with	B-X
the	B-X
intention	B-X
of	B-X
altering	B-X
host	B-X
cell	B-X
physiology	B-X
for	B-X
bacterial	B-X
entry	B-X
and	B-X
survival	B-X
.	B-X
Thus	B-X
,	B-X
once	B-X
delivered	B-X
by	B-X
the	B-X
T3SS	B-X
,	B-X
the	B-X
secreted	B-X
effectors	B-X
play	B-X
critical	B-X
roles	B-X
in	B-X
manipulating	B-X
the	B-X
host	B-X
cell	B-X
to	B-X
allow	B-X
for	B-X
bacteria	B-X
invasion	B-X
,	B-X
induction	B-X
of	B-X
inflammatory	B-X
responses	B-X
,	B-X
and	B-X
the	B-X
assembly	B-X
of	B-X
an	B-X
intracellular	B-X
protective	B-X
niche	B-X
created	B-X
for	B-X
bacterial	B-X
survival	B-X
and	B-X
replication	B-X
.	B-X
Emerging	B-X
evidence	B-X
indicates	B-X
that	B-X
these	B-X
effectors	B-X
are	B-X
modular	B-X
proteins	B-X
consisting	B-X
of	B-X
distinct	B-X
functional	B-X
domains/motifs	B-X
that	B-X
are	B-X
utilized	B-X
by	B-X
the	B-X
bacteria	B-X
to	B-X
activate	B-X
intracellular	B-X
signalling	B-X
pathways	B-X
modifying	B-X
host	B-X
cell	B-X
function	B-X
.	B-X
Also	B-X
,	B-X
recently	B-X
reported	B-X
are	B-X
the	B-X
dual	B-X
functionality	B-X
of	B-X
secreted	B-X
effectors	B-X
and	B-X
the	B-X
concept	B-X
of	B-X
'terminal	B-X
reassortment	B-X
'	B-X
.	B-X
Herein	B-X
,	B-X
we	B-X
highlight	B-X
some	B-X
of	B-X
the	B-X
nascent	B-X
concepts	B-X
regarding	B-X
Salmonella	B-X
effectors	B-X
in	B-X
the	B-X
context	B-X
of	B-X
infection	B-X
.	B-X

SPI	O
-	O
2	O
also	O
has	O
genes	O
,	O
ssrA	O
and	O
ssrB	O
,	O
which	O
code	O
for	O
SsrAB	O
,	O
a	O
two	O
-	O
component	O
regulatory	O
system	O
needed	O
for	O
expression	O
of	O
the	O
T3SS	O
[	O
6	O
,	O
7	O
]	O
.	O

SsrB	O
regulates	O
the	O
expression	O
of	O
SPI	O
-	O
2	O
encoded	O
substrate	O
effectors	O
including	O
ssaB	O
,	O
as	O
well	O
as	O
several	O
integrated	O
virulence	O
effectors	O
such	O
as	O
sseL	O
[	O
8	O
]	O
and	O
srfN	O
[	O
9	O
]	O
that	O
are	O
encoded	O
elsewhere	O
on	O
the	O
chromosome	O
but	O
that	O
have	O
integrated	O
into	O
the	O
SsrB	O
regulon	O
.	O

Mutants	O
lacking	O
ssrAB	O
are	O
unable	O
to	O
survive	O
within	O
macrophages	O
and	O
are	O
avirulent	O
in	O
mice	B-Organism
[	O
1	O
]	O
.	O

Alternative	O
sigma	O
factors	O
coordinate	O
gene	O
expression	O
in	O
response	O
to	O
environmental	O
cues	O
sensed	O
by	O
the	O
bacterium	O
.	O
<EOS>	B-X
Regulation	B-X
of	B-X

Sigma	O
factors	O
have	O
a	O
specific	O
recognition	O
motif	O
at	O
the	O
-	O
35	O
and	O
-	O
10	O
positions	O
and	O
function	O
to	O
concentrate	O
RNA	O
polymerase	O
at	O
a	O
subset	O
of	O
promoters	O
[	O
10	O
]	O
.	O

One	O
alternative	O
sigma	O
factor	O
,	O
RpoE	O
(	O
sigmaE	O
)	O
responds	O
to	O
envelope	O
stress	O
at	O
the	O
cell	O
surface	O
.	O

Release	O
of	O
sigmaE	O
from	O
its	O
inner	O
membrane	O
anchored	O
anti	O
-	O
sigma	O
factor	O
,	O
RseA	O
,	O
leads	O
to	O
induction	O
of	O
genes	O
required	O
to	O
maintain	O
cell	O
envelope	O
integrity	O
[	O
11	O
]	O
.	O

SsrB	O
-	O
regulated	O
translocated	O
effectors	O
protect	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
against	O
host	O
cell	O
defences	O
such	O
as	O
oxidative	O
stress	O
and	O
antimicrobial	O
peptides	O
that	O
perturb	O
bacterial	O
membrane	O
integrity	O
and	O
provide	O
a	O
stimulus	O
for	O
sigmaE	O
release	O
[	O
4	O
,	O
12	O
-	O
15	O
]	O
.	O

Although	O
proficient	O
at	O
cellular	O
invasion	O
,	O
rpoE	B-Organism
or	O
ssrB	O
mutants	O
are	O
highly	O
attenuated	O
for	O
intracellular	O
survival	O
in	O
both	O
cultured	O
cells	O
and	O
animal	O
hosts	O
[	O
16	O
]	O
.	O

In	O
addition	O
,	O
the	O
expression	O
of	O
rpoE	O
and	O
ssrB	O
is	O
up	O
-	O
regulated	O
within	O
macrophages	O
[	O
17	O
]	O
.	O

Links	O
between	O
RpoE	O
and	O
virulence	O
gene	O
expression	O
is	O
evident	O
in	O
other	O
bacterial	O
systems	O
as	O
well	O
.	O
<EOS>	B-X
The	B-X
cell	B-X
envelope	B-X
of	B-X
pathogenic	B-X
bacteria	B-X
is	B-X
a	B-X
barrier	B-X
against	B-X
host	B-X
environmental	B-X
conditions	B-X
and	B-X
immunity	B-X
molecules	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
site	B-X
where	B-X
many	B-X
virulence	B-X
factors	B-X
are	B-X
assembled	B-X
.	B-X
These	B-X
ESRs	B-X
also	B-X
have	B-X
important	B-X
links	B-X
to	B-X
the	B-X
production	B-X
of	B-X
envelope-associated	B-X
virulence	B-X
systems	B-X
by	B-X
the	B-X
bacteria	B-X
themselves	B-X
.	B-X
One	B-X
such	B-X
virulence	B-X
factor	B-X
is	B-X
the	B-X
type	B-X
III	B-X
secretion	B-X
system	B-X
(	B-X
T3SS	B-X
)	B-X
,	B-X
the	B-X
first	B-X
example	B-X
of	B-X
which	B-X
was	B-X
provided	B-X
by	B-X
the	B-X
pathogenic	B-X
Yersinia	B-X
.	B-X
Conversely	B-X
,	B-X
the	B-X
response	B-X
regulator	B-X
of	B-X
the	B-X
Y.	B-X
pseudotuberculosis	B-X
Cpx	B-X
ESR	B-X
can	B-X
down-regulate	B-X
production	B-X
of	B-X
the	B-X
Ysc-Yop	B-X
T3SS	B-X
,	B-X
and	B-X
at	B-X
least	B-X
one	B-X
other	B-X
envelope	B-X
virulence	B-X
factor	B-X
(	B-X
invasin	B-X
)	B-X
,	B-X
by	B-X
direct	B-X
repression	B-X
.	B-X
Also	B-X
in	B-X
Y.	B-X
pseudotuberculosis	B-X
,	B-X
there	B-X
is	B-X
some	B-X
evidence	B-X
suggesting	B-X
that	B-X
an	B-X
intact	B-X
RpoE	B-X
ESR	B-X
might	B-X
be	B-X
important	B-X
for	B-X
normal	B-X
Yersinia	B-X
outer	B-X
proteins	B-X
(	B-X
Yop	B-X
)	B-X
production	B-X
and	B-X
secretion	B-X
.	B-X
Besides	B-X
these	B-X
regulatory	B-X
links	B-X
between	B-X
ESRs	B-X
and	B-X
T3SSs	B-X
,	B-X
perhaps	B-X
the	B-X
most	B-X
striking	B-X
connection	B-X
between	B-X
T3SS	B-X
function	B-X
and	B-X
an	B-X
ESR	B-X
is	B-X
that	B-X
between	B-X
the	B-X
phage	B-X
shock	B-X
protein	B-X
(	B-X
Psp	B-X
)	B-X
and	B-X
Ysc-Yop	B-X
systems	B-X
of	B-X
Y.	B-X
enterocolitica	B-X
.	B-X

Deletion	O
of	O
rseA	O
in	O
Yersinia	B-Organism
pseudotuberculosis	I-Organism
causes	O
elevated	O
virulence	O
effector	O
synthesis	O
and	O
secretion	O
[	O
18	O
]	O
,	O
establishing	O
links	O
between	O
alternative	O
sigma	O
factors	O
and	O
virulence	O
-	O
specific	O
regulators	O
.	O

Taken	O
together	O
,	O
a	O
connection	O
between	O
sigmaE	O
and	O
SsrB	O
is	O
suggested	O
from	O
the	O
available	O
literature	O
,	O
however	O
the	O
role	O
of	O
sigmaE	O
in	O
activating	O
SsrB	O
-	O
regulated	O
genes	O
has	O
not	O
been	O
studied	O
.	O

We	O
tested	O
the	O
hypothesis	O
that	O
RpoE	O
is	O
involved	O
in	O
expression	O
of	O
genes	O
that	O
use	O
the	O
SsrB	O
response	O
regulator	O
for	O
activation	O
.	O

By	O
testing	O
six	O
promoters	O
representing	O
four	O
classes	O
of	O
SsrB	O
-	O
regulated	O
promoters	O
(	O
(	O
i	O
)	O
two	O
type	O
III	O
secretion	O
structural	O
operons	O
in	O
SPI	O
-	O
2	O
,	O
(	O
ii	O
)	O
the	O
effector	O
operon	O
in	O
SPI	O
-	O
2	O
,	O
(	O
iii	O
)	O
two	O
effector	O
genes	O
unlinked	O
with	O
SPI	O
-	O
2	O
,	O
and	O
(	O
iv	O
)	O
an	O
integrated	O
virulence	O
gene	O
unlinked	O
with	O
SPI	O
-	O
2	O
)	O
we	O
demonstrate	O
that	O
RpoE	O
elicits	O
an	O
effect	O
on	O
a	O
subset	O
of	O
SsrB	O
-	O
regulated	O
genes	O
.	O

This	O
effect	O
was	O
bidirectional	O
depending	O
on	O
the	O
promoter	O
and	O
was	O
downstream	O
of	O
ssrB	O
expression	O
itself	O
,	O
since	O
deletion	O
of	O
rpoE	O
had	O
no	O
effect	O
on	O
SsrB	O
levels	O
in	O
the	O
mutant	O
cells	O
.	O

These	O
data	O
help	O
unite	O
the	O
virulence	O
phenotypes	O
of	O
strains	O
lacking	O
SsrB	O
and	O
RpoE	O
,	O
and	O
highlight	O
new	O
transcriptional	O
regulation	O
that	O
might	O
be	O
essential	O
for	O
appropriate	O
temporal	O
and	O
spatial	O
control	O
of	O
the	O
virulence	O
-	O
associated	O
type	O
III	O
secretion	O
system	O
during	O
host	O
infection	O
.	O

Results	O

Deletion	O
of	O
rpoE	O
affects	O
a	O
subset	O
of	O
SsrB	O
-	O
regulated	O
virulence	O
genes	O
Salmonella	B-Organism
virulence	O
gene	O
expression	O
is	O
coordinated	O
in	O
vivo	O
and	O
may	O
be	O
regulated	O
,	O
in	O
part	O
,	O
by	O
alternative	O
sigma	O
factor	O
(	O
s	O
)	O
in	O
order	O
to	O
quickly	O
respond	O
to	O
the	O
host	O
environment	O
.	O

To	O
date	O
,	O
no	O
sigma	O
factor	O
has	O
been	O
identified	O
as	O
regulating	O
SsrB	O
-	O
dependent	O
virulence	O
genes	O
.	O

To	O
start	O
,	O
we	O
first	O
screened	O
four	O
alternative	O
sigma	O
factor	O
mutants	O
of	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
(	O
rpoS	O
,	O
rpoN	O
,	O
rpoE	O
,	O
rpoH	O
)	O
for	O
their	O
ability	O
to	O
express	O
a	O
key	O
virulence	O
gene	O
,	O
sseB	O
,	O
that	O
requires	O
SsrB	O
for	O
expression	O
and	O
whose	O
gene	O
product	O
is	O
essential	O
for	O
intracellular	O
pathogenesis	O
.	O

For	O
an	O
rpoH	O
deletion	O
,	O
this	O
strain	O
was	O
only	O
viable	O
at	O
temperatures	O
below	O
30degreesC	O
.	O

Since	O
SPI	O
-	O
2	O
gene	O
activation	O
is	O
integrated	O
into	O
a	O
thermosensing	O
circuit	O
[	O
19	O
]	O
we	O
were	O
unable	O
to	O
test	O
the	O
role	O
of	O
sigmaH	O
in	O
this	O
study	O
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
this	O
screen	O
,	O
rpoS	O
deletion	O
resulted	O
in	O
a	O
slight	O
increase	O
in	O
SseB	O
levels	O
(	O
Figure	O
1A	O
)	O
indicating	O
a	O
role	O
for	O
RpoS	O
in	O
the	O
repression	O
of	O
SPI	O
-	O
2	O
.	O

Both	O
rpoE	O
and	O
rpoN	O
deletions	O
resulted	O
in	O
decreased	O
SseB	O
levels	O
with	O
a	O
more	O
pronounced	O
effect	O
in	O
the	O
rpoE	O
deletion	O
.	O

Since	O
we	O
were	O
predominantly	O
interested	O
in	O
sigma	O
factors	O
that	O
activate	O
SPI	O
-	O
2	O
and	O
which	O
could	O
be	O
linked	O
to	O
the	O
previous	O
observation	O
that	O
rpoE	O
mutants	O
are	O
highly	O
attenuated	O
in	O
vivo	O
we	O
choose	O
to	O
focus	O
on	O
RpoE	O
in	O
the	O
current	O
study	O
,	O
which	O
had	O
the	O
most	O
influence	O
on	O
SseB	O
levels	O
in	O
the	O
cell	O
.	O

An	O
unmarked	O
in	O
-	O
frame	O
deletion	O
of	O
rpoE	O
was	O
then	O
generated	O
in	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
strain	I-Organism
SL1344	I-Organism
and	O
we	O
verified	O
that	O
this	O
in	O
-	O
frame	O
deletion	O
had	O
the	O
same	O
effect	O
on	O
SseB	O
as	O
the	O
rpoE	O
:	O
:	O
cat	O
mutant	O
used	O
previously	O
(	O
Figure	O
1B	O
)	O
.	O

A	O
low	O
-	O
copy	O
plasmid	O
containing	O
full	O
-	O
length	O
rpoE	O
and	O
the	O
three	O
endogenous	O
promoters	O
that	O
can	O
drive	O
its	O
expression	O
[	O
20	O
]	O
was	O
able	O
to	O
restore	O
wild	O
type	O
levels	O
of	O
SseB	O
to	O
DeltarpoE	O
cells	O
(	O
Figure	O
1B	O
)	O
demonstrating	O
that	O
the	O
results	O
were	O
specific	O
to	O
the	O
rpoE	O
deletion	O
.	O

In	O
these	O
complementation	O
experiments	O
,	O
attempts	O
were	O
made	O
to	O
examine	O
the	O
levels	O
of	O
SseB	O
secreted	O
into	O
the	O
culture	O
supernatant	O
[	O
21	O
]	O
,	O
however	O
consistent	O
with	O
previous	O
observations	O
[	O
22	O
,	O
23	O
]	O
perturbations	O
to	O
the	O
rpoE	O
pathway	O
increased	O
cell	O
lysis	O
resulting	O
in	O
contamination	O
of	O
secreted	O
fractions	O
with	O
cytosolic	O
proteins	O
which	O
precluded	O
accurate	O
interpretation	O
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
order	O
to	O
examine	O
the	O
effect	O
of	O
sigmaE	O
(	O
rpoE	O
)	O
on	O
the	O
expression	O
of	O
a	O
broad	O
range	O
of	O
SsrB	O
-	O
regulated	O
virulence	O
genes	O
,	O
we	O
tested	O
whether	O
or	O
not	O
the	O
effect	O
of	O
rpoE	O
deletion	O
was	O
specific	O
to	O
sseB	O
or	O
if	O
it	O
extended	O
to	O
other	O
SsrB	O
-	O
regulated	O
genes	O
.	O
<EOS>	B-X
The	B-X
transcription	B-X
factors	B-X
HilA	B-X
and	B-X
SsrB	B-X
activate	B-X
expression	B-X
of	B-X
two	B-X
type	B-X
III	B-X
secretion	B-X
systems	B-X
(	B-X
T3SSs	B-X
)	B-X
and	B-X
cognate	B-X
effectors	B-X
that	B-X
reprogram	B-X
host	B-X
cell	B-X
functions	B-X
to	B-X
benefit	B-X
infecting	B-X
Salmonella	B-X
in	B-X
the	B-X
host	B-X
.	B-X
These	B-X
transcription	B-X
factors	B-X
,	B-X
the	B-X
secretion	B-X
systems	B-X
,	B-X
and	B-X
the	B-X
effectors	B-X
are	B-X
all	B-X
encoded	B-X
by	B-X
horizontally	B-X
acquired	B-X
genes	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
SsrB	B-X
influences	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
diverse	B-X
range	B-X
of	B-X
proteins	B-X
,	B-X
many	B-X
of	B-X
which	B-X
are	B-X
ancestral	B-X
to	B-X
the	B-X
acquisition	B-X
of	B-X
ssrB	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
the	B-X
known	B-X
regulon	B-X
of	B-X
T3SS-related	B-X
proteins	B-X
,	B-X
we	B-X
show	B-X
that	B-X
,	B-X
through	B-X
SodCI	B-X
and	B-X
bacterioferritin	B-X
,	B-X
SsrB	B-X
controls	B-X
resistance	B-X
to	B-X
reactive	B-X
oxygen	B-X
species	B-X
and	B-X
that	B-X
SsrB	B-X
down-regulates	B-X
flagella	B-X
and	B-X
motility	B-X
.	B-X
This	B-X
indicates	B-X
that	B-X
SsrB-controlled	B-X
proteins	B-X
not	B-X
only	B-X
redirect	B-X
host	B-X
cell	B-X
membrane	B-X
traffic	B-X
to	B-X
establish	B-X
a	B-X
supportive	B-X
niche	B-X
within	B-X
host	B-X
cells	B-X
but	B-X
also	B-X
have	B-X
adapted	B-X
to	B-X
the	B-X
chemistry	B-X
and	B-X
physical	B-X
constraints	B-X
of	B-X
that	B-X
niche	B-X
.	B-X

To	O
do	O
this	O
we	O
examined	O
the	O
levels	O
of	O
SseL	O
-	O
2HA	O
,	O
SifA	O
-	O
2HA	O
and	O
SrfN	O
-	O
2HA	O
expressed	O
from	O
their	O
endogenous	O
promoters	O
under	O
SPI	O
-	O
2	O
inducing	O
conditions	O
(	O
Figure	O
1C	O
)	O
.	O

Consistent	O
with	O
the	O
results	O
for	O
SseB	O
,	O
there	O
was	O
a	O
decrease	O
in	O
SifA	O
-	O
2HA	O
levels	O
in	O
DeltarpoE	O
compared	O
to	O
wild	O
type	O
,	O
although	O
deletion	O
of	O
rpoE	O
did	O
not	O
have	O
an	O
effect	O
on	O
SseL	O
-	O
2HA	O
.	O

Relative	O
to	O
its	O
expression	O
in	O
wild	O
type	O
cells	O
,	O
the	O
level	O
of	O
SrfN	O
-	O
2HA	O
was	O
reproducibly	O
increased	O
in	O
the	O
DeltarpoE	O
cells	O
,	O
suggesting	O
a	O
role	O
for	O
sigmaE	O
in	O
the	O
repression	O
of	O
SrfN	O
,	O
although	O
it	O
is	O
unlikely	O
that	O
this	O
is	O
through	O
a	O
direct	O
mechanism	O
.	O

RpoE	O
is	O
involved	O
in	O
transcriptional	O
activity	O
of	O
a	O
subset	O
of	O
virulence	O
genes	O

In	O
order	O
to	O
confirm	O
the	O
effect	O
of	O
sigmaE	O
on	O
the	O
expression	O
of	O
a	O
broad	O
range	O
of	O
SsrB	O
-	O
regulated	O
virulence	O
genes	O
,	O
we	O
used	O
wild	O
type	O
and	O
DeltarpoE	O
cells	O
and	O
integrated	O
into	O
the	O
chromosome	O
individually	O
six	O
single	O
-	O
copy	O
transcriptional	O
fusions	O
representing	O
promoters	O
for	O
four	O
classes	O
of	O
SsrB	O
-	O
dependent	O
genes	O
or	O
operons	O
(	O
(	O
i	O
)	O
type	O
III	O
secretion	O
effector	O
operon	O
(	O
sseA	O
)	O
;	O
(	O
ii	O
)	O
structural	O
operon	O
I	O
(	O
ssaB	O
)	O
;	O
(	O
iii	O
)	O
structural	O
operon	O
II	O
(	O
ssaG	O
)	O
;	O
(	O
iv	O
and	O
v	O
)	O
effectors	O
encoded	O
outside	O
of	O
SPI	O
-	O
2	O
(	O
sseL	O
and	O
sifA	O
)	O
;	O
and	O
(	O
vi	O
)	O
integrated	O
virulence	O
genes	O
unlinked	O
to	O
SPI	O
-	O
2	O
(	O
srfN	O
)	O
[	O
9	O
]	O
.	O

Transcriptional	O
fusions	O
to	O
lacZ	O
of	O
the	O
sseA	O
,	O
ssaB	O
,	O
ssaG	O
,	O
sseL	O
,	O
sifA	O
and	O
srfN	O
promoters	O
(	O
mapped	O
previously	O
;	O
[	O
9	O
,	O
24	O
]	O
were	O
integrated	O
into	O
the	O
chromosome	O
of	O
wild	O
type	O
and	O
DeltarpoE	O
cells	O
and	O
then	O
grown	O
in	O
the	O
SsrB	O
-	O
activating	O
medium	O
LPM	O
.	O

The	O
activity	O
of	O
each	O
promoter	O
was	O
measured	O
using	O
a	O
beta	O
-	O
galactosidase	O
assay	O
during	O
exponential	O
growth	O
.	O
<EOS>	B-X
dlt	B-X
expression	B-X
was	B-X
assessed	B-X
using	B-X
the	B-X
dlt	B-X
promoter-lacZ	B-X
reporter	B-X
gene	B-X
assay	B-X
,	B-X
LTA	B-X
d-alanine	B-X
content	B-X
measurements	B-X
and	B-X
dlt	B-X
mRNA	B-X
quantification	B-X
.	B-X
The	B-X
results	B-X
showed	B-X
that	B-X
dlt	B-X
expression	B-X
was	B-X
growth	B-X
phase-dependent	B-X
,	B-X
with	B-X
the	B-X
greatest	B-X
expression	B-X
at	B-X
the	B-X
mid-exponential	B-X
phase	B-X
of	B-X
growth	B-X
.	B-X
We	B-X
evaluated	B-X
sigma	B-X
(	B-X
B	B-X
)	B-X
activity	B-X
in	B-X
wild	B-X
type	B-X
and	B-X
DeltasigB	B-X
mutant	B-X
L.	B-X
monocytogenes	B-X
containing	B-X
reporter	B-X
fusions	B-X
(	B-X
sigma	B-X
(	B-X
B	B-X
)	B-X
-dependent	B-X
opuCA	B-X
promoter	B-X
and	B-X
a	B-X
lacZ	B-X
reporter	B-X
gene	B-X
)	B-X
during	B-X
the	B-X
early	B-X
exponential	B-X
growth	B-X
phase	B-X
by	B-X
measuring	B-X
the	B-X
specific	B-X
activity	B-X
of	B-X
beta-galactosidase	B-X
after	B-X
vancomycin	B-X
(	B-X
2	B-X
microg	B-X
mL	B-X
(	B-X
-1	B-X
)	B-X
final	B-X
concentration	B-X
)	B-X
stress	B-X
.	B-X
sigma	B-X
(	B-X
B	B-X
)	B-X
activity	B-X
is	B-X
significantly	B-X
induced	B-X
only	B-X
in	B-X
the	B-X
wild-type	B-X
strain	B-X
by	B-X
addition	B-X
of	B-X
vancomycin	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
identified	B-X
sigma	B-X
(	B-X
B	B-X
)	B-X
-dependent	B-X
vancomycin-inducible	B-X
proteins	B-X
using	B-X
LC-ESI-MS/MS	B-X
analysis	B-X
.	B-X

Although	O
DeltarpoE	O
was	O
observed	O
to	O
have	O
a	O
slightly	O
prolonged	O
lag	O
phase	O
relative	O
to	O
wild	O
type	O
cells	O
under	O
these	O
experimental	O
conditions	O
,	O
at	O
later	O
time	O
points	O
the	O
mutant	O
grew	O
similarly	O
to	O
wild	O
type	O
.	O

To	O
account	O
for	O
any	O
differences	O
in	O
growth	O
kinetics	O
of	O
the	O
cultures	O
,	O
all	O
data	O
was	O
normalized	O
to	O
the	O
optical	O
density	O
at	O
600	O
nm	O
of	O
the	O
culture	O
,	O
which	O
permitted	O
direct	O
comparisons	O
.	O

In	O
wild	O
type	O
cells	O
,	O
promoter	O
activity	O
from	O
all	O
the	O
transcriptional	O
fusions	O
was	O
high	O
,	O
as	O
expected	O
,	O
because	O
LPM	O
medium	O
is	O
highly	O
inducing	O
for	O
SsrB	O
activity	O
[	O
21	O
]	O
.	O

In	O
contrast	O
,	O
promoter	O
activity	O
for	O
sseA	O
,	O
ssaB	O
,	O
and	O
sifA	O
decreased	O
in	O
the	O
rpoE	O
mutant	O
compared	O
to	O
wild	O
type	O
cells	O
(	O
Figure	O
2A	O
,	O
B	O
and	O
2D	O
)	O
,	O
whereas	O
promoter	O
activity	O
from	O
the	O
ssaG	O
and	O
srfN	O
reporters	O
was	O
upregulated	O
in	O
the	O
rpoE	O
mutant	O
(	O
Figure	O
2C	O
and	O
2F	O
)	O
.	O
beta	O
-	O
galactosidase	O
activity	O
observed	O
from	O
the	O
sseL	O
reporter	O
was	O
unaltered	O
in	O
the	O
rpoE	O
deletion	O
compared	O
to	O
that	O
in	O
wild	O
type	O
cells	O
(	O
Figure	O
2E	O
)	O
.	O

These	O
data	O
are	O
consistent	O
with	O
the	O
protein	O
levels	O
detected	O
for	O
these	O
gene	O
products	O
.	O
<EOS>	B-X
We	B-X
found	B-X
that	B-X
both	B-X
cGAS-	B-X
and	B-X
STING-deficiency	B-X
not	B-X
only	B-X
failed	B-X
to	B-X
rescue	B-X
mice	B-X
from	B-X
TMPD-induced	B-X
SLE	B-X
,	B-X
but	B-X
resulted	B-X
in	B-X
increased	B-X
autoantibody	B-X
production	B-X
and	B-X
higher	B-X
proteinuria	B-X
levels	B-X
compared	B-X
to	B-X
cGAS	B-X
STING	B-X
sufficient	B-X
mice	B-X
.	B-X
Further	B-X
,	B-X
we	B-X
generated	B-X
cGAS	B-X
Dysregulation	B-X
of	B-X
the	B-X
complement	B-X
system	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
play	B-X
a	B-X
major	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
age-related	B-X
macular	B-X
degeneration	B-X
(	B-X
AMD	B-X
)	B-X
.	B-X
Apolipoprotein	B-X
A-V	B-X
(	B-X
apoA-V	B-X
)	B-X
was	B-X
discovered	B-X
in	B-X
2001	B-X
both	B-X
by	B-X
comparative	B-X
sequencing	B-X
and	B-X
as	B-X
a	B-X
liver	B-X
regeneration	B-X
protein	B-X
.	B-X
The	B-X
gene	B-X
is	B-X
a	B-X
located	B-X
at	B-X
the	B-X
APOA1/C3/A4/A5	B-X
gene	B-X
cluster	B-X
on	B-X
chromosome	B-X
11q23	B-X
,	B-X
a	B-X
locus	B-X
well	B-X
known	B-X
for	B-X
playing	B-X
a	B-X
major	B-X
role	B-X
in	B-X
regulating	B-X
plasma	B-X
cholesterol	B-X
and	B-X
triglyceride	B-X
(	B-X
TG	B-X
)	B-X
levels	B-X
.	B-X
Mice	B-X
lacking	B-X
apoA-V	B-X
have	B-X
4-fold	B-X
increased	B-X
TG	B-X
levels	B-X
,	B-X
whereas	B-X
apoA-V	B-X
overexpression	B-X
leads	B-X
to	B-X
40	B-X
%	B-X
plasma	B-X
TG	B-X
reduction	B-X
.	B-X
Based	B-X
on	B-X
metabolic	B-X
studies	B-X
in	B-X
vivo	B-X
,	B-X
apoA-V	B-X
enhances	B-X
the	B-X
catabolism	B-X
of	B-X
TG	B-X
rich	B-X
lipoproteins	B-X
rather	B-X
than	B-X
affecting	B-X
their	B-X
intestinal	B-X
or	B-X
hepatic	B-X
production	B-X
.	B-X
By	B-X
activating	B-X
proteoglycans-bound	B-X
lipoprotein	B-X
lipase	B-X
(	B-X
LPL	B-X
)	B-X
,	B-X
apoA-V	B-X
can	B-X
accelerate	B-X
TG	B-X
hydrolysis	B-X
from	B-X
VLDL	B-X
and	B-X
chylomicrons	B-X
independent	B-X
from	B-X
other	B-X
apoproteins	B-X
.	B-X
Several	B-X
variants	B-X
at	B-X
the	B-X
APOA5	B-X
gene	B-X
locus	B-X
have	B-X
been	B-X
detected	B-X
in	B-X
humans	B-X
.	B-X
Some	B-X
single	B-X
nucleotide	B-X
polymorphisms	B-X
(	B-X
SNPs	B-X
)	B-X
are	B-X
associated	B-X
with	B-X
significantly	B-X
higher	B-X
plasma	B-X
TG	B-X
levels	B-X
in	B-X
patients	B-X
(	B-X
e.g.	B-X
,	B-X
-1131T	B-X
>	B-X
C	B-X
,	B-X
S19W	B-X
,	B-X
G185C	B-X
)	B-X
.	B-X
However	B-X
,	B-X
data	B-X
for	B-X
a	B-X
possible	B-X
association	B-X
of	B-X
APOA5	B-X
variants	B-X
with	B-X
coronary	B-X
heart	B-X
disease	B-X
are	B-X
not	B-X
consistent	B-X
.	B-X

Together	O
,	O
these	O
data	O
indicate	O
that	O
sigmaE	O
can	O
have	O
a	O
variable	O
and	O
bidirectional	O
effect	O
on	O
SsrB	O
-	O
regulated	O
virulence	O
genes	O
.	O

The	O
effect	O
of	O
RpoE	O
on	O
virulence	O
genes	O
is	O
downstream	O
of	O
ssrB	O
expression	O

The	O
variable	O
effects	O
of	O
rpoE	O
deletion	O
on	O
SsrB	O
-	O
regulated	O
effectors	O
suggested	O
that	O
RpoE	O
might	O
direct	O
transcription	O
downstream	O
of	O
ssrB	O
expression	O
.	O

To	O
test	O
this	O
,	O
we	O
replaced	O
the	O
ssrB	O
gene	O
in	O
DeltarpoE	O
and	O
wild	O
type	O
cells	O
with	O
an	O
ssrB	O
:	O
:	O
FLAG	O
allele	O
[	O
19	O
]	O
and	O
examined	O
the	O
levels	O
of	O
SsrB	O
protein	O
in	O
the	O
strains	O
by	O
western	O
blot	O
.	O

There	O
was	O
no	O
change	O
in	O
the	O
levels	O
of	O
SsrB	O
-	O
FLAG	O
between	O
wild	O
type	O
and	O
DeltarpoE	O
cells	O
(	O
Figure	O
3	O
)	O
,	O
indicating	O
that	O
the	O
effects	O
of	O
RpoE	O
on	O
the	O
four	O
classes	O
of	O
virulence	O
gene	O
promoters	O
examined	O
here	O
was	O
not	O
mediated	O
through	O
changes	O
to	O
SsrB	O
protein	O
levels	O
.	O

Together	O
these	O
data	O
establish	O
a	O
role	O
for	O
RpoE	O
in	O
the	O
fine	O
-	O
tuning	O
of	O
virulence	O
gene	O
expression	O
in	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
.	O
<EOS>	B-X
Salmonella	B-X
enterica	B-X
subspecies	B-X
I	B-X
,	B-X
serovar	B-X
Typhimurium	B-X
(	B-X
S.	B-X
typhimurium	B-X
)	B-X
,	B-X
is	B-X
a	B-X
leading	B-X
cause	B-X
of	B-X
human	B-X
gastroenteritis	B-X
,	B-X
and	B-X
is	B-X
used	B-X
as	B-X
a	B-X
mouse	B-X
model	B-X
of	B-X
human	B-X
typhoid	B-X
fever	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
focus	B-X
on	B-X
Salmonella	B-X
enterica	B-X
Typhimurium	B-X
(	B-X
S.	B-X
Typhimurium	B-X
)	B-X
,	B-X
a	B-X
frequent	B-X
cause	B-X
of	B-X
acute	B-X
,	B-X
self-limiting	B-X
food-borne	B-X
diarrhea	B-X
and	B-X
a	B-X
model	B-X
that	B-X
has	B-X
revealed	B-X
key	B-X
principles	B-X
of	B-X
enteropathogen	B-X
infection	B-X
.	B-X
We	B-X
review	B-X
the	B-X
steps	B-X
of	B-X
gut	B-X
infection	B-X
and	B-X
the	B-X
mucosal	B-X
innate-immune	B-X
defenses	B-X
limiting	B-X
pathogen	B-X
burdens	B-X
,	B-X
and	B-X
we	B-X
discuss	B-X
how	B-X
inflammation	B-X
boosts	B-X
gut	B-X
luminal	B-X
S.	B-X
Typhimurium	B-X
growth	B-X
.	B-X
We	B-X
also	B-X
discuss	B-X
how	B-X
S.	B-X
Typhimurium-induced	B-X
inflammation	B-X
accelerates	B-X
the	B-X
transfer	B-X
of	B-X
plasmids	B-X
and	B-X
phages	B-X
,	B-X
which	B-X
may	B-X
promote	B-X
the	B-X
transmission	B-X
of	B-X
antibiotic	B-X
resistance	B-X
and	B-X
facilitate	B-X
emergence	B-X
of	B-X
pathobionts	B-X
and	B-X
pathogens	B-X
with	B-X
enhanced	B-X
virulence	B-X
.	B-X

Discussion	O
<EOS>	B-X
Discussion	B-X
structures	B-X
are	B-X
argumentation-theoretical	B-X
tools	B-X
that	B-X
can	B-X
be	B-X
employed	B-X
to	B-X
tackle	B-X
three	B-X
barriers	B-X
that	B-X
separate	B-X
lay	B-X
stakeholders	B-X
from	B-X
policy	B-X
debates	B-X
:	B-X
difficulty	B-X
,	B-X
magnitude	B-X
,	B-X
and	B-X
complexity	B-X
.	B-X
Discussions	B-X
about	B-X
preventive	B-X
behaviors	B-X
were	B-X
assessed	B-X
before	B-X
testing	B-X
and	B-X
1	B-X
and	B-X
6	B-X
months	B-X
post-testing	B-X
.	B-X
Discussion	B-X
of	B-X
preventive	B-X
behaviors	B-X
declined	B-X
following	B-X
test	B-X
reporting	B-X
,	B-X
with	B-X
more	B-X
rapid	B-X
decline	B-X
reported	B-X
by	B-X
noncarriers	B-X
.	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X

In	O
this	O
work	O
we	O
found	O
that	O
the	O
alternative	O
sigma	O
factor	O
,	O
sigmaE	O
,	O
is	O
involved	O
in	O
fine	O
tuning	O
the	O
expressing	O
of	O
a	O
subset	O
of	O
SsrB	O
-	O
regulated	O
virulence	O
genes	O
required	O
for	O
Salmonella	B-Organism
pathogenesis	O
.	O

Although	O
the	O
effect	O
of	O
rpoE	O
deletion	O
on	O
promoter	O
activity	O
in	O
some	O
cases	O
was	O
mild	O
,	O
we	O
have	O
previously	O
shown	O
that	O
gene	O
regulators	O
providing	O
only	O
modest	O
transcriptional	O
input	O
have	O
a	O
profound	O
influence	O
on	O
bacterial	O
fitness	O
in	O
a	O
host	O
animal	O
[	O
25	O
]	O
.	O

In	O
cases	O
where	O
the	O
regulator	O
is	O
deleted	O
,	O
the	O
loss	O
of	O
genetic	O
fine	O
-	O
tuning	O
causes	O
incongruous	O
changes	O
in	O
the	O
timing	O
and	O
magnitude	O
of	O
virulence	O
gene	O
expression	O
,	O
leading	O
to	O
fitness	O
loss	O
and	O
strong	O
attenuation	O
.	O

We	O
predict	O
that	O
RpoE	O
confers	O
a	O
similar	O
fine	O
-	O
tuning	O
effect	O
on	O
Salmonella	B-Organism
virulence	O
gene	O
expression	O
that	O
is	O
required	O
for	O
optimal	O
within	O
-	O
host	O
fitness	O
during	O
infection	O
.	O

When	O
we	O
examined	O
the	O
-	O
10	O
and	O
-	O
35	O
positions	O
of	O
the	O
promoters	O
studied	O
here	O
relative	O
to	O
the	O
transcriptional	O
start	O
sites	O
identified	O
previously	O
[	O
24	O
]	O
,	O
these	O
promoters	O
did	O
not	O
appear	O
to	O
contain	O
sigmaE	O
consensus	O
sequences	O
.	O

Instead	O
they	O
appeared	O
to	O
have	O
consensus	O
sites	O
for	O
sigma70	O
.	O

Although	O
a	O
bioinformatics	O
screen	O
identified	O
sigmaE	O
consensus	O
sequences	O
upstream	O
of	O
the	O
SPI	O
-	O
2	O
genes	O
ssaU	O
,	O
ssaJ	O
,	O
sscA	O
and	O
ssaC	O
[	O
26	O
]	O
,	O
these	O
genes	O
were	O
not	O
tested	O
for	O
sigmaE	O
-	O
dependence	O
in	O
the	O
present	O
study	O
because	O
the	O
identified	O
consensus	O
sites	O
are	O
in	O
coding	O
sequence	O
within	O
operons	O
,	O
and	O
as	O
a	O
result	O
may	O
not	O
be	O
directly	O
relevant	O
.	O

Due	O
to	O
the	O
high	O
degree	O
of	O
conservation	O
in	O
sigma	O
factor	O
binding	O
sequences	O
,	O
sigmaE	O
may	O
not	O
be	O
directly	O
regulating	O
SsrB	O
-	O
dependent	O
promoters	O
.	O

The	O
lack	O
of	O
a	O
canonical	O
sigmaE	O
sequence	O
at	O
these	O
promoters	O
suggests	O
that	O
another	O
regulatory	O
gene	O
may	O
be	O
epistatic	O
to	O
sigmaE	O
or	O
that	O
these	O
promoters	O
encode	O
functional	O
,	O
but	O
non	O
-	O
canonical	O
sigmaE	O
-	O
binding	O
sites	O
due	O
to	O
their	O
horizontal	O
acquisition	O
and	O
gradual	O
integration	O
into	O
the	O
sigmaE	O
regulatory	O
network	O
.	O

This	O
integration	O
may	O
help	O
Salmonella	B-Organism
coordinate	O
expression	O
of	O
the	O
virulence	O
-	O
associated	O
T3SS	O
in	O
response	O
to	O
host	O
factors	O
that	O
compromise	O
bacterial	O
membrane	O
integrity	O
(	O
Figure	O
4	O
)	O
.	O

This	O
mechanism	O
would	O
activate	O
a	O
restorative	O
sigmaE	O
pathway	O
,	O
which	O
is	O
consistent	O
with	O
the	O
enhanced	O
susceptibility	O
of	O
rpoE	O
mutants	O
to	O
oxidative	O
stress	O
and	O
antimicrobial	O
peptides	O
[	O
13	O
,	O
15	O
,	O
16	O
]	O
,	O
both	O
of	O
which	O
perturb	O
membrane	O
integrity	O
in	O
vivo	O
.	O

Although	O
there	O
is	O
no	O
evidence	O
that	O
sigmaE	O
can	O
directly	O
repress	O
transcription	O
,	O
the	O
negative	O
effect	O
on	O
two	O
promoters	O
observed	O
here	O
might	O
be	O
due	O
to	O
an	O
intermediate	O
RpoE	O
-	O
regulated	O
repressor	O
or	O
compensatory	O
effect	O
where	O
loss	O
of	O
rpoE	O
increases	O
the	O
relative	O
abundance	O
of	O
another	O
sigma	O
factor	O
that	O
can	O
directly	O
activate	O
the	O
ssaG	O
and	O
srfN	O
promoters	O
.	O

Future	O
work	O
will	O
be	O
required	O
to	O
resolve	O
these	O
possibilities	O
.	O

Our	O
results	O
indicate	O
that	O
rpoE	O
deletion	O
has	O
no	O
effect	O
on	O
SsrB	O
levels	O
under	O
SPI	O
-	O
2	O
inducing	O
conditions	O
suggesting	O
that	O
the	O
sigmaE	O
pathway	O
regulates	O
effector	O
expression	O
downstream	O
of	O
ssrAB	O
transcription	O
.	O

Unlinking	O
ssrAB	O
transcription	O
from	O
the	O
sigmaE	O
regulon	O
would	O
be	O
advantageous	O
to	O
the	O
cell	O
to	O
prevent	O
commitment	O
to	O
a	O
virulence	O
gene	O
expression	O
program	O
in	O
response	O
to	O
envelope	O
stress	O
not	O
associated	O
with	O
infection	O
.	O

The	O
results	O
from	O
this	O
study	O
demonstrate	O
that	O
sigmaE	O
has	O
the	O
ability	O
to	O
affect	O
expression	O
of	O
SsrB	O
-	O
regulated	O
virulence	O
genes	O
and	O
offers	O
potential	O
insight	O
into	O
the	O
virulence	O
attenuation	O
of	O
rpoE	O
mutants	O
.	O

Although	O
when	O
considered	O
individually	O
,	O
each	O
promoter	O
was	O
modestly	O
affected	O
by	O
deletion	O
of	O
rpoE	O
,	O
the	O
cumulative	O
effects	O
of	O
mild	O
rewired	O
inputs	O
on	O
multiple	O
virulence	O
promoters	O
has	O
been	O
shown	O
to	O
severely	O
compromise	O
in	O
-	O
host	O
fitness	O
and	O
virulence	O
ability	O
[	O
25	O
]	O
.	O

Conclusion	O
<EOS>	B-X
Conclusion	B-X
.	B-X
[	B-X
Conclusion	B-X
]	B-X
.	B-X
[	B-X
Conclusion	B-X
]	B-X
.	B-X
[	B-X
Conclusion	B-X
]	B-X
.	B-X

Based	O
on	O
these	O
and	O
other	O
data	O
[	O
4	O
,	O
12	O
-	O
15	O
]	O
,	O
the	O
genetic	O
interaction	O
between	O
sigmaE	O
and	O
a	O
subset	O
of	O
SsrB	O
-	O
regulated	O
genes	O
may	O
serve	O
to	O
coordinate	O
the	O
spatial	O
and	O
temporal	O
activation	O
of	O
virulence	O
genes	O
in	O
a	O
host	O
setting	O
,	O
likely	O
in	O
response	O
to	O
membrane	O
damage	O
resulting	O
from	O
oxidative	O
anti	O
-	O
microbial	O
systems	O
and	O
membrane	O
-	O
targeted	O
host	O
defence	O
peptides	O
.	O

Caenorhabditis	B-Organism
elegans	I-Organism
Semi	O
-	O
Automated	O
Liquid	O
Screen	O
Reveals	O
a	O
Specialized	O
Role	O
for	O
the	O
Chemotaxis	O
Gene	O
cheB2	O
in	O
Pseudomonas	B-Organism
aeruginosa	I-Organism
Virulence	O
<EOS>	B-X
Pseudomonas	B-X
aeruginosa	B-X
is	B-X
an	B-X
opportunistic	B-X
human	B-X
pathogen	B-X
that	B-X
causes	B-X
infections	B-X
in	B-X
a	B-X
variety	B-X
of	B-X
animal	B-X
and	B-X
plant	B-X
hosts	B-X
.	B-X
Caenorhabditis	B-X
elegans	B-X
is	B-X
a	B-X
simple	B-X
model	B-X
with	B-X
which	B-X
one	B-X
can	B-X
identify	B-X
bacterial	B-X
virulence	B-X
genes	B-X
.	B-X
Previous	B-X
studies	B-X
with	B-X
C.	B-X
elegans	B-X
have	B-X
shown	B-X
that	B-X
depending	B-X
on	B-X
the	B-X
growth	B-X
medium	B-X
,	B-X
P.	B-X
aeruginosa	B-X
provokes	B-X
different	B-X
pathologies	B-X
:	B-X
slow	B-X
or	B-X
fast	B-X
killing	B-X
,	B-X
lethal	B-X
paralysis	B-X
and	B-X
red	B-X
death	B-X
.	B-X
We	B-X
screened	B-X
a	B-X
2,200-member	B-X
STM	B-X
mutant	B-X
library	B-X
generated	B-X
in	B-X
a	B-X
cystic	B-X
fibrosis	B-X
airway	B-X
P.	B-X
aeruginosa	B-X
isolate	B-X
,	B-X
TBCF10839	B-X
.	B-X
Twelve	B-X
mutants	B-X
were	B-X
isolated	B-X
each	B-X
showing	B-X
at	B-X
least	B-X
70	B-X
%	B-X
attenuation	B-X
in	B-X
C.	B-X
elegans	B-X
killing	B-X
.	B-X
The	B-X
cheB2	B-X
mutant	B-X
was	B-X
tested	B-X
in	B-X
a	B-X
murine	B-X
lung	B-X
infection	B-X
model	B-X
and	B-X
found	B-X
to	B-X
have	B-X
a	B-X
highly	B-X
attenuated	B-X
virulence	B-X
.	B-X
The	B-X
cheB2	B-X
gene	B-X
is	B-X
part	B-X
of	B-X
the	B-X
chemotactic	B-X
gene	B-X
cluster	B-X
II	B-X
,	B-X
which	B-X
was	B-X
shown	B-X
to	B-X
be	B-X
required	B-X
for	B-X
an	B-X
optimal	B-X
mobility	B-X
in	B-X
vitro	B-X
.	B-X
In	B-X
P.	B-X
aeruginosa	B-X
,	B-X
the	B-X
main	B-X
player	B-X
in	B-X
chemotaxis	B-X
and	B-X
mobility	B-X
is	B-X
the	B-X
chemotactic	B-X
gene	B-X
cluster	B-X
I	B-X
,	B-X
including	B-X
cheB1	B-X
.	B-X
We	B-X
show	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
the	B-X
cheB2	B-X
mutant	B-X
,	B-X
a	B-X
cheB1	B-X
mutant	B-X
is	B-X
not	B-X
attenuated	B-X
for	B-X
virulence	B-X
in	B-X
C.	B-X
elegans	B-X
whereas	B-X
in	B-X
vitro	B-X
motility	B-X
and	B-X
chemotaxis	B-X
are	B-X
severely	B-X
impaired	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
the	B-X
virulence	B-X
defect	B-X
of	B-X
the	B-X
cheB2	B-X
mutant	B-X
is	B-X
not	B-X
linked	B-X
with	B-X
a	B-X
global	B-X
motility	B-X
defect	B-X
but	B-X
that	B-X
instead	B-X
the	B-X
cheB2	B-X
gene	B-X
is	B-X
involved	B-X
in	B-X
a	B-X
specific	B-X
chemotactic	B-X
response	B-X
,	B-X
which	B-X
takes	B-X
place	B-X
during	B-X
infection	B-X
and	B-X
is	B-X
required	B-X
for	B-X
P.	B-X
aeruginosa	B-X
pathogenicity	B-X
.	B-X

Pseudomonas	B-Organism
aeruginosa	I-Organism
is	O
an	O
opportunistic	O
human	B-Organism
pathogen	O
that	O
causes	O
infections	O
in	O
a	O
variety	O
of	O
animal	O
and	O
plant	O
hosts	O
.	O

Caenorhabditis	B-Organism
elegans	I-Organism
is	O
a	O
simple	O
model	O
with	O
which	O
one	O
can	O
identify	O
bacterial	O
virulence	O
genes	O
.	O
<EOS>	B-X
Caenorhabditis	B-X
elegans	B-X
is	B-X
a	B-X
simple	B-X
model	B-X
with	B-X
which	B-X
one	B-X
can	B-X
identify	B-X
bacterial	B-X
virulence	B-X
genes	B-X
.	B-X
Previous	B-X
studies	B-X
with	B-X
C.	B-X
elegans	B-X
have	B-X
shown	B-X
that	B-X
depending	B-X
on	B-X
the	B-X
growth	B-X
medium	B-X
,	B-X
P.	B-X
aeruginosa	B-X
provokes	B-X
different	B-X
pathologies	B-X
:	B-X
slow	B-X
or	B-X
fast	B-X
killing	B-X
,	B-X
lethal	B-X
paralysis	B-X
and	B-X
red	B-X
death	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
high-throughput	B-X
semi-automated	B-X
liquid-based	B-X
assay	B-X
such	B-X
that	B-X
an	B-X
entire	B-X
genome	B-X
can	B-X
readily	B-X
be	B-X
scanned	B-X
for	B-X
virulence	B-X
genes	B-X
in	B-X
a	B-X
short	B-X
time	B-X
period	B-X
.	B-X
Twelve	B-X
mutants	B-X
were	B-X
isolated	B-X
each	B-X
showing	B-X
at	B-X
least	B-X
70	B-X
%	B-X
attenuation	B-X
in	B-X
C.	B-X
elegans	B-X
killing	B-X
.	B-X
The	B-X
selected	B-X
mutants	B-X
had	B-X
insertions	B-X
in	B-X
regulatory	B-X
genes	B-X
,	B-X
such	B-X
as	B-X
a	B-X
histidine	B-X
kinase	B-X
sensor	B-X
of	B-X
two-component	B-X
systems	B-X
and	B-X
a	B-X
member	B-X
of	B-X
the	B-X
AraC	B-X
family	B-X
,	B-X
or	B-X
in	B-X
genes	B-X
involved	B-X
in	B-X
adherence	B-X
or	B-X
chemotaxis	B-X
.	B-X
The	B-X
cheB2	B-X
mutant	B-X
was	B-X
tested	B-X
in	B-X
a	B-X
murine	B-X
lung	B-X
infection	B-X
model	B-X
and	B-X
found	B-X
to	B-X
have	B-X
a	B-X
highly	B-X
attenuated	B-X
virulence	B-X
.	B-X
We	B-X
show	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
the	B-X
cheB2	B-X
mutant	B-X
,	B-X
a	B-X
cheB1	B-X
mutant	B-X
is	B-X
not	B-X
attenuated	B-X
for	B-X
virulence	B-X
in	B-X
C.	B-X
elegans	B-X
whereas	B-X
in	B-X
vitro	B-X
motility	B-X
and	B-X
chemotaxis	B-X
are	B-X
severely	B-X
impaired	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
the	B-X
virulence	B-X
defect	B-X
of	B-X
the	B-X
cheB2	B-X
mutant	B-X
is	B-X
not	B-X
linked	B-X
with	B-X
a	B-X
global	B-X
motility	B-X
defect	B-X
but	B-X
that	B-X
instead	B-X
the	B-X
cheB2	B-X
gene	B-X
is	B-X
involved	B-X
in	B-X
a	B-X
specific	B-X
chemotactic	B-X
response	B-X
,	B-X
which	B-X
takes	B-X
place	B-X
during	B-X
infection	B-X
and	B-X
is	B-X
required	B-X
for	B-X
P.	B-X
aeruginosa	B-X
pathogenicity	B-X
.	B-X

Previous	O
studies	O
with	O
C	B-Organism
.	I-Organism
elegans	I-Organism
have	O
shown	O
that	O
depending	O
on	O
the	O
growth	O
medium	O
,	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
provokes	O
different	O
pathologies	O
:	O
slow	O
or	O
fast	O
killing	O
,	O
lethal	O
paralysis	O
and	O
red	O
death	O
.	O
<EOS>	B-X
Pseudomonas	B-X
aeruginosa	B-X
is	B-X
an	B-X
opportunistic	B-X
human	B-X
pathogen	B-X
that	B-X
causes	B-X
infections	B-X
in	B-X
a	B-X
variety	B-X
of	B-X
animal	B-X
and	B-X
plant	B-X
hosts	B-X
.	B-X
Caenorhabditis	B-X
elegans	B-X
is	B-X
a	B-X
simple	B-X
model	B-X
with	B-X
which	B-X
one	B-X
can	B-X
identify	B-X
bacterial	B-X
virulence	B-X
genes	B-X
.	B-X
Previous	B-X
studies	B-X
with	B-X
C.	B-X
elegans	B-X
have	B-X
shown	B-X
that	B-X
depending	B-X
on	B-X
the	B-X
growth	B-X
medium	B-X
,	B-X
P.	B-X
aeruginosa	B-X
provokes	B-X
different	B-X
pathologies	B-X
:	B-X
slow	B-X
or	B-X
fast	B-X
killing	B-X
,	B-X
lethal	B-X
paralysis	B-X
and	B-X
red	B-X
death	B-X
.	B-X
We	B-X
screened	B-X
a	B-X
2,200-member	B-X
STM	B-X
mutant	B-X
library	B-X
generated	B-X
in	B-X
a	B-X
cystic	B-X
fibrosis	B-X
airway	B-X
P.	B-X
aeruginosa	B-X
isolate	B-X
,	B-X
TBCF10839	B-X
.	B-X
Twelve	B-X
mutants	B-X
were	B-X
isolated	B-X
each	B-X
showing	B-X
at	B-X
least	B-X
70	B-X
%	B-X
attenuation	B-X
in	B-X
C.	B-X
elegans	B-X
killing	B-X
.	B-X
The	B-X
selected	B-X
mutants	B-X
had	B-X
insertions	B-X
in	B-X
regulatory	B-X
genes	B-X
,	B-X
such	B-X
as	B-X
a	B-X
histidine	B-X
kinase	B-X
sensor	B-X
of	B-X
two-component	B-X
systems	B-X
and	B-X
a	B-X
member	B-X
of	B-X
the	B-X
AraC	B-X
family	B-X
,	B-X
or	B-X
in	B-X
genes	B-X
involved	B-X
in	B-X
adherence	B-X
or	B-X
chemotaxis	B-X
.	B-X
One	B-X
mutant	B-X
had	B-X
an	B-X
insertion	B-X
in	B-X
a	B-X
cheB	B-X
gene	B-X
homologue	B-X
,	B-X
encoding	B-X
a	B-X
methylesterase	B-X
involved	B-X
in	B-X
chemotaxis	B-X
(	B-X
CheB2	B-X
)	B-X
.	B-X
The	B-X
cheB2	B-X
gene	B-X
is	B-X
part	B-X
of	B-X
the	B-X
chemotactic	B-X
gene	B-X
cluster	B-X
II	B-X
,	B-X
which	B-X
was	B-X
shown	B-X
to	B-X
be	B-X
required	B-X
for	B-X
an	B-X
optimal	B-X
mobility	B-X
in	B-X
vitro	B-X
.	B-X
In	B-X
P.	B-X
aeruginosa	B-X
,	B-X
the	B-X
main	B-X
player	B-X
in	B-X
chemotaxis	B-X
and	B-X
mobility	B-X
is	B-X
the	B-X
chemotactic	B-X
gene	B-X
cluster	B-X
I	B-X
,	B-X
including	B-X
cheB1	B-X
.	B-X
We	B-X
show	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
the	B-X
cheB2	B-X
mutant	B-X
,	B-X
a	B-X
cheB1	B-X
mutant	B-X
is	B-X
not	B-X
attenuated	B-X
for	B-X
virulence	B-X
in	B-X
C.	B-X
elegans	B-X
whereas	B-X
in	B-X
vitro	B-X
motility	B-X
and	B-X
chemotaxis	B-X
are	B-X
severely	B-X
impaired	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
the	B-X
virulence	B-X
defect	B-X
of	B-X
the	B-X
cheB2	B-X
mutant	B-X
is	B-X
not	B-X
linked	B-X
with	B-X
a	B-X
global	B-X
motility	B-X
defect	B-X
but	B-X
that	B-X
instead	B-X
the	B-X
cheB2	B-X
gene	B-X
is	B-X
involved	B-X
in	B-X
a	B-X
specific	B-X
chemotactic	B-X
response	B-X
,	B-X
which	B-X
takes	B-X
place	B-X
during	B-X
infection	B-X
and	B-X
is	B-X
required	B-X
for	B-X
P.	B-X
aeruginosa	B-X
pathogenicity	B-X
.	B-X

In	O
this	O
study	O
,	O
we	O
developed	O
a	O
high	O
-	O
throughput	O
semi	O
-	O
automated	O
liquid	O
-	O
based	O
assay	O
such	O
that	O
an	O
entire	O
genome	O
can	O
readily	O
be	O
scanned	O
for	O
virulence	O
genes	O
in	O
a	O
short	O
time	O
period	O
.	O

We	O
screened	O
a	O
2	O
,	O
200	O
-	O
member	O
STM	O
mutant	O
library	O
generated	O
in	O
a	O
cystic	O
fibrosis	O
airway	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
isolate	O
,	O
TBCF10839	B-Organism
.	O

Twelve	O
mutants	O
were	O
isolated	O
each	O
showing	O
at	O
least	O
70	O
%	O
attenuation	O
in	O
C	B-Organism
.	I-Organism
elegans	I-Organism
killing	O
.	O

The	O
selected	O
mutants	O
had	O
insertions	O
in	O
regulatory	O
genes	O
,	O
such	O
as	O
a	O
histidine	O
kinase	O
sensor	O
of	O
two	O
-	O
component	O
systems	O
and	O
a	O
member	O
of	O
the	O
AraC	O
family	O
,	O
or	O
in	O
genes	O
involved	O
in	O
adherence	O
or	O
chemotaxis	O
.	O
<EOS>	B-X
From	B-X
an	B-X
individual	B-X
bacterium	B-X
to	B-X
the	B-X
cells	B-X
that	B-X
compose	B-X
the	B-X
human	B-X
immune	B-X
system	B-X
,	B-X
cellular	B-X
chemotaxis	B-X
plays	B-X
a	B-X
fundamental	B-X
role	B-X
in	B-X
allowing	B-X
cells	B-X
to	B-X
navigate	B-X
,	B-X
interpret	B-X
,	B-X
and	B-X
respond	B-X
to	B-X
their	B-X
environments	B-X
.	B-X
While	B-X
many	B-X
features	B-X
of	B-X
cellular	B-X
chemotaxis	B-X
are	B-X
shared	B-X
among	B-X
systems	B-X
as	B-X
diverse	B-X
as	B-X
bacteria	B-X
and	B-X
human	B-X
immune	B-X
cells	B-X
,	B-X
the	B-X
machinery	B-X
that	B-X
guides	B-X
the	B-X
migration	B-X
of	B-X
these	B-X
model	B-X
organisms	B-X
varies	B-X
widely	B-X
.	B-X
These	B-X
facets	B-X
of	B-X
cellular	B-X
chemotaxis	B-X
are	B-X
compared	B-X
among	B-X
E.	B-X
coli	B-X
,	B-X
Dictyostelium	B-X
discoideum	B-X
,	B-X
and	B-X
mammalian	B-X
neutrophils	B-X
to	B-X
derive	B-X
organizational	B-X
principles	B-X
by	B-X
which	B-X
diverse	B-X
cell	B-X
systems	B-X
sense	B-X
and	B-X
respond	B-X
to	B-X
chemotactic	B-X
gradients	B-X
to	B-X
initiate	B-X
cellular	B-X
migration	B-X
.	B-X
Inspired	B-X
by	B-X
the	B-X
natural	B-X
chemotaxis	B-X
,	B-X
colloidal	B-X
motors	B-X
with	B-X
chemotactic	B-X
ability	B-X
can	B-X
realize	B-X
intelligent	B-X
sense	B-X
and	B-X
targeted	B-X
navigation	B-X
,	B-X
which	B-X
bring	B-X
a	B-X
revolutionary	B-X
method	B-X
to	B-X
biomedical	B-X
applications	B-X
like	B-X
precision	B-X
medicine	B-X
.	B-X
Particularly	B-X
,	B-X
the	B-X
torque-driven	B-X
reorientation	B-X
motion	B-X
of	B-X
the	B-X
submicrometer-sized	B-X
colloidal	B-X
motors	B-X
during	B-X
chemotaxis	B-X
is	B-X
discussed	B-X
,	B-X
and	B-X
also	B-X
their	B-X
underlying	B-X
mechanism	B-X
is	B-X
proposed	B-X
.	B-X

One	O
mutant	O
had	O
an	O
insertion	O
in	O
a	O
cheB	O
gene	O
homologue	O
,	O
encoding	O
a	O
methylesterase	O
involved	O
in	O
chemotaxis	O
(	O
CheB2	O
)	O
.	O

The	O
cheB2	O
mutant	O
was	O
tested	O
in	O
a	O
murine	B-Organism
lung	O
infection	O
model	O
and	O
found	O
to	O
have	O
a	O
highly	O
attenuated	O
virulence	O
.	O

The	O
cheB2	O
gene	O
is	O
part	O
of	O
the	O
chemotactic	O
gene	O
cluster	O
II	O
,	O
which	O
was	O
shown	O
to	O
be	O
required	O
for	O
an	O
optimal	O
mobility	O
in	O
vitro	O
.	O
<EOS>	B-X
Caenorhabditis	B-X
elegans	B-X
is	B-X
a	B-X
simple	B-X
model	B-X
with	B-X
which	B-X
one	B-X
can	B-X
identify	B-X
bacterial	B-X
virulence	B-X
genes	B-X
.	B-X
Previous	B-X
studies	B-X
with	B-X
C.	B-X
elegans	B-X
have	B-X
shown	B-X
that	B-X
depending	B-X
on	B-X
the	B-X
growth	B-X
medium	B-X
,	B-X
P.	B-X
aeruginosa	B-X
provokes	B-X
different	B-X
pathologies	B-X
:	B-X
slow	B-X
or	B-X
fast	B-X
killing	B-X
,	B-X
lethal	B-X
paralysis	B-X
and	B-X
red	B-X
death	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
high-throughput	B-X
semi-automated	B-X
liquid-based	B-X
assay	B-X
such	B-X
that	B-X
an	B-X
entire	B-X
genome	B-X
can	B-X
readily	B-X
be	B-X
scanned	B-X
for	B-X
virulence	B-X
genes	B-X
in	B-X
a	B-X
short	B-X
time	B-X
period	B-X
.	B-X
We	B-X
screened	B-X
a	B-X
2,200-member	B-X
STM	B-X
mutant	B-X
library	B-X
generated	B-X
in	B-X
a	B-X
cystic	B-X
fibrosis	B-X
airway	B-X
P.	B-X
aeruginosa	B-X
isolate	B-X
,	B-X
TBCF10839	B-X
.	B-X
The	B-X
selected	B-X
mutants	B-X
had	B-X
insertions	B-X
in	B-X
regulatory	B-X
genes	B-X
,	B-X
such	B-X
as	B-X
a	B-X
histidine	B-X
kinase	B-X
sensor	B-X
of	B-X
two-component	B-X
systems	B-X
and	B-X
a	B-X
member	B-X
of	B-X
the	B-X
AraC	B-X
family	B-X
,	B-X
or	B-X
in	B-X
genes	B-X
involved	B-X
in	B-X
adherence	B-X
or	B-X
chemotaxis	B-X
.	B-X
One	B-X
mutant	B-X
had	B-X
an	B-X
insertion	B-X
in	B-X
a	B-X
cheB	B-X
gene	B-X
homologue	B-X
,	B-X
encoding	B-X
a	B-X
methylesterase	B-X
involved	B-X
in	B-X
chemotaxis	B-X
(	B-X
CheB2	B-X
)	B-X
.	B-X
The	B-X
cheB2	B-X
mutant	B-X
was	B-X
tested	B-X
in	B-X
a	B-X
murine	B-X
lung	B-X
infection	B-X
model	B-X
and	B-X
found	B-X
to	B-X
have	B-X
a	B-X
highly	B-X
attenuated	B-X
virulence	B-X
.	B-X
The	B-X
cheB2	B-X
gene	B-X
is	B-X
part	B-X
of	B-X
the	B-X
chemotactic	B-X
gene	B-X
cluster	B-X
II	B-X
,	B-X
which	B-X
was	B-X
shown	B-X
to	B-X
be	B-X
required	B-X
for	B-X
an	B-X
optimal	B-X
mobility	B-X
in	B-X
vitro	B-X
.	B-X
In	B-X
P.	B-X
aeruginosa	B-X
,	B-X
the	B-X
main	B-X
player	B-X
in	B-X
chemotaxis	B-X
and	B-X
mobility	B-X
is	B-X
the	B-X
chemotactic	B-X
gene	B-X
cluster	B-X
I	B-X
,	B-X
including	B-X
cheB1	B-X
.	B-X
We	B-X
show	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
the	B-X
cheB2	B-X
mutant	B-X
,	B-X
a	B-X
cheB1	B-X
mutant	B-X
is	B-X
not	B-X
attenuated	B-X
for	B-X
virulence	B-X
in	B-X
C.	B-X
elegans	B-X
whereas	B-X
in	B-X
vitro	B-X
motility	B-X
and	B-X
chemotaxis	B-X
are	B-X
severely	B-X
impaired	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
the	B-X
virulence	B-X
defect	B-X
of	B-X
the	B-X
cheB2	B-X
mutant	B-X
is	B-X
not	B-X
linked	B-X
with	B-X
a	B-X
global	B-X
motility	B-X
defect	B-X
but	B-X
that	B-X
instead	B-X
the	B-X
cheB2	B-X
gene	B-X
is	B-X
involved	B-X
in	B-X
a	B-X
specific	B-X
chemotactic	B-X
response	B-X
,	B-X
which	B-X
takes	B-X
place	B-X
during	B-X
infection	B-X
and	B-X
is	B-X
required	B-X
for	B-X
P.	B-X
aeruginosa	B-X
pathogenicity	B-X
.	B-X

In	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
,	O
the	O
main	O
player	O
in	O
chemotaxis	O
and	O
mobility	O
is	O
the	O
chemotactic	O
gene	O
cluster	O
I	O
,	O
including	O
cheB1	O
.	O

We	O
show	O
that	O
,	O
in	O
contrast	O
to	O
the	O
cheB2	O
mutant	O
,	O
a	O
cheB1	O
mutant	O
is	O
not	O
attenuated	O
for	O
virulence	O
in	O
C	B-Organism
.	I-Organism
elegans	I-Organism
whereas	O
in	O
vitro	O
motility	O
and	O
chemotaxis	O
are	O
severely	O
impaired	O
.	O

We	O
conclude	O
that	O
the	O
virulence	O
defect	O
of	O
the	O
cheB2	O
mutant	O
is	O
not	O
linked	O
with	O
a	O
global	O
motility	O
defect	O
but	O
that	O
instead	O
the	O
cheB2	O
gene	O
is	O
involved	O
in	O
a	O
specific	O
chemotactic	O
response	O
,	O
which	O
takes	O
place	O
during	O
infection	O
and	O
is	O
required	O
for	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
pathogenicity	O
.	O
<EOS>	B-X
Pseudomonas	B-X
aeruginosa	B-X
is	B-X
an	B-X
opportunistic	B-X
human	B-X
pathogen	B-X
that	B-X
causes	B-X
infections	B-X
in	B-X
a	B-X
variety	B-X
of	B-X
animal	B-X
and	B-X
plant	B-X
hosts	B-X
.	B-X
Caenorhabditis	B-X
elegans	B-X
is	B-X
a	B-X
simple	B-X
model	B-X
with	B-X
which	B-X
one	B-X
can	B-X
identify	B-X
bacterial	B-X
virulence	B-X
genes	B-X
.	B-X
Previous	B-X
studies	B-X
with	B-X
C.	B-X
elegans	B-X
have	B-X
shown	B-X
that	B-X
depending	B-X
on	B-X
the	B-X
growth	B-X
medium	B-X
,	B-X
P.	B-X
aeruginosa	B-X
provokes	B-X
different	B-X
pathologies	B-X
:	B-X
slow	B-X
or	B-X
fast	B-X
killing	B-X
,	B-X
lethal	B-X
paralysis	B-X
and	B-X
red	B-X
death	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
high-throughput	B-X
semi-automated	B-X
liquid-based	B-X
assay	B-X
such	B-X
that	B-X
an	B-X
entire	B-X
genome	B-X
can	B-X
readily	B-X
be	B-X
scanned	B-X
for	B-X
virulence	B-X
genes	B-X
in	B-X
a	B-X
short	B-X
time	B-X
period	B-X
.	B-X
We	B-X
screened	B-X
a	B-X
2,200-member	B-X
STM	B-X
mutant	B-X
library	B-X
generated	B-X
in	B-X
a	B-X
cystic	B-X
fibrosis	B-X
airway	B-X
P.	B-X
aeruginosa	B-X
isolate	B-X
,	B-X
TBCF10839	B-X
.	B-X
Twelve	B-X
mutants	B-X
were	B-X
isolated	B-X
each	B-X
showing	B-X
at	B-X
least	B-X
70	B-X
%	B-X
attenuation	B-X
in	B-X
C.	B-X
elegans	B-X
killing	B-X
.	B-X
The	B-X
selected	B-X
mutants	B-X
had	B-X
insertions	B-X
in	B-X
regulatory	B-X
genes	B-X
,	B-X
such	B-X
as	B-X
a	B-X
histidine	B-X
kinase	B-X
sensor	B-X
of	B-X
two-component	B-X
systems	B-X
and	B-X
a	B-X
member	B-X
of	B-X
the	B-X
AraC	B-X
family	B-X
,	B-X
or	B-X
in	B-X
genes	B-X
involved	B-X
in	B-X
adherence	B-X
or	B-X
chemotaxis	B-X
.	B-X
One	B-X
mutant	B-X
had	B-X
an	B-X
insertion	B-X
in	B-X
a	B-X
cheB	B-X
gene	B-X
homologue	B-X
,	B-X
encoding	B-X
a	B-X
methylesterase	B-X
involved	B-X
in	B-X
chemotaxis	B-X
(	B-X
CheB2	B-X
)	B-X
.	B-X
The	B-X
cheB2	B-X
mutant	B-X
was	B-X
tested	B-X
in	B-X
a	B-X
murine	B-X
lung	B-X
infection	B-X
model	B-X
and	B-X
found	B-X
to	B-X
have	B-X
a	B-X
highly	B-X
attenuated	B-X
virulence	B-X
.	B-X
The	B-X
cheB2	B-X
gene	B-X
is	B-X
part	B-X
of	B-X
the	B-X
chemotactic	B-X
gene	B-X
cluster	B-X
II	B-X
,	B-X
which	B-X
was	B-X
shown	B-X
to	B-X
be	B-X
required	B-X
for	B-X
an	B-X
optimal	B-X
mobility	B-X
in	B-X
vitro	B-X
.	B-X
In	B-X
P.	B-X
aeruginosa	B-X
,	B-X
the	B-X
main	B-X
player	B-X
in	B-X
chemotaxis	B-X
and	B-X
mobility	B-X
is	B-X
the	B-X
chemotactic	B-X
gene	B-X
cluster	B-X
I	B-X
,	B-X
including	B-X
cheB1	B-X
.	B-X
We	B-X
show	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
the	B-X
cheB2	B-X
mutant	B-X
,	B-X
a	B-X
cheB1	B-X
mutant	B-X
is	B-X
not	B-X
attenuated	B-X
for	B-X
virulence	B-X
in	B-X
C.	B-X
elegans	B-X
whereas	B-X
in	B-X
vitro	B-X
motility	B-X
and	B-X
chemotaxis	B-X
are	B-X
severely	B-X
impaired	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
the	B-X
virulence	B-X
defect	B-X
of	B-X
the	B-X
cheB2	B-X
mutant	B-X
is	B-X
not	B-X
linked	B-X
with	B-X
a	B-X
global	B-X
motility	B-X
defect	B-X
but	B-X
that	B-X
instead	B-X
the	B-X
cheB2	B-X
gene	B-X
is	B-X
involved	B-X
in	B-X
a	B-X
specific	B-X
chemotactic	B-X
response	B-X
,	B-X
which	B-X
takes	B-X
place	B-X
during	B-X
infection	B-X
and	B-X
is	B-X
required	B-X
for	B-X
P.	B-X
aeruginosa	B-X
pathogenicity	B-X
.	B-X

Introduction	O

The	O
ubiquitous	O
Gram	O
-	O
negative	O
bacterium	O
Pseudomonas	B-Organism
aeruginosa	I-Organism
is	O
an	O
opportunistic	O
pathogen	O
able	O
to	O
infect	O
a	O
broad	O
range	O
of	O
animals	O
and	O
plants	O
hosts	O
including	O
humans	B-Organism
.	O

In	O
the	O
course	O
of	O
infection	O
,	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
adapts	O
to	O
changing	O
environmental	O
conditions	O
and	O
coordinates	O
the	O
production	O
of	O
molecular	O
determinants	O
involved	O
in	O
host	O
colonization	O
and	O
virulence	O
[	O
1	O
]	O
.	O

Among	O
these	O
are	O
pili	O
and	O
flagella	O
,	O
which	O
are	O
required	O
for	O
attachment	O
and	O
spreading	O
on	O
surfaces	O
[	O
2	O
]	O
,	O
[	O
3	O
]	O
.	O
<EOS>	B-X
Swarming	B-X
motility	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
bacterium	B-X
's	B-X
spread	B-X
to	B-X
new	B-X
environments	B-X
,	B-X
attachment	B-X
to	B-X
surfaces	B-X
,	B-X
and	B-X
biofilm	B-X
formation	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
tested	B-X
the	B-X
effect	B-X
of	B-X
a	B-X
2-alkyl-4	B-X
(	B-X
1H	B-X
)	B-X
-quinolone	B-X
(	B-X
AHQ	B-X
)	B-X
signal	B-X
,	B-X
the	B-X
Pseudomonas	B-X
quinolone	B-X
signal	B-X
(	B-X
PQS	B-X
)	B-X
on	B-X
P.	B-X
aeruginosa	B-X
swarming	B-X
and	B-X
biofilm	B-X
formation	B-X
.	B-X
Such	B-X
repression	B-X
was	B-X
independent	B-X
of	B-X
its	B-X
cognate	B-X
receptor	B-X
PqsR	B-X
and	B-X
was	B-X
not	B-X
related	B-X
to	B-X
changes	B-X
in	B-X
the	B-X
flagellae	B-X
,	B-X
type	B-X
IV	B-X
pili	B-X
or	B-X
the	B-X
production	B-X
of	B-X
the	B-X
surface-wetting	B-X
agent	B-X
rhamnolipid	B-X
surfactant	B-X
.	B-X
While	B-X
PQS	B-X
did	B-X
not	B-X
affect	B-X
twitching	B-X
motility	B-X
in	B-X
PAO1	B-X
,	B-X
a	B-X
pqsR	B-X
deletion	B-X
abolished	B-X
twitching	B-X
motility	B-X
,	B-X
indicating	B-X
that	B-X
pqsR	B-X
is	B-X
required	B-X
for	B-X
twitching	B-X
motility	B-X
.	B-X

Also	O
necessary	O
are	O
protein	O
secretion	O
systems	O
[	O
4	O
]	O
and	O
toxins	O
required	O
for	O
cytotoxicity	O
and	O
survival	O
within	O
the	O
host	O
.	O
<EOS>	B-X
The	B-X
type	B-X
III	B-X
secretion	B-X
system	B-X
(	B-X
T3SS	B-X
)	B-X
is	B-X
a	B-X
highly	B-X
conserved	B-X
protein	B-X
delivery	B-X
system	B-X
found	B-X
in	B-X
multiple	B-X
Gram-negative	B-X
pathogens	B-X
,	B-X
including	B-X
Yersinia	B-X
pseudotuberculosis	B-X
.	B-X
Most	B-X
studies	B-X
of	B-X
Yersinia	B-X
species	B-X
type	B-X
III	B-X
intoxication	B-X
of	B-X
host	B-X
cells	B-X
have	B-X
focused	B-X
on	B-X
the	B-X
bacterial	B-X
determinants	B-X
that	B-X
promote	B-X
assembly	B-X
and	B-X
function	B-X
of	B-X
the	B-X
secretion	B-X
system	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
performed	B-X
a	B-X
pooled	B-X
RNA	B-X
interference	B-X
(	B-X
RNAi	B-X
)	B-X
screen	B-X
to	B-X
identify	B-X
mammalian	B-X
host	B-X
proteins	B-X
required	B-X
for	B-X
the	B-X
cytotoxic	B-X
effects	B-X
associated	B-X
with	B-X
the	B-X
Yersinia	B-X
translocated	B-X
substrate	B-X
YopE	B-X
,	B-X
a	B-X
GTPase-activating	B-X
protein	B-X
(	B-X
GAP	B-X
)	B-X
that	B-X
inactivates	B-X
the	B-X
small	B-X
Rho	B-X
GTPases	B-X
.	B-X
Depletion	B-X
of	B-X
CCR5	B-X
in	B-X
293T	B-X
cells	B-X
yielded	B-X
a	B-X
defect	B-X
in	B-X
YopB/D	B-X
pore	B-X
formation	B-X
and	B-X
effector	B-X
translocation	B-X
,	B-X
while	B-X
both	B-X
phenotypes	B-X
could	B-X
be	B-X
complemented	B-X
by	B-X
overexpression	B-X
of	B-X
CCR5	B-X
protein	B-X
.	B-X
We	B-X
postulate	B-X
that	B-X
CCR5	B-X
acts	B-X
to	B-X
promote	B-X
translocation	B-X
by	B-X
modulating	B-X
cytoskeletal	B-X
activities	B-X
necessary	B-X
for	B-X
proper	B-X
assembly	B-X
of	B-X
the	B-X
YopB/D	B-X
translocation	B-X
pore	B-X
.	B-X
Overall	B-X
,	B-X
this	B-X
study	B-X
presents	B-X
a	B-X
new	B-X
approach	B-X
to	B-X
investigating	B-X
the	B-X
contribution	B-X
of	B-X
the	B-X
host	B-X
cell	B-X
to	B-X
T3SS	B-X
in	B-X
Y.	B-X
pseudotuberculosis	B-X
.	B-X

One	O
powerful	O
approach	O
to	O
dissect	O
the	O
interaction	O
between	O
pathogen	O
and	O
host	O
is	O
the	O
use	O
of	O
simple	O
infection	O
models	O
.	O

It	O
has	O
been	O
demonstrated	O
that	O
the	O
nematode	O
Caenorhabditis	B-Organism
elegans	I-Organism
can	O
be	O
an	O
effective	O
model	O
for	O
studying	O
virulence	O
mechanisms	O
used	O
by	O
a	O
variety	O
of	O
bacterial	O
pathogens	O
[	O
5	O
]	O
,	O
[	O
6	O
]	O
.	O

P	B-Organism
.	I-Organism
aeruginosa	I-Organism
is	O
capable	O
of	O
killing	O
C	B-Organism
.	I-Organism
elegans	I-Organism
in	O
several	O
distinct	O
ways	O
.	O

When	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
strain	I-Organism
PA14	I-Organism
is	O
cultured	O
on	O
a	O
high	O
-	O
osmolarity	O
peptone	O
-	O
glucose	O
-	O
sorbitol	O
medium	O
(	O
PGS	O
)	O
,	O
worms	O
succumb	O
to	O
intoxication	O
termed	O
"	O
fast	O
killing	O
"	O
,	O
as	O
the	O
exposed	O
worms	O
die	O
within	O
hours	O
[	O
7	O
]	O
.	O

Nematodes	O
exposed	O
to	O
PA14	B-Organism
grown	O
on	O
nematode	O
growth	O
media	O
(	O
NGM	O
)	O
,	O
succumb	O
to	O
"	O
slow	O
killing	O
"	O
.	O

In	O
this	O
case	O
the	O
bacteria	O
colonize	O
the	O
gut	O
and	O
the	O
infected	O
worms	O
die	O
over	O
a	O
number	O
of	O
days	O
rather	O
than	O
hours	O
[	O
8	O
]	O
.	O

The	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
isolate	I-Organism
PAO1	I-Organism
cultured	O
on	O
Brain	O
Heart	O
Infusion	O
(	O
BHI	O
)	O
agar	O
induces	O
worm	O
paralysis	O
and	O
death	O
within	O
hours	O
[	O
9	O
]	O
.	O

Finally	O
,	O
C	B-Organism
.	I-Organism
elegans	I-Organism
death	O
,	O
called	O
red	O
death	O
,	O
is	O
observed	O
in	O
response	O
to	O
PAO1	B-Organism
grown	O
on	O
phosphate	O
-	O
depleted	O
medium	O
in	O
conjunction	O
with	O
physiological	O
stress	O
on	O
the	O
nematodes	O
[	O
10	O
]	O
.	O

It	O
is	O
known	O
that	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
isolates	I-Organism
PA14	I-Organism
and	O
PAO1	B-Organism
show	O
genomic	O
diversity	O
.	O

Strains	O
cultured	O
in	O
vitro	O
for	O
years	O
are	O
known	O
to	O
undergo	O
changes	O
in	O
gene	O
expression	O
.	O

Individual	O
genes	O
and	O
even	O
entire	O
genomic	O
islands	O
have	O
been	O
lost	O
from	O
laboratory	O
isolates	O
when	O
compared	O
to	O
pathogenic	O
strains	O
[	O
11	O
]	O
,	O
[	O
12	O
]	O
,	O
[	O
13	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
used	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
strain	I-Organism
TBCF10839	I-Organism
(	O
TB	B-Organism
)	O
,	O
which	O
was	O
isolated	O
from	O
a	O
Cystic	O
Fibrosis	O
(	O
CF	O
)	O
patient	B-Organism
[	O
14	O
]	O
.	O

The	O
TB	B-Organism
strain	O
belongs	O
to	O
an	O
abundant	O
clonal	O
complex	O
in	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
population	O
[	O
15	O
]	O
.	O

It	O
has	O
a	O
high	O
resistance	O
to	O
detergents	O
[	O
16	O
]	O
and	O
reactive	O
oxygen	O
intermediates	O
[	O
17	O
]	O
and	O
is	O
able	O
to	O
grow	O
within	O
polymorphonuclear	O
leukocytes	O
[	O
18	O
]	O
.	O

We	O
developed	O
a	O
high	O
-	O
throughput	O
killing	O
assay	O
using	O
C	B-Organism
.	I-Organism
elegans	I-Organism
as	O
a	O
host	O
,	O
which	O
will	O
be	O
appropriate	O
for	O
a	O
systematic	O
screen	O
of	O
mutant	O
libraries	O
of	O
any	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
isolate	O
of	O
interest	O
.	O

Increasing	O
throughput	O
in	O
an	O
assay	O
such	O
that	O
an	O
entire	O
genome	O
can	O
readily	O
be	O
scanned	O
in	O
a	O
short	O
time	O
period	O
is	O
an	O
important	O
advance	O
.	O

Our	O
protocol	O
is	O
based	O
on	O
a	O
standard	O
killing	O
assay	O
and	O
makes	O
use	O
of	O
a	O
Biosorter	O
to	O
distribute	O
nematodes	O
into	O
the	O
wells	O
of	O
microtitre	O
plates	O
in	O
a	O
fully	O
automated	O
manner	O
.	O

We	O
screened	O
a	O
TB	B-Organism
STM	I-Organism
(	I-Organism
signature	I-Organism
tagged	I-Organism
mutagenesis	I-Organism
)	I-Organism
mutant	I-Organism
library	O
of	O
2	O
,	O
200	O
non	O
-	O
redundant	O
clones	O
[	O
19	O
]	O
,	O
[	O
20	O
]	O
and	O
selected	O
a	O
small	O
group	O
of	O
mutants	O
,	O
significantly	O
attenuated	O
for	O
virulence	O
in	O
C	B-Organism
.	I-Organism
elegans	I-Organism
.	O

By	O
testing	O
these	O
mutants	O
in	O
additional	O
phenotypic	O
assays	O
,	O
including	O
adherence	O
to	O
epithelial	O
cells	O
and	O
virulence	O
in	O
a	O
mouse	B-Organism
model	O
,	O
we	O
identified	O
a	O
gene	O
,	O
cheB2	O
,	O
necessary	O
for	O
in	O
vivo	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
virulence	O
.	O

The	O
cheB2	O
gene	O
belongs	O
to	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
chemotaxis	O
che2	O
gene	O
cluster	O
(	O
cluster	O
II	O
,	O
PA0180	O
-	O
PA0173	O
)	O
(	O
Figure	O
1	O
)	O
[	O
21	O
]	O
.	O

P	B-Organism
.	I-Organism
aeruginosa	I-Organism
has	O
multiple	O
copies	O
of	O
chemotaxis	O
genes	O
arranged	O
in	O
five	O
clusters	O
(	O
Figure	O
1	O
)	O
[	O
22	O
]	O
.	O

The	O
chemotaxis	O
gene	O
cluster	O
I	O
(	O
PA1456	O
-	O
PA1464	O
)	O
and	O
cluster	O
V	O
(	O
PA3349	O
-	O
PA3348	O
)	O
have	O
previously	O
been	O
shown	O
to	O
be	O
essential	O
for	O
chemotaxis	O
and	O
flagellar	O
mobility	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
[	O
23	O
]	O
,	O
[	O
24	O
]	O
.	O

The	O
wsp	O
genes	O
contained	O
in	O
cluster	O
III	O
(	O
PA3708	O
-	O
PA3702	O
)	O
have	O
been	O
proposed	O
to	O
contribute	O
to	O
bacterial	O
biofilm	O
formation	O
[	O
25	O
]	O
,	O
whereas	O
the	O
cluster	O
IV	O
(	O
Pil	O
-	O
Chp	O
system	O
,	O
PA0408	O
-	O
PA0417	O
)	O
has	O
been	O
shown	O
to	O
be	O
involved	O
in	O
twitching	O
motility	O
[	O
26	O
]	O
,	O
[	O
27	O
]	O
.	O

The	O
che2	O
genes	O
from	O
cluster	O
II	O
,	O
and	O
more	O
particularly	O
the	O
cheB2	O
gene	O
,	O
were	O
initially	O
identified	O
as	O
required	O
for	O
an	O
optimal	O
chemotactic	O
response	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
.	O

The	O
CheB	O
proteins	O
are	O
essential	O
components	O
of	O
the	O
chemotactic	O
response	O
and	O
are	O
responsible	O
for	O
demethylation	O
of	O
glutamate	O
residues	O
in	O
methyl	O
-	O
accepting	O
chemotaxis	O
proteins	O
(	O
MCPs	O
)	O
and	O
also	O
deamidation	O
of	O
glutamine	O
residues	O
to	O
form	O
methyl	O
-	O
accepting	O
glutamates	O
[	O
28	O
]	O
.	O

MCPs	O
sense	O
the	O
chemical	O
stimuli	O
that	O
initiate	O
the	O
chemotactic	O
activity	O
[	O
29	O
]	O
.	O

In	O
Escherichia	B-Organism
coli	I-Organism
,	O
the	O
loss	O
of	O
CheB	O
leads	O
decreased	O
receptor	O
sensitivity	O
,	O
due	O
to	O
an	O
inability	O
to	O
reset	O
the	O
MCP	O
'	O
s	O
[	O
30	O
]	O
.	O

This	O
modification	O
leaves	O
the	O
chemotactic	O
pathway	O
in	O
active	O
states	O
causing	O
clockwise	O
rotation	O
of	O
the	O
flagella	O
and	O
continuous	O
tumbling	O
instead	O
of	O
runs	O
and	O
tumbles	O
.	O

It	O
has	O
been	O
reported	O
previously	O
in	O
Salmonella	B-Organism
typhimurium	I-Organism
that	O
a	O
loss	O
of	O
proper	O
chemotaxis	O
control	O
through	O
a	O
cheB	O
mutation	O
,	O
leads	O
to	O
a	O
'	O
tumbly	O
'	O
swimming	O
phenotype	O
and	O
a	O
strong	O
reduction	O
in	O
the	O
isolates	O
ability	O
to	O
invade	O
human	B-Organism
epithelial	O
HEP2	O
cells	O
as	O
well	O
as	O
a	O
reduction	O
in	O
infectivity	O
in	O
a	O
mouse	B-Organism
ligated	O
-	O
loop	O
model	O
[	O
31	O
]	O
.	O

In	O
our	O
study	O
we	O
further	O
compare	O
the	O
phenotypes	O
of	O
cheB2	O
and	O
cheB1	O
mutants	O
and	O
propose	O
that	O
the	O
cheB2	O
gene	O
has	O
a	O
specific	O
role	O
during	O
infection	O
,	O
which	O
is	O
essential	O
for	O
pathogenesis	O
.	O

Results	O

High	O
Throughput	O
Assay	O
for	O
Nematode	O
Killing	O
by	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
It	O
was	O
reported	O
earlier	O
that	O
relatively	O
high	O
-	O
throughput	O
screening	O
procedures	O
performed	O
on	O
plates	O
could	O
be	O
used	O
to	O
identify	O
virulence	O
factors	O
in	O
various	O
pathogens	O
such	O
as	O
Staphylococcus	B-Organism
aureus	I-Organism
[	O
32	O
]	O
,	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
[	O
8	O
]	O
or	O
Serratia	B-Organism
marcescens	I-Organism
[	O
33	O
]	O
.	O
<EOS>	B-X
Serratia	B-X
marcescens	B-X
infections	B-X
.	B-X
Serratia	B-X
marcescens	B-X
is	B-X
a	B-X
gram-negative	B-X
,	B-X
facultatively-anaerobic	B-X
bacterium	B-X
and	B-X
opportunistic	B-X
pathogen	B-X
which	B-X
produces	B-X
the	B-X
red	B-X
pigment	B-X
prodigiosin	B-X
.	B-X
Pigmentation	B-X
correlated	B-X
with	B-X
an	B-X
increased	B-X
rate	B-X
of	B-X
ATP	B-X
production	B-X
during	B-X
population	B-X
lag	B-X
phase	B-X
.	B-X
Results	B-X
with	B-X
a	B-X
lacZ	B-X
transcriptional	B-X
fusion	B-X
to	B-X
the	B-X
prodigiosin	B-X
(	B-X
pig	B-X
)	B-X
biosynthetic	B-X
operon	B-X
revealed	B-X
that	B-X
operon	B-X
transcription	B-X
is	B-X
activated	B-X
by	B-X
low	B-X
cellular	B-X
levels	B-X
of	B-X
ATP	B-X
at	B-X
high	B-X
cell	B-X
density	B-X
.	B-X
Furthermore	B-X
,	B-X
these	B-X
data	B-X
enabled	B-X
estimation	B-X
of	B-X
the	B-X
ATP	B-X
per	B-X
cell	B-X
minimum	B-X
value	B-X
at	B-X
which	B-X
the	B-X
operon	B-X
is	B-X
induced	B-X
.	B-X
Pigmented	B-X
cells	B-X
were	B-X
found	B-X
to	B-X
accumulate	B-X
ATP	B-X
more	B-X
rapidly	B-X
and	B-X
to	B-X
multiply	B-X
more	B-X
quickly	B-X
than	B-X
non-pigmented	B-X
cells	B-X
during	B-X
the	B-X
high	B-X
density	B-X
growth	B-X
phase	B-X
.	B-X
Finally	B-X
,	B-X
results	B-X
with	B-X
both	B-X
batch	B-X
and	B-X
chemostat	B-X
culture	B-X
revealed	B-X
that	B-X
pigmented	B-X
cells	B-X
grow	B-X
to	B-X
approximately	B-X
twice	B-X
the	B-X
biomass	B-X
yield	B-X
as	B-X
non-pigmented	B-X
S.	B-X
marcescens	B-X
bacteria	B-X
.	B-X
Prodigiosin	B-X
production	B-X
may	B-X
,	B-X
therefore	B-X
,	B-X
provide	B-X
a	B-X
growth	B-X
advantage	B-X
at	B-X
ambient	B-X
temperatures	B-X
.	B-X

Here	O
,	O
we	O
developed	O
a	O
high	O
throughput	O
screening	O
method	O
,	O
in	O
which	O
C	B-Organism
.	I-Organism
elegans	I-Organism
killing	O
is	O
assessed	O
in	O
a	O
liquid	O
assay	O
and	O
which	O
allows	O
a	O
quick	O
selection	O
of	O
attenuated	O
candidates	O
within	O
large	O
transposon	O
libraries	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
.	O

We	O
prepared	O
a	O
bacterial	O
culture	O
medium	O
that	O
both	O
allowed	O
the	O
worms	O
to	O
thrive	O
feeding	O
on	O
the	O
non	O
-	O
pathogenic	O
E	B-Organism
.	I-Organism
coli	I-Organism
OP50	I-Organism
,	O
and	O
bacterial	O
isolates	O
being	O
tested	O
to	O
have	O
normal	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

We	O
filled	O
96	O
well	O
plates	O
with	O
the	O
medium	O
and	O
inoculated	O
the	O
bacterial	O
strains	O
to	O
be	O
tested	O
.	O

The	O
virulence	O
of	O
each	O
isolate	O
was	O
assessed	O
in	O
a	O
second	O
microtitre	O
plate	O
,	O
into	O
which	O
a	O
specific	O
population	O
of	O
nematodes	O
had	O
been	O
deposited	O
.	O

Evaluation	O
of	O
virulence	O
was	O
based	O
upon	O
the	O
number	O
of	O
live	O
worms	O
recovered	O
after	O
24	O
h	O
exposure	O
to	O
bacteria	O
.	O

Under	O
our	O
assay	O
conditions	O
,	O
more	O
than	O
90	O
%	O
of	O
the	O
worms	O
grown	O
on	O
E	B-Organism
.	I-Organism
coli	I-Organism
were	O
still	O
alive	O
after	O
24	O
h	O
.	O

In	O
contrast	O
,	O
more	O
than	O
50	O
%	O
of	O
the	O
worms	O
were	O
killed	O
within	O
24	O
h	O
when	O
cultured	O
with	O
any	O
one	O
of	O
three	O
isolates	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
,	O
PA14	B-Organism
,	O
PAO1	B-Organism
and	O
TB	B-Organism
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
order	O
to	O
confirm	O
that	O
this	O
assay	O
would	O
allow	O
the	O
recovery	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
mutants	O
with	O
an	O
attenuated	O
virulence	O
,	O
we	O
tested	O
previously	O
characterized	O
mutants	O
.	O

We	O
used	O
a	O
gacA	O
mutant	O
from	O
the	O
PA14	B-Organism
transposon	O
library	O
(	O
http	O
:	O
/	O
/	O
ausubellab	O
.	O
mgh	O
.	O
harvard	O
.	O
edu	O
/	O
cgi	O
-	O
bin	O
/	O
pa14	O
/	O
home	O
.	O
cgi	O
)	O
[	O
34	O
]	O
,	O
which	O
is	O
affected	O
in	O
a	O
gene	O
encoding	O
a	O
response	O
regulator	O
involved	O
in	O
virulence	O
[	O
8	O
]	O
.	O

C	B-Organism
.	I-Organism
elegans	I-Organism
infection	O
using	O
this	O
mutant	O
in	O
the	O
liquid	O
assay	O
resulted	O
in	O
only	O
40	O
%	O
killing	O
at	O
24	O
h	O
,	O
whereas	O
95	O
%	O
killing	O
was	O
observed	O
with	O
the	O
parental	O
PA14	B-Organism
strain	O
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
order	O
to	O
screen	O
a	O
large	O
number	O
of	O
bacterial	O
isolates	O
more	O
rapidly	O
,	O
the	O
assay	O
was	O
automated	O
using	O
the	O
COPAS	O
(	O
Complex	O
Object	O
Parametric	O
Analyzer	O
and	O
Sorter	O
)	O
Biosort	O
system	O
(	O
Union	O
Biometrica	O
)	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
unionbio	O
.	O
com	O
/	O
)	O
.	O

The	O
sorter	O
is	O
able	O
to	O
dispatch	O
systematically	O
a	O
fixed	O
number	O
of	O
worms	O
of	O
a	O
precise	O
developmental	O
stage	O
,	O
into	O
each	O
well	O
of	O
a	O
microtitre	O
plate	O
.	O

Screening	O
the	O
TB	B-Organism
Transposon	O
Library	O
for	O
Mutants	O
Attenuated	O
in	O
Virulence	O

A	O
signature	O
tagged	O
mutagenesis	O
(	O
STM	O
)	O
library	O
was	O
previously	O
generated	O
in	O
the	O
virulent	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
CF	I-Organism
isolate	I-Organism
,	O
TB	B-Organism
,	O
using	O
the	O
plasposon	O
vector	O
pTnModOGm	O
[	O
20	O
]	O
,	O
[	O
35	O
]	O
.	O

Auxotrophic	O
mutants	O
were	O
removed	O
from	O
the	O
library	O
by	O
pre	O
-	O
screening	O
post	O
-	O
conjugation	O
TB	B-Organism
isolates	O
onto	O
minimal	O
media	O
and	O
selecting	O
only	O
clones	O
,	O
which	O
grew	O
normally	O
.	O

This	O
pre	O
-	O
screening	O
eliminated	O
clones	O
that	O
might	O
have	O
exhibited	O
attenuated	O
virulence	O
based	O
upon	O
reduced	O
growth	O
or	O
viability	O
,	O
rather	O
than	O
loss	O
of	O
a	O
specific	O
virulence	O
function	O
.	O
<EOS>	B-X
Pathogenic	B-X
fungi	B-X
require	B-X
optimum	B-X
V-ATPase	B-X
function	B-X
for	B-X
secretion	B-X
of	B-X
virulence	B-X
factors	B-X
,	B-X
induction	B-X
of	B-X
stress	B-X
response	B-X
pathways	B-X
,	B-X
hyphal	B-X
morphology	B-X
and	B-X
homeostasis	B-X
of	B-X
pH	B-X
and	B-X
other	B-X
cations	B-X
in	B-X
order	B-X
to	B-X
successfully	B-X
survive	B-X
within	B-X
and	B-X
colonize	B-X
the	B-X
host	B-X
.	B-X
This	B-X
review	B-X
discusses	B-X
why	B-X
impairment	B-X
of	B-X
V-ATPase	B-X
activity	B-X
confers	B-X
multidrug	B-X
sensitivity	B-X
and	B-X
loss	B-X
of	B-X
virulence	B-X
.	B-X
Depletion	B-X
of	B-X
ergosterol	B-X
from	B-X
vacuolar	B-X
membranes	B-X
led	B-X
to	B-X
progressive	B-X
alkalization	B-X
of	B-X
yeast	B-X
vacuoles	B-X
,	B-X
loss	B-X
of	B-X
V-ATPase	B-X
activity	B-X
and	B-X
growth	B-X
inhibition	B-X
that	B-X
could	B-X
be	B-X
rescued	B-X
by	B-X
exogenous	B-X
ergosterol	B-X
feeding	B-X
.	B-X
Other	B-X
studies	B-X
point	B-X
to	B-X
a	B-X
critical	B-X
role	B-X
for	B-X
sphingolipids	B-X
,	B-X
phospholipids	B-X
and	B-X
cardiolipin	B-X
in	B-X
V-ATPase	B-X
function	B-X
.	B-X
Thus	B-X
,	B-X
drugs	B-X
that	B-X
inhibit	B-X
the	B-X
V-ATPase	B-X
directly	B-X
,	B-X
or	B-X
indirectly	B-X
by	B-X
modulating	B-X
the	B-X
membrane	B-X
milieu	B-X
,	B-X
can	B-X
profoundly	B-X
affect	B-X
fungal	B-X
viability	B-X
and	B-X
virulence	B-X
.	B-X
These	B-X
findings	B-X
justify	B-X
a	B-X
systematic	B-X
screen	B-X
for	B-X
fungal	B-X
specific	B-X
V-ATPase	B-X
inhibitors	B-X
or	B-X
membrane	B-X
active	B-X
compounds	B-X
that	B-X
can	B-X
be	B-X
used	B-X
in	B-X
antifungal	B-X
chemotherapy	B-X
.	B-X

After	O
this	O
initial	O
segregation	O
,	O
2	O
,	O
200	O
clones	O
were	O
picked	O
into	O
a	O
96	O
-	O
well	O
plate	O
and	O
tested	O
with	O
the	O
C	B-Organism
.	I-Organism
elegans	I-Organism
high	O
throughput	O
-	O
killing	O
assay	O
.	O

Each	O
mutant	O
was	O
tested	O
at	O
least	O
four	O
times	O
using	O
this	O
assay	O
.	O
<EOS>	B-X
This	B-X
study	B-X
aimed	B-X
to	B-X
develop	B-X
a	B-X
rapid	B-X
and	B-X
accurate	B-X
ddPCR	B-X
assay	B-X
to	B-X
detect	B-X
FQ-resistant	B-X
C.	B-X
jejuni	B-X
mutants	B-X
based	B-X
on	B-X
the	B-X
crucial	B-X
resistance	B-X
mutation	B-X
C257T	B-X
(	B-X
Thr-86-Ile	B-X
)	B-X
in	B-X
The	B-X
emergence	B-X
of	B-X
Severe	B-X
Acute	B-X
Respiratory	B-X
Syndrome	B-X
Coronavirus	B-X
(	B-X
SARS-CoV-2	B-X
)	B-X
was	B-X
met	B-X
with	B-X
rapid	B-X
development	B-X
of	B-X
robust	B-X
molecular-based	B-X
detection	B-X
assays	B-X
.	B-X
Despite	B-X
the	B-X
relatively	B-X
moderate	B-X
mutational	B-X
rate	B-X
of	B-X
SARS-CoV-2	B-X
,	B-X
numerous	B-X
mutations	B-X
with	B-X
known	B-X
negative	B-X
impact	B-X
on	B-X
diagnostic	B-X
assays	B-X
have	B-X
been	B-X
identified	B-X
.	B-X
In	B-X
early	B-X
2021	B-X
,	B-X
we	B-X
identified	B-X
four	B-X
samples	B-X
positive	B-X
for	B-X
SARS-CoV-2	B-X
with	B-X
a	B-X
nucleocapsid	B-X
(	B-X
N	B-X
)	B-X
gene	B-X
drop	B-X
out	B-X
on	B-X
Cepheid	B-X
Xpert	B-X
Xpress	B-X
SARS-CoV-2	B-X
assay	B-X
.	B-X
Spatiotemporal	B-X
analysis	B-X
showed	B-X
that	B-X
the	B-X
mutation	B-X
was	B-X
found	B-X
in	B-X
at	B-X
least	B-X
six	B-X
different	B-X
Canadian	B-X
provinces	B-X
from	B-X
May	B-X
2020	B-X
until	B-X
May	B-X
2021	B-X
.	B-X
Phylogenetic	B-X
analysis	B-X
showed	B-X
that	B-X
this	B-X
mutation	B-X
arose	B-X
multiple	B-X
times	B-X
in	B-X
Canadian	B-X
samples	B-X
and	B-X
is	B-X
present	B-X
in	B-X
six	B-X
different	B-X
variants	B-X
of	B-X
interest	B-X
and	B-X
of	B-X
concern	B-X
.	B-X
While	B-X
commercial	B-X
SARS-CoV-2	B-X
molecular	B-X
detection	B-X
assays	B-X
have	B-X
contributed	B-X
immensely	B-X
to	B-X
the	B-X
response	B-X
effort	B-X
,	B-X
many	B-X
vendors	B-X
are	B-X
reluctant	B-X
to	B-X
make	B-X
primer/probe	B-X
sequences	B-X
publicly	B-X
available	B-X
.	B-X
We	B-X
hope	B-X
that	B-X
our	B-X
industry	B-X
partners	B-X
will	B-X
seriously	B-X
consider	B-X
making	B-X
primer/probe	B-X
sequences	B-X
available	B-X
,	B-X
so	B-X
that	B-X
diagnostic	B-X
escape	B-X
mutants	B-X
can	B-X
be	B-X
identified	B-X
promptly	B-X
and	B-X
responded	B-X
to	B-X
appropriately	B-X
to	B-X
maintain	B-X
diagnostic	B-X
accuracy	B-X
.	B-X

The	O
mutants	O
selected	O
were	O
segregated	O
into	O
three	O
groups	O
based	O
upon	O
their	O
level	O
of	O
virulence	O
attenuation	O
as	O
compared	O
to	O
the	O
TB	B-Organism
parental	O
strain	O
,	O
which	O
killed	O
85	O
%	O
of	O
worms	O
under	O
the	O
test	O
conditions	O
.	O

In	O
group	O
1	O
,	O
we	O
included	O
187	O
mutants	O
(	O
9	O
%	O
of	O
total	O
library	O
)	O
which	O
allowed	O
more	O
than	O
50	O
%	O
worm	O
survival	O
,	O
group	O
2	O
between	O
30	O
%	O
and	O
50	O
%	O
(	O
536	O
mutants	O
,	O
25	O
%	O
)	O
,	O
and	O
group	O
3	O
below	O
30	O
%	O
(	O
1450	O
mutants	O
,	O
65	O
%	O
)	O
,	O
approaching	O
the	O
same	O
level	O
of	O
killing	O
as	O
the	O
parental	O
isolate	O
.	O

Within	O
group	O
1	O
,	O
the	O
12	O
most	O
highly	O
attenuated	O
isolates	O
,	O
classified	O
as	O
group	O
1A	O
(	O
0	O
.	O
4	O
%	O
of	O
the	O
total	O
library	O
)	O
,	O
were	O
further	O
studied	O
.	O

When	O
cultured	O
in	O
the	O
presence	O
of	O
these	O
mutants	O
more	O
than	O
70	O
%	O
of	O
worms	O
survived	O
,	O
representing	O
a	O
near	O
5	O
-	O
fold	O
reduction	O
in	O
virulence	O
compared	O
to	O
TB	B-Organism
.	O

Characterization	O
of	O
Selected	O
Attenuated	O
Mutants	O
<EOS>	B-X
BI-3406	B-X
,	B-X
a	B-X
Potent	B-X
and	B-X
Selective	B-X
SOS1-KRAS	B-X
Interaction	B-X
Inhibitor	B-X
,	B-X
Is	B-X
Effective	B-X
in	B-X
KRAS-Driven	B-X
Cancers	B-X
through	B-X
Combined	B-X
MEK	B-X
Inhibition	B-X
.	B-X
Characterization	B-X
of	B-X
Cell	B-X
Envelope	B-X
Multiple	B-X
Mutants	B-X
of	B-X
Mutants	B-X
of	B-X
attenuated	B-X
Bacillus	B-X
anthracis	B-X
with	B-X
high-level	B-X
ciprofloxacin	B-X
resistance	B-X
were	B-X
isolated	B-X
using	B-X
a	B-X
three-step	B-X
in	B-X
vitro	B-X
selection	B-X
.	B-X
Mutants	B-X
for	B-X
which	B-X
MICs	B-X
were	B-X
64	B-X
microg/ml	B-X
had	B-X
one	B-X
of	B-X
two	B-X
additional	B-X
mutations	B-X
within	B-X
the	B-X
gyrA	B-X
QRDR	B-X
or	B-X
one	B-X
of	B-X
two	B-X
mutations	B-X
within	B-X
the	B-X
gyrB	B-X
QRDR	B-X
.	B-X
Mutants	B-X
for	B-X
which	B-X
MICs	B-X
were	B-X
32	B-X
microg/ml	B-X
had	B-X
no	B-X
additional	B-X
target	B-X
modifications	B-X
but	B-X
showed	B-X
evidence	B-X
of	B-X
enhanced	B-X
ciprofloxacin	B-X
efflux	B-X
.	B-X

Genomic	O
DNA	O
was	O
recovered	O
from	O
the	O
12	O
group	O
1A	O
isolates	O
.	O
<EOS>	B-X
In	B-X
order	B-X
to	B-X
contribute	B-X
to	B-X
the	B-X
knowledge	B-X
of	B-X
the	B-X
architecture	B-X
and	B-X
epidemiology	B-X
of	B-X
class	B-X
2	B-X
integrons	B-X
,	B-X
we	B-X
performed	B-X
a	B-X
class	B-X
2	B-X
integron	B-X
molecular	B-X
survey	B-X
in	B-X
which	B-X
we	B-X
analyzed	B-X
726	B-X
isolates	B-X
in	B-X
two	B-X
bacterial	B-X
populations	B-X
from	B-X
environmental	B-X
and	B-X
nonepidemiologically	B-X
related	B-X
clinical	B-X
samples	B-X
,	B-X
respectively	B-X
,	B-X
collected	B-X
from	B-X
1982	B-X
to	B-X
2007	B-X
.	B-X
We	B-X
recovered	B-X
the	B-X
intI2	B-X
gene	B-X
from	B-X
130	B-X
of	B-X
726	B-X
isolates	B-X
,	B-X
most	B-X
of	B-X
which	B-X
were	B-X
clinical	B-X
isolates	B-X
,	B-X
and	B-X
only	B-X
1	B-X
(	B-X
a	B-X
psychrophilic	B-X
Pseudomonas	B-X
sp	B-X
.	B-X
)	B-X
A	B-X
bioinformatic	B-X
analysis	B-X
performed	B-X
with	B-X
the	B-X
tns	B-X
genes	B-X
present	B-X
in	B-X
sequence	B-X
databases	B-X
,	B-X
the	B-X
finding	B-X
of	B-X
intI2	B-X
not	B-X
associated	B-X
with	B-X
tns	B-X
genes	B-X
,	B-X
and	B-X
the	B-X
genetic	B-X
examination	B-X
of	B-X
novel	B-X
tns-like	B-X
genes	B-X
found	B-X
in	B-X
three	B-X
isolates	B-X
indicated	B-X
the	B-X
possibility	B-X
of	B-X
the	B-X
independent	B-X
evolution	B-X
of	B-X
the	B-X
two	B-X
components	B-X
related	B-X
to	B-X
horizontal	B-X
gene	B-X
transfer	B-X
,	B-X
the	B-X
class	B-X
2	B-X
integrons	B-X
and	B-X
the	B-X
Tn7	B-X
transposons	B-X
.	B-X
Crenarchaeal	B-X
16S	B-X
rRNA	B-X
sequences	B-X
constituted	B-X
over	B-X
70	B-X
%	B-X
of	B-X
the	B-X
archaeal	B-X
clones	B-X
recovered	B-X
from	B-X
three	B-X
salt	B-X
marsh	B-X
sites	B-X
dominated	B-X
by	B-X
different	B-X
grasses	B-X
.	B-X
Group	B-X
I.1a	B-X
Crenarchaeota	B-X
dominated	B-X
at	B-X
two	B-X
sites	B-X
,	B-X
while	B-X
group	B-X
I.3b	B-X
Crenarchaeota	B-X
sequences	B-X
were	B-X
most	B-X
abundant	B-X
at	B-X
a	B-X
third	B-X
site	B-X
.	B-X

The	O
transposon	O
insertion	O
site	O
was	O
determined	O
through	O
direct	O
genomic	O
DNA	O
sequencing	O
,	O
using	O
primers	O
located	O
upstream	O
from	O
each	O
transposon	O
inverted	O
repeat	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

The	O
sequences	O
obtained	O
were	O
compared	O
to	O
the	O
PAO1	B-Organism
genome	O
sequence	O
database	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
pseudomonas	O
.	O
com	O
)	O
[	O
22	O
]	O
followed	O
by	O
comparison	O
with	O
the	O
general	O
sequence	O
database	O
.	O

The	O
genes	O
identified	O
are	O
shown	O
in	O
Table	O
1	O
.	O
<EOS>	B-X
Overexpression	B-X
confers	B-X
resistance	B-X
to	B-X
broad-spectrum	B-X
cephalosporins	B-X
including	B-X
cefotaxime	B-X
,	B-X
ceftazidime	B-X
,	B-X
and	B-X
ceftriaxone	B-X
and	B-X
is	B-X
a	B-X
problem	B-X
especially	B-X
in	B-X
infections	B-X
due	B-X
to	B-X
Enterobacter	B-X
aerogenes	B-X
and	B-X
Enterobacter	B-X
cloacae	B-X
,	B-X
where	B-X
an	B-X
isolate	B-X
initially	B-X
susceptible	B-X
to	B-X
these	B-X
agents	B-X
may	B-X
become	B-X
resistant	B-X
upon	B-X
therapy	B-X
.	B-X
Transmissible	B-X
plasmids	B-X
have	B-X
acquired	B-X
genes	B-X
for	B-X
AmpC	B-X
enzymes	B-X
,	B-X
which	B-X
consequently	B-X
can	B-X
now	B-X
appear	B-X
in	B-X
bacteria	B-X
lacking	B-X
or	B-X
poorly	B-X
expressing	B-X
a	B-X
chromosomal	B-X
bla	B-X
(	B-X
AmpC	B-X
)	B-X
gene	B-X
,	B-X
such	B-X
as	B-X
Escherichia	B-X
coli	B-X
,	B-X
Klebsiella	B-X
pneumoniae	B-X
,	B-X
and	B-X
Proteus	B-X
mirabilis	B-X
.	B-X
AmpC	B-X
enzymes	B-X
encoded	B-X
by	B-X
both	B-X
chromosomal	B-X
and	B-X
plasmid	B-X
genes	B-X
are	B-X
also	B-X
evolving	B-X
to	B-X
hydrolyze	B-X
broad-spectrum	B-X
cephalosporins	B-X
more	B-X
efficiently	B-X
.	B-X
The	B-X
cancer	B-X
genome	B-X
atlas	B-X
(	B-X
TCGA	B-X
)	B-X
project	B-X
identified	B-X
299	B-X
genes	B-X
and	B-X
24	B-X
pathways/biological	B-X
processes	B-X
that	B-X
drive	B-X
tumor	B-X
progression	B-X
(	B-X
Cell	B-X
173	B-X
:	B-X
371-385	B-X
e318	B-X
,	B-X
2018	B-X
)	B-X
.	B-X
Of	B-X
the	B-X
299	B-X
driver	B-X
genes	B-X
,	B-X
12	B-X
genes	B-X
are	B-X
involved	B-X
in	B-X
histones	B-X
,	B-X
histone	B-X
methylation	B-X
,	B-X
and	B-X
demethylation	B-X
(	B-X
Table	B-X
1	B-X
)	B-X
.	B-X
Among	B-X
these	B-X
12	B-X
genes	B-X
,	B-X
those	B-X
encoding	B-X
the	B-X
histone	B-X
demethylases	B-X
JARID1C/KDM5C	B-X
and	B-X
UTX/KDM6A	B-X
were	B-X
identified	B-X
as	B-X
cancer	B-X
driver	B-X
genes	B-X
.	B-X
Furthermore	B-X
,	B-X
gain-of-function	B-X
mutations	B-X
in	B-X
genes	B-X
encoding	B-X
metabolic	B-X
enzymes	B-X
,	B-X
such	B-X
as	B-X
isocitrate	B-X
dehydrogenases	B-X
(	B-X
IDH	B-X
)	B-X
1/2	B-X
,	B-X
drive	B-X
tumor	B-X
progression	B-X
by	B-X
producing	B-X
an	B-X
oncometabolite	B-X
,	B-X
D-2-hydroxyglutarate	B-X
(	B-X
D-2HG	B-X
)	B-X
,	B-X
which	B-X
is	B-X
a	B-X
competitive	B-X
inhibitor	B-X
of	B-X
-ketoglutarate	B-X
,	B-X
O	B-X

Two	O
potential	O
regulatory	O
genes	O
were	O
found	O
.	O
<EOS>	B-X
However	B-X
,	B-X
the	B-X
prognostic	B-X
value	B-X
of	B-X
m5C	B-X
regulatory	B-X
genes	B-X
and	B-X
the	B-X
correlation	B-X
between	B-X
m5C	B-X
methylation	B-X
and	B-X
the	B-X
tumor	B-X
microenvironment	B-X
(	B-X
TME	B-X
)	B-X
in	B-X
prostate	B-X
cancer	B-X
remain	B-X
unknown	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
regulatory	B-X
genes	B-X
,	B-X
micro-RNAs	B-X
(	B-X
miRNAs	B-X
)	B-X
and	B-X
transcription	B-X
factors	B-X
(	B-X
TFs	B-X
)	B-X
that	B-X
influence	B-X
keloid	B-X
development	B-X
by	B-X
comparing	B-X
keloid	B-X
and	B-X
normal	B-X
scar	B-X
as	B-X
well	B-X
as	B-X
keloid	B-X
and	B-X
normal	B-X
skin	B-X
.	B-X
Using	B-X
interpretable	B-X
machine	B-X
learning	B-X
,	B-X
we	B-X
sought	B-X
to	B-X
define	B-X
the	B-X
immune	B-X
microenvironment	B-X
subtypes	B-X
and	B-X
distinctive	B-X
genes	B-X
in	B-X
AD	B-X
.	B-X
However	B-X
,	B-X
the	B-X
responsible	B-X
genes	B-X
and	B-X
detailed	B-X
molecular	B-X
mechanisms	B-X
regulating	B-X
eggshell	B-X
brownness	B-X
have	B-X
not	B-X
been	B-X
defined	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
applied	B-X
the	B-X
RNA-seq	B-X
technology	B-X
to	B-X
analyze	B-X
the	B-X
transcriptome	B-X
data	B-X
of	B-X
the	B-X
shell	B-X
gland	B-X
epithelium	B-X
of	B-X
hens	B-X
and	B-X
investigated	B-X
the	B-X
candidate	B-X
genes	B-X
associated	B-X
with	B-X
eggshell	B-X
brownness	B-X
.	B-X
The	B-X
results	B-X
indicated	B-X
that	B-X
8461	B-X
genes	B-X
were	B-X
expressed	B-X
in	B-X
the	B-X
shell	B-X
gland	B-X
epithelium	B-X
,	B-X
of	B-X
which	B-X
34	B-X
genes	B-X
were	B-X
differentially	B-X
expressed	B-X
in	B-X
hens	B-X
laying	B-X
dark	B-X
vs.	B-X
light	B-X
brown	B-X
eggs	B-X
.	B-X
Functional	B-X
analysis	B-X
revealed	B-X
that	B-X
two	B-X
genes	B-X
,	B-X
ovotransferrin	B-X
(	B-X
TF	B-X
)	B-X
and	B-X
heat-shock	B-X
protein	B-X
70	B-X
(	B-X
HSP70	B-X
)	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
oxidative	B-X
phosphorylation	B-X
pathway	B-X
were	B-X
involved	B-X
in	B-X
the	B-X
synthesis	B-X
and	B-X
transport	B-X
of	B-X
protoporphyrin	B-X
	B-X
,	B-X
which	B-X
might	B-X
influence	B-X
the	B-X
formation	B-X
of	B-X
eggshell	B-X
brownness	B-X
and	B-X
result	B-X
in	B-X
different	B-X
shades	B-X
of	B-X
brown	B-X
.	B-X

The	O
first	O
,	O
PA2588	O
,	O
encodes	O
an	O
AraC	O
-	O
type	O
regulatory	O
protein	O
,	O
with	O
48	O
%	O
similarity	O
to	O
the	O
PAO1	B-Organism
PA0831	O
gene	O
product	O
,	O
OruR	O
[	O
36	O
]	O
.	O

The	O
second	O
matched	O
PA4380	O
,	O
which	O
encodes	O
a	O
protein	O
with	O
76	O
%	O
similarity	O
to	O
Pseudomonas	B-Organism
fluorescens	I-Organism
ColS	O
,	O
a	O
histidine	O
kinase	O
sensor	O
from	O
a	O
two	O
-	O
component	O
regulatory	O
system	O
.	O

In	O
P	B-Organism
.	I-Organism
fluorescens	I-Organism
ColS	O
has	O
been	O
implicated	O
in	O
root	O
colonization	O
while	O
in	O
Pseudomonas	B-Organism
putida	I-Organism
it	O
has	O
been	O
reported	O
to	O
be	O
involved	O
in	O
regulating	O
TN4652	O
transposition	O
and	O
heavy	O
metal	O
resistance	O
[	O
37	O
]	O
,	O
[	O
38	O
]	O
,	O
[	O
39	O
]	O
,	O
[	O
40	O
]	O
.	O

Another	O
gene	O
was	O
identified	O
as	O
PA4554	O
,	O
which	O
encodes	O
the	O
type	O
4	O
fimbrial	O
adhesin	O
PilY1	O
[	O
41	O
]	O
.	O

We	O
recovered	O
two	O
additional	O
mutants	O
with	O
transposon	O
insertion	O
into	O
genes	O
which	O
have	O
functions	O
related	O
to	O
motility	O
.	O

First	O
,	O
PA4953	O
encodes	O
a	O
protein	O
with	O
similarity	O
to	O
the	O
E	B-Organism
.	I-Organism
coli	I-Organism
MotB	O
,	O
one	O
of	O
a	O
pair	O
of	O
proteins	O
,	O
which	O
contributes	O
to	O
flagellar	O
rotation	O
[	O
23	O
]	O
,	O
[	O
42	O
]	O
,	O
[	O
43	O
]	O
.	O

Secondly	O
,	O
we	O
found	O
an	O
insertion	O
in	O
PA0173	O
(	O
cheB2	O
)	O
,	O
one	O
of	O
four	O
cheB	O
gene	O
homologues	O
in	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
genome	O
sequence	O
.	O

PA0173	O
lies	O
within	O
the	O
chemotactic	O
gene	O
cluster	O
II	O
found	O
in	O
the	O
PAO1	B-Organism
genome	O
(	O
Figure	O
1	O
)	O
[	O
21	O
]	O
.	O

CheB	O
proteins	O
are	O
responsible	O
for	O
removing	O
methyl	O
groups	O
from	O
MCPs	O
[	O
44	O
]	O
.	O

The	O
adaptation	O
of	O
the	O
chemotaxis	O
system	O
in	O
response	O
to	O
changes	O
in	O
attractant	O
binding	O
is	O
dependent	O
on	O
the	O
methylation	O
state	O
of	O
the	O
MCPs	O
.	O

CheB2	O
has	O
been	O
proposed	O
to	O
be	O
an	O
essential	O
component	O
for	O
an	O
optimal	O
chemotactic	O
response	O
[	O
21	O
]	O
.	O

In	O
the	O
remaining	O
mutants	O
,	O
one	O
contained	O
a	O
transposon	O
insertion	O
in	O
PA5479	O
,	O
which	O
encodes	O
a	O
protein	O
similar	O
to	O
GltP	O
from	O
E	B-Organism
.	I-Organism
coli	I-Organism
,	O
a	O
glutamate	O
-	O
aspartate	O
carrier	O
protein	O
.	O

Another	O
mutant	O
had	O
an	O
insertion	O
in	O
PA2585	O
encoding	O
the	O
UvrABC	O
endonuclease	O
subunit	O
UvrC	O
,	O
required	O
for	O
the	O
excision	O
of	O
damaged	O
DNA	O
.	O

The	O
uvrC	O
gene	O
is	O
located	O
downstream	O
from	O
the	O
gacA	O
gene	O
encoding	O
a	O
response	O
regulator	O
known	O
to	O
be	O
involved	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
virulence	O
.	O

Since	O
,	O
in	O
addition	O
to	O
the	O
insertion	O
in	O
PA2585	O
,	O
we	O
isolated	O
a	O
mutant	O
with	O
an	O
insertion	O
in	O
a	O
neighbor	O
gene	O
PA2588	O
,	O
it	O
suggests	O
that	O
this	O
cluster	O
of	O
genes	O
might	O
be	O
required	O
for	O
virulence	O
.	O

Another	O
interrupted	O
gene	O
,	O
PA2478	O
,	O
encodes	O
a	O
probable	O
thiol	O
:	O
disulfide	O
interchange	O
protein	O
of	O
the	O
DsbD	O
family	O
.	O

Finally	O
,	O
4	O
interrupted	O
genes	O
,	O
PA0946	O
,	O
PA3080	O
,	O
PA0260	O
and	O
PA2769	O
,	O
encode	O
proteins	O
of	O
unknown	O
function	O
.	O

In	O
order	O
to	O
compare	O
our	O
liquid	O
assay	O
with	O
the	O
established	O
C	B-Organism
.	I-Organism
elegans	I-Organism
slow	O
killing	O
assay	O
,	O
we	O
compared	O
the	O
lethality	O
of	O
the	O
TB	B-Organism
strain	O
with	O
the	O
previously	O
tested	O
PA14	B-Organism
strain	O
.	O

We	O
observed	O
that	O
both	O
strains	O
kill	O
worms	O
with	O
similar	O
efficiency	O
(	O
data	O
not	O
shown	O
)	O
.	O

Each	O
of	O
the	O
12	O
group	O
1A	O
mutants	O
derived	O
from	O
TB	B-Organism
was	O
further	O
tested	O
in	O
the	O
slow	O
killing	O
assay	O
.	O

The	O
parental	O
TB	B-Organism
isolate	O
is	O
able	O
to	O
kill	O
50	O
%	O
of	O
exposed	O
nematodes	O
in	O
the	O
slow	O
killing	O
assay	O
within	O
3	O
days	O
.	O

Seven	O
of	O
the	O
twelve	O
group	O
1A	O
isolates	O
showed	O
significant	O
virulence	O
attenuation	O
(	O
Table	O
1	O
)	O
.	O

For	O
example	O
,	O
three	O
group	O
1A	O
mutants	O
TB0173s	B-Organism
(	O
cheB2	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
TB4554s	B-Organism
(	O
pilY1	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
TB4380s	B-Organism
(	O
colS	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
each	O
required	O
at	O
least	O
one	O
additional	O
day	O
(	O
4	O
days	O
)	O
in	O
order	O
to	O
reach	O
50	O
%	O
killing	O
(	O
data	O
not	O
shown	O
)	O
.	O

Survival	O
curves	O
are	O
considered	O
significantly	O
different	O
from	O
the	O
control	O
when	O
p	O
-	O
values	O
are	O
<	O
0	O
.	O
05	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

Phenotypic	O
Analysis	O
of	O
Selected	O
TB	B-Organism
mutants	I-Organism
<EOS>	B-X
We	B-X
set	B-X
out	B-X
to	B-X
systematically	B-X
determine	B-X
the	B-X
PZA	B-X
susceptibility	B-X
profiles	B-X
and	B-X
mutations	B-X
in	B-X
the	B-X
pyrazinamidase	B-X
(	B-X
pncA	B-X
)	B-X
gene	B-X
of	B-X
a	B-X
collection	B-X
of	B-X
multidrug-resistant	B-X
tuberculosis	B-X
(	B-X
MDR-TB	B-X
)	B-X
clinical	B-X
isolates	B-X
and	B-X
PZA-resistant	B-X
(	B-X
PZA	B-X
(	B-X
r	B-X
)	B-X
)	B-X
spontaneous	B-X
mutants	B-X
.	B-X
Selection	B-X
at	B-X
a	B-X
lower	B-X
concentration	B-X
of	B-X
PZA	B-X
yielded	B-X
a	B-X
significantly	B-X
larger	B-X
number	B-X
of	B-X
spontaneous	B-X
mutants	B-X
.	B-X
The	B-X
methodical	B-X
approach	B-X
employed	B-X
allowed	B-X
for	B-X
determination	B-X
of	B-X
the	B-X
frequency	B-X
of	B-X
the	B-X
PZA	B-X
(	B-X
r	B-X
)	B-X
phenotype	B-X
correlated	B-X
with	B-X
mutations	B-X
in	B-X
the	B-X
pncA	B-X
gene	B-X
,	B-X
which	B-X
was	B-X
87.5	B-X
%	B-X
for	B-X
the	B-X
laboratory-selected	B-X
spontaneous	B-X
mutants	B-X
examined	B-X
in	B-X
this	B-X
study	B-X
.	B-X
Twelve	B-X
percent	B-X
of	B-X
the	B-X
PZA	B-X
(	B-X
r	B-X
)	B-X
mutants	B-X
did	B-X
not	B-X
have	B-X
a	B-X
pncA	B-X
mutation	B-X
,	B-X
strongly	B-X
indicating	B-X
the	B-X
presence	B-X
of	B-X
at	B-X
least	B-X
one	B-X
other	B-X
mechanism	B-X
(	B-X
s	B-X
)	B-X
of	B-X
PZA	B-X
(	B-X
r	B-X
)	B-X
.	B-X

Several	O
of	O
the	O
clones	O
recovered	O
were	O
mutated	O
in	O
genes	O
putatively	O
associated	O
with	O
adherence	O
and	O
motility	O
,	O
such	O
as	O
cheB2	O
(	O
PA0173	O
)	O
,	O
motB	O
(	O
PA4953	O
)	O
and	O
pilY1	O
(	O
PA4554	O
)	O
.	O

It	O
has	O
been	O
shown	O
that	O
adherence	O
is	O
an	O
essential	O
first	O
step	O
in	O
the	O
process	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
colonization	O
,	O
allowing	O
the	O
bacteria	O
to	O
persist	O
,	O
expand	O
in	O
numbers	O
and	O
develop	O
a	O
biofilm	O
or	O
establish	O
intimate	O
contact	O
with	O
host	O
cells	O
[	O
45	O
]	O
,	O
[	O
46	O
]	O
.	O
<EOS>	B-X
Cyclosporine-induced	B-X
pseudo-graft-versus-host	B-X
disease	B-X
(	B-X
CIPGVHD	B-X
)	B-X
in	B-X
syngeneic	B-X
or	B-X
autologous	B-X
rat	B-X
marrow	B-X
chimeras	B-X
has	B-X
clinical	B-X
and	B-X
histologic	B-X
features	B-X
closely	B-X
resembling	B-X
classic	B-X
graft-versus-host	B-X
disease	B-X
in	B-X
the	B-X
allogeneic	B-X
chimera	B-X
.	B-X
We	B-X
describe	B-X
here	B-X
the	B-X
pathology	B-X
and	B-X
immunopathology	B-X
of	B-X
the	B-X
usual	B-X
target	B-X
tissues	B-X
in	B-X
CIPGVHD	B-X
developing	B-X
in	B-X
the	B-X
first	B-X
week	B-X
following	B-X
CsA	B-X
(	B-X
early	B-X
group	B-X
)	B-X
.	B-X
The	B-X
findings	B-X
are	B-X
constrasted	B-X
to	B-X
the	B-X
CIPGVHD	B-X
developing	B-X
during	B-X
the	B-X
second	B-X
week	B-X
post-CsA	B-X
(	B-X
later	B-X
group	B-X
)	B-X
.	B-X
Six	B-X
of	B-X
9	B-X
rats	B-X
in	B-X
the	B-X
early	B-X
group	B-X
had	B-X
acute-type	B-X
CIPGVHD	B-X
in	B-X
the	B-X
tongue	B-X
,	B-X
skin	B-X
,	B-X
liver	B-X
,	B-X
intestines	B-X
,	B-X
and	B-X
mainstem	B-X
bronchi	B-X
.	B-X
In	B-X
general	B-X
,	B-X
the	B-X
lymphocytic	B-X
infiltrates	B-X
in	B-X
these	B-X
tissues	B-X
were	B-X
in	B-X
intimate	B-X
contact	B-X
with	B-X
injured	B-X
epithelial	B-X
cells	B-X
.	B-X
All	B-X
of	B-X
the	B-X
lymphocytes	B-X
infiltrating	B-X
the	B-X
mucosa	B-X
were	B-X
CD8+	B-X
(	B-X
OX-8	B-X
)	B-X
/CD4-	B-X
(	B-X
W3/25	B-X
)	B-X
T	B-X
cells	B-X
(	B-X
OX-19+	B-X
)	B-X
.	B-X
In	B-X
the	B-X
later	B-X
group	B-X
,	B-X
6	B-X
of	B-X
7	B-X
rats	B-X
had	B-X
chronic-type	B-X
CIPGVHD	B-X
(	B-X
1	B-X
with	B-X
acute	B-X
and	B-X
chronic	B-X
)	B-X
while	B-X
1	B-X
rat	B-X
had	B-X
no	B-X
GVHD	B-X
(	B-X
P	B-X
=	B-X
.02	B-X
,	B-X
Fisher	B-X
's	B-X
exact	B-X
test	B-X
compared	B-X
with	B-X
the	B-X
early	B-X
group	B-X
)	B-X
.	B-X
These	B-X
animals	B-X
had	B-X
features	B-X
characteristic	B-X
of	B-X
established	B-X
chronic	B-X
GVHD	B-X
in	B-X
the	B-X
skin	B-X
,	B-X
tongue	B-X
,	B-X
liver	B-X
,	B-X
intestines	B-X
,	B-X
and	B-X
salivary	B-X
glands	B-X
.	B-X
More	B-X
than	B-X
90	B-X
%	B-X
of	B-X
these	B-X
cells	B-X
were	B-X
T	B-X
cells	B-X
,	B-X
as	B-X
detected	B-X
by	B-X
OX-19	B-X
,	B-X
and	B-X
expressed	B-X
both	B-X
CD4	B-X
and	B-X
CD8	B-X
markers	B-X
.	B-X
While	B-X
most	B-X
lamina	B-X
propria	B-X
lymphocytes	B-X
expressed	B-X
the	B-X
CD4	B-X
antigen	B-X
,	B-X
there	B-X
were	B-X
significantly	B-X
fewer	B-X
CD8+	B-X
cells	B-X
,	B-X
consistent	B-X
with	B-X
increased	B-X
numbers	B-X
of	B-X
CD8-/CD4+	B-X
helper-phenotype	B-X
cells	B-X
.	B-X
The	B-X
observations	B-X
indicate	B-X
that	B-X
immediately	B-X
post-CsA	B-X
,	B-X
the	B-X
CIPGVHD	B-X
is	B-X
primarily	B-X
acute	B-X
,	B-X
with	B-X
epithelial	B-X
infiltrates	B-X
of	B-X
CD8+/CD4-	B-X
T	B-X
cells	B-X
and	B-X
lamina	B-X
propria	B-X
infiltrates	B-X
that	B-X
include	B-X
double-labeled	B-X
cells	B-X
consistent	B-X
with	B-X
immature	B-X
thymocytes	B-X
.	B-X
There	B-X
is	B-X
a	B-X
rapid	B-X
transition	B-X
to	B-X
established	B-X
chronic-type	B-X
CIPGVHD	B-X
by	B-X
the	B-X
second	B-X
week	B-X
.	B-X
The	B-X
residual	B-X
mucosal	B-X
infiltrate	B-X
is	B-X
now	B-X
dominated	B-X
by	B-X
double-labeled	B-X
T	B-X
cells	B-X
or	B-X
thymocytes	B-X
while	B-X
the	B-X
lamina	B-X
propria	B-X
infiltrate	B-X
has	B-X
more	B-X
mature	B-X
helper-phenotype	B-X
T	B-X
cells	B-X
.	B-X

We	O
wished	O
to	O
determine	O
if	O
our	O
selected	O
mutants	O
showed	O
a	O
reduction	O
in	O
their	O
capacity	O
to	O
adhere	O
to	O
a	O
biological	O
surface	O
such	O
as	O
the	O
human	B-Organism
epithelial	O
cell	O
line	O
16HBE14o	O
-	O
.	O

In	O
addition	O
to	O
TB4953s	B-Organism
(	O
motB	O
,	O
p	O
<	O
0	O
.	O
0001	O
)	O
and	O
TB0173s	B-Organism
(	O
cheB2	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
that	O
presented	O
strongly	O
reduced	O
adherence	O
,	O
five	O
other	O
clones	O
were	O
significantly	O
affected	O
in	O
their	O
adherence	O
to	O
cells	O
when	O
compared	O
to	O
the	O
parental	O
TB	B-Organism
isolate	O
(	O
Figure	O
S1	O
and	O
Table	O
1	O
)	O
.	O

These	O
mutants	O
were	O
TB2588s	B-Organism
(	O
araC	O
-	O
like	O
,	O
PA2588	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
TB4380s	B-Organism
(	O
colS	O
-	O
like	O
,	O
PA4380	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
TB3080s	B-Organism
(	O
hypothetical	O
,	O
PA3080	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
TB2769s	B-Organism
(	O
hypothetical	O
,	O
PA2769	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
TB5479s	B-Organism
(	O
gltP	O
-	O
like	O
,	O
PA5479	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Motility	O
is	O
also	O
an	O
important	O
factor	O
for	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
colonization	O
and	O
spread	O
.	O
<EOS>	B-X
Opportunistic	B-X
infections	B-X
caused	B-X
by	B-X
Pseudomonas	B-X
aeruginosa	B-X
can	B-X
be	B-X
acute	B-X
or	B-X
chronic	B-X
.	B-X
While	B-X
acute	B-X
infections	B-X
often	B-X
spread	B-X
rapidly	B-X
and	B-X
can	B-X
cause	B-X
tissue	B-X
damage	B-X
and	B-X
sepsis	B-X
with	B-X
high	B-X
mortality	B-X
rates	B-X
,	B-X
chronic	B-X
infections	B-X
can	B-X
persist	B-X
for	B-X
weeks	B-X
,	B-X
months	B-X
,	B-X
or	B-X
years	B-X
in	B-X
the	B-X
face	B-X
of	B-X
intensive	B-X
clinical	B-X
intervention	B-X
.	B-X
Remarkably	B-X
,	B-X
this	B-X
diverse	B-X
infectious	B-X
capability	B-X
is	B-X
not	B-X
accompanied	B-X
by	B-X
extensive	B-X
variation	B-X
in	B-X
genomic	B-X
content	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
genetic	B-X
capacity	B-X
to	B-X
be	B-X
an	B-X
acute	B-X
or	B-X
a	B-X
chronic	B-X
pathogen	B-X
is	B-X
present	B-X
in	B-X
most	B-X
P.	B-X
aeruginosa	B-X
strains	B-X
.	B-X
To	B-X
investigate	B-X
the	B-X
genetic	B-X
requirements	B-X
for	B-X
acute	B-X
and	B-X
chronic	B-X
pathogenesis	B-X
in	B-X
P.	B-X
aeruginosa	B-X
infections	B-X
,	B-X
we	B-X
combined	B-X
high-throughput	B-X
sequencing-mediated	B-X
transcriptome	B-X
profiling	B-X
(	B-X
RNA-seq	B-X
)	B-X
and	B-X
genome-wide	B-X
insertion	B-X
mutant	B-X
fitness	B-X
profiling	B-X
(	B-X
Tn-seq	B-X
)	B-X
to	B-X
characterize	B-X
gene	B-X
expression	B-X
and	B-X
fitness	B-X
determinants	B-X
in	B-X
murine	B-X
models	B-X
of	B-X
burn	B-X
and	B-X
non-diabetic	B-X
chronic	B-X
wound	B-X
infection	B-X
.	B-X
By	B-X
combining	B-X
metabolic	B-X
models	B-X
generated	B-X
from	B-X
in	B-X
vivo	B-X
gene	B-X
expression	B-X
data	B-X
with	B-X
mutant	B-X
fitness	B-X
profiles	B-X
,	B-X
we	B-X
determined	B-X
the	B-X
nutritional	B-X
requirements	B-X
for	B-X
colonization	B-X
and	B-X
persistence	B-X
in	B-X
these	B-X
infections	B-X
.	B-X
Specifically	B-X
,	B-X
we	B-X
found	B-X
that	B-X
long-chain	B-X
fatty	B-X
acids	B-X
represent	B-X
a	B-X
major	B-X
carbon	B-X
source	B-X
in	B-X
both	B-X
chronic	B-X
and	B-X
acute	B-X
wounds	B-X
,	B-X
and	B-X
P.	B-X
aeruginosa	B-X
must	B-X
biosynthesize	B-X
purines	B-X
,	B-X
several	B-X
amino	B-X
acids	B-X
,	B-X
and	B-X
most	B-X
cofactors	B-X
during	B-X
infection	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
determined	B-X
that	B-X
P.	B-X
aeruginosa	B-X
requires	B-X
chemotactic	B-X
flagellar	B-X
motility	B-X
for	B-X
fitness	B-X
and	B-X
virulence	B-X
in	B-X
acute	B-X
burn	B-X
wound	B-X
infections	B-X
,	B-X
but	B-X
not	B-X
in	B-X
non-diabetic	B-X
chronic	B-X
wound	B-X
infections	B-X
.	B-X
Our	B-X
results	B-X
provide	B-X
novel	B-X
insight	B-X
into	B-X
the	B-X
genetic	B-X
requirements	B-X
for	B-X
acute	B-X
and	B-X
chronic	B-X
P.	B-X
aeruginosa	B-X
wound	B-X
infections	B-X
and	B-X
demonstrate	B-X
the	B-X
power	B-X
of	B-X
using	B-X
both	B-X
gene	B-X
expression	B-X
and	B-X
fitness	B-X
profiling	B-X
for	B-X
probing	B-X
bacterial	B-X
virulence	B-X
.	B-X

We	O
evaluated	O
each	O
of	O
the	O
twelve	O
attenuated	O
mutants	O
for	O
both	O
swarming	O
and	O
swimming	O
motility	O
(	O
data	O
not	O
shown	O
,	O
Table	O
1	O
and	O
Figure	O
2	O
)	O
.	O

The	O
TB0173s	B-Organism
(	O
cheB2	O
)	O
(	O
Figure	O
2	O
and	O
Table	O
1	O
)	O
and	O
TB4953s	B-Organism
(	O
motB	O
)	O
(	O
Table	O
1	O
)	O
mutants	O
showed	O
a	O
reduction	O
in	O
swimming	O
and	O
swarming	O
motility	O
,	O
respectively	O
.	O

Furthermore	O
,	O
the	O
mutants	O
TB0260s	B-Organism
(	O
hypothetical	O
,	O
PA0260	O
)	O
and	O
TB5479s	B-Organism
(	O
gltP	O
-	O
like	O
)	O
had	O
a	O
significant	O
reduction	O
in	O
swimming	O
motility	O
(	O
Table	O
1	O
)	O
whereas	O
the	O
mutants	O
TB2588s	B-Organism
(	O
araC	O
-	O
like	O
)	O
and	O
TB3080s	B-Organism
(	O
hypothetical	O
)	O
had	O
a	O
significant	O
reduction	O
in	O
swarming	O
motility	O
(	O
Table	O
1	O
)	O
.	O

Characterization	O
of	O
the	O
cheB2	O
Mutant	O

We	O
chose	O
to	O
further	O
characterize	O
the	O
TB0173s	B-Organism
mutant	O
(	O
cheB2	O
)	O
,	O
as	O
this	O
isolate	O
was	O
affected	O
in	O
all	O
phenotypes	O
tested	O
and	O
thus	O
exhibited	O
a	O
general	O
motility	O
and	O
virulence	O
defect	O
(	O
Table	O
1	O
)	O
.	O

To	O
ensure	O
that	O
the	O
cheB2	O
gene	O
in	O
the	O
TB	B-Organism
strain	O
is	O
located	O
in	O
a	O
cluster	O
similar	O
to	O
the	O
che2	O
cluster	O
described	O
for	O
the	O
PAO1	B-Organism
or	O
PA14	B-Organism
strains	O
,	O
we	O
further	O
analyzed	O
the	O
corresponding	O
TB	B-Organism
chromosomal	O
region	O
.	O

A	O
series	O
of	O
8	O
PCR	O
reactions	O
were	O
performed	O
using	O
oligonucleotides	O
based	O
on	O
the	O
nucleotide	O
sequence	O
obtained	O
from	O
the	O
PA14	B-Organism
genome	O
sequence	O
(	O
Table	O
S1	O
)	O
.	O

The	O
8	O
PCR	O
products	O
were	O
meant	O
to	O
cover	O
the	O
totality	O
of	O
the	O
che2	O
cluster	O
(	O
Figure	O
1	O
and	O
Figure	O
S2	O
)	O
starting	O
from	O
the	O
mcpA	O
gene	O
to	O
the	O
PA0171	B-Organism
gene	O
located	O
downstream	O
cheB2	O
(	O
PA0173	O
)	O
.	O

The	O
reactions	O
were	O
performed	O
simultaneously	O
using	O
PA14	B-Organism
or	O
TB	B-Organism
genomic	O
DNA	O
as	O
matrix	O
.	O
<EOS>	B-X
We	B-X
use	B-X
multiple	B-X
lines	B-X
of	B-X
independent	B-X
evidence	B-X
to	B-X
show	B-X
that	B-X
different	B-X
variant	B-X
types	B-X
in	B-X
a	B-X
single	B-X
gene	B-X
,	B-X
SATB1	B-X
,	B-X
cause	B-X
clinically	B-X
overlapping	B-X
but	B-X
distinct	B-X
neurodevelopmental	B-X
disorders	B-X
.	B-X
Clinical	B-X
evaluation	B-X
of	B-X
42	B-X
individuals	B-X
carrying	B-X
SATB1	B-X
variants	B-X
identified	B-X
overt	B-X
genotype-phenotype	B-X
relationships	B-X
,	B-X
associated	B-X
with	B-X
different	B-X
pathophysiological	B-X
mechanisms	B-X
,	B-X
established	B-X
by	B-X
functional	B-X
assays	B-X
.	B-X
Missense	B-X
variants	B-X
in	B-X
the	B-X
CUT1	B-X
and	B-X
CUT2	B-X
DNA-binding	B-X
domains	B-X
result	B-X
in	B-X
stronger	B-X
chromatin	B-X
binding	B-X
,	B-X
increased	B-X
transcriptional	B-X
repression	B-X
,	B-X
and	B-X
a	B-X
severe	B-X
phenotype	B-X
.	B-X
We	B-X
analyzed	B-X
tumor	B-X
DNA	B-X
methylation	B-X
profiles	B-X
in	B-X
relation	B-X
to	B-X
immunological	B-X
parameters	B-X
and	B-X
response	B-X
to	B-X
anti-programmed	B-X
cell	B-X
death	B-X
1	B-X
(	B-X
anti-PD-1	B-X
)	B-X
immune	B-X
checkpoint	B-X
inhibitor	B-X
(	B-X
ICI	B-X
)	B-X
therapy	B-X
in	B-X
patients	B-X
with	B-X
sarcoma	B-X
.	B-X

Each	O
paired	O
reaction	O
set	O
(	O
TB	B-Organism
/	O
PA14	B-Organism
)	O
resulted	O
in	O
products	O
running	O
at	O
the	O
same	O
migratory	O
rate	O
within	O
the	O
1	O
.	O
5	O
%	O
agarose	O
gel	O
(	O
data	O
not	O
shown	O
)	O
.	O

These	O
results	O
show	O
that	O
there	O
is	O
little	O
difference	O
between	O
the	O
two	O
isolates	O
,	O
TB	B-Organism
and	O
PA14	B-Organism
,	O
with	O
regards	O
the	O
overall	O
organization	O
of	O
the	O
che2	O
chromosomal	O
region	O
.	O

To	O
validate	O
that	O
the	O
loss	O
of	O
virulence	O
and	O
other	O
phenotypic	O
changes	O
observed	O
with	O
the	O
TB	B-Organism
strain	O
were	O
a	O
result	O
of	O
the	O
transposon	O
disruption	O
of	O
the	O
cheB2	O
gene	O
,	O
we	O
generated	O
a	O
new	O
mutant	O
by	O
interrupting	O
the	O
cheB2	O
gene	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

As	O
shown	O
in	O
Figure	O
3A	O
,	O
the	O
newly	O
engineered	O
cheB2	O
mutant	O
,	O
called	O
TB0173i	B-Organism
(	O
p	O
<	O
0	O
.	O
005	O
)	O
,	O
showed	O
a	O
delayed	O
C	B-Organism
.	I-Organism
elegans	I-Organism
killing	O
comparable	O
to	O
the	O
original	O
STM	O
cheB2	O
mutant	O
TB0173s	O
(	O
p	O
<	O
0	O
.	O
004	O
)	O
.	O

Both	O
cheB2	O
mutants	O
,	O
TB0173s	B-Organism
and	O
TB0173i	B-Organism
,	O
required	O
at	O
least	O
one	O
additional	O
day	O
,	O
as	O
compared	O
to	O
TB	B-Organism
,	O
to	O
kill	O
50	O
%	O
of	O
exposed	O
nematodes	O
.	O

In	O
addition	O
,	O
we	O
engineered	O
a	O
similar	O
cheB2	O
mutation	O
in	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
PA14	I-Organism
strain	I-Organism
,	O
yielding	O
PA140173i	B-Organism
(	O
see	O
Materials	O
and	O
Methods	O
)	O
,	O
and	O
observed	O
similar	O
virulence	O
attenuation	O
on	O
C	B-Organism
.	I-Organism
elegans	I-Organism
(	O
Figure	O
S3	O
)	O
.	O

This	O
further	O
confirmed	O
the	O
virulence	O
phenotype	O
of	O
a	O
cheB2	O
mutant	O
and	O
indicated	O
that	O
it	O
is	O
not	O
a	O
TB	B-Organism
strain	O
-	O
specific	O
trait	O
.	O

Finally	O
,	O
a	O
complementation	O
assay	O
was	O
performed	O
.	O
<EOS>	B-X
Fanconi	B-X
anemia	B-X
complementation	B-X
group	B-X
E	B-X
(	B-X
FANCE	B-X
)	B-X
is	B-X
a	B-X
Fanconi	B-X
anemia	B-X
(	B-X
FA	B-X
)	B-X
pathway	B-X
gene	B-X
that	B-X
regulates	B-X
DNA	B-X
repair	B-X
.	B-X
A	B-X
microarray	B-X
analysis	B-X
was	B-X
performed	B-X
on	B-X
the	B-X
liver	B-X
of	B-X
rats	B-X
injected	B-X
with	B-X
PS-341	B-X
(	B-X
Bortezomib	B-X
,	B-X
Velcade	B-X
)	B-X
,	B-X
and	B-X
the	B-X
results	B-X
showed	B-X
that	B-X
proteasome	B-X
inhibitor	B-X
treatment	B-X
significantly	B-X
reduced	B-X
the	B-X
mRNA	B-X
expression	B-X
of	B-X
SREBP-1c	B-X
,	B-X
and	B-X
the	B-X
downstream	B-X
lipogenic	B-X
enzymes	B-X
,	B-X
such	B-X
as	B-X
fatty	B-X
acid	B-X
synthase	B-X
(	B-X
FAS	B-X
)	B-X
and	B-X
acetyl-CoA	B-X
carboxylase	B-X
(	B-X
ACC	B-X
)	B-X
,	B-X
which	B-X
catalyzes	B-X
the	B-X
carboxylation	B-X
of	B-X
acetyl-CoA	B-X
to	B-X
malonyl-CoA	B-X
,	B-X
the	B-X
rate-limiting	B-X
step	B-X
in	B-X
fatty	B-X
acid	B-X
synthesis	B-X
.	B-X
Finally	B-X
,	B-X
PS-341	B-X
was	B-X
found	B-X
to	B-X
downregulate	B-X
the	B-X
enzyme	B-X
3-hydroxy-3-methylglutaryl-CoenzymeA	B-X
synthase	B-X
(	B-X
HMG-CoA	B-X
synthase	B-X
)	B-X
that	B-X
is	B-X
responsible	B-X
for	B-X
cholesterol	B-X
synthesis	B-X
.	B-X
Proteasome	B-X
inhibitor	B-X
treatment	B-X
also	B-X
decreased	B-X
apobec-1	B-X
complementation	B-X
factor	B-X
(	B-X
ACF	B-X
)	B-X
leading	B-X
to	B-X
lower	B-X
level	B-X
of	B-X
editing	B-X
and	B-X
production	B-X
of	B-X
ApoB	B-X
protein	B-X
.	B-X
A	B-X
morphologic	B-X
analysis	B-X
,	B-X
performed	B-X
on	B-X
the	B-X
liver	B-X
of	B-X
rats	B-X
fed	B-X
ethanol	B-X
for	B-X
one	B-X
month	B-X
and	B-X
treated	B-X
with	B-X
PS-341	B-X
,	B-X
showed	B-X
that	B-X
proteasome	B-X
inhibitor	B-X
treatment	B-X
significantly	B-X
decreased	B-X
ethanol-induced	B-X
liver	B-X
steatosis	B-X
.	B-X

We	O
reintroduced	O
,	O
in	O
the	O
cheB2	O
mutant	O
,	O
the	O
wild	O
-	O
type	O
cheB2	O
gene	O
using	O
an	O
integration	O
-	O
proficient	O
vector	O
,	O
mini	O
-	O
CTX1	O
[	O
47	O
]	O
.	O

This	O
vector	O
contains	O
the	O
phiCTX	O
attachment	O
site	O
allowing	O
integration	O
of	O
exogenous	O
DNA	O
fragments	O
at	O
the	O
attB	O
site	O
within	O
the	O
genome	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
.	O

The	O
cheB2	O
gene	O
was	O
cloned	O
into	O
the	O
mini	O
-	O
CTX1	O
,	O
yielding	O
CTXp2B2	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

This	O
construct	O
was	O
introduced	O
into	O
the	O
cheB2	O
mutant	O
,	O
TB0173s	B-Organism
,	O
generating	O
the	O
TB0173sp2B2	B-Organism
strain	O
.	O

The	O
empty	O
vector	O
,	O
mini	O
-	O
CTX1	O
,	O
was	O
also	O
introduced	O
into	O
the	O
TB0173s	O
cheB2	O
mutant	O
,	O
generating	O
TB0173sCTX	B-Organism
.	O

As	O
shown	O
in	O
Figure	O
3B	O
the	O
virulence	O
was	O
restored	O
in	O
the	O
complemented	O
cheB2	O
mutant	O
TB0173sp2B2	O
(	O
p	O
<	O
0	O
.	O
009	O
)	O
,	O
whereas	O
the	O
cheB2	O
mutant	O
strain	O
TB0173sCTX	O
(	O
p	O
<	O
0	O
.	O
005	O
)	O
remained	O
fully	O
attenuated	O
.	O

A	O
cheB1	O
Mutant	O
Is	O
not	O
Attenuated	O
for	O
C	B-Organism
.	I-Organism
elegans	I-Organism
Virulence	O
<EOS>	B-X
CheB1	B-X
and	B-X
CheB3	B-X
from	B-X
Leptospira	B-X
interrogans	B-X
strain	B-X
Lai	B-X
are	B-X
predicted	B-X
to	B-X
have	B-X
a	B-X
global	B-X
CheB-like	B-X
domain	B-X
,	B-X
but	B-X
CheB2	B-X
is	B-X
predicted	B-X
to	B-X
have	B-X
a	B-X
C-terminal	B-X
effector	B-X
domain	B-X
only	B-X
.	B-X
The	B-X
results	B-X
of	B-X
swarming	B-X
assays	B-X
and	B-X
the	B-X
predicted	B-X
ternary	B-X
structures	B-X
of	B-X
CheB1	B-X
and	B-X
CheB3	B-X
of	B-X
L.	B-X
interrogans	B-X
strain	B-X
Lai	B-X
suggested	B-X
that	B-X
the	B-X
absence	B-X
of	B-X
an	B-X
N-terminal	B-X
regulatory	B-X
domain	B-X
may	B-X
be	B-X
one	B-X
of	B-X
the	B-X
reasons	B-X
for	B-X
the	B-X
failure	B-X
of	B-X
CheB2	B-X
to	B-X
complement	B-X
an	B-X
E.	B-X
coli	B-X
cheB	B-X
mutant	B-X
.	B-X
Furthermore	B-X
,	B-X
CheB2	B-X
links	B-X
solely	B-X
to	B-X
CheR1	B-X
and	B-X
CheR3	B-X
in	B-X
the	B-X
interaction	B-X
network	B-X
of	B-X
leptospires	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
results	B-X
indicated	B-X
that	B-X
CheB2	B-X
may	B-X
not	B-X
function	B-X
alone	B-X
,	B-X
and	B-X
under	B-X
certain	B-X
physiological	B-X
conditions	B-X
,	B-X
it	B-X
may	B-X
require	B-X
CheB3	B-X
and	B-X
CheR1	B-X
to	B-X
function	B-X
.	B-X

Several	O
chemotactic	O
gene	O
clusters	O
have	O
been	O
identified	O
in	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
genome	O
[	O
21	O
]	O
,	O
[	O
23	O
]	O
.	O

The	O
che1	O
gene	O
cluster	O
encodes	O
the	O
principle	O
chemotactic	O
device	O
controlling	O
flagellar	O
mobility	O
[	O
23	O
]	O
.	O

We	O
investigated	O
whether	O
the	O
loss	O
of	O
virulence	O
observed	O
in	O
the	O
cheB2	O
mutant	O
on	O
C	B-Organism
.	I-Organism
elegans	I-Organism
is	O
specific	O
,	O
and	O
results	O
from	O
a	O
loss	O
of	O
chemotaxis	O
under	O
the	O
direction	O
of	O
the	O
che2	O
chemotactic	O
cluster	O
,	O
rather	O
than	O
being	O
linked	O
with	O
more	O
global	O
chemotactic	O
or	O
motility	O
deficiency	O
.	O
<EOS>	B-X
Novel	B-X
therapeutic	B-X
targets	B-X
for	B-X
cancer	B-X
metastasis	B-X
.	B-X
Cell	B-X
migration	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
development	B-X
and	B-X
maintenance	B-X
of	B-X
multicellular	B-X
organisms	B-X
,	B-X
contributing	B-X
to	B-X
embryogenesis	B-X
,	B-X
wound	B-X
healing	B-X
,	B-X
immune	B-X
response	B-X
,	B-X
and	B-X
other	B-X
critical	B-X
processes	B-X
.	B-X
It	B-X
is	B-X
also	B-X
involved	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
many	B-X
diseases	B-X
,	B-X
including	B-X
immune	B-X
deficiency	B-X
disorders	B-X
and	B-X
cancer	B-X
metastasis	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
review	B-X
recent	B-X
studies	B-X
describing	B-X
the	B-X
functions	B-X
of	B-X
EVs	B-X
in	B-X
multiple	B-X
aspects	B-X
of	B-X
cell	B-X
motility	B-X
,	B-X
including	B-X
directional	B-X
sensing	B-X
,	B-X
cell	B-X
adhesion	B-X
,	B-X
extracellular	B-X
matrix	B-X
(	B-X
ECM	B-X
)	B-X
degradation	B-X
,	B-X
and	B-X
leader-follower	B-X
behavior	B-X
.	B-X

We	O
thus	O
investigated	O
the	O
fate	O
of	O
a	O
cheB1	O
mutant	O
in	O
a	O
similar	O
assay	O
.	O

The	O
cheB1	O
mutation	O
was	O
engineered	O
in	O
the	O
TB	B-Organism
strain	O
as	O
described	O
in	O
materials	O
and	O
methods	O
,	O
yielding	O
TB1459i	B-Organism
.	O

The	O
cheB1	O
mutant	O
was	O
used	O
to	O
feed	O
C	B-Organism
.	I-Organism
elegans	I-Organism
in	O
the	O
slow	O
killing	O
assay	O
and	O
the	O
survival	O
percentage	O
was	O
compared	O
to	O
those	O
obtained	O
when	O
using	O
the	O
cheB2	O
mutant	O
or	O
the	O
parental	O
TB	B-Organism
strain	O
(	O
Figure	O
3C	O
)	O
.	O

Interestingly	O
,	O
the	O
cheB1	O
mutant	O
showed	O
no	O
significant	O
reduction	O
in	O
C	B-Organism
.	I-Organism
elegans	I-Organism
killing	O
when	O
compared	O
to	O
the	O
parental	O
TB	B-Organism
strain	O
,	O
with	O
only	O
36	O
%	O
of	O
the	O
worms	O
alive	O
after	O
4	O
days	O
post	O
infection	O
.	O

This	O
is	O
in	O
contrast	O
to	O
the	O
loss	O
of	O
virulence	O
in	O
the	O
original	O
cheB2	O
mutant	O
(	O
TB0173s	B-Organism
)	O
and	O
the	O
insertional	O
cheB2	O
mutant	O
TB0173i	O
.	O

The	O
mobility	O
of	O
the	O
cheB1	O
mutant	O
was	O
also	O
analyzed	O
and	O
both	O
swimming	O
and	O
swarming	O
motility	O
appeared	O
to	O
be	O
affected	O
as	O
shown	O
in	O
Figure	O
2	O
.	O

The	O
swimming	O
or	O
swarming	O
motility	O
defect	O
is	O
,	O
however	O
,	O
much	O
more	O
severe	O
in	O
the	O
cheB1	O
mutant	O
as	O
compared	O
to	O
the	O
cheB2	O
mutant	O
.	O
<EOS>	B-X
The	B-X
majority	B-X
of	B-X
propulsive	B-X
forces	B-X
in	B-X
swimming	B-X
are	B-X
produced	B-X
from	B-X
the	B-X
upper	B-X
body	B-X
,	B-X
with	B-X
strong	B-X
correlations	B-X
between	B-X
upper	B-X
body	B-X
strength	B-X
and	B-X
sprint	B-X
performance	B-X
.	B-X
There	B-X
are	B-X
significant	B-X
gaps	B-X
in	B-X
the	B-X
literature	B-X
relating	B-X
to	B-X
the	B-X
impact	B-X
of	B-X
resistance	B-X
training	B-X
on	B-X
swimming	B-X
performance	B-X
,	B-X
specifically	B-X
the	B-X
transfer	B-X
to	B-X
swimming	B-X
performance	B-X
.	B-X
Triathlon	B-X
is	B-X
an	B-X
increasingly	B-X
popular	B-X
sport	B-X
that	B-X
includes	B-X
swimming	B-X
,	B-X
cycling	B-X
,	B-X
followed	B-X
by	B-X
running	B-X
.	B-X
At	B-X
any	B-X
given	B-X
speed	B-X
,	B-X
C	B-X
is	B-X
lower	B-X
on	B-X
land	B-X
(	B-X
e.g.	B-X
,	B-X
running	B-X
or	B-X
cycling	B-X
)	B-X
than	B-X
in	B-X
water	B-X
(	B-X
e.g.	B-X
,	B-X
swimming	B-X
or	B-X
kayaking	B-X
)	B-X
and	B-X
this	B-X
difference	B-X
can	B-X
be	B-X
easily	B-X
understood	B-X
when	B-X
one	B-X
considers	B-X
that	B-X
energy	B-X
should	B-X
be	B-X
expended	B-X
(	B-X
among	B-X
the	B-X
others	B-X
)	B-X
to	B-X
overcome	B-X
resistive	B-X
forces	B-X
since	B-X
these	B-X
,	B-X
at	B-X
any	B-X
given	B-X
speed	B-X
,	B-X
are	B-X
far	B-X
larger	B-X
in	B-X
water	B-X
(	B-X
hydrodynamic	B-X
resistance	B-X
,	B-X
drag	B-X
)	B-X
than	B-X
on	B-X
land	B-X
(	B-X
aerodynamic	B-X
resistance	B-X
)	B-X
.	B-X
These	B-X
two	B-X
parameters	B-X
(	B-X
drag	B-X
and	B-X
efficiency	B-X
)	B-X
not	B-X
only	B-X
can	B-X
explain	B-X
the	B-X
differences	B-X
in	B-X
C	B-X
between	B-X
land	B-X
and	B-X
water	B-X
locomotion	B-X
but	B-X
can	B-X
also	B-X
explain	B-X
the	B-X
differences	B-X
in	B-X
C	B-X
within	B-X
a	B-X
given	B-X
form	B-X
of	B-X
locomotion	B-X
(	B-X
swimming	B-X
at	B-X
the	B-X
surface	B-X
,	B-X
which	B-X
is	B-X
the	B-X
topic	B-X
of	B-X
this	B-X
review	B-X
)	B-X
:	B-X
e.g.	B-X
,	B-X
differences	B-X
between	B-X
strokes	B-X
or	B-X
between	B-X
swimmers	B-X
of	B-X
different	B-X
age	B-X
,	B-X
sex	B-X
,	B-X
and	B-X
technical	B-X
level	B-X
.	B-X

Finally	O
,	O
we	O
used	O
a	O
chemotactic	O
assay	O
using	O
tryptone	O
as	O
chemo	O
-	O
attractant	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

The	O
parental	O
TB	B-Organism
strain	O
was	O
able	O
to	O
move	O
towards	O
the	O
attractant	O
(	O
an	O
increase	O
of	O
slightly	O
more	O
than	O
half	O
a	O
log	O
of	O
bacteria	O
over	O
45	O
min	O
)	O
and	O
the	O
TB0173s	B-Organism
strain	O
(	O
cheB2	O
mutant	O
)	O
was	O
also	O
capable	O
of	O
chemotaxis	O
,	O
even	O
though	O
much	O
reduced	O
as	O
compared	O
to	O
TB	B-Organism
(	O
Figure	O
S4	O
)	O
.	O

However	O
,	O
the	O
TB1459i	B-Organism
strain	O
(	O
cheB1	O
mutant	O
)	O
was	O
no	O
longer	O
able	O
to	O
move	O
towards	O
the	O
attractant	O
,	O
and	O
thus	O
showed	O
a	O
defect	O
in	O
this	O
chemotaxis	O
assay	O
(	O
Figure	O
S4	O
)	O
.	O

The	O
cheB2	O
Mutant	O
Shows	O
Reduced	O
Virulence	O
in	O
Mice	B-Organism

We	O
further	O
tested	O
the	O
virulence	O
of	O
the	O
cheB2	O
mutant	O
TB0173s	O
in	O
a	O
mouse	B-Organism
model	O
of	O
lung	O
infection	O
,	O
utilizing	O
the	O
view	O
-	O
controlled	O
intratracheal	O
infection	O
protocol	O
[	O
48	O
]	O
.	O

Ten	O
female	O
C3H	B-Organism
/	I-Organism
HeN	I-Organism
mice	I-Organism
each	O
were	O
inoculated	O
with	O
7	O
.	O
5x106	O
CFU	O
equivalent	O
to	O
the	O
LD50	O
dose	O
of	O
the	O
wild	O
type	O
strain	O
determined	O
in	O
prior	O
experiments	O
(	O
data	O
not	O
shown	O
)	O
.	O

Figure	O
4	O
displays	O
the	O
representative	O
outcome	O
of	O
one	O
of	O
three	O
independent	O
infection	O
experiments	O
.	O

The	O
cheB2	O
mutant	O
(	O
TB0173s	B-Organism
)	O
showed	O
a	O
significantly	O
attenuated	O
virulence	O
during	O
respiratory	O
tract	O
infection	O
of	O
mice	B-Organism
as	O
compared	O
to	O
the	O
parental	O
strain	O
TB	B-Organism
and	O
the	O
complemented	O
strain	O
TB0173sp2B2	B-Organism
.	O

Infection	O
with	O
the	O
wild	O
type	O
resulted	O
in	O
50	O
%	O
dead	O
animals	O
(	O
5	O
of	O
10	O
)	O
by	O
day	O
5	O
compared	O
to	O
10	O
%	O
deaths	O
for	O
the	O
TB0173s	O
cheB2	O
mutant	O
(	O
1	O
of	O
10	O
;	O
P	O
=	O
0	O
.	O
036	O
,	O
Fisher	O
'	O
s	O
exact	O
test	O
)	O
.	O

Infection	O
with	O
the	O
complemented	O
strain	O
TB0173sp2B2	B-Organism
resulted	O
in	O
60	O
%	O
dead	O
by	O
day	O
3	O
(	O
6	O
of	O
10	O
;	O
P	O
=	O
0	O
,	O
0018	O
,	O
Fisher	O
'	O
s	O
exact	O
test	O
)	O
(	O
Figure	O
4A	O
)	O
.	O

We	O
have	O
also	O
evaluated	O
the	O
body	O
condition	O
of	O
the	O
mice	B-Organism
during	O
bacterial	O
infection	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

Surviving	O
mice	B-Organism
infected	O
with	O
the	O
cheB2	O
mutant	O
showed	O
a	O
significantly	O
less	O
troubled	O
body	O
condition	O
from	O
days	O
3	O
to	O
6	O
post	O
infection	O
(	O
P	O
<	O
0	O
.	O
01	O
,	O
Mann	O
-	O
Whitney	O
rank	O
test	O
)	O
than	O
surviving	O
mice	B-Organism
infected	O
with	O
the	O
wild	O
type	O
strain	O
indicating	O
that	O
the	O
former	O
group	O
recovered	O
earlier	O
than	O
the	O
latter	O
(	O
Figure	O
4B	O
)	O
.	O

Pathohistological	O
Analysis	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
Infection	O
<EOS>	B-X
I	B-X
)	B-X
The	B-X
author	B-X
has	B-X
successfully	B-X
produced	B-X
a	B-X
model	B-X
of	B-X
experimental	B-X
osteomyelitis	B-X
caused	B-X
by	B-X
pseudomonas	B-X
aeruginosa	B-X
using	B-X
the	B-X
following	B-X
procedure	B-X
though	B-X
such	B-X
a	B-X
demonstration	B-X
has	B-X
been	B-X
said	B-X
to	B-X
be	B-X
very	B-X
difficult	B-X
.	B-X
After	B-X
impregnation	B-X
in	B-X
a	B-X
solution	B-X
containing	B-X
about	B-X
10	B-X
(	B-X
5	B-X
)	B-X
pseudomonas	B-X
aeruginosa	B-X
,	B-X
3	B-X
mm	B-X
silk	B-X
thread	B-X
of	B-X
No	B-X
.	B-X
B	B-X
)	B-X
Injection	B-X
of	B-X
B.	B-X
fragilis	B-X
(	B-X
10	B-X
(	B-X
6	B-X
)	B-X
CFU	B-X
)	B-X
with	B-X
5	B-X
%	B-X
sodium	B-X
morrhuate	B-X
into	B-X
the	B-X
medullary	B-X
cavity	B-X
of	B-X
the	B-X
rat	B-X
tibia	B-X
through	B-X
a	B-X
microsyringe	B-X
did	B-X
not	B-X
induce	B-X
osteomyelitis	B-X
produced	B-X
by	B-X
S.	B-X
aureus	B-X
or	B-X
P.	B-X
aeruginosa	B-X
.	B-X

To	O
further	O
evaluate	O
the	O
change	O
in	O
virulence	O
between	O
the	O
parental	O
TB	B-Organism
isolate	O
and	O
the	O
TB0173s	O
cheB2	O
mutant	O
,	O
mice	B-Organism
were	O
sacrificed	O
2	O
days	O
after	O
bacterial	O
challenge	O
and	O
the	O
lungs	O
were	O
formalin	O
fixed	O
and	O
paraffin	O
embedded	O
.	O

Lungs	O
from	O
infected	O
mice	B-Organism
challenged	O
with	O
the	O
TB	B-Organism
strain	O
as	O
well	O
as	O
the	O
complemented	O
TB0173sp2B2	B-Organism
strain	O
had	O
a	O
pronounced	O
polymorphonuclear	O
neutrophil	O
(	O
PMN	O
)	O
infiltration	O
as	O
well	O
as	O
strong	O
peribronchiolar	O
and	O
perivascular	O
inflammation	O
(	O
Figure	O
5A	O
)	O
.	O

In	O
contrast	O
,	O
the	O
TB0173s	O
cheB2	O
mutant	O
had	O
caused	O
markedly	O
reduced	O
inflammation	O
and	O
very	O
little	O
PMN	O
infiltration	O
(	O
Figure	O
5B	O
)	O
.	O

Discussion	O
<EOS>	B-X
Discussion	B-X
structures	B-X
are	B-X
argumentation-theoretical	B-X
tools	B-X
that	B-X
can	B-X
be	B-X
employed	B-X
to	B-X
tackle	B-X
three	B-X
barriers	B-X
that	B-X
separate	B-X
lay	B-X
stakeholders	B-X
from	B-X
policy	B-X
debates	B-X
:	B-X
difficulty	B-X
,	B-X
magnitude	B-X
,	B-X
and	B-X
complexity	B-X
.	B-X
Discussions	B-X
about	B-X
preventive	B-X
behaviors	B-X
were	B-X
assessed	B-X
before	B-X
testing	B-X
and	B-X
1	B-X
and	B-X
6	B-X
months	B-X
post-testing	B-X
.	B-X
Discussion	B-X
of	B-X
preventive	B-X
behaviors	B-X
declined	B-X
following	B-X
test	B-X
reporting	B-X
,	B-X
with	B-X
more	B-X
rapid	B-X
decline	B-X
reported	B-X
by	B-X
noncarriers	B-X
.	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X

C	B-Organism
.	I-Organism
elegans	I-Organism
is	O
a	O
convenient	O
model	O
for	O
studying	O
bacterial	O
virulence	O
mechanisms	O
[	O
7	O
]	O
,	O
[	O
49	O
]	O
and	O
it	O
was	O
shown	O
that	O
virulence	O
factors	O
important	O
in	O
the	O
killing	O
of	O
C	B-Organism
.	I-Organism
elegans	I-Organism
are	O
relevant	O
for	O
virulence	O
in	O
mammalian	O
hosts	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
.	O

Growth	O
conditions	O
and	O
host	O
-	O
pathogen	O
interactions	O
affect	O
the	O
physiology	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
via	O
complex	O
regulatory	O
networks	O
,	O
which	O
in	O
turn	O
control	O
an	O
arsenal	O
of	O
virulence	O
factors	O
[	O
52	O
]	O
,	O
[	O
53	O
]	O
,	O
[	O
54	O
]	O
,	O
[	O
55	O
]	O
.	O

We	O
developed	O
a	O
liquid	O
-	O
based	O
high	O
throughput	O
C	B-Organism
.	I-Organism
elegans	I-Organism
killing	O
assay	O
to	O
speed	O
the	O
screening	O
process	O
of	O
bacterial	O
libraries	O
and	O
to	O
perform	O
multiple	O
screens	O
on	O
virulent	O
clinical	O
isolates	O
.	O

This	O
method	O
was	O
automated	O
using	O
the	O
COPAS	O
Biosort	O
worm	O
sorting	O
system	O
,	O
which	O
greatly	O
reduced	O
the	O
time	O
required	O
to	O
perform	O
the	O
assay	O
.	O

Under	O
slow	O
killing	O
conditions	O
(	O
Figure	O
3	O
)	O
the	O
TB	B-Organism
strain	O
requires	O
approximately	O
three	O
days	O
to	O
kill	O
50	O
%	O
of	O
a	O
given	O
worm	O
population	O
,	O
and	O
up	O
to	O
8	O
days	O
to	O
kill	O
all	O
the	O
worms	O
in	O
a	O
population	O
of	O
50	O
nematodes	O
.	O

The	O
liquid	O
killing	O
assay	O
by	O
contrast	O
,	O
is	O
read	O
after	O
overnight	O
feeding	O
of	O
the	O
nematodes	O
with	O
the	O
bacterial	O
strains	O
.	O

It	O
is	O
worth	O
noting	O
that	O
a	O
mutant	O
affected	O
in	O
the	O
gacA	O
gene	O
,	O
previously	O
identified	O
in	O
the	O
slow	O
killing	O
assay	O
,	O
appeared	O
to	O
be	O
attenuated	O
in	O
our	O
liquid	O
-	O
based	O
killing	O
assay	O
.	O

We	O
used	O
our	O
killing	O
assay	O
to	O
screen	O
a	O
STM	O
library	O
of	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
CF	I-Organism
isolate	I-Organism
TB	I-Organism
[	O
20	O
]	O
.	O

We	O
identified	O
several	O
factors	O
,	O
not	O
yet	O
associated	O
with	O
virulence	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
.	O
<EOS>	B-X
To	B-X
facilitate	B-X
high-throughput	B-X
genetic	B-X
testing	B-X
and	B-X
functional	B-X
identification	B-X
of	B-X
tumor	B-X
drivers	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
platform	B-X
for	B-X
pooled	B-X
CRISPR-Cas9	B-X
screening	B-X
in	B-X
human	B-X
colon	B-X
organoids	B-X
.	B-X
Using	B-X
transforming	B-X
growth	B-X
factor	B-X
	B-X
(	B-X
TGF-	B-X
)	B-X
resistance	B-X
as	B-X
a	B-X
paradigm	B-X
to	B-X
establish	B-X
sensitivity	B-X
and	B-X
scalability	B-X
in	B-X
vitro	B-X
,	B-X
we	B-X
identified	B-X
optimal	B-X
conditions	B-X
and	B-X
strict	B-X
guide	B-X
RNA	B-X
(	B-X
gRNA	B-X
)	B-X
requirements	B-X
for	B-X
screening	B-X
in	B-X
3D	B-X
organoids	B-X
.	B-X
We	B-X
then	B-X
screened	B-X
a	B-X
pan-cancer	B-X
tumor	B-X
suppressor	B-X
gene	B-X
(	B-X
TSG	B-X
)	B-X
library	B-X
in	B-X
pre-malignant	B-X
organoids	B-X
with	B-X
APC	B-X
If	B-X
a	B-X
cause	B-X
is	B-X
identified	B-X
,	B-X
specific	B-X
etiology-based	B-X
treatments	B-X
may	B-X
be	B-X
available	B-X
.	B-X
In	B-X
most	B-X
cases	B-X
,	B-X
a	B-X
specific	B-X
cause	B-X
can	B-X
not	B-X
be	B-X
identified	B-X
,	B-X
and	B-X
treatments	B-X
are	B-X
based	B-X
on	B-X
symptoms	B-X
.	B-X
Treatment	B-X
options	B-X
include	B-X
counseling	B-X
,	B-X
education	B-X
,	B-X
oral	B-X
medications	B-X
,	B-X
botulinum	B-X
toxin	B-X
injections	B-X
,	B-X
and	B-X
several	B-X
surgical	B-X
procedures	B-X
.	B-X

Several	O
of	O
the	O
genes	O
identified	O
relate	O
to	O
regulatory	O
,	O
motility	O
or	O
unknown	O
functions	O
.	O
<EOS>	B-X
There	B-X
are	B-X
frequent	B-X
mentions	B-X
of	B-X
the	B-X
endemic	B-X
goiter	B-X
in	B-X
the	B-X
works	B-X
of	B-X
doctors	B-X
from	B-X
Ancient	B-X
China	B-X
,	B-X
Ancient	B-X
India	B-X
and	B-X
Ancient	B-X
Greece.Although	B-X
the	B-X
link	B-X
between	B-X
iodine	B-X
and	B-X
the	B-X
thyroid	B-X
was	B-X
not	B-X
known	B-X
,	B-X
algae	B-X
and	B-X
dried	B-X
sea	B-X
sponges	B-X
were	B-X
using	B-X
for	B-X
treating	B-X
swollen	B-X
neck.There	B-X
are	B-X
many	B-X
descriptions	B-X
of	B-X
neuroendocrine	B-X
pathologies	B-X
in	B-X
historical	B-X
sources	B-X
,	B-X
for	B-X
example	B-X
the	B-X
Bible	B-X
describes	B-X
gigantism	B-X
and	B-X
the	B-X
Talmud	B-X
-	B-X
hypoprolactinaemia.Special	B-X
attention	B-X
was	B-X
paid	B-X
to	B-X
the	B-X
study	B-X
of	B-X
diabetes	B-X
mellitus	B-X
,	B-X
although	B-X
the	B-X
pathogenesis	B-X
and	B-X
treatment	B-X
of	B-X
the	B-X
disease	B-X
remained	B-X
unknown	B-X
until	B-X
the	B-X
20th	B-X
century	B-X
.	B-X
At	B-X
the	B-X
biological	B-X
level	B-X
,	B-X
there	B-X
is	B-X
strong	B-X
evidence	B-X
for	B-X
genetic	B-X
factors	B-X
,	B-X
although	B-X
the	B-X
mechanism	B-X
is	B-X
,	B-X
as	B-X
yet	B-X
,	B-X
unknown	B-X
.	B-X
As	B-X
an	B-X
example	B-X
,	B-X
pathology	B-X
plays	B-X
a	B-X
role	B-X
in	B-X
the	B-X
identification	B-X
of	B-X
hereditary	B-X
disease	B-X
,	B-X
while	B-X
it	B-X
offers	B-X
the	B-X
tools	B-X
for	B-X
complementing	B-X
molecular	B-X
genetics	B-X
,	B-X
for	B-X
example	B-X
,	B-X
validation	B-X
of	B-X
variants	B-X
of	B-X
unknown	B-X
significance	B-X
deriving	B-X
from	B-X
targeted	B-X
sequencing	B-X
or	B-X
whole	B-X
exome/genome	B-X
sequencing	B-X
approach	B-X
.	B-X
Herein	B-X
,	B-X
a	B-X
comprehensive	B-X
review	B-X
focusing	B-X
on	B-X
novel	B-X
and	B-X
emerging	B-X
biomarkers	B-X
is	B-X
presented	B-X
in	B-X
order	B-X
pathologists	B-X
and	B-X
other	B-X
endocrine-related	B-X
specialists	B-X
to	B-X
remain	B-X
updated	B-X
and	B-X
become	B-X
aware	B-X
of	B-X
potential	B-X
pitfalls	B-X
and	B-X
limitations	B-X
in	B-X
the	B-X
field	B-X
of	B-X
endocrine	B-X
pathology	B-X
.	B-X

We	O
tested	O
additional	O
virulence	O
and	O
motility	O
related	O
phenotypes	O
including	O
C	B-Organism
.	I-Organism
elegans	I-Organism
slow	O
killing	O
,	O
swarming	O
and	O
swimming	O
motility	O
,	O
or	O
adherence	O
to	O
human	B-Organism
cells	O
(	O
Table	O
1	O
)	O
.	O
<EOS>	B-X
Benign	B-X
prostatic	B-X
hyperplasia	B-X
(	B-X
BPH	B-X
)	B-X
is	B-X
a	B-X
histologic	B-X
diagnosis	B-X
describing	B-X
proliferation	B-X
of	B-X
smooth	B-X
muscle	B-X
and	B-X
epithelial	B-X
cells	B-X
within	B-X
the	B-X
prostatic	B-X
transition	B-X
zone	B-X
.	B-X
See	B-X
the	B-X
accompanying	B-X
algorithm	B-X
for	B-X
a	B-X
summary	B-X
of	B-X
the	B-X
procedures	B-X
detailed	B-X
in	B-X
the	B-X
Guideline	B-X
(	B-X
figures	B-X
1	B-X
and	B-X
2	B-X
[	B-X
Figure	B-X
:	B-X
see	B-X
text	B-X
]	B-X
[	B-X
Figure	B-X
:	B-X
see	B-X
text	B-X
]	B-X
)	B-X
.	B-X
High-quality	B-X
comprehensive	B-X
data	B-X
on	B-X
short-/long-term	B-X
physical/mental	B-X
health	B-X
effects	B-X
of	B-X
the	B-X
COVID-19	B-X
pandemic	B-X
are	B-X
needed	B-X
.	B-X
Most	B-X
cases	B-X
are	B-X
caused	B-X
by	B-X
yeast	B-X
(	B-X
predominantly	B-X
Candida	B-X
albicans	B-X
)	B-X
,	B-X
the	B-X
protozoan	B-X
Trichomonas	B-X
vaginalis	B-X
,	B-X
or	B-X
a	B-X
specific	B-X
mixture	B-X
of	B-X
bacteria	B-X
(	B-X
bacterial	B-X
vaginosis	B-X
)	B-X
.	B-X
The	B-X
clinical	B-X
signs	B-X
used	B-X
in	B-X
differentiating	B-X
among	B-X
these	B-X
and	B-X
the	B-X
associated	B-X
bacterial	B-X
flora	B-X
are	B-X
shown	B-X
in	B-X
Table	B-X
3	B-X
.	B-X
Bacterial	B-X
vaginosis	B-X
may	B-X
be	B-X
diagnosed	B-X
in	B-X
the	B-X
clinic	B-X
by	B-X
detecting	B-X
three	B-X
or	B-X
more	B-X
of	B-X
the	B-X
following	B-X
on	B-X
examination	B-X
:	B-X
(	B-X
1	B-X
)	B-X
homogeneous	B-X
adherent	B-X
discharge	B-X
,	B-X
(	B-X
2	B-X
)	B-X
vaginal	B-X
fluid	B-X
pH	B-X
greater	B-X
than	B-X
4.5	B-X
,	B-X
(	B-X
3	B-X
)	B-X
amine	B-X
odor	B-X
,	B-X
and	B-X
(	B-X
4	B-X
)	B-X
clue	B-X
cells	B-X
.	B-X

Most	O
of	O
our	O
selected	O
mutants	O
were	O
impaired	O
in	O
at	O
least	O
one	O
of	O
the	O
additional	O
tested	O
phenotypes	O
.	O

One	O
of	O
the	O
identified	O
mutants	O
showed	O
reductions	O
in	O
all	O
aspects	O
of	O
virulence	O
we	O
tested	O
.	O

This	O
mutant	O
,	O
named	O
TB0173s	B-Organism
,	O
has	O
a	O
transposon	O
insertion	O
in	O
PA0173	O
,	O
cheB2	O
,	O
one	O
of	O
four	O
cheB	O
genes	O
found	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
.	O

CheB	O
protein	O
functions	O
involve	O
interactions	O
with	O
MCPs	O
.	O

As	O
many	O
as	O
26	O
MCPs	O
have	O
been	O
identified	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
[	O
56	O
]	O
,	O
and	O
it	O
has	O
been	O
proposed	O
that	O
the	O
CheB2	O
protein	O
functions	O
at	O
least	O
with	O
McpB	O
[	O
57	O
]	O
.	O

In	O
the	O
high	O
throughput	O
C	B-Organism
.	I-Organism
elegans	I-Organism
liquid	O
-	O
based	O
killing	O
assay	O
and	O
the	O
slow	O
killing	O
assay	O
,	O
the	O
cheB2	O
mutant	O
showed	O
significant	O
virulence	O
attenuation	O
.	O

The	O
cheB2	O
mutant	O
was	O
also	O
found	O
to	O
have	O
reduced	O
adhesive	O
capabilities	O
to	O
bronchial	O
epithelial	O
cells	O
(	O
Figure	O
S1	O
)	O
.	O

Finally	O
,	O
the	O
reductions	O
seen	O
in	O
the	O
motility	O
assays	O
,	O
swimming	O
and	O
swarming	O
,	O
are	O
in	O
agreement	O
with	O
previously	O
reported	O
results	O
revealing	O
a	O
partial	O
loss	O
of	O
motility	O
capabilities	O
[	O
21	O
]	O
.	O

Most	O
importantly	O
in	O
a	O
mouse	B-Organism
lung	O
model	O
of	O
infection	O
,	O
the	O
cheB2	O
mutant	O
was	O
highly	O
attenuated	O
and	O
failed	O
to	O
induce	O
strong	O
inflammatory	O
response	O
in	O
the	O
infected	O
mice	B-Organism
lungs	O
.	O

Interestingly	O
,	O
we	O
observed	O
that	O
a	O
mutation	O
in	O
the	O
cheB1	O
gene	O
yields	O
different	O
phenotypes	O
compared	O
to	O
the	O
cheB2	O
mutation	O
.	O

The	O
cheB1	O
mutant	O
virulence	O
is	O
not	O
attenuated	O
in	O
the	O
slow	O
killing	O
assay	O
.	O
<EOS>	B-X
Motility	B-X
and	B-X
chemotaxis	B-X
systems	B-X
are	B-X
critical	B-X
for	B-X
the	B-X
virulence	B-X
of	B-X
leptospires	B-X
.	B-X
The	B-X
results	B-X
of	B-X
swarming	B-X
assays	B-X
and	B-X
the	B-X
predicted	B-X
ternary	B-X
structures	B-X
of	B-X
CheB1	B-X
and	B-X
CheB3	B-X
of	B-X
L.	B-X
interrogans	B-X
strain	B-X
Lai	B-X
suggested	B-X
that	B-X
the	B-X
absence	B-X
of	B-X
an	B-X
N-terminal	B-X
regulatory	B-X
domain	B-X
may	B-X
be	B-X
one	B-X
of	B-X
the	B-X
reasons	B-X
for	B-X
the	B-X
failure	B-X
of	B-X
CheB2	B-X
to	B-X
complement	B-X
an	B-X
E.	B-X
coli	B-X
cheB	B-X
mutant	B-X
.	B-X

Moreover	O
,	O
it	O
shows	O
more	O
severe	O
motility	O
defect	O
than	O
the	O
cheB2	O
mutant	O
.	O

Finally	O
,	O
in	O
chemotaxis	O
assays	O
using	O
tryptone	O
as	O
chemo	O
-	O
attractant	O
,	O
we	O
observed	O
that	O
,	O
while	O
the	O
cheB1	O
mutant	O
was	O
strongly	O
affected	O
,	O
the	O
cheB2	O
mutant	O
had	O
a	O
mild	O
phenotype	O
.	O

These	O
observations	O
suggest	O
that	O
the	O
attenuation	O
in	O
virulence	O
of	O
the	O
cheB2	O
mutant	O
is	O
specific	O
and	O
not	O
due	O
to	O
a	O
global	O
effect	O
on	O
motility	O
or	O
chemotaxis	O
.	O
<EOS>	B-X
From	B-X
an	B-X
individual	B-X
bacterium	B-X
to	B-X
the	B-X
cells	B-X
that	B-X
compose	B-X
the	B-X
human	B-X
immune	B-X
system	B-X
,	B-X
cellular	B-X
chemotaxis	B-X
plays	B-X
a	B-X
fundamental	B-X
role	B-X
in	B-X
allowing	B-X
cells	B-X
to	B-X
navigate	B-X
,	B-X
interpret	B-X
,	B-X
and	B-X
respond	B-X
to	B-X
their	B-X
environments	B-X
.	B-X
While	B-X
many	B-X
features	B-X
of	B-X
cellular	B-X
chemotaxis	B-X
are	B-X
shared	B-X
among	B-X
systems	B-X
as	B-X
diverse	B-X
as	B-X
bacteria	B-X
and	B-X
human	B-X
immune	B-X
cells	B-X
,	B-X
the	B-X
machinery	B-X
that	B-X
guides	B-X
the	B-X
migration	B-X
of	B-X
these	B-X
model	B-X
organisms	B-X
varies	B-X
widely	B-X
.	B-X
These	B-X
facets	B-X
of	B-X
cellular	B-X
chemotaxis	B-X
are	B-X
compared	B-X
among	B-X
E.	B-X
coli	B-X
,	B-X
Dictyostelium	B-X
discoideum	B-X
,	B-X
and	B-X
mammalian	B-X
neutrophils	B-X
to	B-X
derive	B-X
organizational	B-X
principles	B-X
by	B-X
which	B-X
diverse	B-X
cell	B-X
systems	B-X
sense	B-X
and	B-X
respond	B-X
to	B-X
chemotactic	B-X
gradients	B-X
to	B-X
initiate	B-X
cellular	B-X
migration	B-X
.	B-X
Inspired	B-X
by	B-X
the	B-X
natural	B-X
chemotaxis	B-X
,	B-X
colloidal	B-X
motors	B-X
with	B-X
chemotactic	B-X
ability	B-X
can	B-X
realize	B-X
intelligent	B-X
sense	B-X
and	B-X
targeted	B-X
navigation	B-X
,	B-X
which	B-X
bring	B-X
a	B-X
revolutionary	B-X
method	B-X
to	B-X
biomedical	B-X
applications	B-X
like	B-X
precision	B-X
medicine	B-X
.	B-X
Particularly	B-X
,	B-X
the	B-X
torque-driven	B-X
reorientation	B-X
motion	B-X
of	B-X
the	B-X
submicrometer-sized	B-X
colloidal	B-X
motors	B-X
during	B-X
chemotaxis	B-X
is	B-X
discussed	B-X
,	B-X
and	B-X
also	B-X
their	B-X
underlying	B-X
mechanism	B-X
is	B-X
proposed	B-X
.	B-X

As	O
cluster	O
I	O
of	O
che	O
genes	O
plays	O
the	O
dominant	O
role	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
chemotaxis	O
and	O
flagellar	O
mobility	O
,	O
cluster	O
II	O
genes	O
may	O
be	O
induced	O
under	O
very	O
specific	O
conditions	O
and	O
function	O
in	O
fine	O
-	O
tuning	O
the	O
bacterial	O
response	O
to	O
conditions	O
encountered	O
within	O
a	O
host	O
.	O

Schuster	O
and	O
collaborators	O
have	O
reported	O
that	O
the	O
cluster	O
II	O
genes	O
are	O
induced	O
during	O
stationary	O
phase	O
,	O
are	O
regulated	O
by	O
quorum	O
sensing	O
and	O
that	O
RpoS	O
,	O
the	O
stationary	O
phase	O
RNA	O
polymerase	O
sigma	O
factor	O
,	O
plays	O
a	O
role	O
in	O
controlling	O
cheB2	O
gene	O
expression	O
[	O
58	O
]	O
.	O

Moreover	O
,	O
Burrowes	O
and	O
collaborators	O
reported	O
that	O
RsmA	O
exerted	O
control	O
over	O
cheB2	O
with	O
a	O
10	O
-	O
fold	O
reduction	O
in	O
expression	O
of	O
cheB2	O
in	O
an	O
rsmA	O
mutant	O
[	O
59	O
]	O
.	O

RsmA	O
works	O
in	O
conjunction	O
with	O
small	O
non	O
-	O
coding	O
RNA	O
to	O
regulate	O
the	O
expression	O
of	O
multiple	O
virulence	O
genes	O
,	O
including	O
the	O
quorum	O
sensing	O
lasI	O
and	O
rhlI	O
genes	O
[	O
60	O
]	O
.	O

Finally	O
,	O
using	O
fluorescent	O
protein	O
-	O
tagged	O
CheY	O
and	O
CheA	O
,	O
it	O
was	O
shown	O
that	O
the	O
Che1	O
proteins	O
(	O
cluster	O
I	O
)	O
localized	O
to	O
the	O
flagellated	O
pole	O
throughout	O
growth	O
[	O
61	O
]	O
.	O

While	O
the	O
Che1	O
proteins	O
are	O
still	O
found	O
as	O
bacterial	O
cells	O
entered	O
stationary	O
phase	O
,	O
a	O
patch	O
of	O
Che2	O
proteins	O
begins	O
to	O
co	O
-	O
localize	O
with	O
the	O
Che1	O
proteins	O
at	O
that	O
stage	O
.	O

This	O
might	O
indicate	O
that	O
during	O
stationary	O
phase	O
,	O
the	O
chemotactic	O
response	O
will	O
be	O
different	O
than	O
the	O
one	O
observed	O
with	O
exponentially	O
growing	O
cells	O
and	O
the	O
function	O
of	O
the	O
Che2	O
cluster	O
,	O
even	O
though	O
currently	O
unknown	O
,	O
might	O
be	O
to	O
respond	O
to	O
particular	O
stimuli	O
encountered	O
at	O
that	O
stage	O
.	O

It	O
has	O
been	O
shown	O
that	O
a	O
cheW	O
mutant	O
in	O
Helicobacter	B-Organism
pylori	I-Organism
is	O
unable	O
to	O
establish	O
a	O
normal	O
long	O
-	O
term	O
infection	O
in	O
mice	B-Organism
,	O
remaining	O
only	O
in	O
one	O
portion	O
of	O
the	O
stomach	O
.	O

The	O
bacterial	O
pathogen	O
may	O
lose	O
its	O
ability	O
to	O
perceive	O
its	O
niche	O
due	O
to	O
the	O
absence	O
of	O
chemotaxis	O
[	O
62	O
]	O
.	O

It	O
is	O
a	O
possibility	O
that	O
within	O
a	O
host	O
,	O
the	O
cluster	O
II	O
che	O
genes	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
might	O
play	O
a	O
similar	O
role	O
in	O
sensing	O
particular	O
conditions	O
during	O
infection	O
.	O

As	O
previously	O
mentioned	O
,	O
even	O
though	O
the	O
cheB2	O
mutant	O
is	O
impaired	O
in	O
motility	O
,	O
it	O
is	O
likely	O
that	O
the	O
cheB2	O
defect	O
in	O
virulence	O
is	O
not	O
linked	O
to	O
this	O
phenotype	O
but	O
to	O
additional	O
traits	O
of	O
virulence	O
and	O
attachment	O
that	O
have	O
not	O
yet	O
been	O
determined	O
.	O

We	O
have	O
shown	O
that	O
the	O
cheB1	O
mutant	O
is	O
affected	O
in	O
motility	O
but	O
still	O
is	O
virulent	O
.	O

Furthermore	O
,	O
in	O
our	O
study	O
,	O
we	O
isolated	O
a	O
second	O
mutant	O
with	O
reduced	O
motility	O
TB4953s	B-Organism
(	O
motB	O
mutant	O
)	O
(	O
Table	O
1	O
)	O
,	O
and	O
while	O
this	O
isolate	O
was	O
attenuated	O
in	O
the	O
high	O
throughput	O
assay	O
,	O
it	O
did	O
not	O
show	O
a	O
reduction	O
in	O
killing	O
in	O
the	O
slow	O
assay	O
(	O
data	O
not	O
shown	O
)	O
,	O
further	O
suggesting	O
that	O
the	O
loss	O
of	O
virulence	O
seen	O
in	O
the	O
cheB2	O
mutant	O
strain	O
(	O
TB0173s	B-Organism
)	O
is	O
not	O
solely	O
due	O
to	O
a	O
reduction	O
or	O
change	O
in	O
motility	O
.	O
<EOS>	B-X
While	B-X
migrating	B-X
through	B-X
a	B-X
mechanically	B-X
and	B-X
spatially	B-X
heterogeneous	B-X
microenvironment	B-X
,	B-X
changes	B-X
in	B-X
metabolism	B-X
allow	B-X
cells	B-X
to	B-X
dynamically	B-X
tune	B-X
energy	B-X
generation	B-X
and	B-X
bioenergetics	B-X
in	B-X
response	B-X
to	B-X
fluctuating	B-X
energy	B-X
needs	B-X
.	B-X
In	B-X
cancer	B-X
,	B-X
altered	B-X
mechanosensing	B-X
and	B-X
metabolic	B-X
reprogramming	B-X
supports	B-X
metabolic	B-X
plasticity	B-X
and	B-X
high	B-X
energy	B-X
production	B-X
while	B-X
cells	B-X
migrate	B-X
and	B-X
metastasize	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
discuss	B-X
the	B-X
role	B-X
of	B-X
mechanoresponsive	B-X
metabolism	B-X
in	B-X
regulating	B-X
cell	B-X
migration	B-X
and	B-X
supporting	B-X
metastasis	B-X
as	B-X
well	B-X
as	B-X
the	B-X
potential	B-X
of	B-X
therapeutically	B-X
targeting	B-X
cancer	B-X
metabolism	B-X
to	B-X
block	B-X
motility	B-X
and	B-X
potentially	B-X
metastasis	B-X
.	B-X
Podocytes	B-X
,	B-X
the	B-X
postmitotic	B-X
and	B-X
highly	B-X
branched	B-X
epithelial	B-X
cells	B-X
of	B-X
the	B-X
glomerulus	B-X
,	B-X
play	B-X
a	B-X
pivotal	B-X
role	B-X
for	B-X
the	B-X
function	B-X
of	B-X
the	B-X
glomerular	B-X
filtration	B-X
barrier	B-X
and	B-X
the	B-X
development	B-X
of	B-X
chronic	B-X
kidney	B-X
disease	B-X
.	B-X
Such	B-X
motility	B-X
would	B-X
also	B-X
be	B-X
the	B-X
prerequisite	B-X
for	B-X
the	B-X
replacement	B-X
of	B-X
lost	B-X
podocytes	B-X
by	B-X
progenitor	B-X
cells	B-X
.	B-X
Additionally	B-X
,	B-X
the	B-X
change	B-X
of	B-X
the	B-X
podocyte	B-X
foot	B-X
processes	B-X
from	B-X
a	B-X
normal	B-X
to	B-X
an	B-X
effaced	B-X
morphology	B-X
,	B-X
like	B-X
it	B-X
is	B-X
found	B-X
in	B-X
many	B-X
kidney	B-X
diseases	B-X
,	B-X
would	B-X
require	B-X
a	B-X
dynamic	B-X
behavior	B-X
of	B-X
podocytes	B-X
.	B-X
Since	B-X
the	B-X
actin	B-X
cytoskeleton	B-X
is	B-X
expressed	B-X
in	B-X
podocytes	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
and	B-X
the	B-X
morphology	B-X
of	B-X
podocytes	B-X
is	B-X
highly	B-X
dependent	B-X
on	B-X
actin	B-X
,	B-X
actin-associated	B-X
,	B-X
and	B-X
actin-regulating	B-X
proteins	B-X
,	B-X
it	B-X
was	B-X
assumed	B-X
that	B-X
podocytes	B-X
are	B-X
dynamic	B-X
and	B-X
motile	B-X
.	B-X
After	B-X
earlier	B-X
technical	B-X
limitations	B-X
had	B-X
been	B-X
overcome	B-X
and	B-X
novel	B-X
microscopic	B-X
techniques	B-X
like	B-X
multiphoton	B-X
microscopy	B-X
had	B-X
been	B-X
developed	B-X
,	B-X
it	B-X
became	B-X
possible	B-X
to	B-X
continuously	B-X
study	B-X
the	B-X
behavior	B-X
of	B-X
podocytes	B-X
in	B-X
living	B-X
rodents	B-X
and	B-X
zebrafish	B-X
larvae	B-X
under	B-X
physiological	B-X
and	B-X
pathological	B-X
conditions	B-X
.	B-X
This	B-X
review	B-X
discusses	B-X
recent	B-X
findings	B-X
concerning	B-X
different	B-X
forms	B-X
of	B-X
motility	B-X
(	B-X
like	B-X
lateral	B-X
translocative	B-X
(	B-X
LTM	B-X
)	B-X
,	B-X
apical	B-X
translocative	B-X
(	B-X
ATM	B-X
)	B-X
,	B-X
and	B-X
stationary	B-X
motility	B-X
(	B-X
SM	B-X
)	B-X
)	B-X
and	B-X
their	B-X
role	B-X
for	B-X
podocytopathies	B-X
.	B-X

While	O
some	O
bacteria	O
require	O
host	O
-	O
derived	O
factors	O
for	O
their	O
growth	O
and	O
are	O
difficult	O
to	O
grow	O
in	O
vitro	O
,	O
others	O
,	O
such	O
as	O
S	B-Organism
.	I-Organism
marcescens	I-Organism
during	O
its	O
infection	O
of	O
C	B-Organism
.	I-Organism
elegans	I-Organism
[	O
33	O
]	O
,	O
grow	O
at	O
a	O
much	O
lower	O
rate	O
in	O
the	O
host	O
compared	O
to	O
in	O
vitro	O
.	O

Our	O
observations	O
support	O
the	O
hypothesis	O
that	O
the	O
che2	O
gene	O
cluster	O
plays	O
a	O
major	O
role	O
during	O
host	O
colonization	O
.	O

For	O
example	O
,	O
we	O
may	O
hypothesize	O
that	O
within	O
the	O
gut	O
of	O
the	O
nematode	O
,	O
or	O
the	O
lungs	O
of	O
the	O
mice	B-Organism
,	O
bacteria	O
might	O
reach	O
high	O
cell	O
density	O
and	O
develop	O
as	O
biofilm	O
.	O
<EOS>	B-X
We	B-X
hypothesize	B-X
herein	B-X
that	B-X
synthetic	B-X
mitochondria	B-X
,	B-X
engineered	B-X
,	B-X
or	B-X
reprogrammed	B-X
to	B-X
be	B-X
more	B-X
energetically	B-X
efficient	B-X
and	B-X
to	B-X
have	B-X
mildly	B-X
elevated	B-X
levels	B-X
of	B-X
reactive	B-X
oxygen	B-X
species	B-X
(	B-X
ROS	B-X
)	B-X
production	B-X
,	B-X
would	B-X
be	B-X
an	B-X
effective	B-X
form	B-X
of	B-X
therapeutics	B-X
against	B-X
systemic	B-X
aging	B-X
.	B-X
The	B-X
free	B-X
radical	B-X
and	B-X
mitochondria	B-X
theories	B-X
of	B-X
aging	B-X
hold	B-X
that	B-X
mitochondria-generated	B-X
ROS	B-X
underlies	B-X
chronic	B-X
organelle	B-X
,	B-X
cell	B-X
and	B-X
tissues	B-X
damages	B-X
that	B-X
contribute	B-X
to	B-X
systemic	B-X
aging	B-X
.	B-X
More	B-X
recent	B-X
findings	B-X
,	B-X
however	B-X
,	B-X
collectively	B-X
suggest	B-X
that	B-X
while	B-X
acute	B-X
and	B-X
massive	B-X
ROS	B-X
generation	B-X
during	B-X
events	B-X
such	B-X
as	B-X
tissue	B-X
injury	B-X
is	B-X
indeed	B-X
detrimental	B-X
,	B-X
subacute	B-X
stresses	B-X
,	B-X
and	B-X
chronic	B-X
elevation	B-X
in	B-X
ROS	B-X
production	B-X
may	B-X
instead	B-X
induce	B-X
a	B-X
state	B-X
of	B-X
mitochondrial	B-X
hormesis	B-X
(	B-X
or	B-X
``	B-X
mitohormesis	B-X
''	B-X
)	B-X
that	B-X
could	B-X
extend	B-X
lifespan	B-X
.	B-X
Importantly	B-X
,	B-X
mitohormetic	B-X
signaling	B-X
could	B-X
also	B-X
occur	B-X
in	B-X
a	B-X
non-cell	B-X
autonomous	B-X
manner	B-X
,	B-X
with	B-X
its	B-X
induction	B-X
in	B-X
neurons	B-X
affecting	B-X
gut	B-X
cells	B-X
,	B-X
for	B-X
example	B-X
.	B-X
Technologies	B-X
are	B-X
outlined	B-X
that	B-X
could	B-X
lead	B-X
towards	B-X
testing	B-X
of	B-X
the	B-X
hypothesis	B-X
,	B-X
which	B-X
include	B-X
genetic	B-X
and	B-X
epigenetic	B-X
engineering	B-X
of	B-X
the	B-X
mitochondria	B-X
,	B-X
as	B-X
well	B-X
as	B-X
intercellular	B-X
transfer	B-X
of	B-X
mitochondria	B-X
from	B-X
transplanted	B-X
helper	B-X
cells	B-X
to	B-X
target	B-X
tissues	B-X
.	B-X

This	O
could	O
be	O
a	O
condition	O
to	O
set	O
the	O
function	O
of	O
the	O
Che2	O
proteins	O
and	O
allow	O
non	O
-	O
growing	O
cells	O
to	O
sense	O
and	O
respond	O
to	O
the	O
environment	O
in	O
a	O
different	O
manner	O
as	O
compared	O
to	O
fast	O
-	O
growing	O
cells	O
.	O

While	O
the	O
idea	O
that	O
the	O
Che2	O
system	O
might	O
be	O
a	O
specialized	O
chemotaxis	O
system	O
required	O
during	O
host	O
infection	O
is	O
appealing	O
,	O
further	O
experiments	O
are	O
required	O
to	O
understand	O
the	O
chain	O
of	O
command	O
,	O
which	O
switches	O
on	O
the	O
Che2	O
system	O
and	O
directs	O
the	O
physiological	O
response	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
to	O
Che2	O
sensing	O
.	O

